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Introduction 
Despite broad societal consensus on the growing importance of sustainable em-
ployability, health problems continue to limit labor participation. The health care 
sector seems rather unresponsive to work and health-related issues, and employers 
and employees remain unable to fulfill their mutual responsibilities to create 
healthy work environments [1, 2]. These key parties have particular difficulties 
addressing the structural problems in this area [3, 4]. The mismatch between 
health-related activities and the deployment of personnel in the workplace contrib-
utes to absenteeism rates and loss of productivity [2, 5]. There is strong potential 
for work-related health interventions to improve labor participation [6]. 
 Like other Westerns countries, the Netherlands has been struggling with struc-
tural barriers to reduce the negative effects of health problems on work and the 
work context [7, 8]. The negative impact of health problems in the work setting can 
hamper labor participation and potentially lead to lost productivity, early retire-
ment and work incapacity, and higher social security costs [9, 10]. In addition, more 
recent developments, such as the rising pension age, call for innovative methods to 
increase sustainable employment of employees with health problems. Despite vari-
ous research projects and significant changes in the legal framework for occupa-
tional health and social security1 the relationship between health and labor is far 
from optimal. Initiatives and experiments remain too vague and fragmented and 
employers are not inclined to pay for them if they are not proven effective. More 
insight into the effectiveness and cost effectiveness of the initiatives targeting this 
important problem is needed. Cost effective interventions are attractive for the 
individual employee, the employer, the broader occupational health practice, but 
also society as a whole because illness duration, care consumption, and the costs of 
lost productivity will decrease when such interventions are utilized. Furthermore, 
cost effective employability interventions are expected to increase labor participa-
tion and public health [11]. 
 In light of this, a more structural approach is necessary to develop appropriate 
responses when health problems impede or threaten employability and labor par-
                                                                  
1 The Dutch social security system promotes active participation and work ability via:  
(i) The Gatekeeper Improvement Act, which was introduced in 2002 to prevent (long term) sickness 
absence and reduce the inflow of beneficiaries in disability pension schemes. The new law stated a 
mutual responsibility for both the employer and employee to improve return to work efforts. In the first 
two years, the employer is provided with salary and mandatory reintegration obligations, and the em-
ployee has to actively participate in the mandatory reintegration obligations and should accept the work 
activities the employer provides. Only if no reintegration is achieved after these two years, the employee 
can apply for long term disability benefits.  
(ii) The Work Capacity Act, which replaced the Work Disability Act in 2005. The focus shifted from ‘what 
the employees should be compensated for’ to ‘what the employee is able to do’. This new approach of 
health-related work functioning, whereby employees are supported to enrich their abilities to meet the 
work demands given their health state, no longer focused on return to work but on staying at work.  
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ticipation. Important first steps have already been taken. The awareness of employ-
ers, employees, and health care providers about the relationship between work and 
health has increased due to recent social developments, such as the aging popula-
tion. Furthermore, aside from work-related or work-caused health problems, sus-
tainable employability has also gained more prominence in connection with health 
issues arising outside of the work context. Several attempts are being made to de-
velop and implement interventions that focus more on the work context, and 
thereby on labor participation, regardless of the cause of the health complaints 
(work or non-work related). However, most interventions remain focused on the 
health problems caused by the work, resulting in an insufficiently dynamic ap-
proach [10, 12-14]. To illustrate this, shifts in the nature of work – from heavy 
physical labor towards knowledge-based and people-oriented work – can cause, 
but also change, work-related disorders. More attention needs to be paid to mental 
disorders impeding sustainable employability (e.g. burnout) and the strong separa-
tion of mental health care and occupational health care [15]. Additionally, growing 
awareness also emerged about the need to better equip employees and their em-
ployers with specific skills. The early detection of health problems that potentially 
hamper work, and the prevention of reduced labor participation, are needed to 
appropriately respond to health problems impeding employability and labor partic-
ipation [16].  
 This PhD-study is part of a broader research program, called ‘The Work and 
Care research program2’. The Work and Care research program was set up to assess 
the complete path from symptoms and calling in sick, to working on medical and 
functional recovery, early return to work, or – if that failed – reintegration within 
two years. The research program focused on how employers and employees can 
gain greater control in this process and on ways to explicitly involve professionals 
in the health sector to achieve employability. It was stated that today's society must 
offer people opportunities (i) to maintain their work, with or without adjustments, 
(ii) to return to suitable work, (iii) to make a start with work that suits their physi-
cal and mental capabilities. 
 In that context, this PhD-thesis provides insight into both methodological and 
empirical (experimental) analyses of interventions aimed at achieving sustainable 
employability for employees with health problems that potentially impede their 
labor participation. This thesis mainly focuses on the underlying health economic 
aspects, and thus on the cost effectiveness of interventions aimed to achieve sus-
tainable employability. The assessed interventions target employees who devel-
oped complaints and/or a disease impeding their labor participation, and for that 
matter also their potential to achieve sustainable employability. This might involve 
either acute injuries or a chronic illness or disability. The objectives of the studied 
                                                                  
2 The Work and Care national research program is commissioned and financed by the Foundation Insti-
tute Gak (In Dutch: Stichting Instituut Gak) 
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interventions include prolonging successful and sustainable employability for em-
ployees with health problems (for example by preventing absenteeism among em-
ployees with a chronic disease) and increasing compliance with the existing legisla-
tion when performing labor (for example by increasing cooperation among em-
ployees and employers). 
 
Sustainable employability implies that employees throughout their working life 
continuously have real opportunities, a set of capabilities, and the necessary condi-
tions that allow them to achieve valuable work functioning in current and future 
work with preservation of health and welfare. This implies a work context that 
facilitates them, as well as the attitude and motivation to exploit these opportuni-
ties [17]. 
 
Employees are a heterogeneous group, involving people of all ages, both men and 
women, with different levels of education and work experience, and varying work 
barriers spanning the whole spectrum of psychiatric, psychological and physical 
limitations. Accordingly, it is important to study a diverse range of employability 
interventions. The included employability interventions in this PhD-thesis there-
fore allow for the economic evaluation of any employability intervention, regard-
less of the population they were developed for. To illustrate this, employability 
interventions provided in the primary and secondary health sectors, as well as 
those delivered within the workplace, are evaluated. The analyses of these inter-
ventions lead to an understanding of the quantitative effects (including reduced 
absenteeism, health care utilization, and improved work abilities) for employees to 
continue to participate in labor, or to increase their sustainable employability. 
 Throughout this PhD-thesis, two different existing employability interventions 
and three innovative employability interventions are studied. Each employability 
intervention included in this PhD-thesis – new or exisiting – has a common goal: to 
increase the potential of achieving sustainabale employability among employees 
with health complaints. 
 
Employability interventions aim to improve or restore the sustainable employabil-
ity of employees with health problems or those at risk of developing health prob-
lems that might potentially hamper the employee’s work 
 
As described above, demographic changes and political decisions influence the 
achievement of sustainable employability. Furthermore, companies need to remain 
productive and competitive in the global market and healthy work forces play an 
important role in achieving these outcomes. However, ensuring workforce health is 
not a simple task due to the diverse range of stakeholders involved at the individu-
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al, workplace, and/or societal level [4] and the local and national arrangements 
regarding disability benefits and compensation schemes for illness and disease3.  
This complexity is especially relevant for countries where not only the employees, 
but also other parties and systems have responsibilities for and contribute to the 
work disability context, as is the case in the Netherlands [18]. Because of the in-
creasing responsibilities (and thus also potential risks) that employers and em-
ployees face in the Dutch ‘participation society’, this research is of social value. 
 To properly assess the added value of employability interventions aimed at 
achieving sustainable employability for employees with health problems, evidence 
comprising economic evaluations and cost effectiveness results are needed. This 
PhD-thesis generates new evidence on the cost effectiveness of the assessed em-
ployability interventions. 
 
An economic evaluation can be defined as the comparative analysis of alternative 
courses of action in terms of both their costs and consequences [19].  
 
When conducting an economic evaluation it is necessary to identify the relevant 
costs and effects attributable to the intervention in question in a comparative anal-
ysis. Claiming that an intervention is cost effective is equivalent to saying that the 
extra effect is worth the extra cost [19]. Identifying the costs and effects is often 
influenced by the chosen perspective. Because employability issues affect multiple 
stakeholders, such as employees and their families, but also firms, insurers, 
healthcare providers, and even society as a whole, considering a broad societal 
perspective is essential [20]. Choosing the appropriate kind of evaluation to assess 
employability interventions can be challenging because of the range of stakeholders 
involved. Therefore, different types of economic evaluations exist, whereby the key 
consideration is the trade-off that matters most to the decision maker.  
 The three main types of economic evaluations used throughout this PhD-
research are cost benefit-, cost effectiveness-, and cost utility analyses. All three 
analyses express costs in monetary currencies, but differ in effect countenance. An 
important feature within economic evaluations is measuring and valuing the costs 
and effects. When all costs and effects relevant for the comparative analysis are 
identified, measured and valued, they can be averaged across all participants in 
both groups (often illustrated as the intervention (i) and control (c) group). The mean 
costs (C) and mean effects (E) are obtained for each group in order to calculate the 
                                                                  
3 Disability pension schemes provide disabled employees with income replacement benefits after sick-
ness absence benefit ends. They are also called disability benefits, and the level and eligibility vary 
between and within countries. Eligibility criteria to receive disability benefits and the length of coverage 
differ from one disability insurance plan to another. In the Netherlands, the social insurance physician (if 
there is still work-ability), and a vocational expert (in Dutch: arbeidsdeskundige) decide on the percent-
age of loss of income due to work disability for which the employee will be partly compensated for.  
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incremental cost effectiveness ratio (ICER). The ICER represents the difference in 
costs divided by the difference in effects: ICER=(Ci–Cc)/(Ei–Ec). To deal with sam-
pling uncertainty, bootstrapped ICERs can be calculated and plotted on a cost effec-
tiveness plane (see Figure 1) whereby the X-axis shows the difference in effective-
ness and the Y-axis the difference in costs for both groups. When the majority of the 
ICERs are located in the south east quadrant of the cost effectiveness plane, indicat-
ing fewer costs and more effects, the intervention should be adopted. To deal with 
uncertainty related to the assumptions made, or to test the robustness of the find-
ings, sensitivity analyses can be conducted [21-23].  
 
Figure 1. Cost effectiveness plane 
 
 
An economic evaluation assessment for interventions aimed at obtaining sustaina-
ble employability for employees with health problems requires a different ap-
proach than an economic evaluation of health care programs [20, 24]. To illustrate 
this, the policy arena for social security and labor legislation for occupational health 
are both complex, each having a diversity of involved stakeholders [24, 25]. These 
stakeholders potentially have different perspectives on which costs and effects 
should be quantified and expressed in monetary values. Importantly, the burden of 
the costs and the benefits of the consequences may be borne by different stake-
holders in the system [24]. Furthermore, the benefits in this field are not primarily 
focused on health, but instead focus on such outcomes as productivity, work ability, 
remaining at work, preventing presenteeism and absenteeism. Consequently, no 
generic methodology accurately captures the full costs and consequences of inter-
ventions in the field of occupational health [26]. Therefore, it is necessary to devel-
op an economic evaluation methodology expressly for use in the evaluation of sus-
tainable employability interventions, accounting for the diverse stakeholders’ re-
sponsibilities. 
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This PhD-thesis aims to fill this gap by providing insight in how the methodology 
underlying economic evaluations within occupational health can be improved. It 
does this by focussing on the psychometric issues at stake when measuring neces-
sary aspects (such as productivity changes or health care utilization) when con-
ducting an economic evaluation in the field. Furthermore, this PhD-thesis demon-
strates how an economic evaluation can contribute to the development and imple-
mentation of employability interventions.  
To summarize, this PhD-thesis thus aims to provide new insight into: 
 the methodological challenges when conducting economic evaluations of em-
ployability interventions, 
 the application of this methodological knowledge to different employability 
interventions and the thereby generated evidence of the economic evaluation 
(cost effectiveness) of different existing and innovative interventions aimed at 
achieving sustainable employability for employees with health problems. 
By combining the exploration of methodological challenges and the economic eval-
uation results, an answer is provided to whether or not it is recommended to ‘invest 
in employability interventions.’  
 
Outline of the PhD-thesis 
Following the introduction, this PhD-thesis is subdivided in four main part: Part I 
represents the methodological challenges when conducting economic evaluations of 
employability interventions, Part II applies this methodological knowledge to sev-
eral existing practices aimed at achieving sustainable employability for employees 
with health problems, Part III also applies this methodological knowledge, and gen-
erates evidence of the cost effectiveness of innovative interventions aimed at im-
proving or restoring sustainable employability for employees with health problems, 
Part IV presents a discussion of the main results and issues, and provides recom-
mendations and identifies challenges associated with implementing this evidence.  
 In Part I, Chapters 2 to 4, measurements for health-related productivity and 
resource use are critically assessed to improve the methodology of economic evalu-
ation and a methodological design for the economic evaluation of diverse employa-
bility interventions is presented. In recent decades, a debate has developed about 
how productivity costs should be monetarily valued (e.g. friction cost-, or human 
capital approach). Before proceeding further with this discussion, correctly meas-
uring health-related productivity due to health problems is essential. Until now, 
methods of lost productivity and associated costs have varied substantially. Chap-
ter 2 presents a critical quality appraisal of the measurement properties of instru-
ments measuring lost productivity. This appraisal is needed to calculate health-
related productivity costs in a valid and reliable manner. Additionally, when calcu-
lating costs for health economic evaluations, insight into healthcare resource use is 
also crucial. Because healthcare resource quantities can be defined in different 
ways, a robust data collection method is critical. Chapter 3 provides insight into 
C H A P T E R  1  
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the validation evidence and the methodological reporting quality of self-reported 
and administrative healthcare resource use measurement methods. These insights 
are warranted before estimating health care resource utilization costs. Chapter 4 
describes the study design of the CASE-study, which refers to ‘Cost Effectiveness 
Sustainable Employability’.  
 In Part II, Chapters 5 to 7, several existing practices are critically assessed to 
generate evidence on their abilities to achieve sustainable employability for em-
ployees with health problems by means of economic evaluations. The existing em-
ployability interventions are those already operational in the field of occupational 
healthcare during, or at the start of the PhD trajectory. Chapter 5 presents the 
comparison of two strategies to promote work functioning among nurses at risk of 
mental health complaints and Chapter 6 provides an in-depth analysis to detect 
whether this preventive intervention in the work setting might also be cost saving 
from an employer’s perspective. In Chapter 7 the results of a pilot economic evalu-
ation for a web-based employability intervention are used to guide the improve-
ment of the intervention content and study design.  
 In part III, Chapters 8 to 10, employability interventions which use an innova-
tive, systematic approach in order to support work participation in employees with 
health complaints are economically evaluated. The innovative employability inter-
ventions have been newly developed for this research and not yet implemented in 
the occupational health care practice. Chapter 8 reports on the cost effectiveness, - 
utility, and –benefit of an innovative intervention called COSS (COoperation be-
tween Sick-listed employees and their Supervisors) to improve cooperation be-
tween employees with health problems and their supervisor. Chapter 9 presents 
the results of a short-term economic evaluation of an intervention program aimed 
at improving work productivity for employees with rheumatoid arthritis (RA). In 
Chapter 10, a short-term economic evaluation provides insight in the abilities of 
general practitioners (GPs) to address work-related problems among their patients.  
 In Part IV, Chapter 11 to 12, a general conclusion and valorization of the find-
ings are provided. Practical and methodological issues in occupational health re-
search, and implications and recommendations for practice and future research are 
presented.  
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Abstract 
Background: Health impairments can result in disability and changed work productivity 
imposing considerable costs for the employee, employer and society as a whole. A large 
number of instruments exist to measure health-related productivity changes; however their 
methodological quality remains unclear. This systematic review critically appraised the 
measurement properties in generic self-reported instruments that measure health-related 
productivity changes to recommend appropriate instruments for use in occupational and 
economic health practice. 
Methods: PubMed, PsycINFO, Econlit and Embase were systematically searched for studies 
whereof: (i) instruments measured health-related productivity changes; (ii) the aim was to 
evaluate instrument measurement properties; (iii) instruments were generic; (iv) ratings 
were self-reported; (v) full-texts were available. Next, methodological quality appraisal was 
based on COSMIN elements: (i) internal consistency; (ii) reliability; (iii) measurement error; 
(iv) content validity; (v) structural validity; (vi) hypotheses testing; (vii) cross-cultural valid-
ity; (viii) criterion validity; and (ix) responsiveness. Recommendations are based on evi-
dence syntheses.  
Results: This review included 25 articles assessing the reliability, validity and responsive-
ness of 15 different generic self-reported instruments measuring health-related productivity 
changes. Most studies evaluated criterion validity, none evaluated cross-cultural validity and 
information on measurement error is lacking. The Work Limitation Questionnaire (WLQ) 
was most frequently evaluated with moderate respectively strong positive evidence for 
content and structural validity and negative evidence for reliability, hypothesis testing and 
responsiveness. Less frequently evaluated, the Stanford Presenteeism Scale (SPS) showed 
strong positive evidence for internal consistency and structural validity, and moderate posi-
tive evidence for hypotheses testing and criterion validity. The Productivity and Disease 
Questionnaire (PRODISQ) yielded strong positive evidence for content validity, evidence for 
other properties is lacking. The other instruments resulted in mostly fair-to-poor quality 
ratings with limited evidence. 
Conclusions: Decisions based on the content of the instrument, usage purpose, target coun-
try and population, and available evidence are recommended. Until high-quality studies are 
in place to accurately assess the measurement properties of the currently available instru-
ments, the WLQ and, in a Dutch context, the PRODISQ are cautiously preferred based on its 
strong positive evidence for content validity. Based on its strong positive evidence for inter-
nal consistency and structural validity, the SPS is cautiously recommended. 
 
Keywords: absenteeism, presenteeism, disability, productivity, self-report, psychometrics, 
validation. 
 
Published as: C. Y. Noben, S. M. Evers, F. J. Nijhuis, A. E. de Rijk. Quality appraisal of generic 
self-reported instruments measuring health-related productivity changes: a systematic 
review. BMC Public Health 2014;14:115.  
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Introduction 
When information about the costs of alternative treatments is to be used to guide 
healthcare policy decision making, it is the total budget needed to treat patients 
with the disease that is relevant. Estimates of these total costs are based on various 
cost categories, such as direct health care costs (costs of healthcare resources used 
by patients) and indirect healthcare costs (costs due to lost productivity). As it is 
known, health impairments among workers can result in considerable costs due to 
work disability, sickness absence, and productivity loss at work, all imposing a sub-
stantial financial burden for the employee, employer and society as a whole. Vari-
ous studies on different diseases have shown that indirect costs, henceforth called 
‘productivity costs’, contributed substantially to total costs, illustrating how im-
portant the consequences of disease are for work performance [1-4]. Productivity 
costs refer to the costs associated with lost or impaired ability to work or to engage 
in leisure activities due to morbidity and lost economic productivity due to death 
[5]. A study in the Netherlands showed that the productivity costs due to low back 
pain can be as high as 93% of the total costs of this impairment [3]. In Germany, 
productivity costs due to asthma amounted to 75% of the total costs [2]. A large 
study in the USA among workers with common health conditions showed that 
productivity costs substantially exceeded the direct costs. Moreover, presenteeism 
costs, or costs due to reduced productivity while still at work, appeared to repre-
sent up to 60% of all costs [4].  
 Converting the changes of health-related productivity into a financial metric 
makes these changes more interpretable. However, there is no agreement on how 
to quantify time lost due to health impairments or how to assign a monetary value 
to the lost productivity. To help improve the comparability and interpretability of 
productivity changes, a sound estimation of productivity costs requires sound 
measurements of the relevant components. The comparability of estimated produc-
tivity costs is hampered by substantial differences in the costs of the items consid-
ered and the methods used for measuring sickness absence and presenteeism, as 
well as differences in and insufficient methodology used in the valuation of these 
measurement tools.  
 In the last decades, a large number of measurement methods and instruments 
have been developed to quantify health-related productivity changes. These in-
struments are preferably self-administered by workers with health impairments 
because objective measurements of productivity changes are unable to capture 
reduced productivity while still at work (i.e. presenteeism). Several studies have 
shown that presenteeism contributes substantially to the estimated total costs of 
health impairments among workers [6-10]. The comparability across studies esti-
mating productivity changes and associated costs is poor, since methods of measur-
ing changed productivity seem to vary considerably.  
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There is thus an urgent need for practical and applicable knowledge and insight 
into the reliability, validity and responsiveness of these instruments. Regarding the 
validity of the instruments, one should keep in mind that the extent to which a valid 
measurement of productivity loss, especially presenteeism, can be achieved is often 
influenced by many factors (e.g. the amount of teamwork required in the job, the 
work setting, the desired actual production output, etc.) [6, 11].  
 Although several researchers have provided comprehensive reviews of existing 
instruments that measure productivity changes, the methodological quality of the 
reviewed studies remains unclear [12, 13]. Consequently, judgments on the quality 
of the studies cannot be made. If the methodological quality of a study on the meas-
urement properties of a specific instrument is appropriate, the results can be used 
to assess the quality of the instrument at issue, including its measurement proper-
ties. However, if the methodological quality of the study is inadequate, the results 
cannot be trusted and the quality of the instrument under study remains unclear, 
despite of the magnitude or strength of the estimates presented [14]. Therefore, in 
this systematic review both the methodological quality of the study and the quality 
of the instrument, based on its psychometric properties, are taken into account. The 
main aim of this systematic review is therefore to critically appraise and compare 
the measurement properties of generic, self-reported instruments measuring 
health-related productivity changes.  
Methods 
Search strategy  
A systematic review was conducted of studies evaluating the measurement proper-
ties of generic, self-reported health-related productivity instruments. In February 
2013, the following relevant electronic databases were searched for English-
language peer-reviewed journal articles: Medline (PubMed), PsychINFO (EBSCO-
host), Embase and EconLit. The search query (see Additional file 1) consisted of a 
combination of related terms for the following features: the construct of interest 
(i.e. workplace productivity loss OR absenteeism OR presenteeism) ‘AND’ studies 
on measurement properties ‘AND’ the instrument of interest (i.e. generic AND self-
report). The complete search strategies, including a sensitive search filter and ex-
clusion filter [15] can be obtained via the corresponding author. No restrictions for 
the year of publication were made. Additional relevant studies were identified by 
performing database searches using the names of retrieved instruments and infor-
mation from the retrieved reference lists.  
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Eligibility criteria 
Study selection was based on the following eligibility criteria: (i) the aim of the 
study is the development or evaluation of the measurement properties of the in-
strument; (ii) the instrument under review measures health-related productivity 
changes; (iii) the instrument is generic and thus not solely focus on productivity 
changes due to a specific health impairment; (iv) health-related productivity 
change is rated from a worker’s perspective (i.e. is self-reported); (v) full-text arti-
cles published in English were available.  
Selection process  
Three reviewers (CYGN, SMAAE and AER) independently determined the eligibility 
of all studies based on the title, keywords and abstracts. Studies in which an in-
strument of potential interest was used as an outcome measure, such as in inter-
vention trials, were excluded. Review articles were excluded as well.  
 All reference lists and instruments of interest mentioned in all articles (both 
included and excluded from the review) were used in a secondary database search 
to identify additional relevant studies. If there was any doubt as to whether the 
studies met the eligibility criteria after individual selection, discrepancies were 
resolved through discussion between the reviewers, and a consensus decision was 
made. In case of remaining uncertainty, the full text was reviewed. Reasons for 
excluding the abstracts can be retrieved from the first author.  
Measurement properties  
The Consensus-based Standards for the selection of health Measurement Instru-
ments (COSMIN) covers relevant measurement properties for health-related, pa-
tient-reported outcomes and is based on international consensus [14, 16, 17].  
 The COSMIN checklist was used to rate the methodological quality of each arti-
cle evaluating measurement properties. It covers three main quality domains: reli-
ability, validity and responsiveness. Each domain is divided into different meas-
urement properties and aspects with questions ranking the quality level of the de-
sign and statistical analyses [16]. Table 1 illustrates the most appropriate measures 
to critically appraise the measurement properties.  
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The domain ‘reliability’ is defined as the degree to which the measurement is free 
from error and the degree to which patient scores have not changed for repeated 
measurements over different sets of items from the same questionnaire (internal 
consistency), over time (test-retest), over different persons (inter-rater), or over 
different occasions (intra-rater). Reliability is further assessed based on the meas-
urement properties: (i) internal consistency: the degree of interrelatedness among 
the items: (ii) reliability: the proportion of total variance in the measurement due 
to ‘true’ (free of error) differences between patients; and (iii) measurement error: 
systematic and random error of patient scores (not attributed to true changes in 
the construct to be measured).  
 The second domain, ‘validity’, is described as the degree to which the instru-
ment measures what it purports to measure. Three measurement properties are 
assessed: (i) content validity: the degree to which content of the instrument ade-
quately reflects the construct to be measured, including face validity; (ii) construct 
validity, or the degree to which the scores of the instrument are consistent with the 
hypotheses, is divided into three aspects: (a) structural validity: the degree to 
which the scores of the instrument are an adequate reflection of the dimensionality 
of the construct to be measured; (b) hypotheses testing: the degree to which scores 
of the instrument are consistent with hypotheses; (c) cross-cultural validity: the 
degree to which performance of the items on a translated or culturally adapted 
instrument are an adequate reflection of the performance of the items of the origi-
nal version of the instrument; and finally (iii) criterion validity: the degree to which 
the scores of the instrument are an adequate reflection of a ‘gold standard’ [17].  
 The third domain, ‘responsiveness’, is defined as the ability of the instrument to 
detect change over time in the construct to be measured.  
Data extraction 
Three reviewers (CYGN, AER, SMAAE) independently extracted the target data from 
the full text articles. The studies (n=25) are described based on information re-
trieved from the original publications and contain information regarding the study 
country, population, sampling methods, setting, age, gender and response rates. 
The instruments (n=15) are described based on information retrieved from the 
original publications (e.g. content, number of items, rating, item example, recall, 
and discipline).  
Methodological quality assessment  
To determine the methodological quality of the studies, each was assessed inde-
pendently by three reviewers (CYGN, AER, SMAAE). Consensus was reached by 
pairing the reviewers’ results. The pairing was CYGN and SMAAE (pair 1) and CYGN 
and AER (pair 2). When a pair of reviewers disagreed, consensus was reached 
through discussion within the project group (CYGN, SMAAE, FJN, AER). The meth-
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odological quality assessment of the studies was conducted by scoring each of the 
nine measurement properties as presented in nine boxes by the COSMIN-checklist. 
A four-point rating scale was used (i.e. poor, fair, good, or excellent) to calculate the 
quality score per measurement property. The scores took into account, for example, 
the used sample size which may differ between methods (rules of thumbs for factor 
analyses vary between a subject-to-variables ratio of 4:1 to 10:1 or a sample size of 
50 is needed to obtain confidence intervals from 0.70-0.90 around an ICC to assess 
reliability estimates); the missing items and the missing responses per items and 
how they were handled; the description of the comparator; and the appropriate-
ness of the statistics (e.g. the internal consistency statistic only gets an interpreta-
ble meaning when the interrelatedness among the items is determined of a set of 
items that together form a reflective model). The methodological quality was de-
termined per study for each measurement property separately by taking the lowest 
rating of the items to that measurement property in each box (worse score counts) 
[14].  
Best evidence synthesis 
For each instrument, a best evidence synthesis was performed by combining the 
methodological quality score for each measurement property per instrument as 
assessed in this study (excellent, good, fair or poor) with the consistency of their 
results concerning the measurement property (positive or negative evidence for a 
measurement property). The ratings correspond to the Cochrane Back Review 
Group levels of evidence [18]. The levels of evidence are strong, moderate, limited, 
conflicting, or unknown. A strong level of evidence represents consistent findings in 
multiple studies of good methodological quality or in one study of excellent meth-
odological quality; moderate levels of evidence represent consistent findings in 
multiple studies of fair methodological quality or in one study of good methodologi-
cal quality; a limited level of evidence occurs when one study of fair methodological 
quality is being presented; an unknown level of evidence is noted when only stud-
ies of poor methodological quality are obtained and a conflicting level of evidence 
represents for multiple studies with conflicting findings.  
Results 
Study selection 
The first search in MEDLINE (PubMed) resulted in 103 hits. The searches in Psych-
INFO, Embase and EconLit resulted in 34, 10 and 2 hits, respectively. Manual 
searches based on reference lists and names of original instruments identified 12 
additional records. Duplicates (N=15) were automatically discarded via Endnote X4 
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resulting in 146 records to be screened. After screening abstracts and titles, 45 
articles were reviewed, and 25 met the eligibility criteria. The most common rea-
sons for exclusion were: (i) the main aim of the study was not about assessing the 
psychometric properties of a health-related productivity instrument; (ii) the focus 
of productivity changes was related to specific health impairment; (iii) the instru-
ment did not measure health-related productivity changes; (iv) health-related 
productivity was not self-reported. A flow chart illustrates the process of inclusion 
(see Figure 1). 
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Figure 1. Flowchart of inclusion 
 
General description of the identified studies  
Finally, 25 articles evaluating 15 different instruments were included in this study. 
The characteristics of the 25 included studies are presented in Table 2. Several 
studies evaluated the measurement properties of multiple instruments and are 
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therefore mentioned several times [19-21]. Two studies were conducted in the UK 
and Ireland [22, 23] , three in the Netherlands [20, 24, 25], three in Canada [26-28], 
and 17 in the USA [19, 21, 29-43]. The largest proportion (44%) of the studies fo-
cused on physical disorders [20, 22, 23, 25-28, 30, 35, 37, 42]. Mental health prob-
lems were only addressed in two studies [19, 29]. Populations with varying health 
problems (physical and mental constraints) were included in four studies [24, 31, 
36, 41]. Finally, workers with non-specified health issues [32, 34, 38, 40, 43] or 
workers with job-related injuries [21, 33, 39] were also included in five and three 
studies respectively. Twelve studies were conducted at the workplace [20, 21, 24, 
31-34, 38-41, 43] and nine studies were conducted in a healthcare institution [19, 
26-29, 35-37, 39]. One study was conducted at the workplace and at a healthcare 
institution and is therefore mentioned twice [39]. One study took place at an occu-
pational medicine college [30], and four studies derived their participants from a 
database [22, 23, 25, 42].  
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Fifteen different generic self-reported instruments measuring health-related 
productivity changes are included in this study. The general characteristics of the 
instruments are presented below. An additional Table shows a more detailed de-
scription of the instruments (see Additional file 2).  
 In Table 3, the methodological quality of each study per measurement property 
and instrument is presented. The Work Limitations Questionnaire (WLQ) is the 
most frequently evaluated instrument [19, 21, 26-28, 36, 37, 42], followed by the 
Work Productivity and Activity Impairment Instrument (WPAI) [19, 22, 39], and 
the Work Productivity Short Inventory (WPSI) [19, 21, 31]. Criterion validity was 
evaluated in 21 studies [19-23, 25, 28-41, 43]. Hypotheses testing was evaluated in 
15 studies [19, 22, 26-36, 39, 41]. Only one study addressed measurement error 
[39], and none of the studies evaluated cross-cultural validity.  
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Table 4 presents the level of evidence for each measurement properties per in-
strument by synthesizing the results per instrument and their accompanying level 
of evidence. The methodological quality for each instrument and measurement 
property according to the three main quality domains (reliability, validity and re-
sponsiveness) is outlined below, along with a brief description of the aim and the 
content of the instrument. The synthesis of results per instrument and their accom-
panying level of evidence are presented in line with the content of Table 4.   
 The evidence for each measurement property is mostly limited; for eight out of 
15 instruments at least 50% of the information on measurement properties is lack-
ing. 
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The Work Limitations Questionnaire (WLQ) 
The WLQ measures the degree to which health problems interfere with specific 
aspects of job performance and the productivity impact of these work limitations. 
The questionnaire consists of four domains and includes a total of 25 items to be 
rated on a five-point scale [19, 21, 26-28, 36, 37, 42]. 
 Reliability: Six studies evaluated the internal consistency of the WLQ [19, 26, 
27, 36, 37, 42]. The methodological quality of three studies is poor due to small 
sample sizes [19, 26] and lacking factor analysis to check the unidimensionality of 
the instrument scale [19, 36]. One article is of good methodological quality regard-
ing internal consistency [37]. Although it was not explicitly described, it was possi-
ble to deduce how missing items were handled. Furthermore, the authors referred 
to another study in which factor analysis was performed in a similar population, 
making it possible to check the unidimensionality of the scale. The paper of Tang, 
Pitts, Solway & Beaton is of fair methodological quality due to the moderate sample 
size, and it was unclear whether the factor analysis referred to was appropriate to 
assess the internal consistency of the WLQ because it was not conducted in a simi-
lar population [27]. The last study that evaluated the internal consistency of the 
WLQ was conducted by Walker, Michaud & Wolfe which is of excellent methodolog-
ical quality [42]. Sample sizes were adequate, the article clearly described how 
missing items were handled and the unidimensionality of the scale was checked 
appropriately. The internal consistency statistic was calculated for each separate 
WLQ component. Because the findings are conflicting (three studies with poor 
methodological quality, one of fair, one of good, and one of excellent methodological 
quality and conflicting findings ranging from moderate (Cα 0.74) to very high (Cα 
0.97) Cronbach’s alphas) evidence synthesis of the WLQ resulted in conflicting evi-
dence for internal consistency.  
 Only one study assessed the reliability [36], which is of fair methodological 
quality regarding this psychometric property. Although the authors calculated in-
traclass correlation coefficients (ICC 0.58 – 0.92) and a weighted kappa for continu-
ous and dichotomous scores respectively, it was unclear if patients were stable in 
the interim period of the measurement. Furthermore, the time interval was not 
stated, the sample size was moderate and there was no description of how missing 
items were handled [36]. Evidence synthesis of the WLQ resulted in limited nega-
tive evidence for reliability (fair methodological quality and correlation coefficients 
<0.70).  
 Validity: Three studies examined the content validity [27, 36, 37]. Lerner et al. 
[36] reported high validity after assessing whether all items referred to relevant 
measurement constructs, whether all items were relevant for the study population, 
and whether all items together comprehensively reflected the construct. The meth-
odological quality of the study is good. Both other studies are of fair methodological 
quality because the aspects of the construct to be measured were poorly described, 
and it was not taken into account whether all items referred to relevant aspects of 
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the WLQ [27, 37]. Evidence synthesis of the WLQ resulted in moderate positive 
evidence for content validity. 
 The structural validity was assessed in two studies [37, 42], resulting in good 
methodological quality. Both studies performed confirmatory factor analysis, which 
was an appropriate analysis in view of the existing information. Further, the sample 
size included was adequate, and the way the missing items were handled was either 
described or could be deduced [37, 42]. Evidence synthesis of the WLQ resulted in 
strong positive evidence for structural validity due to the consistent positive find-
ings in two studies of good methodological quality.  
 Five studies performed hypotheses testing [19, 26-28, 36]. Three studies for-
mulated a priori hypotheses. However, the measurement properties of the compar-
ator instrument were not adequately described, and there was no evidence that the 
comparator could be applied to a similar study population [26-28]. Therefore, the 
methodological quality regarding hypotheses testing is rated fair in these three 
studies. Two studies are of poor methodological quality because they did not state 
clear a priori hypotheses [19, 36]. Due to the lack of information on the measure-
ment properties of the comparator instruments, it was unclear what was expected 
in one study [36]. Evidence synthesis of the WLQ resulted in moderate negative 
evidence for hypotheses testing (three studies with fair methodological quality and 
two with poor methodological quality and only 60% of the results were in accord-
ance with the hypotheses).  
 Criterion validity was evaluated in five studies [19, 21, 28, 36, 37]. Three of the 
studies are rated as having poor methodological quality regarding criterion validity 
[19, 36, 37]. In two studies it was not clear whether the criterion used could be 
considered an adequate gold standard [19, 36]. In all three studies, the statistical 
methods applied were inappropriate to assess criterion validity. Although claiming 
acceptable criterion validity, two studies failed to determine the calculation of spec-
ificity and sensitivity for dichotomous scores and solely mentioned the sensitivity 
to change (in clinical improvements) related to productivity [19, 36]. Lerner, Reed, 
Massarotti, Wester & Burke [37] did not calculate correlations, or areas under the 
receiver operating curves, for continuous scores but merely calculated averages. 
Although Ozminkowski, Goetzel, Chang & Long [21] assumed the criterion used 
could be considered as a gold standard, no evidence was provided. Therefore, the 
methodological quality is rated fair. One study [28] reported sufficient evidence on 
the criterion used to consider an adequate gold standard and applied appropriate 
statistical methods to assess criterion validity. Therefore the paper is of good 
methodological quality. Evidence synthesis of the WLQ resulted in conflicting evi-
dence for criterion validity because three studies resulted in poor, one in fair, and 
one in good methodological quality and not all studies present the degree to which 
the scores of the instrument are an adequate reflection of a ‘gold standard’.  
 Responsiveness: The responsiveness evaluated by two studies [26, 28] is of fair 
methodological quality because of a poor description of the constructs measured by 
the comparator instrument [28], a lack of information regarding measurement 
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properties of the comparator instrument [26, 28], a vague description of the hy-
potheses [26] and a moderate sample size [26]. Roy et al. [28] observed low corre-
lation between change scores (0.22<r<0.41), demonstrating moderate responsive-
ness. To evaluate responsiveness, Erickson et al. [19] calculated the effect sizes 
(which were moderate, ranging from 0.36 to 0.73) between change scores based on 
changes in disease severity. The methodological quality is poor because the statisti-
cal method applied is not appropriate to test the hypotheses. Furthermore, the 
calculation methods for sensitivity and specificity were not determined, but were 
solely mentioned [19]. Evidence synthesis of the WLQ resulted in moderate nega-
tive evidence regarding responsiveness (fair and poor methodological quality and 
negative results).  
 There were no methodologically sound studies evaluating measurement error 
and cross-cultural validity of the WLQ.  
The Endicott Work Productivity Scale (EWPS)  
The EWPS assesses the degree to which a wide variety of mental and medical dis-
orders of persons working in a wide variety of job settings, including self-
employment, affect the work functioning of these persons. The EWPS contains 25 
items scored on a five-point scale [19, 29]. 
 Reliability: Internal consistency was studied in two papers that evaluated the 
measurement properties of the EWPS [19, 29]. Both studies are of poor methodo-
logical quality because no factor analyses were performed, and sample sizes were 
small [19, 29]. Although the internal consistency estimates show positive results 
with a Cronbach’s alpha of 0.95 [19] and an internal consistency coefficient of 0.93 
[29], evidence synthesis of the EWPS resulted in unknown evidence for internal 
consistency because only studies of poor methodological quality were available.  
 Endicott et al. [29] assessed the intraclass correlation coefficient of reliability 
(total score was 0.92). However, test-retest reliability was only assessed in a lim-
ited population including a small sample size (N=16), resulting in poor methodolog-
ical quality for the paper [29]. Evidence synthesis of the EWPS resulted in unknown 
evidence regarding reliability because of the paper’s poor methodological quality.  
 Validity : Hypotheses testing were performed in both papers, though no hy-
potheses were formulated a priori. However, in Endicott et al. [29] it was possible 
to deduce what was expected. Although the EWPS showed considerable promise as 
a sensitive measure for assessing the effects on work performance of various disor-
ders, the instruments and constructs used were poorly described, and, therefore 
the paper is of fair methodological quality. Erickson et al. [19] confirmed their hy-
pothesized expectations. However, the study is of poor methodological quality be-
cause expected differences and directions, and the magnitude of the differences 
were not stated, making it unclear what was expected. Evidence synthesis resulted 
in conflicting levels of evidence regarding hypotheses testing (one paper of fair, one 
of poor methodological quality, and conflicting findings in accordance to the de-
duced hypotheses).  
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Both papers are of poor methodological quality for criterion validity because the 
degrees to which the scores of instruments are an adequate reflection of a reasona-
ble gold standard are unknown in both studies [19, 29]. Evidence synthesis of the 
EWPS resulted in unknown evidence for criterion validity because both studies 
were of poor methodological quality.  
 Responsiveness: Evidence synthesis of the EWPS resulted in unknown evidence 
for responsiveness because Erickson et al. [19] calculated the effect sizes between 
change scores based on changes in disease severity (-0.45). The methodological 
quality is poor because the statistical method applied is not appropriate to test the 
hypotheses.  
 There were no methodologically sound studies evaluating measurement error, 
content validity, structural validity or cross-cultural validity of the EWPS.  
The Work Productivity and Activity Impairment Instrument (WPAI)  
The WPAI measures the effect of general health and symptom severity on work 
productivity via six questions to be rated on a five-point scale [19, 22, 39]. 
 Reliability: The evidence synthesis of the WPAI resulted in unknown evidence 
for internal consistency because Erickson et al. [19] did not apply factor analysis to 
check for unidimensionality of the instrument scale, and because the sample size 
was small, resulting in poor methodological quality.  
 Reliability was studied by Reilly, Zbrozek & Dukes [39]. Although correlation 
coefficients were calculated (ranging from 0.69 up to 0.95), the measurements were 
not independent, the time interval was not appropriate, and the test conditions 
were not similar. Therefore, the paper is of poor methodological quality. The evi-
dence synthesis of the WPAI resulted in unknown evidence for reliability because of 
the paper’s poor methodological quality.  
 The study by Reilly, Zbrozek & Dukes [39] included measurement error but 
because the measurements were not independent and the time interval was not 
appropriate, the methodological quality is poor. The evidence synthesis of the WPAI 
resulted in unknown evidence for measurement error due to the study’s poor 
methodological quality.  
 Validity: Three studies performed hypotheses testing [19, 22, 39]. Although two 
studies [22, 39] stated a priori hypotheses and expected directions of the differ-
ences, the relationships were not always as pronounced as were expected and in 
both studies only a reference to a study on measurement properties of the compar-
ator instrument was provided, resulting in fair methodological quality. Although it 
could be deduced what was expected in one study [19], and they confirmed their 
expectations, the study is of poor methodological quality because expected differ-
ences and directions, and the magnitude of the differences were lacking. This study 
is therefore of poor methodological quality. The evidence synthesis of the WPAI 
resulted in moderate negative evidence for hypotheses testing (two studies of fair 
methodological quality and one of poor methodological quality). 
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Criterion validity was assessed in all papers. The paper of Erickson et al. [19] used 
other instruments (EWPS and WLQ) as a comparator (significant correlation), 
which cannot be considered as a reasonable gold standard because the WPAI uses 
single item scales. Therefore, the paper is of poor methodological quality [19]. The 
two other papers [22, 39] are of fair methodological quality because it was not clear 
how missing items were handled [22] or whether the criterion used could be con-
sidered an adequate gold standard [39]. Correlations between the WPAI and SF-36 
measures ranged from 0.20 to 0.52 [39] and from 0.34 up to 0.77 when comparing 
the WPAI outcomes with health status outcomes from another instrument [22]. The 
evidence synthesis of the WPAI regarding criterion validity resulted in moderate 
negative evidence (two studies of fair methodological quality and one of poor 
methodological quality and correlations <0.70). 
 Responsiveness: Responsiveness over time was evaluated by Erickson et al. [19] 
by calculating effect sizes (ranging from 0.19 to -0.87) between change scores 
based on changes in disease severity. The study results therefore in poor methodo-
logical quality. Evidence synthesis of the WPAI results in unknown evidence for 
responsiveness because of the study’s poor methodological quality.  
 There were no methodologically sound studies evaluating the content validity, 
structural validity or cross-cultural validity of the WPAI.  
The Work Productivity Short Inventory (WPSI)  
The WPSI assesses the prevalence of medical problems that might influence work 
productivity based on 22 open questions [19, 21, 31]. 
 Reliability: The internal consistency was studied by Erickson et al. [19], result-
ing in a Cronbach’s alpha of 0.82. The paper results in poor methodological quality 
because no factor analyses were performed and sample sizes were small. Evidence 
synthesis of the WPSI resulted in unknown evidence for internal consistency be-
cause of the paper’s poor methodological quality.  
 Goetzel, Ozminkowski & Long [31] evaluated the reliability of the WPAI but 
used only one measurement and calculated solely percentage agreement. There-
fore, the paper is of poor methodological quality. Evidence synthesis of the WPSI 
resulted in unknown evidence for reliability because of the study’s poor methodo-
logical quality.  
 Validity: The content validity was assessed by Goetzel, Ozminkowski & Long 
[31], and the paper results in poor methodological quality because there was no 
information on the degree to which the content of the instrument is an adequate 
representative of the constructs to be measured. No assessment of whether all 
items were relevant for the study population occurred, solely a simple description 
on how the most prevalent conditions in a firm are presented and allow for valid 
data collection. Evidence synthesis of the WPSI resulted in unknown evidence for 
content validity because of the study’s poor methodological quality.  
 Two studies performed hypotheses testing [19, 31]. Erickson et al. [19] did not 
report expected differences and directions, and the magnitude of the differences 
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were not stated, making it unclear what was expected. Goetzel, Ozminkowski & 
Long [31] did not provide any information on the psychometrics of the comparator 
instrument and the statistical methods (t-test) were inadequate to test the hypoth-
eses. Both papers result in poor methodological quality. Evidence synthesis of the 
WPSI resulted in unknown evidence regarding hypotheses testing because of the 
poor methodological quality of the studies.  
 Three studies assessed the criterion validity for the WPSI [19, 21, 31]. The pa-
per of Erickson et al. [19] used a comparator without appropriate evidence that it 
could be considered a reasonable gold standard. Furthermore, only significance 
levels were reported, an inadequate method to assess criterion validity. The study 
of Goetzel, Ozminkowski & Long [31] compared three different versions, varying by 
recall period, based on coefficient of variation to assess criterion validity (resulting 
all higher than expected (>10)). As the validation of the WPSI cannot (yet) be em-
pirically confirmed, the method used in this study is inappropriate. Furthermore, 
no correlation coefficients or area under the receiver operating curve were calcu-
lated [31]. Therefore, both papers are of poor methodological quality. Ozminkowski 
et al. [21] provided some information on the criterion used as a gold standard, but 
no evidence was provided. All correlations were positive and significantly different 
from zero, although none exceeded 0.38 in magnitude [21]. The methodological 
quality is rated fair. Evidence synthesis of the WPSI resulted in conflicting evidence 
for criterion validity.  
 Responsiveness: The responsiveness was evaluated by an effect size (0.49) be-
tween change scores based on changes in disease severity [19] and by significant 
marginal differences between groups with different conditions [31] making the 
statistical methods applied inappropriate for the hypotheses to be tested. There-
fore, the paper results in poor methodological quality. Evidence synthesis of the 
WPSI resulted in unknown evidence regarding responsiveness due to the paper’s 
poor methodological quality.  
 There were no methodologically sound studies evaluating measurement error, 
structural validity or cross-cultural validity of the WPSI.  
The American Medical Association (AMA)-guides  
The AMA-guides rate loss of functioning and evaluate workability after injury or 
illness via fifteen questions rated on a ten-point scale [30]. 
 Reliability: Forst, Friedman & Chukwu [30] presents intra-class correlation 
coefficients comparing impairment raters using the fifth versus the sixth editions of 
AMA’s-Guides and ranged from 0.65 to 0.77. The paper is of poor methodological 
quality because the sample size was small (N=16) and only reliability for each or 
between two editions was calculated. Evidence synthesis of the AMA-guides result-
ed in unknown evidence for reliability because of the paper’s poor methodological 
quality.  
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Validity: Although hypotheses were vague, it was possible to deduce what was ex-
pected. However, because the sample size was small and other flaws in the design 
were presented; e.g. no information was provided regarding the measurement 
properties of the comparator instrument and the data presented a comparison of 
two versions of the same instrument, resulted in poor methodological quality of the 
paper of Forst, Friedman & Chukwu [30] is poor. Evidence synthesis of the AMA-
guides therefore resulted in unknown evidence for hypotheses testing because of 
the study’s poor methodological quality.  
 Because of the small sample size and the lack of psychometric characteristics of 
the previous version of the guide, the criterion used cannot be considered an ade-
quate gold standard. Therefore, the methodological quality of the study by Forst, 
Friedman & Chukwu [30] is poor. Evidence synthesis of the AMA-guides resulted in 
unknown evidence for criterion validity because of the study’s poor methodological 
quality.  
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, content validity, structural validity, cross-cultural 
validity or responsiveness of the AMA-guides.  
The WHO Health and work Performance Questionnaire (WHO HPQ) 
The WHO HPQ uses open questions, divided into three categories, to asses indirect 
workplace costs of illness by measuring absenteeism and presenteeism and critical 
incidents [32, 33]. 
 Reliability: Kessler et al. [32] investigated the reliability (correlation 0.521) but 
did not report how missing items were handled, did not state the time interval, and 
did not clearly indicate whether the population was stable during the period of 
measurement. Therefore, the paper is of fair methodological quality. Evidence syn-
thesis of the WHO HPQ resulted in limited negative evidence for reliability because 
of the study’s fair methodological quality and correlation <0.70.   
 Validity: Two studies assessed the content validity of the WHO HPQ [32, 33]. 
Although one study did not clearly state the sample size [33], it was possible to 
assume that all items were relevant for the study population and that the purpose 
was to reflect on the measurement construct in both studies. Both papers are of 
good methodological quality. Evidence synthesis of the WHO HPQ resulted in 
strong positive evidence for content validity (good methodological quality and posi-
tive results). 
 To assess structural validity, Kessler et al. [32] conducted exploratory factor 
analysis. The overall model fit was excellent (X2 =1.1, P=0.3). However, because it 
was not clear how missing items were handled, the study is of fair methodological 
quality. Evidence synthesis of the WHO HPQ resulted in limited positive evidence 
for structural validity.  
 Hypotheses testing were performed in both studies [32, 33]. In both studies 
hypotheses were vaguely formulated; however, it was possible to deduce what was 
expected. In one study the deduced hypotheses appeared obtained [32], while in 
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the other not all results were in accordance with the deduced hypotheses [33]. The 
studies resulted in fair and poor methodological quality respectively. Evidence 
synthesis of the WHO HPQ resulted in conflicting evidence for hypotheses testing.  
 Both studies assessed the criterion validity and specified sensitivity and speci-
ficity [32, 33]. In one study [33], the criterion used could be considered an adequate 
‘gold standard’, and the evidence was provided. However, it could only be deduced 
how missing items were handled. This study resulted in good methodological quali-
ty. Area under the ROC curve calculated ranged from 0.63 to 0.69. The other study 
[32] reported sensitivity and specificity but did not provide a description of how 
missing items were handled, and it was unclear whether the gold standard was 
appropriate. The methodological quality of this study is fair. Evidence synthesis of 
the WHO HPQ resulted in conflicting evidence for criterion validity. 
 Responsiveness: Because the background of the studies from which the re-
spondents are derived was unclear, and there was lacking information on how 
missing items were handled, the responsiveness in Kessler et al. [32] results in poor 
methodological quality. Evidence synthesis resulted in unknown evidence for re-
sponsiveness because of the study’s poor methodological quality.  
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, cross-cultural validity or responsiveness of the WHO 
HPQ.  
The Stanford Presenteeism Scale (SPS)  
The SPS evaluates the impact of health problems on individual performance and 
productivity by rating six statements on a five-point scale [34, 41]. 
 Reliability: Two studies assessed the internal consistency of the SPS [34, 41]. 
Both studies performed factor analyses and calculated Cronbach’s alpha; 0.80 and 
0.82 respectively. Though there was no description of how missing items were 
handled, it could be deduced. Therefore, the studies result in good methodological 
quality. Evidence synthesis of the SPS resulted in strong positive evidence for inter-
nal consistency (two studies of good methodological quality and positive findings).  
 Turpin et al. [41] assessed reliability without stating the time interval, and 
without describing how missing items were handled. The Pearson correlation coef-
ficient was calculated and indicated a strong negative relationship of -0.60 
(P<0.001). The methodological quality of the study is fair. Evidence synthesis of the 
SPS resulted in limited negative evidence for reliability.  
 Validity: Because Koopman et al. [34] solely assessed discriminative validity for 
a scale, where none of the relationships showed a strong degree of magnitude, and 
did not assess whether all items were relevant for the purpose of the instrument. 
The methodological quality of the study is fair and evidence synthesis of the SPS 
resulted in limited negative evidence for content validity. 
 In both studies, (classical) factor analysis was conducted to assess structural 
validity [34, 41], and indicated that the instrument captured the dimensions in-
tended to assess, providing positive evidence for structural validity. The type of 
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factor analysis was appropriate in view of the existing information and the way 
missing items were handled could be deduced. Therefore, the studies are of good 
methodological quality. Evidence synthesis of the SPS resulted in strong positive 
evidence for structural validity (two studies of good methodological quality and 
positive findings). 
 Because hypotheses were vaguely formulated, the comparator instrument was 
the long version of the instrument under evaluation, and information on the meas-
urement properties of the comparator were lacking, [34] is fair. The methodological 
quality for the study by Turpin et al. [41] is also rated fair because solely a number 
of hypotheses were formulated a priori and the comparator instrument measured 
another construct (work output versus work impairment). Therefore, one cannot 
be sure whether the measurement properties of the comparator instrument apply 
to this study population. Evidence synthesis of the SPS resulted in moderate posi-
tive evidence for hypotheses testing (two studies of fair methodological quality and 
the results were in accordance with the hypotheses).  
 Both studies assessed criterion validity but did not provide the percentage of 
missing items [34, 41]. Additionally, Koopman et al. [34] did not provide evidence 
but only assumed that the criterion used could be considered an adequate gold 
standard. The continuous scores on both instruments correlated strongly. To assess 
criterion validity Turpin et al. [41] calculated correlations between SPS metrics and 
comparator dimensions which were in the expected direction and mostly signifi-
cantly different from zero. However, Turpin et al. [41] did not make it clear how 
missing items were handled. Evidence synthesis of the SPS resulted in moderate 
positive evidence for criterion validity (fair methodological quality and positive 
findings).  
 There were no methodologically sound studies evaluating measurement error, 
cross-cultural validity or responsiveness of the SPS.  
The Productivity and Disease Questionnaire (PRODISQ)  
In brief, the PRODISQ measures and valuates productivity costs by assessing the 
relationship between health and productivity based on open and multiple-choice 
questions in seven modules [24]. 
 Validity: Koopmanschap et al. [24] assessed whether all items refer to relevant 
aspects of the constructs to be measured, assessed if all items were relevant to the 
different study populations, and whether the items were relevant for the applica-
tion purpose (positive item relevance). Furthermore, the authors assessed whether 
all items together comprehensively reflected the constructs to be measured (posi-
tive item comprehensiveness). Evidence synthesis of the PRODISQ resulted in 
strong positive evidence for content validity (excellent methodological quality and 
positive findings).  
 There were no methodologically sound studies evaluating the internal con-
sistency, reliability, measurement error, structural validity, hypotheses testing, 
cross-cultural validity or responsiveness of the PRODISQ.  
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The Health-Related Productivity Questionnaire Diary (HRPQ-D)  
The HRPQ-D measures work productivity data related to health-related labor force 
participation via nine open and multiple-choice questions [35]. 
 Reliability: Kumar et al. [35] investigated the reliability by calculating correla-
tion coefficients (generally non-statistically significant, ranging from -0.449 up to 
0.806) between the reported productivity loss data and the symptom scores of 
repeated measurements within individuals but did not provide evidence as to 
whether systematic change had occurred. Additionally, several methodological 
flaws in the design and execution of the study, such as sampling bias, a lack of evi-
dence that the patients were stable and different scoring systems for symptom 
severity resulted in the study being of fair methodological quality. Evidence synthe-
sis of the HRPQ-D resulted in limited negative evidence for reliability. 
 Validity: Kumar et al. [35] did not assess whether all items were relevant for the 
different target populations or whether all items together comprehensively reflect-
ed the construct to be measured. The study is therefore of poor methodological 
quality. Evidence synthesis of the HRPQ-D resulted in unknown evidence for con-
tent validity.  
 A priori hypotheses were vaguely formulated, the expected direction and mag-
nitude of the correlations were poorly described, and no information on the meas-
urement properties of the comparator instrument was given. Generally, the correla-
tions were not statistically significant. The study of Kumar et al. [35] results in poor 
methodological quality and evidence synthesis of the HRPQ-D resulted in unknown 
evidence for hypotheses testing.  
 Kumar et al. [35] did not elaborate on how missing items were handled, and it 
was unclear whether the criterion used could be considered an adequate gold 
standard. Therefore, the study results in fair methodological quality. Evidence syn-
thesis of the HRPQ-D resulted in limited negative evidence for criterion validity 
(fair methodological quality and negative findings).  
 Responsiveness:  Hypotheses were vague, neither magnitudes nor directions of 
the correlations were stated a priori, and information on the psychometrics of the 
comparator was lacking. Evaluating the instrument’s responsiveness to change 
yielded positive findings. However, the significant correlation values ranged from -
0.161 to 0.422 [35]. Evidence synthesis of the HRPQ-D resulted in limited negative 
evidence for responsiveness (fair methodological quality and negative findings).  
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, structural validity or cross-cultural validity of the 
HRPQ-D.  
The Health and Labor Questionnaire (HLQ)  
The HLQ collects data on the relationship between illness and treatment and work 
performance. The HLQ is a modular questionnaire with four modules and response 
options on a four-point scale [20, 25]. 
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Reliability: In the study of Meerding et al. [20], inter-rater reliability was assessed. 
However, because there was no clear description of how missing items were han-
dled and it was only assumable that participants and test conditions were stable in 
the period on the construct to be measured, the methodological quality of the study 
is fair. The agreement on self-reported productivity loss due to health problems 
showed a poor κ-value of 0.18 [20]. Evidence synthesis of the HLQ resulted in lim-
ited negative evidence for reliability.  
 Validity: Two studies assessed the HLQ’s criterion validity [20, 25]. Both studies 
calculated correlation coefficients (significant correlations ranging from 0.33 to 
0.73 [20] and Pearson correlation between 0.41 and 0.56 [25]) However, it was 
unclear for the study conducted by Van Roijen, Essink-Bot, Koopmanschap, Bonsel 
& Rutten [25] whether the criterion used could be considered as a gold standard. 
Meerding et al. [20] lacked information on how missing items were handled. There-
fore, the methodological quality of both studies is fair. Evidence synthesis of the 
HLQ resulted in moderate negative evidence for criterion validity because of the 
fair methodological quality of the studies and negative findings (correlations 
<0.70). 
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, content validity, structural validity, hypotheses test-
ing, cross-cultural validity or responsiveness of the HLQ. 
The Quality and Quantity questionnaire (Q&Q)  
The Q&Q questionnaire scores two questions about the quantity and quality of the 
work performed on the last working day on a 10-point scale [20]. 
 Reliability: Meerding, Ijzelenberg, Koopmanschap, Severens & Burdorf [20] did 
not provide a clear description of how missing items were handled. The stability of 
participants and test conditions in the period on the construct to be measured 
could be deduced. The methodological quality of the study is fair. An unweighted 
kappa (κ-value = 0.18) was calculated to assess the inter-rater reliability [20]. Evi-
dence synthesis of the Q&Q resulted in limited negative evidence for reliability.  
 Validity: Although the criterion used could be considered an adequate gold 
standard based on the evidence provided, Meerding, Ijzelenberg, Koopmanschap, 
Severens & Burdorf [20] lacked a clear description of how missing items were han-
dled. Self-reported productivity measured with the QQ correlated significantly with 
objective work output, however the strength of the correlation (r =0.48) was poor 
[20]. Evidence synthesis of the Q&Q resulted in limited negative evidence for crite-
rion validity.  
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, content validity, structural validity, hypotheses test-
ing, cross-cultural validity or responsiveness of the Q&Q. 
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The Well-Being Assessment for Productivity (WBA-P)  
The WBA-P provides an evaluation of job performance loss due to wellbeing-
related barriers. The barriers are based on twelve items to be rated from zero to 
100 [38]. 
 Validity: Prochaska et al. [38] performed factor analysis to assess the structural 
validity but did not describe the percentage of missing items. Because it could be 
deduced how missing items were handled, the methodological quality of the study 
is good. A hierarchical two-factor model demonstrated good fit (X2 = 544.34) with 
acceptable internal consistency on the subscales (Cronbach’s alpha 0.73 – 0.83) 
[38]. Evidence synthesis of the WBA-P resulted in limited positive evidence for 
structural validity because of the paper’s good methodological quality.  
 Prochaska et al. [38] assessed the criterion validity by calculating correlations 
and multivariate variance analysis. Although no evidence was provided, it was stat-
ed that the criterion used could be considered an adequate gold standard. Signifi-
cant interactions between the WBA-P and the comparator instrument existed [38]. 
Evidence synthesis of the WBA-P resulted in limited positive evidence for structural 
validity (good methodological quality and positive findings).  
 There were no methodologically sound studies evaluating the internal con-
sistency, reliability, measurement error, content validity, hypotheses testing, cross-
cultural validity or responsiveness of the WBA-P. 
The Health and Work Questionnaire (HWQ)  
The HWQ measures workplace productivity and workers’ health multidimensional-
ly via 24 questions to be rated on a ten-point scale [40]. 
 Reliability: Shikiar, Halpern, Rentz & Khan [40] conducted factor analysis to 
check the unidimensionality of the scale. The factor analysis resulted in six factors 
with eigenvalues greater than 1.0 and accounted for 69% of the variance in the 
correlation matrix. The sample size was adequate (N=294), and Cronbach’s coeffi-
cient alpha’s were calculated to assess the internal consistency for each subscale 
separately (ranging from 0.72 to 0.96). The percentage of missing items was not 
described [40]. The methodological quality of the study is rated fair because it was 
not clear how missing items were handled. Evidence synthesis of the HWQ resulted 
in limited positive evidence for internal consistency (fair methodological quality 
and positive findings: correlations >0.70).  
 Validity: Shikiar, Halpern, Rentz & Khan [40] assessed the structural validity by 
conducting a principal components factor analysis with orthogonal rotation con-
firming that the items on the HWQ are measuring several different dimensions 
related to productivity and the items on the HWQ do not ‘hang together’ as well as 
the items on the individual scales [40]. Because it was not clear how missing items 
were handled, the methodological quality of the study is fair. Evidence synthesis of 
the HWQ resulted in limited negative evidence for structural validity.  
 In assessing the criterion validity Shikiar, Halpern, Rentz & Khan [40] did not 
make it clear how missing items were handled nor provided evidence, although it 
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could be deduced, that the criterion used could be considered an adequate gold 
standard. Correlations with two objective productivity measures ranged from -
0.043 to -0.219 and certain subscales did not significantly correlate with overall 
productivity. Evidence synthesis of the HWQ resulted in limited negative evidence 
for criterion validity (fair methodological quality and weak correlations).  
 Responsiveness: Shikiar, Halpern, Rentz & Khan [40] lacked a priori information 
on the measurement properties of the comparator instrument, the expected direc-
tion and magnitude of the correlation. The methodological quality of the study is 
poor. Evidence synthesis of the HWQ resulted in unknown evidence for respon-
siveness.  
 There were no methodologically sound studies evaluating the reliability, meas-
urement error, content validity, hypotheses testing or cross-cultural validity of the 
HWQ.  
The Work and Health Interview (WHI)  
In summary, the WHI captures data on absence time from work, reduced perfor-
mance, and health-related causes based on a six-module, computer-assisted tele-
phone interview [43]. 
 Reliability: Stewart, Ricci, Leotta & Chee [43] studied reliability whereby inde-
pendent measurements with an appropriate time interval were conducted. Both 
Pearson’s (0.59) and Spearman’s (0.63) correlation coefficients were derived be-
tween two measures. Evidence was provided that test conditions were similar, it 
was described how missing items were handled and the sample size (N=66) was 
adequate [43]. Evidence synthesis of the WHI resulted in limited negative level of 
evidence for reliability because of the study’s good methodological quality and rela-
tively negative findings (correlations <0.70). 
 Validity: In the study conducted by Stewart, Ricci, Leotta & Chee [43], it could 
easily be assumed that the criterion used (diary work time measures) could be 
considered an adequate gold standard. The Pearson’s (Spearman’s) correlation 
between the WHI and diary total productivity time measure was 0.50 (0.46) and 
there were no other important methodological flaws in the design of the study [43]. 
Evidence synthesis of the WHI resulted in limited negative evidence for reliability 
(good methodological quality and negative findings).  
 Responsiveness: Hypotheses were vaguely formulated and limited evidence on 
the measurement properties of the comparator instrument was available. The 
methodological quality of the study is fair. The correlations between change scores 
of time not working at work (continuous scores regarding performance data) were 
(Pearson’s correlation) 0.19 and (Spearman’s) 0.33 [43] Evidence synthesis of the 
WHI resulted in limited negative evidence for responsiveness.  
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, content validity, structural validity, hypotheses test-
ing or cross-cultural validity of the WHI. 
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The Valuations of Lost Productivity questionnaire (VOLP)  
The VOLP assesses labor input loss due to health via 36 open and multiple-choice 
questions in six sections [23].  
 Reliability: Zhang, Bansback, Kopec & Anis [23] assessed reliability over time by 
means of a test-retest analysis. Kappa statistics were calculated, all being statistical-
ly significant and reporting adequate agreement. Due to the time frame (2 weeks), 
the type of administration (postal questionnaire) and the environment (at home), it 
could be assumed that the test conditions were similar. The methodological quality 
of the study is good regarding test-retest reliability. Evidence synthesis of the VOLP 
resulted in limited positive evidence for reliability. 
 Validity: In order to assess the constructs of the VOLP, the criterion used could 
be considered as a reasonable gold standard because evidence regarding the psy-
chometric properties of the comparators is provided in the study by Zhang, Bans-
back, Kopec & Anis [23]. There is no description on how missing items were han-
dled; however, it could be deduced. Furthermore, Spearman’s correlation coeffi-
cients were calculated to assess criterion validity. The correlations between the 
VOLP outcomes and corresponding WPAI outcomes ranged from 0.39 to 0.57. The 
methodological quality of the paper is good and thus the evidence synthesis of the 
VOLP resulted in limited negative evidence for reliability (good methodological 
quality and Spearman correlations <0.7).  
 There were no methodologically sound studies evaluating the internal con-
sistency, measurement error, content validity, structural validity, hypotheses test-
ing, cross-cultural validity or responsiveness of the VOLP. 
Conclusion and discussion 
Twenty-five studies on measurement properties of 15 generic self-reported in-
struments measuring health-related productivity changes have been systematically 
reviewed, and their methodological quality has been evaluated using the COSMIN-
checklist in a best evidence synthesis. The WLQ is the most frequently evaluated 
instrument. Structural validity and content validity reported a strong and moderate 
positive level of evidence respectively. For measurement error and cross-cultural 
validity, no information was available and the internal consistency and criterion 
validity resulted in conflicting evidence. Reliability, hypotheses testing and respon-
siveness resulted in limited negative and moderate negative evidence respectively. 
Due to poor methodological quality, the EWPS, WPAI, and WPSI showed unknown 
levels of evidence for almost half of the information on measurement properties. 
For eight questionnaires (AMA-guides, PRODISQ, HLQ, Q&Q, WBA-P, HWQ, WHI, 
VOLP) at least half of the information on measurement properties per question-
naire was lacking. Four instruments (WLQ, WHO-HPQ, SPS, and PRODISQ) showed 
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strong or moderate positive levels of evidence for some of the measurement prop-
erties.  
 The main strength of most studies was that they reported detailed information 
regarding the population characteristics, sampling methods, the setting and the 
country where the studies were conducted.  
 There were, however, many limitations. First, the generalizability of the results 
of the studies on measurement properties was low, mainly because of selective 
samples, the non-reporting of and the lack of information regarding the handling of 
missing values, and inadequate sample sizes.  
 Second, most studies recruited convenience samples, which might not cover the 
entire target population [44]. Ozminkanski et al. was the only study that consecu-
tively recruited workers with job-related accidents or injuries, which could be a 
reasonable representation of the workers with lost productivity at the workplace 
[21].  
 Third, although Zhang and colleagues examined the measurement properties in 
two countries (UK and Ireland), no international samples demonstrated the cross-
cultural validity of their measures [22, 23]. Most studies were conducted in the 
United States, which makes it difficult to discern whether the instruments are ap-
propriate for study populations outside of the United States. The results of this 
review emphasize the need for international studies on measurement properties as 
well as additional evaluation studies conducted worldwide to examine the cross-
cultural appropriateness of these measures to improve generalizability. The Work 
Role Functioning Questionnaire (WRFQ) measures perceived difficulties in meeting 
work demands among employees given their physical and emotional problems. The 
WRFQ addresses work outcomes in an attempt to describe how health affects work 
role functioning [45-48]. Despite the fact that the WRFQ is to be used as a detection 
instrument to identify, and not value decreased productivity, it can serve as an ex-
cellent example since several studies have translated and adapted the WRFQ to 
Canadian French [45], Brazilian Portuguese [46], Dutch [47], and Spanish [48]. 
These studies demonstrate a systematic procedure for translation and cross-
cultural adaptation which can serve as excellent examples for future studies at-
tempting to adapt and validate instruments in other cultures.  
 Fourth, almost half of the reviewed studies reported item and unit nonrespons-
es under 50%, which might indicate selection bias, further hampering the generali-
zability of the results [44]. Inadequate descriptions of the handling of missing val-
ues might suggest non-random missing items, which could bias the results and lead 
to misinterpretation and misjudgment of the measurement properties of an in-
strument. Furthermore, if missing values are inappropriately handled, bias in pa-
rameter estimates can occur, resulting in lower samples sizes and thus lower statis-
tical power. High percentages of missing values on specific items might even indi-
cate that an item is not relevant for the study population, perhaps pointing to am-
biguous formulations and hampering the validity of the instruments [17, 49]. In 
light of the flaws presented from previous studies, response rates should be accu-
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rately reported, including information on the handling of missing items, and if ran-
domness of nonresponse occurred, it should be examined and reported in future 
studies.  
 Fifth, based on the results of this systematic review it can be concluded that the 
information regarding the measurement properties of generic self-reported in-
struments measuring health-related productivity changes is mostly limited or of 
poor to fair methodological quality. The results should be treated with caution due 
to the missing information on the remaining measurement properties. Especially 
when considering measurement error and cross-cultural validity, wherefore (al-
most) no information was available. 
 Sixth, although it is difficult to determine the criterion validity without a real 
gold standard for health-related productivity change instruments, most studies 
considered the extent to which scores on the instrument of interest could be ade-
quately reflected to a predetermined comparator. Criterion validity is therefore 
most frequently evaluated, but only five studies on this measurement property 
were of good methodological quality. As a consequence, the SPS and the WBA-P 
yielded moderate and limited positive levels of evidence for criterion validity re-
spectively.  
 Seventh, it is difficult to determine the responsiveness of the different health-
related productivity change instruments because almost all of the retrieved studies 
were of poor or fair methodological quality regarding responsiveness. Because the 
instruments are often used as an outcome measure to determine the costs of lost 
productivity, specific hypotheses regarding expected correlations with other con-
structs must be formulated a priori when developing a new measure.  
 Eighth, the internal consistency statistic only gets an interpretable meaning 
when the interrelatedness among the items is determined as a set of items that 
together form a reflective model. The internal consistency of an instrument is thus 
reflected in the quality assessment of structural validity, and vice versa. If the struc-
tural validity was not assessed by analyzing the unidimensionality (there is no evi-
dence that the scales are unidimensional), no internal consistency statistic can be 
properly interpreted. Four studies resulted in good methodological quality on 
structural validity for the WLQ and SPS, and also in good internal consistency for 
both instruments. Most of the instruments with unknown levels of evidence due to 
poor methodological quality regarding internal consistency also lacked information 
on structural validity.  
 Ultimately, some general issues on measuring productivity changes should be 
addressed. First, the concept of productivity loss due to illness is, according to eco-
nomic theory, based on the concept of a production function where output is a func-
tion of capital input, labor input and technology. The focus of most productivity 
measurement instruments, as has been seen, is on the individual’s labor input; 
measuring the time a person is not at work due to health complaints (absenteeism), 
or is not productive while at work due to health complaints (presenteeism). How-
ever, job and workplace characteristics also play a key role and differ among coun-
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tries, which are reflected in the socio-political context in which the study takes 
place. For example, in some countries that have a workers’ compensation system, 
such as Canada and the United States, there is a differentiation between work and 
non-work related disability. In other countries, such as the Netherlands, no such 
differentiation exists. Due to these variations arising from the social-political con-
text, one cannot assume a ‘one size fits all’ mentality when comparing instrument 
effectiveness across countries or cultures. Transparency in reporting the key as-
pects of measurement and validation of health-related productivity would simplify 
the comparability and usability of the results for occupational and health economic 
decision making. 
 Another point to be addressed is that although the COSMIN taxonomy might 
contribute to a better understanding in the terminology used in validation studies 
and provides a structured procedure for the evaluation of the methodological quali-
ty of the studies on measurement properties, the taxonomy provides a lot of room 
for interpretation in the checklist items. To minimize interpretability differences 
between reviewers (CYGN, AER, SMAAE), decisions had to be made on how to score 
the different items. For example, a problem encountered during the rating of ‘crite-
rion validity’ was the absence of a gold standard in health-related productivity 
change instruments. One example of how this problem was dealt with was by as-
suming the original long version of the shortened instrument being assessed was an 
adequate comparator, and can thus be seen as a ‘gold standard’. Furthermore, since 
the studies were systematically reviewed on the measurement properties of self-
reported instruments which encounter subjective data, it was agreed that objective, 
registered data could serve as an adequate comparator as well. Predetermined and 
transparent arguments that the gold standard is ‘gold’ had to be thoroughly dis-
cussed and decided beforehand to assess criterion validity.  
 Finally, although an agreement was reached that objective data could be seen as 
a ‘gold standard’ for collecting lost productivity data it should be in mind that both 
objective and self-reported instruments have their advantages and disadvantages, 
which need to be weighed per research question. For example, when using objec-
tive insurance data, a particular disadvantage is that the data reflects what has been 
compensated. What has been compensated does not necessarily reflect the actual 
time a worker has been unable to work. Productivity changes related to sick leave 
should therefore always be supplemented by the productivity changes due to de-
creased work performance; i.e. presenteeism, to avoid underestimations.  
Recommendations  
Although only cautious advice can be provided on the most appropriate instru-
ments to capture changes in productivity for use in occupational and economic 
health practice, the WLQ is cautiously recommended at the moment because the 
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instrument is most frequently evaluated and moderate respectively strong positive 
evidence was found for content and structural validity respectively. However, nega-
tive evidence was found for reliability, hypothesis testing and responsiveness. The 
WLQ is only used in an English-speaking study population. Using the PRODISQ is 
cautiously preferred when conducting a study in the Netherlands based on its 
strong positive evidence for content validity, although evidence for the other meas-
urement properties is lacking. In order to improve the interpretation of the PRO-
DISQ scores, more research regarding the measurement properties (aside from 
content validity) is needed. The Stanford Presenteeism Scale (SPS) can also be cau-
tiously recommended as it is evaluated in two studies and showed strong positive 
results for internal consistency and structural validity, and moderate positive re-
sults for hypotheses testing and criterion validity. Limited negative evidence how-
ever was available for reliability and content validity and information on the other 
measurement properties was lacking.  
 Better knowledge and usage of key methodological principles based on quality 
checklists, such as COSMIN, is recommended to provide high-quality studies evalu-
ating the measurement properties of new and existing instruments in the future. 
High-quality studies that evaluate and provide strong evidence for the unknown 
measurement properties, especially cross-cultural validity, are recommended to 
improve the generalizability and applicability of generic self-reported health-
related productivity change instruments. Given the large number of available 
productivity instruments the development of new instruments is not recommend-
ed, but rather improvement of the existing instruments.  
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ion
 T
yp
e] 
OR
 ‘p
ati
en
t e
du
cat
ion
 h
an
do
ut’
[Pu
bli
cat
ion
 T
yp
e] 
OR
 ‘p
op
ula
r 
wo
rks
’[P
ub
lic
ati
on
 Ty
pe
] O
R ‘
co
ng
res
ses
’[P
ub
lic
ati
on
 Ty
pe
] O
R ‘
co
ns
en
su
s d
ev
elo
pm
en
t c
on
fer
en
ce’
[Pu
bli
cat
ion
 Ty
pe
] O
R ‘
co
ns
en
su
s 
de
ve
lop
me
nt 
co
nfe
ren
ce,
 n
ih’
[Pu
bli
cat
ion
 T
yp
e] 
OR
 ‘p
rac
tic
e g
uid
eli
ne
’[P
ub
lic
ati
on
 T
yp
e])
 N
OT
 (‘
an
im
als
’[M
eS
H 
Te
rm
s] 
NO
T 
‘hu
-
ma
ns
’[M
eS
H T
erm
s] 
Em
ba
se
Co
ns
tru
ct 
Se
arc
h
‘pr
od
uc
tiv
ity
’ O
R ‘
wo
rkp
lac
e p
rod
uc
tiv
ity
 lo
ss’
 OR
 ‘re
du
ced
 w
ork
pla
ce 
pr
od
uc
tiv
ity
’ O
R ‘
los
t w
ork
pla
ce 
pr
od
uc
tiv
ity
’ O
R ‘
los
tp
rod
uc
tiv
ity
’ 
OR
 ‘p
rod
uc
tio
n c
ap
aci
ty’
 OR
 ‘em
plo
ya
bil
ity
’ O
R ‘
wo
rk 
pa
rti
cip
ati
on
’ O
R ‘
wo
rk 
pe
rfo
rm
an
ce’
 OR
 ‘w
ork
 fu
nc
tio
nin
g’ O
R ‘
wo
rk 
lim
ita
tio
ns
’ 
OR
 ‘ab
sen
tee
ism
’ O
R ‘
sic
kn
ess
 ab
sen
ce’
 OR
 ‘re
tur
n t
o w
ork
’ O
R ‘
sic
k l
ea
ve
’ A
ND
 ‘p
res
en
tee
ism
’ O
R ‘
wo
rke
rs'
 co
mp
en
sat
ion
’ 
Pr
eci
se 
va
lid
ity
 
sea
rch
 (m
ea
s-
ur
em
en
t 
pr
op
ert
ies
, 
va
lid
ati
on
 
stu
die
s) 
'in
ter
me
tho
d c
om
pa
ris
on
'/e
xp
 O
R '
da
ta 
co
lle
cti
on
 m
eth
od
'/e
xp
 O
R '
va
lid
ati
on
 st
ud
y'/
ex
p O
R '
fea
sib
ilit
y s
tud
y'/
ex
p O
R '
pil
ot 
stu
dy
'/e
xp
 
OR
 'p
syc
ho
me
try
'/e
xp
 O
R '
rep
rod
uc
ibi
lity
'/e
xp
 O
R r
ep
rod
uc
ib*
:ab
,ti 
OR
 'a
ud
it':
ab
,ti 
OR
 ps
ych
om
etr
*:a
b,t
i O
R c
lin
im
etr
*:a
b,t
i O
R c
li-
no
me
tr*
:ab
,ti 
OR
 'o
bs
erv
er 
va
ria
tio
n'/
ex
p O
R '
ob
ser
ve
r v
ari
ati
on
':a
b,t
i O
R '
dis
cri
mi
na
nt 
an
aly
sis
'/e
xp
 OR
 'v
ali
dit
y'/
ex
p O
R r
eli
ab
*:a
b,t
i 
OR
 va
lid
*:a
b,t
i O
R 
'co
eff
ici
en
t':a
b,t
i O
R 
'in
ter
na
l c
on
sis
ten
cy'
:ab
,ti 
OR
 (c
ron
ba
ch
*:a
b,t
i A
ND
 ('
alp
ha
':a
b,t
i O
R 
'al
ph
as'
:ab
,ti)
) O
R 
'ite
m 
co
rre
lat
ion
':a
b,t
i O
R '
ite
m 
co
rre
lat
ion
s':a
b,t
i O
R '
ite
m 
sel
ect
ion
':a
b,t
i O
R '
ite
m 
sel
ect
ion
s':a
b,t
i O
R '
ite
m 
red
uc
tio
n':
ab
,ti 
OR
 'it
em
 re
du
c-
tio
ns
':a
b,t
i O
R '
ag
ree
me
nt'
:ab
,ti 
OR
 'p
rec
isi
on
':a
b,t
i O
R '
im
pr
eci
sio
n':
ab
,ti 
OR
 'p
rec
ise
 va
lue
s':a
b,t
i O
R '
tes
t-r
ete
st'
:ab
,ti 
OR
 ('t
est
':a
b,t
i 
AN
D 
're
tes
t':a
b,t
i) 
OR
 (r
eli
ab
*:a
b,t
i A
ND
 ('
tes
t':a
b,t
i O
R 
're
tes
t':a
b,t
i))
 O
R 
'st
ab
ilit
y':
ab
,ti 
OR
 'in
ter
rat
er'
:ab
,ti 
OR
 'in
ter
-ra
ter
':a
b,t
i O
R 
'in
tra
rat
er'
:ab
,ti 
OR
 'in
tra
-ra
ter
':a
b,t
i O
R 
'in
ter
tes
ter
':a
b,t
i O
R 
'in
ter
-te
ste
r':a
b,t
i O
R 
'in
tra
tes
ter
':a
b,t
i O
R 
'in
tra
-te
ste
r':a
b,t
i O
R 
'in
ter
-
ob
ese
rve
r':a
b,t
i 
OR
 'i
nte
r-o
bs
erv
er'
:ab
,ti 
OR
 'i
ntr
ao
bs
erv
er'
:ab
,ti 
OR
 'i
ntr
a-o
bs
erv
er'
:ab
,ti 
OR
 'i
nte
rte
ch
nic
ian
':a
b,t
i O
R 
'in
ter
-
tec
hn
ici
an
':a
b,t
i O
R '
int
rat
ech
nic
ian
':a
b,t
i O
R '
int
ra-
tec
hn
ici
an
':a
b,t
i O
R '
int
ere
xa
mi
ne
r':a
b,t
i O
R '
int
er-
ex
am
ine
r':a
b,t
i O
R '
int
rae
xa
mi
n-
er'
:ab
,ti 
OR
 'in
tra
-ex
am
ine
r':a
b,t
i O
R '
int
era
ssa
y':
ab
,ti 
OR
 'in
ter
-as
say
':a
b,t
i O
R '
int
raa
ssa
y':
ab
,ti 
OR
 'in
tra
-as
say
':a
b,t
i O
R '
int
eri
nd
ivi
d-
ua
l':a
b,t
i 
OR
 '
int
er-
ind
ivi
du
al'
:ab
,ti 
OR
 '
int
rai
nd
ivi
du
al'
:ab
,ti 
OR
 '
int
ra-
ind
ivi
du
al'
:ab
,ti 
OR
 '
int
erp
art
ici
pa
nt'
:ab
,ti 
OR
 '
int
er-
pa
rti
cip
an
t':a
b,t
i O
R 
'in
tra
pa
rti
cip
an
t':a
b,t
i O
R 
'in
tra
-pa
rti
cip
an
t':a
b,t
i O
R 
'ka
pp
a':
ab
,ti 
OR
 'k
ap
pa
s':a
b,t
i O
R 
'co
eff
ici
en
t o
f v
ari
a-
tio
n':
ab
,ti 
OR
 re
pe
ata
b*
:ab
,ti 
OR
 (r
ep
lic
ab
*:a
b,t
i O
R '
rep
ea
ted
':a
b,t
i A
ND
 ('m
ea
su
re'
:ab
,ti 
OR
 'm
ea
su
res
':a
b,t
i O
R '
fin
din
gs'
:ab
,ti 
OR
 're
-
su
lt':
ab
,ti 
OR
 'r
esu
lts
':a
b,t
i O
R 
'te
st'
:ab
,ti 
OR
 'te
sts
':a
b,t
i))
 O
R 
ge
ne
ral
iza
*:a
b,t
i O
R 
ge
ne
ral
isa
*:a
b,t
i O
R 
'co
nc
ord
an
ce'
:ab
,ti 
OR
 ('
int
ra-
cla
ss'
:ab
,ti 
AN
D 
co
rre
lat
ion
*:a
b,t
i) 
OR
 'd
isc
rim
ina
tiv
e':
ab
,ti 
OR
 'k
no
wn
 gr
ou
p':
ab
,ti 
OR
 'fa
cto
r a
na
lys
is':
ab
,ti 
OR
 'fa
cto
r a
na
lys
es'
:ab
,ti 
OR
 'fa
cto
r s
tru
ctu
re'
:ab
,ti 
OR
 'fa
cto
r s
tru
ctu
res
':a
b,t
i O
R 
'di
me
ns
ion
ali
ty'
:ab
,ti 
OR
 su
bs
cal
e*:
ab
,ti 
OR
 'm
ult
itr
ait
 sc
ali
ng
 an
aly
sis
':a
b,t
i 
OR
 'm
ult
itr
ait
 sc
ali
ng
 an
aly
ses
':a
b,t
i O
R 
'ite
m 
dis
cri
mi
na
nt'
:ab
,ti 
OR
 'in
ter
sca
le 
co
rre
lat
ion
':a
b,t
i O
R 
'in
ter
sca
le 
co
rre
lat
ion
s':a
b,t
i O
R 
('e
rro
r':a
b,t
i O
R '
err
ors
':a
b,t
i A
ND
 (m
ea
su
re*
:ab
,ti 
OR
 co
rre
lat
*:a
b,t
i O
R e
va
lua
t*:
ab
,ti 
OR
 'a
ccu
rac
y':
ab
,ti 
OR
 'a
ccu
rat
e':
ab
,ti 
OR
 'p
rec
i-
sio
n':
ab
,ti 
OR
 'm
ea
n':
ab
,ti)
) O
R '
ind
ivi
du
al 
va
ria
bil
ity
':a
b,t
i O
R '
int
erv
al 
va
ria
bil
ity
':a
b,t
i O
R '
rat
e v
ari
ab
ilit
y':
ab
,ti 
OR
 'v
ari
ab
ilit
y a
na
ly-
sis
':a
b,t
i O
R 
('u
nc
ert
ain
ty'
:ab
,ti 
AN
D 
('m
ea
su
rem
en
t':a
b,t
i O
R 
'm
ea
su
rin
g':
ab
,ti)
) O
R 
'st
an
da
rd
 er
ror
 of
 m
ea
su
rem
en
t':a
b,t
i O
R 
sen
si-
tiv
*:a
b,t
i O
R r
esp
on
siv
e*:
ab
,ti 
OR
 ('l
im
it':
ab
,ti 
AN
D 
'de
tec
tio
n':
ab
,ti)
 O
R '
mi
nim
al 
de
tec
tab
le 
co
nc
en
tra
tio
n':
ab
,ti 
OR
 in
ter
pre
tab
*:a
b,t
i 
OR
 (s
ma
ll*
:ab
,ti 
AN
D (
're
al'
:ab
,ti 
OR
 'd
ete
cta
ble
':a
b,t
i) A
ND
 ('c
ha
ng
e':
ab
,ti 
OR
 'd
iffe
ren
ce'
:ab
,ti)
) O
R '
me
an
ing
ful
 ch
an
ge
':a
b,t
i O
R '
mi
n-
im
al 
im
po
rta
nt 
ch
an
ge
':a
b,t
i O
R '
mi
nim
al 
im
po
rta
nt 
dif
fer
en
ce'
:ab
,ti 
OR
 'm
ini
ma
lly
 im
po
rta
nt 
ch
an
ge
':a
b,t
i O
R 
'm
ini
ma
lly
 im
po
rta
nt 
dif
fer
en
ce'
:ab
,ti 
OR
 'm
ini
ma
l d
ete
cta
ble
 ch
an
ge
':a
b,t
i O
R '
mi
nim
al 
de
tec
tab
le 
dif
fer
en
ce'
:ab
,ti 
OR
 'm
ini
ma
lly
 de
tec
tab
le 
ch
an
ge
':a
b,t
i O
R 
'm
ini
ma
lly
 de
tec
tab
le 
dif
fer
en
ce'
:ab
,ti 
OR
 'm
ini
ma
l r
ea
l c
ha
ng
e':
ab
,ti 
OR
 'm
ini
ma
l re
al 
dif
fer
en
ce'
:ab
,ti 
OR
 'm
ini
ma
lly
 re
al 
ch
an
ge
':a
b,t
i 
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 OR
 'm
ini
ma
lly
 re
al 
dif
fer
en
ce'
:ab
,ti 
OR
 'c
eil
ing
 e
ffe
ct'
:ab
,ti 
OR
 'f
loo
r e
ffe
ct'
:ab
,ti 
OR
 'i
tem
 re
sp
on
se 
mo
de
l':a
b,t
i O
R 
'irt
':a
b,t
i O
R 
'ra
sch
':a
b,t
i O
R 
'di
ffe
ren
tia
l it
em
 fu
nc
tio
nin
g':
ab
,ti 
OR
 'd
if':
ab
,ti 
OR
 'c
om
pu
ter
 ad
ap
tiv
e t
est
ing
':a
b,t
i O
R 
'ite
m 
ba
nk
':a
b,t
i O
R 
'cr
os
s-
cu
ltu
ral
  
eq
uiv
ale
nc
e':
ab
,ti 
Ins
tru
me
nt 
sea
rch
 
‘qu
est
ion
na
ire
s’ O
R ‘
qu
est
ion
na
ire
’ O
R ‘
sel
f re
po
rt’
 OR
 ‘se
lf r
ep
ort
s’ O
R ‘
ge
ne
ric
 in
str
um
en
ts’
 
Ps
ych
IN
FO
 (E
BS
CO
ho
st)
Co
ns
tru
ct 
Se
arc
h
“pr
od
uc
tiv
ity
” O
R “
wo
rkp
lac
e p
rod
uc
tiv
ity
 lo
ss”
 OR
 “r
ed
uc
ed
 w
ork
pla
ce 
pr
od
uc
tiv
ity
” O
R “
los
t w
ork
pla
ce 
pr
od
uc
tiv
ity
” O
R “
los
t p
rod
uc
tiv
-
ity
” O
R 
“pr
od
uc
tio
n c
ap
aci
ty”
 O
R 
“em
plo
ya
bil
ity
” O
R 
“w
ork
 pa
rti
cip
ati
on
” O
R 
“w
ork
 pe
rfo
rm
an
ce”
 O
R 
“w
ork
 fu
nc
tio
nin
g” 
OR
 “w
ork
 
lim
ita
tio
ns
” O
R “
ab
sen
tee
ism
” O
R “
sic
kn
ess
 ab
sen
ce”
 OR
 “r
etu
rn
 to
 w
or
k” 
OR
 “s
ick
 le
av
e” 
AN
D “
pr
ese
nte
eis
m”
 OR
 "w
ork
ers
' c
om
pe
n-
sat
ion
" 
Pr
eci
se 
va
lid
ity
 
sea
rch
 (m
ea
s-
ur
em
en
t 
pr
op
ert
ies
, 
va
lid
ati
on
 
stu
die
s) 
ins
tru
me
nta
tio
n O
R V
ali
da
tio
n S
tud
ies
 OR
 ‘re
pr
od
uc
ibi
lity
 of
 re
su
lts
’ O
R r
ep
rod
uc
ib*
OR
 ‘p
syc
ho
me
tri
cs’
 OR
 ps
yc
ho
me
tr*
 OR
 cl
ini
me
tr*
 OR
 
cli
no
me
tr*
 re
lia
b*
 OR
 un
rel
iab
* O
R v
ali
d*
OR
 ‘in
ter
na
l co
ns
ist
en
cy’
 OR
 ite
m 
OR
 co
rre
lat
ion
* O
R s
ele
cti
on
* O
R r
ed
uc
tio
n*
) O
R t
est
-re
tes
t 
OR
 st
ab
ilit
y O
R i
nte
rra
ter
 OR
 in
ter
-ra
ter
 OR
 in
tra
rat
er 
OR
 in
tra
-ra
ter
 OR
 in
ter
tes
ter
 OR
 in
ter
-te
ste
r O
R i
ntr
ate
ste
r O
R i
ntr
a-t
est
er 
OR
 
int
ero
bs
erv
er 
OR
 in
ter
-ob
ser
ve
r O
R 
int
rao
bs
erv
er 
OR
 in
tra
-ob
ser
ve
r O
R 
rep
ea
tab
* r
ep
lic
a* 
OR
 ge
ne
ral
iza
*O
R 
ge
ne
ral
isa
*O
R 
int
er 
sca
le 
co
rre
lat
ion
*O
R e
rro
r O
R e
rro
rs 
OR
 ‘in
div
idu
al 
va
ria
bil
ity
’ O
R a
na
lys
is 
OR
 va
lue
s O
R u
nc
ert
ain
ty 
me
asu
rem
en
t O
R m
ea
su
rin
g O
R 
‘st
an
da
rd
 er
ror
 of
 m
ea
su
rem
en
t’ O
R s
en
sit
iv*
 OR
 ‘cr
os
s-c
ult
ur
al 
eq
uiv
ale
nc
e’ 
Ins
tru
me
nt 
sea
rch
 
‘qu
est
ion
na
ire
s’ O
R ‘
qu
est
ion
na
ire
’ O
R ‘
sel
f re
po
rt’
 OR
 ‘se
lf r
ep
ort
s’O
R ‘
ge
ne
ric
 in
str
um
en
ts’
 
Ec
on
Lit
Co
ns
tru
ct 
Se
arc
h
“pr
od
uc
tiv
ity
” O
R “
wo
rkp
lac
e p
rod
uc
tiv
ity
 lo
ss”
 OR
 “r
ed
uc
ed
 w
ork
pla
ce 
pr
od
uc
tiv
ity
” O
R “
los
t w
ork
pla
ce 
pr
od
uc
tiv
ity
” O
R “
los
t p
rod
uc
tiv
-
ity
” O
R 
“pr
od
uc
tio
n c
ap
aci
ty”
 O
R 
“em
plo
ya
bil
ity
” O
R 
“w
ork
 pa
rti
cip
ati
on
” O
R 
“w
ork
 pe
rfo
rm
an
ce”
 O
R 
“w
ork
 fu
nc
tio
nin
g” 
OR
 “w
ork
 
lim
ita
tio
ns
” O
R “
ab
sen
tee
ism
” O
R “
sic
kn
ess
 ab
sen
ce”
 OR
 “r
etu
rn
 to
 w
or
k” 
OR
 “s
ick
 le
av
e” 
AN
D “
pr
ese
nte
eis
m”
 OR
 "w
ork
ers
' c
om
pe
n-
sat
ion
" 
Pr
eci
se 
va
lid
ity
 
sea
rch
 (m
ea
s-
ur
em
en
t 
pr
op
ert
ies
, 
va
lid
ati
on
 
stu
die
s) 
ins
tru
me
nta
tio
n O
R V
ali
da
tio
n S
tud
ies
 OR
 ‘re
pr
od
uc
ibi
lity
 of
 re
su
lts
’ O
R r
ep
rod
uc
ib*
OR
 ‘p
syc
ho
me
tri
cs’
 OR
 ps
yc
ho
me
tr*
 OR
 cl
ini
me
tr*
 OR
 
cli
no
me
tr*
AN
D 
rel
iab
* O
R u
nr
eli
ab
* O
R v
ali
d*
OR
 ‘in
ter
na
l c
on
sis
ten
cy’
 O
R i
tem
 O
R c
orr
ela
tio
n*
 O
R s
ele
cti
on
* O
Rr
ed
uc
tio
n*
) O
R t
est
-re
tes
t O
R s
tab
ilit
y 
OR
 in
teg
rat
e O
R i
nte
r-r
ate
r O
R i
nd
ra 
rat
er 
OR
 in
dr
a-r
ate
r O
R i
nte
res
ted
 OR
 in
ter
-te
ste
r O
R i
nd
ra 
tes
ter
 OR
 in
dr
a-t
est
er 
OR
 in
ter
 Ob
-
ser
ve
r O
R i
nte
r-o
bs
erv
er 
OR
 in
dr
a O
bs
erv
er 
OR
 in
dr
a-o
bs
erv
er 
OR
 re
pe
ata
b*
 
Ins
tru
me
nt 
sea
rch
 
‘qu
est
ion
na
ire
s’ O
R ‘
qu
est
ion
na
ire
’ O
R ‘
sel
f re
po
rt’
 OR
 ‘se
lf r
ep
ort
s’ O
R ‘
ge
ne
ric
 in
str
um
en
ts’
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 Ad
di
ti
on
al
 fi
le
 2
. D
eta
ile
d d
esc
rip
tio
n o
f th
e s
elf
-re
po
rte
d i
ns
tru
me
nts
 m
ea
su
rin
g h
ea
lth
-re
lat
ed
 pr
od
uc
tiv
ity
 ch
an
ge
s 
In
st
ru
m
en
t 
Co
ns
tr
uc
t /
 C
on
te
nt
  
# 
qu
es
ti
on
s 
/ 
it
em
s 
 
Ra
ti
ng
  
It
em
 e
xa
m
pl
e 
 
Re
ca
ll 
pe
ri
od
  
D
is
ci
pl
in
e 
 
Wo
rk 
Lim
ita
tio
ns
 
Qu
est
ion
na
ire
 
(W
LQ
)  
(18
, 2
0, 
26
, 2
7, 
35
, 
36
, 4
1, 
43
) 
De
gre
e t
o w
hic
h h
ea
lth
 
pr
ob
lem
s in
ter
fer
e w
ith
 
sp
eci
fic
 as
pe
cts
 of
 jo
b 
pe
rfo
rm
an
ce 
an
d i
ts 
pr
od
uc
tiv
ity
 im
pa
ct 
 
16
 or
 25
  
4 d
im
en
sio
ns
: p
hy
sic
al 
de
ma
nd
s, t
im
e m
an
ag
e-
me
nt,
 ou
tpu
t d
em
an
ds
, 
an
d m
en
-
tal
/in
ter
pe
rso
na
l d
e-
ma
nd
s 
5-p
oin
t s
cal
e f
orm
 no
ne
 of
 
the
 tim
e (
0%
) to
 al
l o
f th
e 
tim
e (
10
0%
)  
"In
 th
e p
ast
 tw
o w
ee
ks
, h
ow
 
mu
ch
 of
 th
e t
im
e d
id 
yo
ur
 
ph
ysi
cal
 he
alt
h o
r e
mo
tio
na
l 
pr
ob
lem
s m
ak
e i
t d
iffi
cu
lt f
or 
yo
u t
o s
tic
k t
o a
 ro
uti
ne
 or
 
sch
ed
ule
?" 
2 t
o 4
 
we
ek
s  
Me
dic
al 
 
En
dic
ott
 W
ork
 
Pr
od
uc
tiv
ity
 Sc
ale
  
(E
WP
S) 
 
(18
, 2
8) 
Wi
de
 va
rie
ty 
of 
me
nta
l a
nd
 
me
dic
al 
dis
ord
ers
 w
ork
ing
 
in 
a w
ide
 va
rie
ty 
of 
job
 
set
tin
gs 
to 
ass
ess
 th
e 
de
gre
e t
o w
hic
h t
his
 af
fec
ts 
the
 w
ork
 fu
nc
tio
nin
g o
f a
 
su
bje
ct 
25
 
5-p
oin
t s
cal
e o
f h
ow
 of
ten
 
the
 be
ha
vio
ur
 or
 fe
eli
ng
, 
or 
att
itu
de
 ha
s b
ee
n 
ma
nif
est
ed
 du
rin
g t
he
 
pa
st 
we
ek
: 0
 (b
est
 po
ssi
-
ble
 sc
ore
) to
 10
0 (
wo
rst
 
po
ssi
ble
 sc
ore
)  
"D
ur
ing
 th
e p
ast
 w
ee
k, h
ow
 
fre
qu
en
tly
 di
d y
ou
 fin
d y
ou
 ha
ve
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Abstract 
Objective: To assess the exchangeability of self-reported and administrative healthcare 
resource use measurements for cost estimation. 
Study Design: A systematic review (NHS EED & MEDLINE) was conducted. Reviewers work-
ing in duplicate evaluated the methodological reporting quality of studies comparing the 
validation evidence of healthcare resource use measurement instruments. An appraisal tool 
called MERQ (Methodological Reporting Quality) was developed by merging aspects form the 
Guidelines for Reporting Reliability and Agreement Studies (GRASS) and The Standards for 
Reporting Diagnostic Accuracy (STARD). 
Results: Out of 173 studies, 35 full-text articles were assessed for eligibility, of which 16 
articles were included in this study. In seven articles, more than 75% of the reporting criteria 
assessed by the quality appraisal tool were considered ‘good’. The majority of studies scored 
at least ‘fair’ on most of the reporting quality criteria. In the end, six studies scored ‘good’ on 
the minimal criteria for reporting. Varying levels of agreement among the different data 
sources were found, with correlations ranging from 0.14 up to 0.93 and with occurrences of 
both random and systematic errors.  
Conclusion: The validation evidence of the small number of studies with adequate methodo-
logical reporting quality cautiously supports the exchangeability of both the self-reported 
and administrative resource use measurement methods. 
 
Keywords: healthcare, utilization, self-reports, data collection, validation studies, systematic 
review. 
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Introduction  
Essential to the economic evaluation of healthcare treatments is a robust method 
for collecting data on healthcare resource use, which can be used to calculate the 
related costs. Healthcare resource quantities can be defined in different ways. The 
cost types for potential inclusion in an economic evaluation are commonly classi-
fied into healthcare costs, patient and family costs, and costs in other sectors (ab-
senteeism and presenteeism) [1, 2]. Universally recognized methods of collecting 
resource use data are lacking, however, and a wide variety of methods can be used. 
Resource use data is most often measured through patient self-reports (e.g. cost 
questionnaires, diaries, interviews) or through administrative records (e.g. admin-
istrative systems of care providers or insurance companies). 
 Both methods have advantages and disadvantages. One should, for instance, be 
cautious when calculating costs from patient self-reports, especially because pa-
tients may not know or be able to recall precisely their length of stay and diagnoses, 
two of the primary cost drivers [3]. Furthermore, patient self-reports are more 
burdensome for patients, and the different timing of data collection might influence 
accuracy. Although there is no common reference standard for measuring resource 
use, in general, administrative data collection methods are assumed to be the most 
objective and therefore the most accurate source of information. However, as 
healthcare provision has become more integrated, economic evaluations increas-
ingly need to include information from many different care providers. Accordingly, 
it is becoming more difficult and expensive to review the records from the many 
providers involved in administering treatments to patients. Furthermore, given 
prolonged survival rates and the ageing population, it is expensive to obtain longi-
tudinal treatment information by accessing medical records at multiple points in 
time. Even when administrative data are available and accurate, limits on benefit 
coverage might require the collection of healthcare utilization data from other 
sources (i.e. alternative healthcare and out-of-pocket payments) to calculate the 
economic costs. The major advantages and disadvantages of patient self-reported 
versus administrative measurements are listed in Table 1. 
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Table 1. Comparing the advantages and disadvantages of patient self-reported versus administrative 
measurements of resource use 
 Advantages Disadvantages 
Self- reports Low costs 
 
Possibility to include all societal costs  
(formal and informal, reimbursed and  
non-reimbursed) 
 
Higher visibility of additional non- 
specific costs (not directly related to the 
disease or intervention)  
 Selective non-response 
 
Lower compliance in completing over a 
longer period of time 
 
Burdensome for patients 
 
Tendency to record more socially accepta-
ble answers (respondent bias, recall bias) 
Administrative 
data 
No burden for patients 
 
Data already registered 
 
Detectable and detailed information  
on type and volume of care delivered 
Limited feasibility (privacy, time lag) 
 
Inconsistent coding/reporting 
 
Cooperation of many different databases 
necessary 
 
Costs levied to access the data  
 
No visibility of additional resource use not 
directly related to the healthcare institu-
tion and/or insurance company (no rou-
tine records for patient and family re-
source use, additional expenditures, input 
of informal caregivers, presenteeism, etc.) 
 
Impossible to include unrelated costs, 
informal costs and out-of-pocket expenses. 
 
Considerable research effort has been concentrated on the appropriate measure-
ment of outcomes and the policy implications of economic evaluation, but the 
methods for collecting the resource use data have been relatively neglected [4], and 
no standard methodology for estimating healthcare resource use has been devel-
oped. Consequently, the choice for a collection method for resource use data is of-
ten a matter of practicality instead of a decision based on methodological consider-
ations. Earlier review studies primarily focused on the accuracy of patient recall 
and the impact of patient self-reported methods on the accuracy of estimates [3, 5, 
6], but not on the methodological reporting quality of these studies. Due to different 
definitions and the lack of standard statistics regarding the validation evidence (e.g. 
agreement, reliability, validity and accuracy) as well as inconsistent methodological 
reporting quality, caution is warranted when interpreting the study findings.  
 Similar to all other areas of empirical research, high methodological reporting 
quality is a prerequisite for interpreting the validation evidence provided. The aim 
of this systematic review is therefore to assess, based on their Methodological Re-
porting Quality (MeRQ), whether or not the validation evidence of studies on 
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healthcare resource use measurements that are intended for cost estimation sup-
ports the exchangeability of both self-reported and administrative methods of data 
collection. The research questions are:  
1. What are the characteristics of studies that compare self-reported with administra-
tive methods of measuring healthcare resource use? 
2. What is the methodological reporting quality of the studies from which this evi-
dence is derived?  
3. What validation evidence has been reported when comparing self-reported with 
administrative methods of collecting healthcare resource use data that is intended for 
cost estimation? 
4. Given adequate methodological reporting quality, does the validation evidence 
support the exchangeability of both self-reported and administrative measurement 
methods for resource use?  
Methods 
This systematic review was planned, conducted, and reported in adherence to the 
PRISMA reporting guidelines [7]. 
Study eligibility  
Original research in any language that had as a stated purpose the comparison of 
resource use data gathered using patient self-reports with data gathered using 
administrative methods for application in costing studies is included in this review. 
Identification of healthcare resource use should serve as an item for costing and 
application in trial-based economic evaluations. Therefore, studies that solely mod-
eled or described patterns of healthcare use or studies that examined the impact of 
various patients’ characteristics on congruency were excluded from the analysis. 
Only studies that contained validation arguments in the interpretation of each 
study were eligible. Minimal requirements for validation arguments included: iden-
tification of healthcare resource use as an item for costing; identification of collec-
tion methods for resource use data; and identification of validation evidence (i.e. 
agreement, reliability and validity). Due to the lack of consistent terminology, some 
uncertainty existed as to the appropriate application of these specific terms. In 
cases of conflict, consensus was reached through discussion among the reviewers.  
 Patient self-reports were considered if they were made solely by the patient; 
articles using proxies for self-reports were therefore excluded. Any type of direct 
healthcare resource use (e.g. a visit to a clinical provider, medication usage) and 
any type of data collection instrument or method (e.g. diary, interview, question-
naire, GP record, insurance database) were considered.  
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Study identification  
A search in NHS EED, by means of the Cochrane Library or the Center for Reviews 
and Dissemination, along with a supplementary search in MEDLINE (PubMed) was 
conducted, which is generally an appropriate strategy for identifying all published 
economic evaluation studies related to healthcare that are relevant [8, 9]. Details of 
the search strategy are provided in Appendix 2. Both text words and MeSH terms 
were combined with AND and OR for ‘healthcare’, ‘utilization’, ‘patient self-report’, 
‘administrative data’, ‘cost analysis’, ‘validity’, ‘accuracy’, ‘reliability’, ‘agreement’. 
Reference and citation lists of included studies were hand searched to identify addi-
tional studies. International experts were consulted via the ‘International Health 
Economics Discussion List’ in order to identify a wider range of relevant studies. An 
archive of collection methods for healthcare utilization data called DIRUM (Data-
base of Instruments for Resource Use Measurement) [4] was used to test the sensi-
tivity of the search. Titles and abstracts were screened for inclusion, and full texts 
were screened once the articles were judged eligible for inclusion or uncertain. In 
cases of conflict, consensus was reached through discussion among the reviewers.  
Instrument for methodological reporting quality  
A new tool for appraising the methodological reporting quality (MeRQ) for 
healthcare resource use measurement was developed on the basis of two guidelines 
for reporting: Guidelines for Reporting Reliability and Agreement Studies (GRRAS) 
[10] and The Standards for Reporting Diagnostic Accuracy (STARD) [11]. Although 
STARD focuses on improving the reporting quality of studies on diagnostic accura-
cy, some items in the checklist refer to a ‘reference test’, or ‘golden standard’, which 
is less relevant for research on healthcare resource use. Diagnostic accuracy studies 
use a recognized reference standard, whereas reference standards regarding data 
collection methods for healthcare resource use are not available. Nonetheless, over-
lap was found in most reporting domains. GRRAS complimented the STARD by 
emphasizing items specific to reliability studies. An operational adaptation of both 
guidelines into an appraisal tool for evaluating the methodological reporting quality 
(MeRQ) can be found in Appendix 1. Adaptations were made by focusing on the 
methodological content and by deleting the directions and layout positions.  
 MeRQ was rated using the scoring criteria: good (explicit reporting in the 
study); fair (reporting makes it possible to deduce what is expected); poor (not 
explicitly reported and difficult to deduce what is expected), not reported (no in-
formation provided or to be deduced, also unregistered, unreported (for example: 
no information on the measurement procedure)), not addressed (not designating 
the measurement, also undirected (for example: information on the measurement 
procedures, though not clear whether they relate to the self-reports or the adminis-
trative data)), or not applicable. For each study, the quality of reporting on follow-
ing criteria was assessed: (i) explicit identification of the study as an evaluation of 
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the reliability, agreement or validity (accuracy) of a self-reported healthcare re-
source use measurement instrument compared with healthcare resource use 
measured using administrative data; (ii) validation arguments and strategies for 
interpreting validation evidence; (iii) measurement methods (eligibility criteria) 
with a critical review of evidence relevant for the study; (iv) rationale for the rela-
tionship between the self-reports and the administrative data; (v) methods or 
measurement procedures for the self-reports; (vi) methods or measurement pro-
cedures for the administrative data; (vii) time interval between self-reports and 
administrative data collection; (viii) population characteristics; (ix) statistical 
methods for validation estimates; (x) validation estimates; (xi) methods for statisti-
cal uncertainty; (xii) concluding validation argument and/or interpretation of vali-
dation evidence. All authors contributed to the rating of the methodological report-
ing quality of the studies. In cases of conflicting scores, consensus was reached 
through discussion.  
Validation evidence 
There are different concepts in the literature regarding the assessment of meas-
urement validity (i.e. reliability, agreement, validity and accuracy) [12]. In this sys-
tematic review, validation evidence is considered an umbrella term whereby the 
terms reliability, agreement and validity (and accuracy as a sub-concept of validity) 
are used to provide information about the quality of the measurements. Reliability 
is defined here as the ratio of variability between the subjects to the total variability 
of all measurements in the sample. Reliability therefore reflects the ability of a 
measurement to differentiate between subjects or objects (i.e. discriminative abil-
ity). Statistical approaches include intraclass correlation and kappa calculations. 
Agreement is defined as the degree to which scores are identical and is often ex-
pressed in percentages (i.e. proportions of agreement, ranges, limits of agreement). 
Diagnostic accuracy refers to the degree of agreement between the information 
from the test being evaluated (index test) and reference standard, and can be ex-
pressed in many ways, i.e. sensitivity, specificity, likelihood ratios, odds ratio, area 
under a receiver operating curve (ROC). For costing measures, diagnostic accuracy 
is undefined because no reference standard is considered the best available method 
for the collection of data on resource use. However, as mentioned in the introduc-
tion, administrative data collection methods are assumed to be the most accurate 
source of information and therefore often considered the gold standard. Despite 
this anomaly, information on accuracy is provided in this study and considered 
informative to support the validity of the cost estimates. Accuracy is seen as a sub-
concept of validity. In this framework, diagnostic accuracy is undefined because in 
costing measures, no reference standard is considered the best available method 
for the collection of data on resource use. Though this information is considered 
informative to support the validity of the cost estimates, accuracy, if at all consid-
ered, is in this study seen as a sub-concept of validity. Complete and accurate re-
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porting makes it possible to detect the potential for bias in the study (internal valid-
ity) and to evaluate the generalizability and applicability of the results (external 
validity).  
Best evidence 
Studies with ‘good’ reporting on four ‘minimal criteria for reporting’ of MeRQ were 
compared in detail. These minimal criteria include: clear description of the meas-
urement methods (eligibility criteria) with a critical review of evidence relevant for 
the study; rationale for the relationship between the self-report and the administra-
tive data; methods or measurement procedures for self-reports; and methods or 
measurement procedures for the administrative data. A ‘good’ score on reporting 
for these criteria was required to discuss whether or not the validation evidence of 
the studies supported the exchangeability of self-reported and administrative 
measurements of resource use.  
Data extraction  
Data was extracted independently. Basic information was extracted on the year of 
publication and country of origin, study design (e.g. sample of enrollees, case-
control study, RCT), description of the population (e.g. workers, patients/disease 
group) and the sample size, the type of healthcare resource use measured (e.g. 
medication, GP visits, hospital admissions), the method of self-report (e.g. ques-
tionnaire, diary), the type of administrative measure (e.g. hospital record, insurance 
record), and the data collection period. See Table 2. The MeRQ score is reported per 
study by presenting the score on each of the reporting criteria (Table 3). The scor-
ing was abstracted independently and in duplicate for all studies and all criteria, 
and conflicts were resolved by consensus. Validation evidence, as presented in Ta-
ble 4, included the main statistical analysis, the validation estimates and the statis-
tical uncertainty. In the end, studies that scored ‘good’ on four ‘minimal criteria for 
reporting’ of MeRQ were compared in detail. 
Results  
Study selection  
Our search in MEDLINE (PubMed) resulted in 69 hits, and 88 hits were found in the 
NHS Economic Evaluation Database, which is included in The Cochrane Library. 
After consulting experts, 11 articles were added. Citation tracking and hand search-
ing resulted in 9 additional hits. Four duplicates were removed, and the 173 re-
maining records were screened by title and abstract. At this stage, 138 records 
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were excluded. The main reasons for exclusion were that the studies did not aim to 
measure healthcare resource use for the purpose of costing analysis, did not pro-
vide information on the estimation of healthcare costs, and did not address the 
economic significance or the impact on the costs of care but solely described pat-
terns of healthcare use or provided information on how population characteristics 
influenced the agreement or disagreement between both measurement methods. 
Thirty-five full-text articles were assessed for eligibility, whereof another 19 full-
text articles were excluded. The most common reasons for exclusion were that the 
studies reported proxy-recorded resource use; the main aim was not the compari-
son of healthcare resource use measured via self-reports with use measured via 
administrative methods; the studies did not measure healthcare resource use as 
items of costing or did not address the economic impact on costs of care; the stud-
ies were a case-study or review; or the resource use was solely focused on the us-
age of one specific type of medication. In the end, 16 articles were included in this 
comprehensive literature review [13-28]. A flow chart describes the process of 
inclusion (see Figure 1).  
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Figure 1. Flowchart of inclusion 
 
 
Characteristics of the studies  
Table 2 presents an overview of the characteristics of the selected studies (N=16). 
The majority of studies examined at least one of the following types of resource use: 
specialist care [13-19, 21, 22, 25, 26, 28], primary care [13, 17, 22-24], medication 
use [15, 24, 25, 27, 28] or hospitalization [13, 16, 17, 19-21, 26, 28]. Most studies 
collected information on multiple types of resource use [13, 15-17, 19, 21, 22, 24-
26]. Eleven studies were conducted in Europe [13, 14, 16-18, 21-23, 26-28], two in 
Canada [15, 19], one in the USA [20], one in Australia [25] and one in New Zealand 
[24]. The population characteristics varied from patients with mental health com-
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plaints [13, 21, 22, 28] to musculoskeletal disorders [14, 18, 24], chronic disorders 
[15, 16, 19, 20], primary care attenders [23], acute ward patients [26] and cancer 
patients [17, 25, 27]. In most studies, a randomized controlled trial was conducted 
[14, 16-18, 22, 24-26, 28], of which two were conducted in a multi-center setting 
[13, 27]. In four studies, the study design was based on a sample of enrollees from 
another study [21], program [20] or healthcare service [15, 23]. One study used a 
population-based cohort [19].  
 In eight studies, healthcare resource use was measured with a questionnaire 
[15, 18, 22-24, 26-28], in three studies with an interview [13, 19, 21], in another 
three studies with a diary [14, 25, 27], in two studies with a telephone survey [17, 
20] and one with a booklet [16]. The studies that measured healthcare resource use 
based on administrative records used data from medical records [13], including 
care provider registrations [15, 16, 21], record forms [17, 18, 22-24, 27] and pro-
vider reports [26]. Six studies used health insurance data [14, 15, 19, 20, 25, 28].  
 In most studies, the data collection was retrospective [13, 17-24, 26, 28] with 
the largest recall period of twelve months [13, 18, 19]. In three studies that used 
diaries for self-reports, the data was collected prospectively [14, 16, 25]. One study 
collected the data on a daily basis [15]. Another study collected the data both pro-
spectively (via a diary) and retrospectively (via questionnaires) [27].  
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MeRQ scores 
Table 3 summarizes the methodological reporting quality as assessed by the re-
viewers using the MeRQ tool. The reporting of the elements was scored ‘good’, ‘fair’, 
‘poor’, ‘not reported’, ‘not addressed’, or ‘not applicable’. In seven of the sixteen 
studies, more than 75% of the criteria (≥9) were considered ‘good’ (explicit identi-
fication) [17-19, 21, 24, 26, 28]. Overall, the majority of studies scored at least ‘fair’ 
on most of the MeRQ criteria.  
 One study [14] did not explicitly identify its aim as evaluating the validity of 
self-reported measurements compared with administrative measurements. It was 
only at the end of the methods section that the aim of comparing both methods was 
mentioned. The deducibility was low, resulting in a poor reporting quality of the 
first criteria. Another study [13] did not address any validation arguments or strat-
egies for interpreting the validation evidence. The same study lacked a comprehen-
sive description of the measurement procedures for self-reports and administrative 
data. The only information provided was regarding the healthcare services that 
were measured and the time intervals between both collection methods. This study 
scored ‘poor’ on two quality criteria. Seven out of 16 studies did not report the time 
intervals between the self-reported data collection and the administrative data 
collection [16-22]. Pollicino et al. [25] did not report statistical methods for the 
assessment of validation estimates; they instead reported the difference counts 
between agreement and disagreement. Furthermore, no methods for statistical 
uncertainty were reported [25]. Five other studies also failed to report methods for 
statistical uncertainty [14, 16, 22, 27, 28]. Van den Brink et al. [27] calculated con-
cordance between types of medication and care products reported using both 
methods. Percentages were provided in the figures and text; however, it was im-
possible to deduce the statistical methods used and the validation estimates re-
ported. Although Mirandola et al. [21] reported a bias correction factor for preci-
sion, methods for statistical uncertainty were lacking, and the study scored ‘poor’ 
on this reporting element.  
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Validation evidence  
The main statistical analysis and statistical uncertainty analyses, as well as the vali-
dation estimates were also captured during basic data abstraction and presented in 
Table 4.  
 The statistical methods used to calculate the healthcare resource use validation 
estimates varied widely.  Most studies examined the correlation between self-
reported and administrative measurements of healthcare resource use, with calcu-
lations including the Spearman’s (rank) correlation coefficient [16, 17, 28], Pear-
son’s correlation coefficient [19, 27], the interclass correlation coefficient [18], and 
primarily Lin’s concordance correlation coefficient [13, 19, 21, 23, 24]. The Lin 
coefficient combines measurements of precision and accuracy to determine wheth-
er the data significantly deviate from perfect concordance. In an attempt to meas-
ure agreement, another four studies calculated a (weighted) kappa [15, 20, 22, 26]. 
Wilcoxon signed rank tests were used in one study to test differences in estimations 
of non-normal data distributions[14]. Agreement and proportion-perfect agree-
ment were considered in the analyses of five studies [15, 16, 25-27]. In 56% of the 
studies, statistical uncertainty was defined. Most studies presented the 95% confi-
dence intervals around the validation estimates  [13, 15, 17, 18, 20, 24, 26]. The 
95% limits of agreement were calculated in three studies [13, 23, 24]. 
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Best evidence 
In the end, six studies [18, 19, 21, 24, 26, 28] scored ‘good’ on all four MeRQ ‘mini-
mal criteria for reporting’. These studies were assessed and compared in detail. 
Three studies assessed the validity of the methods [19, 24, 28], whereas the other 
three studies assessed the methods based on their levels of agreement [18, 21, 26].  
 Longobardi et al. [19] assessed the validity of self-reported data gathered via 
standardized interviews compared with healthcare utilization drawn from an ad-
ministrative database over a 12-month period for IBD patients. The authors con-
cluded that there was good recall of medical contacts. However, systematic errors 
occurred in the reported frequency of physician visits (under-reporting by 35–
45%) and overnight stays in the hospital (over-reporting by 25–35%) [19]. There 
was a reasonably good correlation of self-reported data with adequate concordance 
(0.59–0.86) and Pearson (0.68–0.93) correlation coefficients for both IBD and non-
IBD related overnight stays in the hospital. Discrepancies in hospitalizations were 
due to failures to estimate a stay within the recall period, omitting stays following 
an emergency room visit, mistakenly including day surgery as hospitalization, and 
misclassifying an IBD stay. The tendency to over-estimate the number of overnight 
stays was not statistically significant, though a difference of this magnitude would 
likely have been significant in a larger sample with a higher base of hospitalizations. 
The self-reported data also underestimated the number of physician visits relative 
to the administrative data, despite the significant correlation. Regardless of wheth-
er IBD was inactive, fluctuating or active across the full 12-months, underestima-
tion of the number of physician visits occurred by one-third when comparing self-
reports with administrative data [19].  
 Pinto et al. [24] compared the validity of questionnaires and medical records 
regarding healthcare resource use over a 3-month period. Lin concordance correla-
tion coefficients were fair to good, ranging from 0.41 for GP contacts to 0.63 for the 
number of medications reported. Generally, patients overestimated medication 
usage and underestimated GP contacts; however, the mean differences between the 
estimation periods were small: -0.22 for medication use and 0.06 for GP contacts. 
Participants more accurately reported their non-use than use of healthcare. GP 
contacts and medication usage had higher levels of sensitivity (93–100%) than 
specificity (63–100%). The three-month measurement period might explain this, as 
the use of healthcare might be relatively low over this short period of time. Com-
pared cost estimations for GP contacts were in agreement with database results 
(0.502 Lin’s concordance correlation coefficient).  
 Zentner et al. [28] assessed the validity of self-reported data gathered using a 
questionnaire compared with data drawn from health insurance administrative 
records over a six-month period. Correlation coefficients were moderate to low 
(0.53–0.31) and reflected statistical differences when comparing one measurement 
method to the other. Hospital admissions measured over a six-month recall period, 
ambulant psychiatric contacts measured over a three-month recall period and med-
C O S T  E S T I M A T I O N S  O F  H E A L T H C A R E  R E S O U R C E  U S E  
 93 
ication use measured over a 1-month recall period were all underreported in the 
study. The low correlations between healthcare resource use measured using ques-
tionnaires and insurance registrations were significant, indicating a difference be-
tween the measurement methods [28].  
 Kennedy et al. [18] compared healthcare use measured via questionnaires with 
use measured via hospital physiotherapy department records. Agreement was 
measured by an intraclass correlation coefficient. The ICC of 0.54 (95% CI 0.31–
0.70) reasonably supports the exchangeability of both the questionnaire and de-
partment records. However, self-reported data overestimated the resource use 
compared with hospital records; a mean of 1.3 (95% CI 0.4–2.2) fewer visits were 
reported in the physiotherapy department notes [18].  
 Mirandola et al. [21] assessed the agreement of self-reported healthcare use 
measured via interviews with psychiatric case registers over a six-month period 
(biannually). Twelve healthcare categories were defined, and agreement between 
self-reports and administrative data varied greatly for each category. Overall, 
agreement was particularly weak for day-patient (hospital) contacts (0.14) and 
very strong for nurses’ outpatient contacts, number of acute psychiatric ward ad-
missions and sheltered accommodation (all ρc > 0.9). These results translate into 
overall agreement (0.93) on the total costs. The findings support that self-reported 
and administrative measurements of healthcare use are exchangeable when esti-
mating the total cost of services. Nonetheless, as the interview tends to overesti-
mate the costs of day and community care (ρc 0.14 and ρc 0.41, respectively) and to 
underestimate outpatient costs (ρc 0.42), one should acknowledge the importance 
of adequate procedures for analyzing the complexity of costs components [21]. 
 Richards et al. [26] assessed the agreement of self-reported data via interview-
er-administered questionnaires compared with healthcare providers’ reports over 
a 12-week period. Recall periods varied for different resources (4–12 weeks). 
Agreement and systematic differences in the distribution of paired responses were 
examined to assess the comparability of the methods. Within a range of 42–93%, 
agreement was over 72%. Systematic differences were observed when comparing 
self-reports with administrative data for routine primary care home visits (over-
reporting). Underreporting of resources use occurred for hospital readmissions, 
requested primary care home visits, surgery consultations, district nursing and 
physiotherapy when compared with provider records over short timeframes (4–12 
weeks). The number of visits was only gathered for hospital readmissions, routine 
and requested primary home care and surgery visits. Kappa coefficients were mod-
erate or good for the four comparisons (kappa 0.42–0.86). The 95% confidence 
intervals of the kappa coefficients were quite wide for all comparisons. Systematic 
bias was indicated for hospital readmissions and surgery visits (P<0.05). Marginally 
significant differences (P=0.05–0.10) were indicated for requested and routine 
primary home care visits. There were adequate levels of crude agreement between 
patient-reported use of healthcare services and usage data from healthcare provid-
ers. However, the analysis of bias between pairs revealed systematic differences 
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and more marginally significant differences in the response patterns. Except for 
primary care routine home visits, patients underreported healthcare use compared 
with healthcare provider records [26].  
Conclusions  
This study draws attention to both the methodological reporting quality and the 
validation evidence of studies comparing self-reported with administrative data 
collection methods used in measuring healthcare resource use for cost estimation. 
Based on the small number of six studies with adequate methodological reporting 
quality presented in this review, the exchangeability of self-reported and adminis-
trative healthcare resource use measurements can only be cautiously supported 
based on the presented validation evidence (e.g. under- and over-reporting oc-
curred, correlation coefficients were heterogeneous—including very weak ones, 
low correlations were presented, etc.). No evidence can be provided to suggest that 
one measurement is better than the other.  
 Throughout these six studies, when measured, patients generally tended to 
underestimate physician and physiotherapy contacts. The most commonly reported 
source of validation evidence was the calculation of correlation coefficients indicat-
ing the strength and direction of association. This approach is insufficient to indi-
cate agreement or absolute measurement errors. Further attention should be paid 
to methods that enhance accuracy and to adequate methodological reporting quali-
ty. Notwithstanding, self-reported data appears to be able to provide adequate gen-
eral estimates of healthcare use when administrative data are not available. 
Limitations  
A limitation of the study is the limited generalizability of the findings due to great 
diversity. Firstly, most studies collected data on multiple types of resource use and 
with divergent populations. However, the validation evidence was not necessarily 
more trustworthy when the population being assessed (e.g. patients with mental 
health complaints) was directly linked to the type of healthcare resource use rele-
vant to the illness (e.g. psychologists). Secondly, as most studies were conducted in 
a randomized controlled trial, the main focus of these studies was on assessing the 
effectiveness and/or cost effectiveness of an intervention or policy adjustment. 
Comparing the self-reported data with administrative data was usually not the 
primary aim. Thirdly, sample sizes were small. In most cases, existing populations 
gathered for a completely different research purpose, were assessed in a secondary 
analysis on agreement levels.  
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Discussion  
The methodological reporting quality was assessed with a newly developed ap-
praisal tool called MeRQ, which was derived by combining items of existing guide-
lines, i.e. GRRAS and STARD. The MeRQ tool was developed to ensure the reporting 
of key elements required to assess the validation evidence and the risk of bias. It 
was difficult to appraise the methodological rigor when key information was re-
ported vaguely or not at all. Interpreting validation evidence requires knowledge of 
the methods and statistics but even then, there are no standard statistics, and dif-
ferent interpretations are possible. Although the use of the MeRQ tool was feasible 
in the current systematic review, further research is warranted to assess its validi-
ty.  
 Adequate methodological reporting quality was found in a minority of the stud-
ies. Six studies assessed in the best evidence section demonstrate the complexity 
between different data sources. Data sets contained both random and systematic 
errors. Systematic errors were generally detected by comparing two imperfect 
sources of information, and taking directional trends into account might explain the 
discrepancies. Possible reasons for random sources of error could include problems 
in recall (for self-reports) or data entry errors (for administrative data). In both, 
interpretation or coding differences might explain random errors. Also, differential 
bias may occur in trials examining innovative services, particularly where the 
boundaries between specific service providers are blurred from the patient’s per-
spective. These discrepancies in healthcare resource use that relate to cost ele-
ments might be of concern, especially when they have a large impact on the overall 
costs of care (e.g. hospital admissions, complex care packages). While the difference 
between two methods of data collection might be statistically significant, they 
might not be economically relevant, or vice versa. For example, if the healthcare 
resource use being researched (e.g. physiotherapy contacts) was one of the domi-
nant costs in the evaluation (i.e. due to the population-specific health complaints), 
then the addition or subtraction of one extra visit per patient may not be statistical-
ly significant but would be economically relevant. Therefore, one needs to properly 
address a priori usage and identification of items for making cost estimations.  
Implications for research and practice  
The assumptions made in some studies that administrative databases should be the 
reference standard is questionable, because they seem to have errors. When using 
the data for cost estimations, statistical corrections might be relevant. However, 
corrections for cost data from administrative databases when computing incremen-
tal cost effectiveness ratios are so far unavailable [29]. Previous reviews identified 
limitations of these databases [3, 5, 6]. The health economic community does not 
yet have a culture of validating resource use measurement, and there is a lack of 
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evidence regarding the collection of resource use data [30]. The MeRQ tool is a 
suitable instrument for further assessing the methodological reporting quality in 
order to deduce the validation evidence. The validation evidence of a (small) num-
ber of studies with adequate methodological reporting quality cautiously supports 
the exchangeability of both the self-reported and administrative resource use 
measurements. Coherent methodological quality which supports the interpreta-
tions of estimates and rigorous, well-reported research providing strategically col-
lected validation evidence is needed.  
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Appendix 2. Search strategy. Database: Medline (PubMed) 
(measure*OR correlat* OR evaluat* OR accuracy OR accurate OR precision OR agreement OR val-
id*[Title/Abstract]) AND (self report [MeSH Terms] OR self-report [Text Word] OR self-assessment[Text 
Word] OR patient self report [Text Word] OR patient-reported [Text Word] OR questionnaires [Mesh 
Term] OR recall [Text Word] OR interviews as topic [Mesh Term] OR health care surveys [Mesh Terms]) 
AND (Medical Records [MeSH Terms] OR Records as Topic [Mesh Term] OR medical records systems, 
computerized [Mesh Term], OR medical record administrators [Mesh Term]) AND (health resources 
[MeSH Terms] OR delivery of health care [MeSH Terms] OR utilization [Text Word] OR resource use 
[Text Word]) AND data collection [Mesh Term]) AND cost analysis 
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Abstract 
 
Background: In the Netherlands, absenteeism and reduced productivity due to work disabil-
ity lead to high yearly costs reaching almost 5% of the gross national product. To reduce the 
economic burden of sick leave and reduced productivity, different employability interven-
tions for work-disabled employees or employees at risk of work disability have been devel-
oped. Within this study, called ‘CASE-study’ (Cost effectiveness Analysis of Sustainable Em-
ployability), five different employability interventions directed at work disabled employees 
with divergent health complaints will be analyzed on their effectiveness and cost effective-
ness. This paper describes a consistent and transparent methodological design to do so.  
Methods/Design: Per employability intervention 138 participants are needed whereof 
approximately 69 participants receiving the intervention will be compared with 69 partici-
pants receiving usual care. Based on the intervention-specific characteristics, a randomized 
control trial or a quasi-experiment with match-criteria will be conducted. Notwithstanding 
the study design, eligible participants will be employees aged 18 to 63, working at least 12 
hours per week, and at risk of work disability, or already work-disabled due to medical re-
strictions. The primary outcome will be the duration of sick leave. Secondary outcomes are 
health status and quality of life. Outcomes will be assessed at baseline and then six, 12 and 
18 months later. Economic costs will consist of healthcare costs and cost of lost production 
due to work disability, and will be evaluated from a societal perspective. 
Discussion: The CASE-study is the first to conduct economic evaluations of multiple differ-
ent employability interventions based on a similar methodological framework. The cost 
effectiveness results for every employability intervention will be published in 2014, but the 
methods, strengths and weaknesses of the study protocol are discussed in this paper. To 
contribute to treatment options in occupational health practice and enable the development 
of guidelines on how to conduct economic evaluation better suited to this field; this paper 
provides an important first step.  
 
Trial Registration: Four trials involved in the CASE-study are registered with the Nether-
lands Trial Registry: Care for Work (NTR2886), Health and Motion (NTR3111), Guidance to 
Excel in Return to Work (NTR3151), Care for Companies/Second Care (NTR3136).  
 
Keywords: economic evaluation, cost effectiveness, employability, return-to-work, work 
disability.  
 
Published as: C. Y. Noben, F. J. Nijhuis, A. E. de Rijk, S. M. Evers. Design of a trial-based 
economic evaluation on the cost effectiveness of employability interventions among work 
disabled employees or employees at risk of work disability: The CASE-study. BMC Public 
Health 2012;12:43. 
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Background  
Work disability  
Many recent studies have focused on reduced productivity and work absence due 
to work disability in Western countries [1-5]. Work disability prevents or detracts 
the employee’s productivity and has many economic and public health consequenc-
es, such as problems for employers, employees, their families, and society [6-8]. In 
Western countries its main consequences are financial, due to reduced productivi-
ty, increased job turnover and the cost of additional rehabilitation programs [9-11]. 
In order to estimate the costs of work disability, staff absence and presence needs 
to be recorded. Absenteeism refers to the total days lost from work. Presenteeism 
refers to attending work whilst still stick or disabled, causing reduced productivity 
while at work [12]. Absenteeism and presenteeism can be used as integrated 
measures of physical, psychological and social functioning in studies of working 
populations [12, 13]. In the Netherlands, the Sickness Absence Reduction Act was 
introduced in 1994 in an attempt to reduce absenteeism. Although there has been a 
major reduction in absenteeism, nearly three million Dutch workers still suffer 
from one or more chronic conditions which constrains their work performance 
[14]. Sickness absence remains a large problem in terms of costs, labor participa-
tion and social consequences [11, 15, 16]. The most common causes of sickness 
absence are: musculoskeletal complaints, mental health problems, and cardiovascu-
lar diseases [17, 18]. Chronic diseases are more common among workers of 45 
years and older, and it is expected that this age group will greatly increase, leading 
to a growing number of occupational health problems [17, 18]. In the Netherlands, 
the total annual costs of absenteeism arising from health complaints and work dis-
ability amounted to 26 billion Euros, which accounts for almost 5% of the gross 
national product [14]. Additionally, Kremer and Steenbeek (2010) have computed 
that approximately 21.5% of absenteeism from work could be avoided if health 
services and employer and employee opportunities improved. To do this, shorter 
referral times, swifter medical care, improved collaboration between health care 
providers, reduced workload and an improved work-life balance are important 
factors [17, 18].  
Return-to-Work  
Different return-to-work (RTW) interventions have been developed and evaluated 
to reduce sickness absence due to work disability. The effect, and occasionally the 
cost effectiveness, of RTW interventions have been demonstrated in several obser-
vational studies [19-24], randomized controlled trials [25-30] and reviews [31, 32]. 
For example, Franche et al. [31] concluded that work-based RTW interventions 
among employees with work-disability caused by musculoskeletal or other pain-
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related conditions can reduce work disability duration and associated costs. 
Lambeek et al. [33] showed that an integrated care program for work-disabled 
participants with chronic low back pain has the potential to significantly reduce 
societal costs and improve care effectiveness, quality of life and function on a broad 
scale [33]. Other studies demonstrate that implementing preventive interventions 
before sickness absence occurs can be successful in preventing long-term sickness 
absence [19, 29, 34, 35]. Whilst these results are very promising for society, partic-
ipants, and employers, more research is necessary to confirm the long-term effects 
and cost effectiveness of such interventions. However, methodological limitations 
in the current literature make it difficult to assess the feasibility of the different 
interventions proposed. These limitations include restriction of the population of 
interest due to the strict inclusion criteria, restrictions in the nature of the interven-
tion evaluated, restrictions in study-design and the measurement of outcomes. 
There is moreover, a lack on transparency and consensus about how to conduct 
trial-based economic evaluations within the general field of employability.  
Objectives 
This paper is the first of its kind to describe a transparent, uniform methodological 
design for the economic evaluation of several different trial-based interventions in 
the field of employability, disability and return-to-work. Known as the ‘CASE-study’ 
(Cost effectiveness Analysis of Sustainable Employability), the project’s aim is to 
evaluate at least five different employability interventions. All of the interventions 
share the common aim of reducing absenteeism and optimizing the employability 
of employees with a known disability or those at risk of disability due to musculo-
skeletal complaints, mental health problems or a combination of both musculoskel-
etal and mental health complaints. In contrast with previous studies, the project 
design has no population restrictions and allows for the economic evaluation of any 
employability intervention regardless of the population they were developed for. 
Furthermore, the project also includes interventions provided in the primary and 
specialist health sectors as well as those delivered within the workplace. It also 
includes interventions aimed at reducing health care costs, wage replacement costs 
and other intervention costs in addition to improvements in return to disability 
duration and work return rates as measured by self-reported return to work dates, 
total duration of absence and subsequent recurrences, etc. Other outcomes include 
quality of life, quality of work life and general health status, etc. In addition, we cast 
a wide net to include a range of study designs since RCTs are not always possible in 
the economic evaluation of employability interventions. This paper describes the 
patient inflow in the event of an RCT or a quasi-experiment with a matched con-
trolled design being conducted. For every employability intervention, an effect 
study will be conducted. In addition, from a societal perspective, a trial-based eco-
nomic evaluation for every employability intervention will be carried out in a con-
sistent manner. The results of these analyses will be discussed elsewhere in the 
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future, but we hypothesize that the employability intervention is preferable in 
terms of costs, effects and utility compared to usual care. This paper will therefore 
demonstrate the strength of the CASE-study project in prescribing a methodological 
design which allows for the assessment of several different types of employability 
interventions within varying populations. 
Methodology 
Methods/design 
Organization of the CASE-study 
We will carry out an economic evaluation designed for at least five Dutch employa-
bility interventions. Those undertaking the evaluation are not connected with 
the organizations or individuals who have developed, or are in the process of de-
veloping the employability interventions so no competing interests arise. Within 
the CASE-study each existing or innovative intervention will be compared with 
usual care for work-disabled employees or those at risk of work disability due to 
medical restrictions. At the start of the CASE-study, nine programs were interested 
in participating in the project. Unfortunately four programs could not collaborate 
because they were unable to provide the minimum required number of participants 
eligible for the study, or could not provide a comparable control group. The remain-
ing five employability interventions have the ability to comply to the minimal re-
quirements and focus on primary care, secondary or specialist care, and/or on the 
interaction between the employer and employee. Two existing employability inter-
ventions (called ‘Best Practices’) and three newly developed employability inter-
ventions are included in the study. The employability intervention focusing on pri-
mary care aims to acknowledge the importance of employability in general practice. 
This intervention is under development at the University of Nijmegen (UMC St Rad-
boud). The employability intervention in specialist care is being developed by the 
VU University Medical Centre Amsterdam (VUmc) and focuses on employability 
among patients who suffer from rheumatoid arthritis. The third newly developed 
intervention aims at improving the interaction between the employee and his/her 
employer by appointing an independent mediator. The intervention is being devel-
oped by a separate team at Maastricht University. One of the ‘Best Practice’ inter-
ventions, developed by Health & Motion Nederland, offers patients with physical 
health complaints the ability to implement a range of exercises learned at the phys-
iotherapeutic setting in their working environment by means of a workplace-
intervention. The fifth and final intervention is developed by Second Care/Care for 
Companies (Best Practice) and aims at achieving sustainable employability among 
patients with physical and/or psychological health complaints using a multidisci-
plinary approach. An overview of these interventions is provided in Figure 1.  
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It is beyond the scope of this design article to describe the precise content of each 
employability intervention in detail. This will be done when the results of the eco-
nomic evaluation per employability intervention are published. What is of im-
portance in this paper is that the employability interventions use an innovative, 
systematic approach in order to support work participation in employees with 
health complaints. These are innovative because both the healthcare system and 
the private/work life of the employees are considered in the intervention. The fea-
tures of the interventions differ according to the patient population, but the aim 
remains the same: to reduce sickness absence and increase the potential of achiev-
ing sustainable employability.  
 The protocol for this study has been approved by the Ethics Committee of Psy-
chology (ECP107) at Maastricht University, the Netherlands.  
D E S I G N  O F  T R A I L - B A S E D  E C O N O M I C  E V A L U A T I O N S  
 109 
Figure 1. Employability interventions included in the CASE-study 
 
Usual work resumption care in the Netherlands  
The Gatekeeper Improvement Act stipulates that the responsibility for work re-
sumption lies with the employer and the employee. The employer is obliged to start 
an employee’s work resumption program as quickly as possible, so the employee 
can resume his/her own work or other adequate work. In return, the employee 
should accept the work activities the employer provides. Furthermore, and unique 
in the world, the Dutch reintegration process provides the employer with salary 
and mandatory reintegration obligations for a period of two years [36]. Participants 
included in the care as usual group will continue to receive care for their health 
complaints, but attention to work-related factors influencing these will only occur 
minimally. Nevertheless, since attention to labor and health-related characteristics 
is obligatory under the Gatekeeper Improvement Act [36], participants in the care 
as usual group who are work-disabled will also receive adequate care (care as usu-
al). Participants included in the control group will be treated and supervised ac-
cording to good clinical practice based on the evidence-based guidelines of the 
Dutch association of occupational physicians [37, 38]. 
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Participants  
Employees eligible for participation in the study will be work-disabled or at risk of 
work disability due to medical restrictions. In order to identify these employees, we 
will use employer registration forms, registrations with health care organizations 
and insurance companies, and registration forms from those providing the inter-
vention. Employees eligible for inclusion will be 18 to 63 years of age, perform paid 
labor for at least 12 hours per week, and are able to communicate in Dutch. Rea-
sons for exclusion are absenteeism for 1.5 years or longer, fulltime students with a 
student job, informal caregivers and/or volunteers.  
 In order to recruit a sufficient number of eligible employees, one or more health 
care providers providing an employability intervention will screen service users for 
inclusion in the study. When appropriate, information on the research will be pro-
vided to the patient. This will be done orally by the health care provider, possibly 
supported by a handout containing contact information for the researchers, what is 
expected of participants, privacy concerns, and so on. A self-completion card will be 
attached to each flyer (handout) consisting of a short checklist for inclusion and 
informed consent form for signing. The employee is requested to fill in the short 
checklist, sign the informed consent form, and send these back to the researcher. 
Participants will have at least one week to consider their participation in the study 
before signing the informed consent form. Participants will be screened for exclu-
sion by the researcher on the basis of answers provided on the checklist. If an em-
ployee meets all the selection criteria and is willing to sign the consent form, ran-
domization or matching will then place. Before the intervention starts, the first 
(baseline) measurement occurs. An email with a login code is sent to all partici-
pants, and they will be asked to fill in the baseline questionnaire. The questionnaire 
for the intervention group is identical to the one for the control group.  
Study design 
As suggested by Drummond et al. (2001), a randomized controlled trial (RCT) re-
mains the standard design for evaluating the relative effect of candidate interven-
tions [39]. However, due to practical reasons, randomly assessing participants to 
the employability intervention or care as usual is not always possible in the CASE-
study. Employers and occupational physicians are legally obliged to offer sickness 
absence guidance, and to do so, they refer employees to one or more employability 
interventions. Thus, a quasi-experiment, comparing employees who are allocated to 
an experimental intervention in a non-random manner with those non-randomly 
assigned to a conventional intervention is regarded as the next best study design. 
Unlike an RCT, a quasi-experiment consists of a control group derived from a large 
non-equivalent population. The variables are not manipulated, and participants are 
selected on the basis of matched criteria with those in the non-intervention group. 
Randomization is not used therefore, and participants/control members are select-
ed on the basis of their having an equal chance of demonstrating a causal relation-
ship between the intervention and its outcomes for the control or experimental 
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intervention. Both quasi-experiments and RCTs are acceptable for the economic 
evaluation of employability interventions. The anticipated flow of subject enrol-
ment in a quasi-experiment or RCT is shown graphically in Figure 2.  
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Figure 2. Participants flow 
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Randomization / matching 
In the case of randomization, the minimization method will be applied. Minimiza-
tion aims to ensure an excellent balance for several prognostic factors in small 
groups [40]. Employees consenting to participate will be pre-stratified according to 
age (18-32 years, 33-48 years, 49-64 years), gender, and working hours (12-24 
hours/week, >24 hours/week). Since health care providers will treat participants 
in both the intervention and in the control groups, the study cannot be blinded. 
Matching i.e. formulating experimental and control groups on the basis of pairing 
participants on the basis of predetermined matching criteria will be used. These 
matched-criteria are age, working hours and health complaints. Thus, an employee 
in the intervention group will be matched to someone meeting the same criteria 
who will then act as a member of the control group.  
Timeline of the study 
During recruitment, employees will be asked whether they want to participate in 
the research by one or more health care providers operating in the employability 
intervention. Participation requires employees to fill in a self-reported online ques-
tionnaire at time points T0 (baseline), T1 (six months after admission), FU1 (12 
month follow-up) and FU2 (18 month follow-up). After eighteen months the study 
results for sustainable employability and quality of life are expected to extend into 
subsequent years. The timeline of the study can also be found in Figure 2. 
Outcome assessment and data collection  
The outcome assessment and data collection is identical for every employability 
intervention. Questions derived from different questionnaires, such as the ‘National 
Working Conditions Survey’ (NEA) [18], ‘EuroQol 5 Dimensions 5 Levels’ (EQ-5D-
5L) [41], ‘Short Form Health Survey’ (SF-36) [42], ‘Trimbos/iMTA questionnaire for 
costs associated with psychiatric illness’ (TIC-P) [43], and ‘the productivity and 
disease questionnaire’ (PRODISQ) [44], are combined into a retrospective self-
reported questionnaire. The economic evaluation will be analyzed from a societal 
perspective. This means that the most appropriate set of costs captured from the 
data (e.g. health care costs, productivity costs etc.), regardless of where the costs or 
benefits occur, will be applied [36]. 
Effect evaluation 
Primary outcome measure 
The primary outcome measure in the CASE-study is reduced sickness absence dura-
tion in calendar days. Reduced sickness absence will be measured subjectively via 
patient self-report records. The duration of sick leave will be calculated as the time 
in calendar days since reduced productivity occurred (baseline). This will then be 
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compared with the productivity time of a person at six, 12, and 18 months. The 
success of an intervention will be defined by comparing the average reduction in 
sickness absence between the intervention group and the control group. The em-
ployability intervention is effective when the employees in the intervention group 
return to work twice as quickly as employees in the control group. Data on sickness 
absence duration will be gathered by using the productivity and disease question-
naire (PRODISQ) [46].  
Secondary outcome measures  
Data on secondary outcome measures will be gathered by means of self-
administered questionnaires such as, NEA [18], EQ-5D-5L [41], SF-36[42], TIC-P 
[43] and PRODISQ[44].  
 Sustainable employability  
After commencing a treatment intervention, a follow-up measurement will take 
place at 12 and 18 months to analyze the sustainability of employability. An inter-
vention will be deemed to be unsuccessful when absenteeism of more than four-
teen consecutive days after receiving the productivity intervention occurs. On the 
basis of previous research, it will be assumed that the long-term effect of the em-
ployability intervention stabilizes after 18 months [24].  
 Self-rated health  
Self-related health will be assessed using one item from the Short Form Health 
Survey (SF-36). This widely used measurement tool describes how a respondent 
values and assess his/her general health [45]. Data gathered via questions derived 
from the NEA [18] will be used to detect health complaints underlying work disabil-
ity and co-morbidity.  
 Quality of Life  
An explorative analysis of productivity costs and quality of life showed a clear rela-
tionship between both variables [45]. Therefore, quality of life will be measured in 
work-disabled employees by using the EuroQoL five dimensions, five levels (EQ-
5D-5L) [41]. The EQ-5D-5L comprises 5 dimensions: mobility, self-care, usual activ-
ities, pain/discomfort and anxiety/depression. There are five possible answers for 
each dimension, defining (55) 3,125 possible health states. Furthermore, the EQ-5D-
5L includes a visual analogue scale (VAS) rating from zero (worst imaginable health 
state) to 100 (best imaginable health state) [41]. 
Economic evaluation 
Self-reported questionnaires will capture the costs and benefits from a societal 
perspective, thus independently of those who bear the costs, and those who receive 
the benefits. Self-reported questionnaires appear to be a reliable alternative for 
cost-diaries, at least for a recall period of six months, since participants will still 
remember significant life events [46-49]. Costs that arise in different years will be 
discounted at 4% [50]. Costs directly related to the provision of the employability 
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intervention will be objectively registered via the providers of the employability 
intervention. Direct healthcare costs and direct non-healthcare costs comprise re-
spectively: costs of visits for primary and secondary care, home care, drugs, and for 
visits to an alternative or informal health therapist. Direct costs will be measured 
by an adapted version of the Trimbos/iMTA questionnaire for costs associated with 
psychiatric illness [43] and will be estimated on the basis of prices suggested in the 
cost calculation guidelines for healthcare in the Netherlands [50]. The prices of 
prescribed drugs will be based on Daily Defined Dosage (DDD) taken from the Roy-
al Dutch Society for Pharmacy [50]. Indirect costs will be determined by measuring 
data on the costs of lost productivity due to work disability and are derived through 
the PRODISQ [45]. The indirect costs of production loss due to sick leave will be 
calculated by means of the friction cost method whereby the number of days of 
sickness absence and lost earnings are used to calculate the costs of production 
losses. Lost earnings will be determined on the basis of the differences between 
income at baseline and income at follow-up. Based on a mean added value of the 
Dutch working population, production losses are confined to the period needed to 
replace a sick employee [44]. The indirect costs of productivity losses without sick 
leave will be based on the number of days in which productivity was hindered due 
to health complaints and an estimation of the efficiency in these days [51]. Fur-
thermore, compensation will be taken into account when determining production 
loss. Information about the number of hours to catch up with the work will be ob-
tained as well as the way in which this compensation was achieved. If these data 
are considered invalid, for example because the income data of too many employ-
ees are unknown, we will use national data of average production value per worker, 
related to the education level and labor sector.  
Sample size 
For the economic evaluation of the three newly developed employability interven-
tions, the study sample size was pre-specified by the researchers and the develop-
ers of the particular interventions. For the sample size calculation of the existing 
‘Best Practices’, we expect that a Hazard Ratio (HR) of 2.0 indicates a relevant dif-
ference in the average number of hours/days of lost work due to work disability 
between employees in the intervention group and employees in the control group 
after 18 months. This HR is based on findings of recent studies in occupational 
health care [25, 52-55]. With a power of 80% at a 0.05 significance level, the sample 
size was calculated to be 120 employees [56]. Taking into account a dropout rate of 
15%, 5% per follow-up measurement time, a total of 138 participants are needed. A 
dropout is defined as an employee who has not filled in the questionnaire at one or 
more measurement time-points.  
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Data analyses  
Effectiveness 
All statistical analyses, performed to distinguish differences between the control 
group and the intervention group, will be performed according to the intention-to-
treat principle. This means that the participants will remain in the group they were 
allocated to at baseline. All data regarding primary and secondary outcomes will be 
analyzed using descriptive statistics. To control for protocol deviations likely to 
cause bias, data will be analyzed using per-protocol analyses whereby outcomes 
will be compared between those participants who received at least one or a partial 
intervention session and the control group. With the aim of correcting for possible 
regression to the mean, the baseline value of the particular outcome variable will be 
added to the model. Days of sick leave in the year before the inclusion, measured at 
baseline, will be added as a potential effect-modifier.  
 Diagnosis and prognostic parameters can be confounders, thus the Cox regres-
sion analysis for confounders will be used to adjust for differences between control 
and intervention groups. If necessary, differences in baseline will be adjusted for 
prognostic dissimilarities. Missing data will be handled using SPSS missing value 
analysis on item level. Completely missing measurements will be handled using 
multiple imputation.  
 The primary dependent variable is days of absence from work. In order to es-
timate the number of absence days, survival analyses will be used. There are two 
reasons why we opted to use survival statistics. Firstly, the time to sustainable em-
ployability is unlikely to be normally distributed which will make parametric statis-
tical analysis difficult or inappropriate. Increasing productivity can occur quite 
early, possibly within months, but can also, as expected in the care as usual situa-
tion, may not be prolonged or may even decrease again. Secondly, survival analysis 
accounts for dropout by the technique of censoring. Participants who drop out will 
have the same hazard of sustainable employment than those that remained in the 
study. The Cox Proportional hazard model will therefore be used to analyze the HR 
of the days of sick leave duration. Reduced sickness absence duration in calendar 
days will be analyzed with the Kaplan Meier survival method, and the differences in 
absence duration between both groups will be tested with a log rank test.  
 To analyze the secondary outcomes, longitudinal multilevel analyses will be 
used to assess the differences in health and quality of life between the control 
group and the intervention group. Data will be analyzed in SPSS 17.0.  
Economic evaluation  
The economic evaluation will be carried out according to the intention-to-treat 
principle. Non-parametric bootstrapping (1,000 replications) will be used to obtain 
95% confidence intervals to estimate the uncertainty surrounding the cost differ-
ences, because cost-data are usually skewed to the right [57].  
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For the cost effectiveness analysis, the incremental cost effectiveness ratio (ICER) 
will be calculated by assessing the ratio of the differences in costs between the 
groups to the differences in effects between the groups. The ICER indicates whether 
the additional investments needed for the interventions gain at least one extra unit 
of effect compared with care as usual [57]. The cost utility ratio will be calculated 
by the incremental costs divided by the difference in QALYs [39, 58].  
 Bootstrapping with 5,000 replications will be used to estimate the sample-
uncertainty around the point estimates (ICER and ICUR). The bootstrapped ICERs 
and ICURs will be graphically presented on a cost effectiveness plane. Furthermore, 
acceptability curves will show the probability that the employability intervention is 
cost effective at a specific ceiling ratio, which is the maximum amount of money 
society is willing to pay to gain one extra unit of effect or a gain in quality of life 
[59]. Finally, the robustness of the different parameters on the cost effectiveness 
calculation will be assessed by sensitivity analyses. Data processing will be done in 
SPSS 17.0 and bootstrapping will be carried out in Excel.  
Discussion  
This study protocol provides detailed information on how to assess the effective-
ness and cost effectiveness of employability interventions among employees with 
work disabilities or employees at risk of becoming work-disabled due to health 
complaints. The results derived from these economic evaluations can benefit the 
individual employee, the employer and the broader occupational health practice 
sector because illness duration, care consumption and costs of lost productivity are 
expected to decrease if the employability intervention is cost effective. For society 
as a whole, cost effective employability interventions are attractive since they are 
expected to increase labor participation and public health. Furthermore, we feel 
that productivity is the key to higher economic growth as we are facing an ageing 
population.  
 A limitation of this study-design is the generalizability to other countries. The 
employability interventions are specifically tailored for the Dutch context in which 
they will be implemented. When applying these interventions in other countries, 
specific characteristics of the population in relation to the societal, political and 
cultural context in which the interventions are to be used should be taken into ac-
count. Although international generalizability might be restricted and require adap-
tation to the intervention, lessons can be learned and implementation advice given 
to those engaging in future work.  
 Selection bias cannot be ruled out in this design because we ask the healthcare 
provider to select employees to participate in our study. As a consequence, 
healthcare providers cannot be blinded. Furthermore, the consultation with the 
health care provider might change the participants’ point of view on work disabil-
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ity. This ‘Hawthorne effect’ will be born in mind and might overestimate or under-
estimate the effect of the intervention. However, we feel that minor interactions 
such as the provision of information about the study will not be an important 
source of bias. 
 The strengths of this pragmatic design looking at the cost effectiveness of em-
ployability interventions versus usual care, is the comparison under ‘real life’ cir-
cumstances of the intervention and control variables. Resource use is self-reported 
by participants and will be collected separately from the unit costs or prices of 
those resources. We will keep in mind the possibility that health care and interven-
tion providers in different settings may wish to apply their own prices to the units 
of resource use. Furthermore, due to the standard recall period of six months, an 
adequate estimation of resource use is linear over time. This linear time trend re-
stricts overestimation and underestimation of resource use between two consecu-
tive measurement moments. An additional strength of this design is the inclusion of 
losses due to sick leave and the costs of using health care facilities together with 
productivity losses during working periods whilst unwell (presenteeism). In devel-
oping the methodology, we kept in mind the possibility that the employability and 
usual care interventions may have different effects on the component of reduced 
productivity while at work and therefore capture these. Besides internal validity, 
external validity of the results of the economic evaluation is reached by analyzing 
the data from a societal perspective. We can split the calculated cost effectiveness 
from the societal perspective to other perspectives, e.g. employee perspective, or-
ganizational perspective, etc.  
 To conclude, the research design provided in this article will be applied to each 
employability intervention included in the CASE-study. The CASE-study is the first 
study assessing the cost effectiveness of different employability interventions. In 
addition, this design might contribute to new and better guidelines in the conduc-
tion of future economic evaluations in the occupational health sector. The results of 
the CASE-study will become available between 2012 and 2014.  
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Abstract 
Background: The specific job demands of working in a hospital may place nurses at elevated 
risk for developing distress, anxiety and depression. Screening followed by referral to early 
interventions may reduce the incidence of these health problems and promote work func-
tioning.  
Objective: To evaluate the comparative cost effectiveness of two strategies to promote work 
functioning among nurses by reducing symptoms of mental health complaints. Three condi-
tions were compared: the control condition consisted of online screening for mental health 
problems without feedback about the screening results. The occupational physician condi-
tion consisted of screening, feedback and referral to the occupational physician for screen-
positive nurses. The third condition included screening, feedback, and referral to e-mental 
health.  
Design: The study was designed as an economic evaluation alongside a pragmatic cluster 
randomised controlled trial with randomisation at hospital-ward level.  
Setting and participants: The study included 617 nurses in one academic medical centre in 
the Netherlands.  
Methods: Treatment response was defined as an improvement on the Nurses Work Func-
tioning Questionnaire of at least 40% between baseline and follow-up. Total per-participant 
costs encompassed intervention costs, direct medical and non-medical costs, and indirect 
costs stemming from lost productivity due to absenteeism and presenteeism. All costs were 
indexed for the year 2011.  
Results: At six months follow-up, significant improvement in work functioning occurred in 
20%, 24% and 16% of the participating nurses in the control condition, the occupational 
physician condition and the e-mental health condition, respectively. In these conditions the 
total average annualised costs were €1,752, €1,266 and €1,375 per nurse. The median in-
cremental cost effectiveness ratio for the occupational physician condition versus the control 
condition was dominant, suggesting cost savings of €5,049 per treatment responder. The 
incremental cost effectiveness ratio for the e-mental health condition versus the control 
condition was estimated at €4,054 (added costs) per treatment responder. Sensitivity anal-
yses attested to the robustness of these findings.  
Conclusions: The occupational physician condition resulted in greater treatment responses 
for less costs relative to the control condition and can therefore be recommended. The e-
mental health condition produced less treatment response than the control condition and 
cannot be recommended as an intervention to improve work functioning among nurses.  
 
Keywords: cost effectiveness, mental disorders, nurses, occupational health, prevention & 
control, randomised controlled trial, stress, work functioning. 
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Introduction 
Nurses are at elevated risk for mental distress, anxiety and depression [1-4]. Possi-
ble explanations for this increased risk are found in work characteristics such as 
high job demands and a lack of autonomy [2,5] Poor mental health is not only unde-
sirable in its own right, but will likely also have an adverse impact on the nurses’ 
job functioning and may thus jeopardise the health and safety of the patients in 
their care. After all, nurses with poor mental health experience significantly more 
medical errors [2,6,7]. For these reasons it is imperative to protect and promote 
mental health in nurses, and to monitor and safeguard the quality of their function-
ing at work [2].   
 Mental disorders carry substantial disease and economic burdens. Preventive 
interventions for mental disorders exist; however, what interventions should be 
financed and implemented is an issue that needs to be addressed by decision mak-
ers. Moreover, the number of health-economic evaluations that were conducted in 
the work setting is very limited. Likewise, information to aid in the transferability 
of available results to different contexts and settings is limited [8]. Economic evalu-
ations can provide answers, select interventions that are cost effective and avoid 
wasting limited resources. An approach to priority setting is largely based on eco-
nomic techniques to assess the cost effectiveness to answer questions regarding the 
economic value for money of competing interventions [9,10]. 
 Periodic screening might be useful to identify nurses with signs of mental 
health problems and encourage help-seeking behaviour. To that end a Worker 
Health Surveillance was developed. The Worker Health Surveillance is a preventive 
strategy that aims at the early detection of negative health effects at work [2,11,12]. 
A Worker Health Surveillance with personalised feedback and referral to dedicated 
early interventions for screen positives might be a successful strategy to prevent 
the onset and further deterioration of mental health problems and to reduce im-
pairments in work functioning [2,13]. In this study we compare a control condition 
consisting of screening without feedback versus Worker Health Surveillance 
screening with feedback plus referral for a consultation with an occupational physi-
cian or referral to preventive e-mental health interventions. These approaches have 
not been evaluated from a health-economic perspective.  
 Therefore, the aim of this study is to assess the comparative cost effectiveness 
of the occupational physician condition and the e-mental health condition versus 
the control condition, with a view to protecting mental health and improving and 
sustaining work functioning in nurses.  
C H A P T E R  5  
 128
Methods 
Design 
The Mental Vitality @ Work study [14] was designed as a pragmatic cluster ran-
domised controlled trial, with randomisation at the level of hospital wards to three 
conditions:  
1) Screening and feedback followed by referral to the occupational physician for 
screen-positives (the occupational physician condition). 
2) Screening and feedback followed by referral and access to preventive e-mental 
health interventions (the e-mental health condition).  
3) Screening without feedback and without referral to either the occupational 
physician or the e-mental health interventions (the control condition).  
Data were recorded at baseline and after three and six months. In the economic 
evaluation, we assessed the comparative cost effectiveness in two contrasting sce-
narios: (1) the occupational physician condition versus the control condition, and 
(2) the e-mental health condition versus the control condition. A medical ethics 
committee approved the study.  
Randomization  
Cluster randomisation was performed at the ward level to prevent contamination 
between participants working in the same ward. A pre-randomisation procedure 
with incomplete-double-consent design was applied [15,16] meaning that individu-
als were only informed about their own group. This further minimised the possibil-
ity of contamination. 
 Randomisation was conducted using the computer software programme 
Nquery Advisor in blocks of three wards. After randomisation, 28 wards with 591 
employees were assigned to the occupational physician condition, 29 wards with 
579 employees to the e-mental health condition, and 29 wards with 561 employees 
to the control-condition.  
Sample  
The study population of the complete trial included all nurses with similar work 
demands and work conditions; including surgical nurses, anaesthetic nurses, and 
allied health professionals (henceforth: nurses) working in one Dutch academic 
medical centre. Nurses who were sick-listed at the start of the study and expected 
to be on sick leave for more than two weeks were excluded from the study. All eli-
gible employees were invited to take part in the study, which for the complete trial 
added up to 1,731 employees working in 86 wards. Cost effectiveness analyses 
were performed according to the intention-to-treat principle for the whole sample. 
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However, participation rates of the nurses in the interventions at baseline were 
34% in the control condition; 32% in the occupational physician condition; and 
31% in the e-mental health condition.  
 After randomisation, 212 nurses were assigned to the e-mental health condi-
tion, 210 to the occupational physician condition and 211 to the control condition. 
Sixteen nurses (three in the occupational physician condition, eight in the e-mental 
health condition and five in the control condition) were sick-listed for more than 
two weeks at the start of the trial, did not contribute to the data and were excluded 
from the analysis. Thus, the study population comprised a total of 617 nurses: 207 
in the occupational physician condition, 204 in the e-mental health condition and 
206 in the control condition.  
Interventions 
All participants were screened for work functioning impairments and six types of 
mental health complaints: distress, work-related fatigue, risky drinking, depression, 
anxiety, and post-traumatic stress disorder. Nurses in the control condition filled 
out the questionnaires and no further steps were taken. After completing the 
screening, the occupational physician condition and the e-mental health condition 
immediately received personalised feedback about their screening results.  
 In the occupational physician condition, screening and feedback were followed 
by an invitation for the screen-positives to attend the occupational physician. The 
nurses consulted the occupational physician or not at their own discretion. In order 
to structure the consultation of the occupational physician, a seven-step protocol 
was applied, with the focus on identifying impairments in work functioning and 
providing advice on how to improve wellbeing and work functioning.  
 In the e-mental health condition, screening and feedback were followed by 
referral to e-mental health interventions. The e-mental health interventions offered 
in the e-mental health condition were Psyfit, aimed at promoting mental fitness and 
wellbeing; Strong at Work, aimed at learning skills to cope better with work-related 
stress; Colour your Life, for coping with depressive symptoms; Don’t Panic Online, to 
reduce symptoms of panic disorder; and Drinking Less, aimed at reducing risky 
alcohol consumption. Nurses who screened positive on one of these health prob-
lems were offered access to the corresponding e-mental health intervention. Nurses 
screening negative on mental health complaints, but positive on work functioning 
impairments were offered Psyfit and an onscreen psycho-educational leaflet about 
dealing with these impairments. Nurses screening negative on both mental health 
complaints and on work functioning impairments were only offered free access to 
Psyfit. The onscreen psycho-educational leaflet was also offered when nurses 
screened positive on mental health complaints and on work functioning impair-
ments. In any case, making use of the e-mental health interventions was strictly 
voluntary and nurses were free to reject the offer of using the interventions [14]. 
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Outcome measure 
The primary outcome was work functioning as measured by the following sub-
scales of the Nurses Work Functioning Questionnaire: cognitive aspects of task 
execution, causing incidents at work, avoidance behaviour, conflicts and irritations 
with colleagues, impaired contact with patients and their family, lack of energy and 
motivation. The Nurses Work Functioning Questionnaire is a 50-item self-report 
questionnaire with Likert-type response scales ranging from 0 (totally disagree) to 
6 (totally agree); 0 (disagree) to 4 (agree); and 0 (no difficulty) to 6 (great difficulty) 
[11]. Internal reliability of the Nurses Work Functioning Questionnaire is high, with 
Cronbach's alphas varying between 0.70 and 0.94 [17].  
 The difference between the occupational physician condition and the e-mental 
health condition versus the control condition was examined as the percentage of 
individuals who improved at follow-up. The primary outcome of work functioning 
is operationalised as job-specific impairments in work functioning and were meas-
ured using a total score of the Nurses Work Functioning Questionnaire. The mini-
mal important change value for improvement was based on the relative pre-post 
change scores, that is (T0 − T1 / T0) × 100%, indicating the percentage of change on 
impaired work functioning in relation to the baseline score. Individuals with a rela-
tive improvement on their Nurses Work Functioning Questionnaire total score of 
40% or more [18], which is the minimal important change (MIC) value, were de-
fined as relevantly improved, and henceforth denoted as treatment responders.  
Resource use and costing 
Resource usage and costs entailed can be split into (a) intervention costs; (b) direct 
medical costs (due to health service uptake and pharmacy use); (c) direct non-
medical costs (the nurses’ out-of-pocket costs for travel and parking, incurred while 
making use of health services); and (d) indirect costs stemming from lost produc-
tivity in paid work due to absenteeism and presenteeism. All costs were in Euro 
indexed for the reference year 2011 based on the price indices from Statistics 
Netherlands [19]. 
Intervention costs 
When calculating the intervention costs, a distinction was made between human 
and material resources. Material resources are divided into capital items that have 
a time span longer than one year, such as the equipment that was needed to build 
the screening module for the provision of the feedback and the interventions, and 
recurrent or revenue items that are consumed in less than one year, such as 
maintenance costs. For human resources, costs were based on the valuation of the 
personnel involved in the development and the application of the intervention. The 
corresponding calculations for the intervention costs can be obtained from the first 
author. 
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The per-participant costs for the online Worker Health Surveillance were estimated 
to be €3.80. The costs of the occupational physician intervention consisted of the 
per-participant screening costs of €3.80 plus the costs of the occupational physician 
at €73.11 per contact. For the e-mental health intervention, the per-participant 
costs were the screening costs of €3.80 plus the costs of the specific e-mental health 
interventions. The costs of the e-mental health interventions were only charged 
when a participant logged in to an e-mental health intervention and thus became a 
user of that intervention. The e-mental health interventions have fixed per-
participant cost prices that are based on their market values, which are subject to 
change over time. In the reference year of 2011, the per-user costs were as follows: 
Psyfit €30, Strong at Work €175, Colour your Life €195, Don’t Panic Online €225 and 
Drinking Less €45.  
Direct medical costs 
Health service costs were calculated by multiplying the health service units (con-
tact, session, hour) with their standard full economic cost price. The standard costs 
were reported in the Dutch guideline for health economic evaluations [20] and 
indexed for the year 2011 using the consumer price index from Statistics Nether-
lands [19]. The costs of prescription drugs were calculated as the price per stand-
ard daily dose as reported in Dutch guidelines and multiplied by the number of 
days [21]. The pharmacist’s dispensing costs of €5.99 and the general practitioners’ 
prescription costs of €14 were added [20]. Over the counter drugs were based on 
their market prices.  
Direct non-medical costs 
The participants’ travel and parking expenses incurred in receiving professional 
help were computed as the distance to a health service multiplied by the costs per 
kilometre (€0.21), with parking costs (€3 per hour) added [20]. 
Indirect non-medical costs 
Finally, the costs stemming from production losses in paid work were calculated 
from the number of days absent from work (absenteeism) plus the number of 
workdays lost due to work cutback (presenteeism). Presenteeism was calculated by 
correcting for the degree of inefficiency, resulting in an inefficiency score used as 
point prevalence for the calculation of presenteeism costs. The inefficiency score 
for work quantity and work quality derived from items from the Productivity and 
Disease Questionnaire (ranging from 0 to 1, with 0 meaning not inefficient and 1 
completely inefficient) was multiplied by the number of days at work while not 
feeling well in order to compute the costs of presenteeism [22]. 
 The valuation method for productivity is rooted in the human capital theory 
whereby the production losses are assumed to equal the present value of all lost 
future earnings of the individual. That is, income (before tax) acts as a proxy for the 
production value of that individual and encompasses all productivity losses by this 
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person [23,24]. The costs of productivity losses were then assessed by multiplying 
the number of workdays lost by the gender and age-specific productivity levels per 
paid employee, indexed for the year 2011 [19,20]. 
Analyses 
All analyses were performed in agreement with the intention-to-treat principle, 
thus including all participants as randomised. To that end, missing data were im-
puted. Since substantial dropout had occurred, sensitivity analyses were conducted 
to gauge the robustness of our findings across different imputation techniques. In 
the main analysis, missing data were replaced by their most likely value under the 
expectation maximisation algorithm in SPSS 19. In one sensitivity analysis, all anal-
yses were repeated with last observation carried forward, as implemented in SPSS. 
In yet another sensitivity analysis, regression imputation as implemented in Stata 
(version 12.1) was used to impute missing data. As predictor variables we used 
baseline costs, baseline work functioning, age, gender, partner status and the Ka-
rasek factors job demands, control, support from colleagues and superiors [25,26]. 
Directing the sensitivity analyses towards the various imputation strategies was an 
a priori decision, because it was imperative to ascertain that the research findings 
did not solely hinge on the chosen imputation technique.  
 The cost effectiveness analysis was conducted from the societal perspective in 
which all costs and benefits were included, irrespective of who bears the costs or 
receives the benefits [9]. Both the incremental costs and incremental effects were 
used to calculate the incremental cost effectiveness ratio. The incremental cost 
effectiveness ratio was calculated as (C1 − C0)/(E1 − E0), where C denotes the aver-
age per-participant costs and E is the effect in the experimental and control condi-
tions (subscripted 1 and 0, respectively). The incremental cost effectiveness ratio 
can be interpreted as the net costs (or savings) per treatment responder.  
 To handle stochastic uncertainty in the cost and effect data, non-parametric 
bootstraps were used to simulate 5,000 incremental cost effectiveness ratios. The 
incremental cost effectiveness ratios were plotted on the cost effectiveness plane to 
capture the uncertainty in the incremental cost effectiveness estimate (see Figure 
2). To be more precise, each simulated incremental cost effectiveness ratio can be 
plotted on one of the four quadrants of the incremental cost effectiveness plane. In 
the North East quadrant the intervention produces superior health gains at addi-
tional costs relative to the control condition. In the North West quadrant less health 
is produced for additional costs. Clearly, this is the worst possible outcome, and the 
intervention is then ‘dominated’ by the control condition. In the South West quad-
rant less health is produced, but there are cost savings. Finally, in the South East 
quadrant the intervention generates superior health gains (relative to the compara-
tor condition) and does so for lower costs. This is the best possible outcome and the 
intervention is then said to ‘dominate’ the control condition. It is often seen that a 
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new intervention falls in the North East quadrant, because better health is obtained 
for additional costs.  
Results 
Sample characteristics 
Baseline characteristics of the groups are shown in Table 1. There were no differ-
ences across the conditions in terms of demographics, baseline costs and work 
functioning. Therefore we concluded that randomisation had resulted in a balanced 
trial.  
 
Table 1. Sample characteristics by condition at baseline. 
  Control condition 
(n = 206) 
Occupational 
physician condition 
(n = 207)  
E-mental health  
condition (n = 204) 
Age, mean (sd) 41.83 (11.3) 42.56 (11.4) 387.5 (12.2) 
Female, N (%) 159  (77.2) 170  (82.1) 169  (82.8) 
Working hours, mean (sd) 30.98 (6.0) 28.73 (8.0) 31.33  (5.2) 
Living with a partner, N 
(%) 154  (74.8) 153  (73.9) 151  (74) 
Born in the Netherlands, N 
(%) 176  (85.4) 167  (80.7) 174  (85.3) 
Work experience, years 
(sd) 11.3 (10.1) 12.53  (10.4) 10.03  (10) 
Turnover intention, N (%) 22  (10.7) 27  (13.0) 25  (12.3) 
Baseline costs,a mean (sd)       
 Medication costs 1.06  (6.6) 1.54 (18.7) 1.68  (11.3) 
 Health care service use  116.97 (229.1) 121.84  (239.5) 211.85  (1,090.4) 
 Absenteeism  491.62 (1,689.3) 659.92 (2,110.1) 376.98 (856.2) 
 Presenteeism  1,068.93 (1,862.8) 1,125.04  (2,429.3) 973.65  (1,541.2) 
 Direct non-medical costs 10.67 (19.87) 10.69 (19.7) 20.1  (104.8) 
Work functioning, mean 
(sd) 14.11 (9.5) 12.56  (9.2) 13.4  (9.2) 
a In €, time horizon of baseline costs was 3 months. 
Missing data and dropout 
At baseline, data on impaired work functioning were missing for 11/206 (5%) par-
ticipants in the control condition, 10/207 (5%) in the occupational physician condi-
tion and 15/204 (7%) in the e-mental health condition. At three months follow-up, 
the dropout rates in the control condition, the occupational physician condition and 
the e-mental health condition were 61 (30%), 77 (37%) and 121 (59%), respective-
C H A P T E R  5  
 134
ly. At 6-months follow-up, dropout rates had increased to 68 (33%), 94 (45%), 133 
(65%). The flow of the participants through the trial is shown in Figure 1.  
 
Figure 1. Participants' flow through the study 
 
 
Since loss to follow-up was substantial, we assessed if dropout was selective. A 
dropout dummy variable (1 = lost, 0 = retained) was computed and regressed on 
condition, baseline costs, baseline work functioning, age, gender, partner status, 
and the Karasek factors (job demands, control, support by colleagues and superi-
ors) [25,26]. The analyses indicated that the occupational physician condition was 
associated with higher dropout than the control condition, and that poorer work 
functioning at baseline increased the risk of dropout, but having a partner was as-
sociated with a smaller likelihood for dropout. When comparing the e-mental 
health condition to the control condition, it was shown that the e-mental health 
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condition was associated with greater dropout, as were poorer work functioning 
and higher job demands at baseline. Again, living together with a partner was asso-
ciated with a reduced likelihood of dropping out. 
Health care service use 
The most frequently used health care services among all three conditions were the 
physiotherapist and GP services. At three months follow-up, consulting the occupa-
tional physician increased only in the occupational physician condition, most likely 
due to the intervention in which these visits were encouraged. Interestingly, the 
occupational physician condition visits showed a substantial decrease at 6-months 
follow-up. After six months a reduction in the average volumes of physiotherapist 
and GP visits is noticeable in all three conditions. Also, use of prescription drugs 
decreased over time in the three groups. 
 Supplementary Table 1 lists the average volumes of resource use by treatment 
group and time (see Appendix 1). 
Incremental cost effectiveness  
Costs  
Table 2 presents the costs of health care uptake and the costs stemming from 
productivity losses by condition and time point. The most significant costs can be 
attributed to the productivity losses. In particular, the costs of presenteeism in-
creased in the control condition between baseline and six months follow-up, but 
decreased in the occupational physician condition and the e-mental health condi-
tion. 
Incremental costs 
Table 3 (upper panel) shows the costs per condition. The average total costs were 
calculated to be €1,266 per participant in the occupational physician condition and 
€1,752 in the control condition. The incremental costs were therefore €1,266 − € 
1,752 = −€486 per-participant (negative costs, hence a cost reduction). The incre-
mental costs for the e-mental health condition were associated with a decrease in 
costs compared to the control condition: €1,375 − €1,752 = −€377. 
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Incremental effects 
Table 3 (upper panel) shows the effects per condition. At follow-up, approximately 
24% of the participating nurses met criteria for treatment response in the occupa-
tional physician condition compared with 20% in the control condition. In the e-
mental health condition, this was about 16%. The incremental effectiveness be-
tween the occupational physician condition and the control condition was therefore 
0.237 – 0.204 = 0.033. This was 0.157 – 0.204 = −0.047 for the e-mental health con-
dition versus the control condition. 
ICER occupational physician condition versus control condition 
As noted for the occupational physician condition, the incremental costs were 
−€486 (savings) and the incremental effect was 0.033. We rely on the median in-
cremental cost effectiveness ratio (ICER) as estimated from the 5,000 non-
parametric bootstraps. The median incremental cost effectiveness ratio for the 
occupational physician condition versus the control condition was estimated as a 
saving of -€5,049 per treatment responder. Figure 2a shows the scatter of boot-
strapped incremental cost effectiveness ratios on the incremental cost effectiveness 
plane. Of the 5,000 simulated incremental cost effectiveness ratios, 75% fall into the 
South East-quadrant, indicating that more treatment responses are generated for 
fewer costs by the occupational physician intervention relative to the control condi-
tion. Another 2% of the simulated incremental cost effectiveness ratios fall in the 
North East-quadrant, indicating a probability of 2% that by applying the interven-
tion an additional treatment response is produced, but at additional costs. The re-
mainder of the stimulated incremental cost effectiveness ratios showed up on the 
west side of the plane, indicating less effectiveness and less costs (21%), or less 
effectiveness and more costs (1%). In sum, the occupational physician condition is 
associated with a 75% probability that the intervention generates better outcomes 
for less money than the control condition. 
ICER e-mental health condition versus control condition 
As noted, in the e-mental health condition the incremental costs were −€377 (nega-
tive costs, hence a cost saving), but the incremental effect was −0.047 (a small loss 
in effectiveness) relative to the control condition. The median incremental cost 
effectiveness ratio could be estimated as €4,054. Figure 2b shows that 76% of the 
simulated incremental cost effectiveness ratios fall in the South West-quadrant 
indicating a probability of 76% that by applying the e-mental health condition few-
er treatment responses are produced, albeit at less additional costs. Another 16% 
of the simulated incremental cost effectiveness ratios fell into the South East-
quadrant, indicating that more treatment responses are generated for less addi-
tional costs by the e-mental health condition relative to the control condition. Final-
ly, 1% indicates more effects at higher costs and 8% indicates less effect at higher 
costs. 
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Figure 2. Scatter of simulated incremental cost effectiveness ratios (n = 5,000) on 
the cost effectiveness plane. 
 
 
Sensitivity analysis 
Sensitivity analyses were conducted by repeating all analyses under two alternative 
imputation strategies: using last observation carried forward imputation (in SPSS 
19) and under regression imputation (in Stata 12.1). Table 3 (lower panels) pre-
sents the summary statistics of the sensitivity analyses. As can be seen, the findings 
that were obtained under expectation maximisation imputation are consistent with 
the results produced under last observation carried forward and regression impu-
tation. In fact, the results obtained under expectation maximisation imputation fall 
between last observation carried forward and regression imputation. 
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Discussion 
Main findings 
This study was conducted to assess the cost effectiveness of two strategies (the 
occupational physician condition and the e-mental health condition) to improve 
work functioning compared to the control condition of screening alone. The pro-
portion of participants that manifested with a reliable change in work functioning 
was higher, although non-significant, in the occupational physician condition: 
23.7% against 20.4% in the control condition. The proportion of improved partici-
pants on work functioning in the e-mental health condition on the other hand was 
lower: 15.7% against 20.4% in the control condition. The average per-responder 
costs in the three conditions were €1,266 in the occupational physician condition, 
€1,375 in the e-mental health condition and €1,752 in the control condition. 
 The median incremental cost effectiveness ratio in the occupational physician 
condition versus the control condition comparison is dominant (−€5,049), hence a 
cost-saving per treatment responder. Therefore, the occupational physician condi-
tion can be recommended over the control condition, because the occupational 
physician condition is associated with a greater likelihood that beneficial effects are 
obtained for fewer costs.  
 The median incremental cost effectiveness ratio in the e-mental health condi-
tion versus the control condition comparison is €4,054 per treatment responder. 
The e-mental health intervention does not outperform the control condition, be-
cause the odds are that nurses derive fewer benefits from this intervention. Sensi-
tivity analyses attested to the robustness of these findings.  
Strengths and limitations 
Some of the strengths of this study are its randomised design and its relatively large 
sample size. This is worth mentioning, because the literature identifies several bar-
riers to conducting randomised trials within the work setting such as the difficul-
ties encountered when randomising employees while also trying to avoid the risk of 
contamination [27-30]. 
 The design with cluster randomisation and pre-randomisation was a strength 
of this study because randomisation at the ward level reduces the contamination of 
study groups. Furthermore, pre-randomisation allowed the participants to be 
blinded with respect to the information related to the other study groups. This min-
imised contamination effect in the study. 
 Next, in an attempt to tie the results of this study to previous research, wherein 
a lack of economic workplace mental health promotion studies is prevailing [8,31], 
this mental health oriented intervention for nurses can be seen as a welcome addi-
tion to the literature strengthening the evidence base. 
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The findings of this study need to be placed in the context of the study’s limitations. 
 First, the trial suffered from dropout, and our own analysis indicated that drop-
out had not occurred randomly. Unfortunately we do not have data on reasons for 
non-responding to the interventions. However, we can speculate that the main 
reason for drop-out in this specific study population might be feelings of work over-
load and the inability to find the time to improve their self-management skills. 
Again, this remains speculative but might have distorted the findings. However, we 
conducted intention-to-treat analysis using expectation maximisation imputation to 
handle missing data. In addition, sensitivity analyses were conducted with different 
imputation techniques and these attested to the robustness of our findings.  
 Second, the follow-up period used in this trial was short and we do not know 
what the cost effectiveness of the interventions would look like beyond six months.  
 Third, the per-participant intervention costs were partly based on assumptions. 
In particular, the assumption about the number of nurses that would engage in the 
online screening was important, because the number of participants affects econo-
mies-of-scale and ultimately determines the costs of online screening. It should be 
mentioned that whenever we had to make an assumption, we preferred to err on 
the conservative side, thus making a conscious choice to steer away from sketching 
too positive a picture of the cost effectiveness of the interventions. It should also be 
noted that the costs for screening are low anyway and are therefore unlikely to 
have a substantial impact on the outcomes overall.  
 Fourth, the study’s results are inevitably conditional on the central clinical end-
point: work functioning. This was an a priori choice, but is also a limitation, because 
in this economic evaluation we did not report on secondary outcomes such as men-
tal wellbeing, changes in symptom level of mental distress and so forth. Had we 
chosen other outcomes, we would have drawn different conclusions, because the 
nurses manifested with favourable response on some of these outcomes, even 
when they did not manifest with treatment response on work functioning. Thus, 
when we say that the e-mental health intervention is not to be recommended, we 
say this only with respect to work functioning and our recommendations cannot be 
generalised towards other outcomes. 
 Fifth, the measurements of work functioning were based on self-report and this 
may have biased outcomes. However, it is difficult to say if this might have led to an 
upward or downward bias. Moreover, we are looking at relative change in work 
functioning over time and this may have cancelled out a constant bias in partici-
pants to exaggerate or diminish the level of their work functioning, while randomi-
sation may have counteracted bias across conditions.  
 Sixth, it should be noted that all costs are computed for a situation in which the 
interventions have been fully implemented. Thus the initial investment required to 
implement the interventions is not part of our study. This was done in agreement 
with guidelines for economic evaluations [9,20,23], but we recognise that the costs 
required for implementing the interventions might be interesting in their own 
right. Estimates of these costs can therefore be obtained from the first author.  
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Seventh, although we complied with the guidelines for pharmaco economic evalua-
tions carried out from the societal perspective whereby direct and indirect costs, 
inside and outside the healthcare system were included, we acknowledge the pos-
sibility of missing costs that might influence the results. Potentially, medical costs 
which may arise during life-years gained as a result of the treatment are lacking in 
this study. However, due to the preventive nature of the intervention, it is rather 
unlikely that these indirect costs within the health care system influence the cost 
effectiveness results in a substantial manner.  
 Finally, this study was designed as a pragmatic trial that was conducted in the 
real-life context of one large academic medical centre in the Netherlands. The 
strength of this approach is that the trial has a good ecological (external) validity 
[32]; its weakness is that the outcomes cannot be interpreted as evidence of the 
interventions’ efficacy – only of the interventions’ effectiveness under real-life con-
ditions. The hospital in which this study was performed is an academic medical 
centre. Therefore, the findings are best generalised towards other teaching hospi-
tals, while some caution must be applied when projecting the study’s outcomes on 
hospitals that are not embedded in a university. In this context, it is important to 
note that the nurses were under constant pressure from their professional obliga-
tions and were free to make use of the interventions offered. We see that uptake 
rates and compliance rates are low, especially regarding the e-mental health inter-
ventions. While this may strengthen the level of realism of the trial’s outcomes, the 
outcomes can now not be read as evidence for or against the efficacy of the inter-
ventions and are likely to differ from estimates that would have been obtained un-
der tightly controlled conditions. 
Recommendations 
For improving work functioning in nurses, we recommend implementing the occu-
pational physician condition over the control condition, because the occupational 
physician condition is associated with better outcomes and cost savings. However, 
we must be careful recommending for or against implementing the e-mental health 
condition, because it is associated with a smaller likelihood of producing beneficial 
effects albeit for lesser costs than the control condition. We also note that had the e-
mental health intervention been embedded more rigorously in the work setting, 
then uptake rates might have looked very different and the e-mental health condi-
tion might have yielded more favourable outcomes. At any rate, we recommend 
that e-health interventions be more fully integrated in the organisation before test-
ing their effectiveness. These recommendations need to be viewed with some cau-
tion, because the economic evaluation was conducted with the specific, perhaps 
somewhat narrow, aim of improving work functioning. Moreover, the outcome was 
based on self-report, was extended over a brief follow-up period of six months, and 
was measured in the context of substantial, possibly selective, drop-out. 
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Abstract 
Objectives: Nurses are at elevated risk of burnout, anxiety and depressive disorders, and 
may then become less productive. This begs the question if a preventive intervention in the 
work setting might be cost-saving from a business perspective.  
Methods: A cost benefit analysis was conducted to evaluate the balance between the costs of 
a preventive intervention among nurses at elevated risk of mental health complaints and the 
cost offsets stemming from improved productivity. This evaluation was conducted alongside 
a cluster-randomized trial in a Dutch academic hospital. The control condition consisted of 
screening without feedback and unrestricted access to usual care (N=206). In the experi-
mental condition screen-positive nurses received personalized feedback and referral to the 
occupational physician (N=207).  
Results: Subtracting intervention costs from the cost offsets due to reduced absenteeism and 
presenteeism resulted in net-savings of €244 per nurse when only absenteeism is regarded, 
and €651 when presenteeism is also taken into account. This corresponds with a return-on-
investment of €5 up to €11 for every Euro invested.  
Conclusions: Within half a year, the costs of offering the preventive intervention were more 
than recouped. Offering the preventive intervention represents a favourable business case as 
seen from the employer’s perspective.  
 
Keywords: prevention, nurses, occupational health, mental disorders, cost benefit, work 
functioning. 
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Introduction 
Some nurses are at elevated risk for stress and mental health problems due to high 
job demands and a lack of autonomy [1, 2]. Poor mental health is undesirable in its 
own right, but it may also have financial implications for the employer [3, 4] via 
absenteeism, presenteeism (reduced at-work job performance) and staff turnover 
[5, 6]. From a business point of view it might therefore be of value to protect and 
promote mental health in nurses and maintain the quality of their work. 
 Periodic screening could be useful to detect early signs of mental health com-
plaints and personalized feedback could encourage help-seeking among nurses. A 
Workers' Health Surveillance (WHS) instrument was developed for this purpose. 
The WHS is a preventive strategy that aims at the early detection of negative health 
effects and work functioning problems and includes personalized feedback. The 
WHS is followed up by referral to the occupational physician (OP) for screen-
positive nurses in need of intervention. This three-tiered intervention aims to de-
tect mental health problems in the earliest stages and prevent further deterioration 
of these problems. In so doing, the intervention may also enhance job performance 
[7, 8].  
 Elsewhere, we published a cost effectiveness analysis of the intervention from 
the societal perspective [9]. That study took account of the costs of health care up-
take, pharmacy use and nurses' out-of-pocket expenses for travelling to health care 
services. The outcome of interest was treatment response. It was concluded that 
screening, feedback and OP care led to improved work functioning and these were 
associated with a 75% likelihood of lower costs than a 'do nothing' scenario as seen 
from a societal perspective. However, an employer is likely to look at a different set 
of financial parameters to inform decisions about implementing an intervention in 
the work setting. This paper adopts the employer’s perspective and assesses 
whether providing screening followed by personalized feedback and referral to the 
OP represents a viable business case. In contrast to the aforementioned cost effec-
tiveness analysis, we now look at the costs that are incurred by the employer of 
offering the preventive intervention. These costs are then compared with the bene-
fits (expressed in Euro, €) that are, again, relevant from the employer's perspective, 
such as the costs differences stemming from reduced absenteeism and improved 
productivity while at work. In short, this paper is conducted as a cost benefit analy-
sis to address the question if the benefits outweigh the costs. If this were the case, 
then the net-benefits would be suggestive of a favourable business case that may 
persuade employers to implement the preventive WHS intervention in the work 
setting.  
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Methods 
Study design 
The study was conducted in an academic medical centre in the Netherlands as a 
pragmatic cluster randomized controlled trial with randomization at the level of 
hospital wards. A cost benefit analysis was conducted from the employer’s perspec-
tive to see if there is a business case for investing in the employees’ mental health 
and work functioning. All costs were calculated in Euro for the reference year 2011 
using the consumer price index from Statistics Netherlands [10]. For the current 
cost benefit analysis we compared two conditions: (1) the OP condition (screening, 
feedback followed by referral to the OP for the screen positives), versus (2) the 
control (CTR) condition (screening without feedback and without referral to the 
OP). Within the hospital, 29 wards (with 207 consenting nurses) were randomized 
to the OP condition and 28 wards (with 206 consenting nurses) to the CTR condi-
tion. Data were collected at baseline and after three and six months (henceforth t0, 
t1 and t2). Both costs and benefits were computed over a six-month time horizon, 
corresponding to the follow-up period of the study. We excluded healthcare costs 
(other than those attributable to the intervention) and nurses’ out-of-pocket costs 
for obtaining health care, because they were deemed not to be relevant from the 
employer’s perspective. Costs and benefits were not discounted because the follow-
up time did not exceed one year. A medical ethics committee approved the study. 
Figure 1 presents the flow of participants through the trial. More information re-
garding the design of the Mental Vitality @ Work study can be obtained elsewhere 
[11]. 
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Figure 1. Flow of participants  
 
Intervention and control conditions 
All participants were screened for work functioning impairments and six types of 
mental health complaints: distress, work-related fatigue, risky drinking, depression, 
anxiety, and post-traumatic stress disorder. Nurses in the CTR condition filled out 
the screening questionnaire and no further steps were taken. In the OP condition, 
screening was followed by personalized feedback and screen-positive nurses re-
ceived an invitation to visit the occupational physician. The subsequent OP consul-
tation was structured according to a seven-step protocol, with the focus on identify-
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ing impairments in work functioning and providing advice on how to improve well-
being and work functioning. The seven-step protocol included the following: i) dis-
cussing expectations; ii) discussing screening results and characteristics of work 
functioning and mental health complaints; iii) discussing possible causes in the 
private, work , and health condition and consequences for work functioning; iv) 
identifying the problem and offering rationale; v) giving advice on how to tackle the 
health complaints, how to improve work functioning, how to prevent consequences 
of impaired work functioning, and how to communicate with the supervisor about 
work functioning and mental health; vi) discussing possible follow-up or referral to 
other care providers; and vii) summarising the consultation. All participating OPs 
received three-hour training in using the protocol [12].  
Computation of intervention costs 
The costs of offering the intervention included (1) the costs of operating the web-
based screening and feedback module, (2) the costs for periodically upgrading the 
module and (3) the costs of hosting the module on a server (including maintenance 
costs). These costs amounted to €4 per user (calculations can be obtained from the 
first author). Furthermore, the per-participant costs for consulting the OP (€73) 
and the costs for the OP-assistant for scheduling the nurses’ visits to the OP (€3) 
are also included. To these we added the costs of training the OPs in using the pre-
ventive consultation protocol (€50 per OP visit). Thus, a nurse who engaged in 
screening, received feedback and made a single visit to the OP would cost €130. 
However, it needs to be borne in mind that some screen-positive nurses did not 
visit their OP, while others made a single visit or multiple visits.  
Computation of the benefits  
As seen from the employer's perspective, the benefits from the intervention are 
related to increased productivity levels due to reduced absenteeism and presentee-
ism. Changes in productivity were valued in monetary terms using the human capi-
tal method. This method assesses the loss of productivity by multiplying the self-
reported number of working days lost due to absenteeism multiplied by the aver-
age gross gender and age specific wages per paid employee. The wage estimation 
was according to the Dutch guideline for health economic evaluation and can be 
found in Table 1 [13-15].  
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Table 1. Productivity by gender and age groups (in €) 
Age groups  Men Women 
15 -19  9.88 8.97 
20 - 24 18.18 17.59 
25 - 29 24.77 24.19 
30 - 35 30.37 28.20 
35 - 40 34.85 29.96 
40 - 45 37.25 29.76 
45 - 50 39.25 29.61 
50 - 55 40.00 29.96 
55 - 60 40.33 30.21 
60 – 65 40.07 29.36 
 
The work days lost due to diminished productivity were based on the self-reported 
number of work days when the nurse did not feel well while at work over the past 6 
months, weighted by an inefficiency score derived from the Productivity and Dis-
ease Questionnaire (PRODISQ)[16]. This was done on a 10-point rating scale, rang-
ing from 0 to 1, with 0 meaning not inefficient and 1 completely inefficient. The 
number of work days lost due to inefficiency was then multiplied with gender and 
age-specific wages indexed for the year 2011 [10, 15]. Finally, the benefits were 
computed by comparing the pre-intervention costs (at t0) with those post interven-
tion (at t2). This yielded a pre-post cost difference in each condition and these could 
then be compared across the conditions. 
Cost benefit analysis 
All analyses were performed in agreement with the intention-to-treat principle, 
thus including all participants as randomized. In the main analysis, missing data 
were replaced by their most likely value under the expectation maximization (EM) 
algorithm in SPSS 19.  
 The incremental costs, C, were the intervention costs of the OP condition minus 
the intervention costs of the CTR condition. The incremental benefits, B, were com-
puted as the cost savings due to reduced productivity losses (owing to pre-post 
changes in both absenteeism and presenteeism) in the OP condition minus the cost 
savings in the CTR condition. Net-benefits were computed as B−C, the cost-to-
benefit ratio as C/B and the return on investment (ROI) as B/C.  
 The net benefits, cost-to-benefit ratio and return on investment were analysed 
in Stata (version 12.1) using non-parametric bootstrap techniques. The analyses 
took into account that observations were clustered, as nurses were 'nested' in dif-
ferent wards at the hospital. Therefore robust sample errors were obtained using 
the first-order Taylor series linearization within each of the 1,000 bootstrap steps. 
This procedure was conducted on the dataset that was imputed using EM.  
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Sensitivity analysis 
Sensitivity analyses were conducted to assess the robustness of our findings by 
making less optimistic assumptions about the benefits. In this context it is of note 
that the benefits due to reduced presenteeism were computed by multiplying the 
inefficiency score by the number of days at work with diminished work productivi-
ty. However, it may be assumed that presenteeism may not impact on productivity 
levels when the diminished productivity is compensated for during normal working 
hours by the nurse or by colleagues [17]. If that is true, then we may have produced 
an overly optimistic estimate of the benefits. Thus to test the robustness of our 
findings, we recomputed the cost benefit ratio by reducing the benefits by 10%, 
20% and 30%, and by omitting the cost offsets of reduced presenteeism altogether.  
Results 
Sample characteristics 
Baseline characteristics of the groups are shown in Table 2. Both groups were quite 
similar regarding demographic and occupational characteristics. The majority of 
the participants were female nurses, born in the Netherlands who lived together 
with a partner. On average the participants were aged 42 years and had more than 
10 years of work experience. We concluded that randomization had resulted in a 
balanced trial.  
 
Table 2. Baseline characteristics of the sample 
  CTR group (n=206) OP group (n=207)  
Age, mean (SD) 41.83 (11.3) 42.56 (11.4) 
Female, N (%) 159 (77.2) 170 (82.1) 
Function, N (%)   
Nurse 146 (70.9) 124 (59.9) 
Surgical nurse 9 (4.4) 14 (6.8) 
Nurse practitioner 23 (11.2) 14 (6.8) 
Allied health professional 21 (10.2) 31 (15) 
Anaesthetic nurse 0 13 (6.3) 
Other 7 (3.4) 11 (5.3) 
Working hours, mean (SD) 30.98 (6) 28.73 (8.1) 
Living with a partner, N (%) 154 (74.8) 153 (73.9) 
Born in the Netherlands, N (%) 176 (85.4) 167 (80.7) 
Work experience, years (SD) 11.3 (10.1) 12.53 (10.4) 
Turnover intention, N (%) 22 (10.7) 27 (13) 
CTR=Control | OP= Occupational Physician 
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Cost benefit analysis  
Table 3 presents the per-nurse intervention costs and benefits in the OP and the 
control condition as well as the net-benefits.  
 The mean per-nurse intervention costs were €89 in the OP condition and €25 
in the CTR condition. The cost difference between the conditions was therefore €64 
(95%CI=52~76), which was statistically significant (robust bootstrapped SE=6.03; 
z=10.5; p<0.001).  
 Cost reductions due to greater productivity were €715 (95% CI= 226~1,203) 
in the OP condition relative to those in the CTR condition. These cost savings were 
statistically significant (robust bootstrapped SE=249; z=2.87; p=0.004) and in favor 
of the OP condition. 
 Subtracting per-participant intervention costs from the per-participant cost 
offsets due to reduced absenteeism and presenteeism resulted in net-savings of 
€651per nurse. The net-benefits were statistically significant (95%CI=167~1,135; 
SE=247.13; z=2.63; p=0.008) and in favour of the OP condition. Benefits stemming 
from reduced presenteeism are hard-to-quantify, by excluding these benefits and 
focusing on net-benefits when only absenteeism is regarded resulted in net-
benefits of €244 per nurse in favour of the OP condition, still representing a fa-
vourable business case as seen from the employer's perspective.  
 
Table 3. Intervention costs, benefits and net-benefits (per nurse, in €) 
 OP group CTR group DIFF (OP–CTR)  
Co
sts
 
 Screening 4 4 0 
 Added costs OP training 50 0 50 
 OP care t0 13 6 7 
 OP care t1 17 7 10 
 OP care t2 5 7 -3 
Total intervention costs 89 25 64  
Be
ne
fits
 
Absenteeism t0 660 492  
Absenteeism t2 234 374  
Averted absenteeism cost 426 118 308  
Presenteeism t0 1,125 1,069  
Presenteeism t2 916 1,267  
Averted presenteeism cost 209 -198 407  
Total benefits  635 -80 715  
Ne
t 
be
ne
-
fits
 Net- benefits (presenteeism included) 546 -105 651 
Net- benefits (presenteeism excluded) 337 93 244  
CTR=Control | OP= Occupational Physician | DIFF (OP-CTR) = Difference (Occupational Physician group 
minus Control group) 
Base-case and sensitivity analyses 
In the base-case analysis the return on investment for the OP condition was €7 per 
invested Euro and -3 Euros per invested Euro for the CTR condition (i.e. negative 
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benefits, thus higher costs). The return on investment was (715/64=) €11 per in-
vested Euro (see Table 4).  
 Various sensitivity analyses were performed to attest the robustness of the 
findings and the results are summarized in Table 4. The results of the sensitivity 
analyses attest to the robustness of the main analysis. The incremental costs of 
offering the intervention are more than compensated for by productivity gains. 
Even when productivity gains in the OP-condition are lowered by 30% the net ben-
efit per employee is still €461 after six months and the return-on-investment is still 
a substantial €8 per invested Euro. When ignoring the hard-to-quantify benefits 
stemming from reduced presenteeism, there still is a return on investment of al-
most €5.  
 
Table 4. Results of base-case and sensitivity analyses in €  
  OP  CTR  DIFF  
(OP–CTR) 
Net-benefits 
(B-C) 
Cost benefit 
ratio (C/B) 
Return on 
investment 
(B/C) 
Ba
se-
Ca
se Costs (C) 89 25 64    
Benefits (B) 635 -80 715 651  0.09  11  
Se
ns
itiv
ity
 
An
aly
ses
 
-10% OP Benefit 571 -80 651 587  0.11  10  
-20% OP Benefit 508 -80 588 524  0.11  9  
-30% OP Benefit 444 -80 525 461  0.12  8  
-Presenteeism 426 118 308 244  0.21  5  
CTR=Control | OP= Occupational Physician | DIFF (OP-CTR) = Difference (Occupational Physician group 
minus Control group) | B = Benefits | C = Costs 
Discussion 
Main findings 
The primary aim of the study was to conduct a cost benefit analysis from the em-
ployer’s perspective by considering the balance of the costs of a preventive inter-
vention and the cost offsets stemming from improved productivity. Net-benefits 
were €651 per nurse and were statistically significant at p=0.008. In other words, 
the pay-out is €11 per Euro invested. It is worth noting that the cost offsets occur 
within six months post intervention, thus representing a favourable business case 
from an employer’s perspective where the initial investments are more than re-
couped within a short period of time. The main conclusion that offering the inter-
vention offers good value for money from the employer's perspective remains in-
tact when confining the analysis to the changes in absenteeism and ignoring any 
benefits due to reduced presenteeism. 
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Placing the results in the wider context of the literature 
There are only a few studies evaluating the costs and benefits of mental health 
promotion and prevention in the workplace. Knapp, McDaid and Parsonage have 
assessed the economic impact of mental health and well-being improvements asso-
ciated with various programs based on a limited range of studies using economic 
modelling [18]. Arends and colleagues evaluated a return-to-work intervention and 
focused on the prevention of recurrent sickness absence and helping workers to 
stay at work. The authors demonstrated the 12-months effectiveness of a problem-
solving intervention for reducing recurrent sickness absence in workers with 
common mental disorders [19]. Iijima and colleagues conducted a cost benefit 
analysis of mental health prevention programs within Japanese workplaces. They 
concluded that the majority of companies gained a net benefit from the mental 
health prevention programs [20]. Another Japanese study concluded that a partici-
patory work environment improvement program and individual-oriented stress 
management programs showed better cost benefits, suggesting primary prevention 
programs for mental health at the workplace economically advantage employers 
[21]. Although the results of our study unite with the results of previously conduct-
ed studies, which took place during and after the sickness absence period, or within 
another cultural, ethical and geographical setting, our study might be seen as a 
welcome addition to a limited evidence-base.  
Strengths and limitations 
Several strengths of this study need to be mentioned. First, this study was a trial-
based economic evaluation and is therefore firmly rooted in empirical data. Second, 
the study was conducted as a pragmatic trial, thus enhancing the ecological validity 
of the results [22]. Third, we reviewed both the cost reductions due to less absen-
teeism and reduced presenteeism. Although including presenteeism is standard 
practice in economic evaluations, it is worth mentioning that owing to their lower 
visibility these costs are not so apparent to an employer and are often overlooked 
[13, 23]. 
 The results need to be placed in the context of the study’s limitations. First, the 
trial data were affected by drop-out and this may have distorted the outcomes. That 
said, we conducted an intention-to-treat analysis by imputing missing observations 
under the EM algorithm. In our health economic evaluation of the same data we 
demonstrated that the results after EM imputation are very similar to those ob-
tained under alternative imputation strategies such as regression imputation and 
last-observation-carried-forward imputation. Nonetheless, drop-out rates were 
substantial and may have biased our outcomes. 
 Second, all outcomes were based on self-report. However, it is hard to see how 
presenteeism can be measured without resorting to self-assessments of diminished 
productivity. Unfortunately, the validity of self-reported presenteeism has not often 
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been researched [24-28]. It is precisely for this reason that we conducted sensitivi-
ty analyses to gauge the robustness of the study's outcomes when less optimistic 
assumptions are being made about the benefits in the OP condition. 
 Third, some potential impacts of the intervention were not assessed, such as 
the costs of staff turnover and the spill-over effects of absenteeism by one nurse on 
the workload of her colleagues. As to staff turnover, the data indicate that turnover 
intention was reduced from 27 nurses at t0 down to ten nurses at t2 in the OP condi-
tion. In the CTR condition these were 22 and 14, respectively. These data suggest 
that the OP intervention may have additional favourable effects on staff turnover, 
but these were not quantifiable in terms of actual changes in staff turnover. As a 
consequence we can now only speculate that the cost benefits that we reported 
represent lower bounds of the true cost benefits. 
 Fourth, it should be noted that all intervention costs are computed for. Thus the 
initial investments required for developing and implementing the interventions 
were part of our study. Although this might contradict with guidelines for economic 
evaluations [29], were one would solely account for intervention costs when fully 
implementing the intervention, we recognized that the costs required for develop-
ing and implementing the interventions were interesting in their own right and 
therefore included in the total intervention costs.  
 Fifth, there are two main approaches to costing productivity losses; the human 
capital approach and the friction cost approach. However, both approaches produce 
similar results in the short term, as is the case in our study with a follow-up after 
six months. We therefore expect that choosing one approach or the other is unlikely 
to have a major impact on our conclusions. From a business case point of view the 
relatively short follow-up time is not a limitation, because it is good to see that the 
costs of offering the intervention are recouped within such short time span. Never-
theless, as yet we do not have data to inform us about the longer-term outcomes.  
Conclusions 
A return-on-investment of €11 within six months represents a very appealing busi-
ness case, and wider implementation of the intervention can be recommended. 
However, and as noted above, the time horizon of this study is limited in that we 
only look at costs and cost reductions over a six month period. Therefore, we do not 
know if effects are maintained over time. In all likelihood the intervention’s impact 
will need to be sustained by periodic repetition of the intervention, e.g. a screening 
plus personalized feedback plus referral to the OP for screen-positives every 12 or 
24 months.  
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Abstract  
Objectives: To perform a pilot cost effectiveness study for a web-based employability inter-
vention aiming at improving intervention content and study design.   
Methods: Uptake rate analysis for the intervention elements, cost effectiveness, cost utility 
and subgroup analyses were conducted to identify potential content-related intervention 
improvements. Differences in work ability and quality adjusted life years and overall contri-
bution of resource items to the total costs were assessed.  These were used to guide study 
design improvements.  
Results: 63 participants were a-select allocated to either the intervention (n=29) or the 
control (n=34) group. Uptake was ≤70%. Cost effectiveness and cost utility analyses resulted 
in negative effects although higher total costs. Incremental effects were marginal (work 
ability -0.51; QALY -0.01).  
Conclusions: The intervention needs to be improved with respect to targeting and intensity; 
outcome measures selected and collection of cost data.  
 
Keywords: pilot study; feasibility; cost effectiveness; web-based intervention; occupational 
health; QALY 
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Introduction 
Since 2000 research has established that sickness absence results in considerable 
negative effects on work for employees, employers, and society as a whole. Absence 
from work due to sickness absence constitutes a large economic burden, especially 
for those on long-term sickness absence [1, 2]. Employees with health complaints, 
chronic illness or disability often worry about the sustainability of their employ-
ment. Due to their health complaints, problems can arise at work, primarily with 
respect to either obtaining work or remaining at work. Franche et al. and Amick et 
al. in 2002 and 2004 respectively, provided evidence regarding the readiness for 
return to work and predictors for successful work functioning [3, 4]. Both studies 
found significantly improved self-efficacy among supportive organizations that 
acknowledged the importance of psychosocial management [4] and the interplay 
between care, workplace and insurance [3]. Additionally, the importance of improv-
ing an employee’s self-efficacy to maintain successful work-role functioning and 
improve work ability has been established [3-6]. More recently, Hoefsmit et 
al.(2013) found that in order to improve work ability, cooperation between em-
ployee and employer is essential [7]. The study showed that in an attempt to 
achieve stakeholder cooperation, employees and employers need to: ‘be aware of 
their mutual dependence’; ‘trust each other’; and ‘have knowledge about the legisla-
tion’. Likewise, employees with higher levels of self-efficacy are better able to stay 
at work despite their health problems and may even return to work faster after 
reporting sick [7]. Furthermore, a recently published study showed that return-to-
work self-efficacy was a significant predictor of reintegration to work among very 
long-term sick-listed employees [8]. Thus, improving self-efficacy may empower an 
employee to handle difficulties in relation to his or her health problems [9].  
 In recent years, the internet is being used more often to locate information on a 
broad range of topics, including work-health related issues. Previous research has 
investigated the reach, compliance and perceived effectiveness of interactive web-
sites or e-therapies aimed at empowering work-disabled employees. However, 
these interventions occurred either prior to the disability assessment undertaken 
by an insurance physicians [10, 11] or focused solely on information provision and 
helping patients to formulate questions to ask their physicians [12, 13]. Because of 
the increasing number of internet users, a growing number of interactive interven-
tions are delivered online.  
 To increase self-perceived work ability (i.e. self-efficacy) among employees 
who experience problems in relation to their employability and work ability, a web-
based employability intervention was developed [14]. A previously conducted 
study among unemployed people assessed the effectiveness of the web-based em-
ployability intervention [15]. These analyzes showed that the intervention had no 
effect on the longing to return to work. Furthermore, no intervention effect was 
found for the period within which the participant thinks to be able to (return to) 
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work. The effects of the web-based employability intervention were contrary to 
what was expected since participants in the control group were more often at work 
during the post-test instead of the participants in the intervention group. When 
conducting separate analyses for the different intervention components, only the 
knowledge website itself showed a small significant (β=0.18 at 0.05 significance 
level) improvement on the degree of self-efficacy. Neither the other intervention 
components (i.e. personal advice, the forum, or the feedback session) nor the com-
plete web-based employability intervention, were able to detect an effect on degree 
of self- control, empowerment, or return to work [15].   
 Therefore, a critical look at the current content and design of the web-based 
employability intervention is needed. However, detailed information on the (cost) 
effectiveness of web-based employability interventions is often lacking or conflict-
ing. Therefore, key analytical decisions regarding the most important data to collect 
and sample sizes are calculated based on smaller pilot trials [16]. A pilot study can 
provide information about the feasibility to conduct (cost-) effectiveness trials, 
which can be costly and time-consuming. This saves valuable resources being un-
necessarily spent on large scale studies that may not be feasible. Typically when 
conducting a pilot study, the intervention is assumed to be effective and the content 
is therefore stated. This pilot study highlights how potential improvements in the 
study design can be detected and improved. This is done by critically assessing the 
content of the intervention with respect to the uptake of the various intervention 
elements, and by studying the effectiveness in diverse employee groups.   
 Therefore, the purpose of this study was to:  
(i) detect whether based on the results of the pilot economic evaluation, the web-
based employability intervention content can be improved to improve widespread 
implementation; 
(ii) detect whether based on the results of the pilot economic evaluation of the web-
based intervention, the study design could be improved to guide future research.  
Materials and methods 
The data collection for this pilot study was conducted in the Netherlands between 
June 2013 and March 2014 with a follow-up period of three months. The web-based 
employability intervention was compared with regular trade union support among 
participants with work-related health problems. Members of the trade union can 
call or use the instant messaging service via the website to ask questions about 
work, health and disease. They are then attended to a union consultant who an-
swers the questions or refers the caller to a disciplined expert. Participants were 
approached via the participating employees’ trade union in the public sector. Mem-
bers of this union predominately worked for privatized government agencies or in 
the care and welfare sector. Eligible participants were adults aged between 18-65 
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years. Participants either had concerns regarding their ability to continue their 
work responsibilities, were at a crossroad of calling in sick for a longer period of 
time, or were absent for more than six weeks and were feeling unable to return to 
work in the near future. Those who were absent from work for more than two 
years were excluded from the study. Advertisements in the trade unions’ newslet-
ters targeted the participant group and based on individual’s own intrinsic motiva-
tion, could be recruited into the research. After the completion of the first ques-
tionnaire participants were randomly divided into either the control group or the 
intervention group. Participants and researchers were not blinded for either the 
treatment allocation or intervention uptake. In the control group, a reward of €10 
was provided to those who completed both questionnaires. In the intervention 
group, participant received free usage of the web-based employability intervention 
for three months.  
Intervention and Control Condition  
Participants from the control group could contact the participating trade union for 
regular support (e.g. information on website, telephone contact, etc.) regarding 
their work- and health related concerns. The control group did not have access to 
the web-based employability intervention.  This was only accessed by the interven-
tion group. 
 The web-based employability intervention focused on improving the self-
efficacy of employees by encouraging and motivating them to take control of their 
own work context and enhance their work ability. The web-based employability 
intervention focused on teaching employees skills to return to work and/or stay at 
work. In particular, the training allowed the participants to ask job and health-
related questions, as well as guiding communication with relevant stakeholders 
(e.g. supervisors, colleagues, occupational physicians, medical practitioners, labor 
experts, job coaches).  Specifically, the intervention aimed to ‘empower’ employees 
to access regular, curative and occupational health care services during their ill-
ness, recovery and work reintegration. The four core elements of the intervention 
were: (i) a knowledge based web-site of current information focusing on work abil-
ity in relation to health; (ii) an assessment of the work ability of respondents (Work 
Ability Index-test), followed by a subsequent telephone interview providing re-
spondents with feedback on their results; (iii) personal and technical expert advice 
via phone and email; and (iv) an online interactive forum on work and health for 
sharing worker’s experiences, questions and answers with content experts. Using 
the intervention elements was voluntary. However, a subscription to the knowledge 
site was needed (http://www.wijzermetwelder.nl/). 
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Aim I: Evaluating the content of the web-based employability intervention   
The first aim of this pilot economic evaluation was to consider whom to include and 
how to target suitable participants for the web-based employability intervention in 
the future. The intervention aimed to provide an easily accessible method for inter-
ested people to ask questions about disability, health and work. Furthermore, the 
intervention was suitable for everybody, regardless of their health or disability. 
Hence, a number of features of the intervention were studied. First, the uptake 
rates for each of the four core elements of the intervention were examined. This 
identified potential improvements for one or more of the core intervention ele-
ments. Recommendations regarding compliance and uptake could then be made. 
Second, a cost effectiveness analysis (CEA) and a cost utility analysis (CUA) were 
conducted by accounting for all costs, irrespective of who pays or bears them. Sub-
group analyses were conducted based on age (under and above 50 years), sex 
(males versus females) and working hours (more than 20 hours per week), to pro-
vide information on how to better target the intervention.  
 
Aim II: Evaluating the study design of the web-based employability interven-
tion   
The second aim of this study was to improve the study design of web-based em-
ployability interventions by using the results of the pilot economic evaluation to 
carefully select outcomes and cost-categories that matter both to the employee and 
society as whole. Differences in work ability and quality adjusted life years (QALY) 
among both groups were assessed. Work ability was measured via “The Work Abil-
ity Index” (WAI), by considering both the physical and mental demands of the work. 
The index helps to identify those that need support in these areas [17]. A point 
improvement on the WAI denoted a substantial improvement and hence, demon-
strated a gained effect (i.e. better work ability). Differences in Quality Adjusted Life 
Years (QALYs) were calculated using the EuroQol-5D-5L [18, 19]. A crosswalk to 
the 3-level value sets was used to calculate the utility weights based on EuroQol 
scores using Dutch tariffs [20, 21]. Utilities at baseline and after three months fol-
low-up were used to compute QALYs, by means of the area under the curve method 
[22]. In order to assess the importance of resource items in their overall contribu-
tion to the total costs, the frequency of consumption and their unit costs were as-
sessed. Questionnaires measuring healthcare resources were provided to the re-
spondents at baseline and three months after the intervention started.  Healthcare 
costs (including primary, secondary, alternative care, hospitalization, and medica-
tion), costs to patient-and family (including travel- and parking, and informal care 
costs), and productivity costs (including costs related to absenteeism and presen-
teeism) were estimated and indexed for the reference year 2013 [23-26]. Costs of 
the web-based employability intervention included those related to implementing 
and operating the intervention.  
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Statistical analysis 
Missing data per respondent were replaced by mean imputation using the mean of 
the series of the appropriate outcome. The analyses required complete cases re-
sponses for both baseline and three month follow-up measures. Therefore, re-
spondents who were lost to follow-up were excluded from the analyses. Baseline 
characteristics of both groups were compared using t-tests of variances, or by the 
non-parametric equivalent. That is, Kruskal-Wallis for analysis of continuous varia-
bles or Ӽ2 test for categorical comparisons of proportions. The costs of both groups 
were compared by the non-parametric bootstrapping method using 95% confi-
dence intervals in percentiles. By bootstrapping, samples of the same size as the 
original data were drawn with replacements from the observed data. An incremen-
tal approach was used to compare the employability intervention with regular 
trade union support. The incremental costs per ‘improved’ respondent on the WAI 
scale and per QALY gained (i.e. the incremental cost effectiveness ratios (ICER)) 
were graphically plotted on one of the four quadrants of the cost effectiveness 
planes. For this, non-parametric bootstrap re-sampling techniques were therefore 
used. In the North West quadrant if fewer effects were produced for additional 
costs, then the intervention was considered “dominated” by the control condition. 
In the South East quadrant, if the intervention generated superior effects (relative 
to the comparator condition) with fewer costs; the intervention was considered 
“dominating” the control condition. Detailed calculations relevant for the economic 
evaluation are found in the Technical Appendix.  
Results 
Participants  
Between June 2013 and March 2014, 70 potential participants were eligible for 
inclusion, provided their informed consent, and were allocated to either the web-
based employability intervention (n=34) or the control (usual care) group (n=36). 
In total, 63 participants (29 in the intervention group; 34 in the control group) 
completed both the baseline and the three month follow-up questionnaires and 
were included in the analyses. The demographic characteristics of the participants 
are shown in Table 1. At baseline, more females were allocated to the intervention 
group. A significant difference was found for mean health scores with participants 
in the intervention group rating their health lower than the control group. Aside 
from gender and self-rated health, no significant differences between the two 
groups with respect to their demographic characteristics were found.  
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Table 1. Baseline characteristics (N=63)
  Intervention Group (n=29) 
Control Group 
(n=34) p value 
Age, mean (sd) 51 (8) 53 (7.9) 0.4(a) 
Female, N (%) 22 (76) 18 (53) 0.06(b) 
Education§, N (%)  
   0.8(b) Low 2 (7) 3 (9)
Intermediate 10 (34) 14 (41)
High 17 (59) 17 (50)
Working hours, mean (sd) 26.5 (8.9) 29.3 (8.5)    0.2(a) 
Living situation, N (%)  
 
   0.4(b) 
Living alone 5 (17) 8 (24)
Living alone with children - 2 (6)
Living together with a partner 14 (48) 17(50)
Living together with partner  
and children   10 (35)  7 (20) 
Job demands, N (%)  
 
   0.8(b) 
Physical 2 (7) 1 (3)
Psychological 14 (48) 18 (53)
Both physical and psychological 13 (45) 15 (44)
Function, N (%)  
 
 
 
  0.14(b) 
Industrial sector - 2 (6)
Agricultural sector 1 (3) -
Administrative sector 3 (10) 10 (29)
Service sector 1 (3) -
Healthcare sector 15 (52) 9 (27)
Research & Development 2 (7) 3 (9)
Other 7 (24) 10 (29)
Social benefits, N (%)  
   
  0.6(b) 
WIA / WGA / WAJONG  3 (10) 3 (9)
Other 2 (7) 1 (3)
None  24 (83) 30 (88)
Permanent employment, N (%) 27 (93) 33 (97) 0.4(b) 
Absenteeism days, mean (sd) 5.47 (8.6) 3.21 (6.9) 0.15(c) 
Self-rated health‡, mean (sd) 67 (12.3) 75 (17.2) 0.015(c) 
Costs, mean in € (sd)   
Intervention 56.51 (22) - - 
Medication  350.86 (926) 197.86 (679) 0.465(c) 
Healthcare  644.91 (858) 918.50 (3052) 0.187(c) 
Patient and Family 68.39 (120) 48.53 (61.93) 0.341(c) 
Absenteeism 847.05 (1439) 543.87 (1195) 0.243(c) 
Presenteeism 241.87 (296) 311.81 (283) 0.189(c) 
§Low=preschool or primary school; Intermediate=lower- or upper secondary; High=tertiary school, university 
or postgraduate 
‡Self-reported health score ranging 0 (worst) to 100(best) 
(a) ANOVA; (b) Ӽ2 test; (c) Kruskal-Wallis Test  
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Improving the content and targeting of the web-based employability 
intervention  
 
The uptake rates for each of the four core elements of the intervention were low. 
Out of the 29 participants in the intervention group,  50% (n=15) logged on to the 
knowledge site, approximately 70% (n=20) of the respondents participated in a 
telephone interview after completing the WAI-test to discuss their results, 16 re-
quested personal and technical expert advice, and only one person used the online 
interactive forum.  
 Marginally lower score on the WAI (-0.51) and higher total costs (€483.8) for 
the intervention group (when compared to the control group) resulted in a negative 
ICER (Δ total costs/Δ total effects) (see also Table 2). The majority of the incremen-
tal cost-effect pairs were located in the northwest quadrant indicating fewer effects, 
albeit higher costs, for the web-based employability intervention (Figure 1). The 
three-month ICER resulted in a large negative incremental cost utility ratio sur-
rounded with large uncertainty which can be seen in the wide distribution of ICERs 
(Figure 1).  82% of the bootstrapped cost utility pairs were situated in the north-
west quadrant, representing less effectiveness (i.e. less quality of life gains) and 
more costs for the intervention group compared to the control group.  
 
 
 
The results of the subgroup analyses are presented in the lower level in Table 2. 
The CEA for the subgroups of respondents aged above 50 years and female genders 
resulted in a minimal increase in work ability (0.03 and 0.05 points improvement 
on the WAI respectively), associated with higher costs compared with the respond-
ents in the usual care condition. In order for the intervention to be effective, a point 
improvement on the WAI was required. However, the results of both subgroup 
analyses should be interpreted with caution as one cannot state that the web-based 
employability intervention was more effective although it had higher associated 
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costs. Furthermore, based on the distribution of ICERs on the CE plane, these esti-
mates are not robust. The subgroup of employees working more than 20 hours per 
week resulted in lower work ability in the web-based employability intervention 
group compared to the control group. There were also higher total costs with a 
negative ICER of -457.69. However, it is important to note that the ICER does not 
fall within the confidence interval (Table 2).  
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Improving the study design of the web-based employability intervention  
Mean incremental differences of -0.51 point improvement on work-ability and 
mean incremental differences of -0.01 QALY were unable to demonstrate an effect 
of the web-based intervention (Table 2). 
 Participants who received the intervention consulted their physiotherapist and 
medical specialist more often than participants in the control condition. They used 
more alternative care and had longer stays in the hospital. Number of visits to the 
general practitioner and the medical specialist were almost equal in both groups. 
The number of hours of informal care was larger in the control group when com-
pared to the intervention group. Table 3 presents the uncorrected costs of different 
healthcare utilization costs after three months. As costs were not distributed nor-
mally (Table 1), aggregated costs per category (healthcare costs, patient and family 
costs, costs in other sectors, and societal costs) were bootstrapped. The highest 
total societal costs were seen in the intervention group (€1,707) vs. (€1,223) in the 
control group. The relative contribution of patient-and family out-of-pocket costs 
was smallest; whilst productivity costs contributed for almost 50% of the total 
societal costs in both groups (Table 3). 
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Conclusion  
This research demonstrates a number of benefits for undertaking a pilot economic 
evaluation to improve both the intervention and the study design. Based on the 
results of this pilot, an attempt is made to bridge the gap between the application of 
research and a real-life setting. Furthermore, this pilot economic evaluation is 
unique as it also closely examines the intervention content and provides recom-
mendations for further development.  
 The first aim of the study was to critically assess the intervention content and 
detect whether, based on the results of the pilot economic evaluation, the content of 
the web-based employability intervention should be modified to improve wide-
spread implementation. The findings of the pilot economic evaluation do not indi-
cate a widespread implementation of the web-based employability intervention in 
practice. Both content related improvements, as well as several practical implica-
tions are required. First, compliance and uptake rates need to be increased before 
implementing a full trial. To do so all four elements of the intervention may need to 
be improved. In particular, the content of the online interactive forum should be 
further investigated, as uptake of this component was very low. These findings, to 
improve all four components, are supported by the qualitative study conducted to 
assess whether the intervention complied to the needs of the interviewed interven-
tion users [14]. Results have shown that the web-based employability intervention 
was insufficient to connect the specific needs and wishes of the users. The inter-
viewees stated that the intervention provided via the website and via contacts with 
experts was too general for their specific situation. Interviewees for the qualitative 
evaluation had relatively prolonged health problems and often very specific ques-
tions about work and health [14]. Additionally, the voluntary usage of all four ele-
ments should be reconsidered and methods to stimulate ongoing involvement with 
web-based employability interventions need to be found. Furthermore, difficulties 
were experienced when recruiting employees to participate in the study, and in 
increasing participation- and intervention uptake rates. As a result, future interven-
tions may need to specifically consider the current workplace culture, company 
specific policies regarding absenteeism and sick-leave, and the employee’s own 
perceived health problems. Careful evaluations incorporating both quantitative- 
and qualitative methods will be needed to document how the web-based employa-
bility intervention can be operationalized and potentially adapted for use in other 
settings. Secondly, the results of this pilot economic evaluation showed that the 
web-based employability intervention was not associated with superior clinical or 
economic impact when compared to regular trade union support. The main anal-
yses indicated that the intervention is being dominated by the control condition 
(i.e. more costs and fewer effects as the ICER is located in the inferior quadrant of 
the cost effectiveness plane). The results for this heterogeneous population were 
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reasonably robust. However, there was a tendency females and participants aged 
50 or older might be more sensitive for an intervention effect.  
 The second aim of the study was to evaluate whether, based on the results of 
the pilot economic evaluation, the study design should be improved. To improve 
the study design implementing a web-based employability intervention, outcomes 
and cost-categories that matter both to the employee and society need to be care-
fully selected. In this pilot economic evaluation, no significant effects in favour of 
the intervention were found. However in this study, only the intervention itself was 
expected to yield differences in outcomes. The true effect of the intervention might 
have been influenced by participants using information other than the information 
derived via the web-based employability intervention. It may be disputed whether 
the most appropriate outcome was selected for this pilot economic evaluation, and 
whether it was able to measure the true effect of the intervention. Additionally, the 
intervention might be used in combination with other resources (e.g. social net-
working, other websites, etc.). The added value of the intervention should be made 
clear as the effects might also depend on the personal characteristics of the individ-
ual user (e.g. healthy or unhealthy behaviour) and on the interaction with alterna-
tive information and support resources. Expert opinions or other forms of qualita-
tive research on the appropriate size of quantitatively important distinction be-
tween baseline and follow-up might be helpful. Secondly, given the time and effort 
required to collect cost effectiveness data, this pilot indicates that the collection of 
patient- and family costs might be omitted based on their relative contribution to 
the total costs. Productivity costs on the other hand appear to be essential in the 
economic evaluation of web-based employability.  
Discussion 
The study results should be placed in the light of other research conducted within 
the field of e-health and web-based interventions. A recently conducted review 
summarized the effectiveness (empowerment related outcomes) of several web-
based interventions. They concluded that when small positive effects on empow-
erment were found, the duration and intensity of the interventions were much 
higher than the web-based employability intervention described here [9]. For clini-
cal problems and the work ability assessment of employees, a long-term time span 
might have been more appropriate to capture all consequences of the intervention 
under study. The limited follow-up period (3 months) of this pilot might also mask 
the visibility of a true effect (e.g. increase in work ability over a longer period of 
time). However, another study with a longer follow-up period (6 months) was also 
unable to detect improvements in work functioning [27]. They indicated that the 
reasons for poor implementation of the e-health intervention included the inter-
vention not fully being integrated into the organisation before testing its effective-
ness.  These are similar finding to our pilot study which had low uptake rates.  
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In addition, although randomised controlled trials (RCT) are considered the best 
method to examine the effectiveness of an intervention or treatment, this pilot 
questions the feasibility of conducting an RCT in a pragmatic setting. The use of 
web-based employability interventions within a non-disease specific population 
raises the issue of generalizability of the results versus the applicability of the re-
sults in a disease specific population. As mentioned before, no significant effects 
were found. On the other hand, because of the inclusion of many types of work-
related disabilities, the generalizability of the results of the RCT is upturned. Con-
sidering the challenges of using RCT methods to study the effectiveness of the in-
tervention, observational methods or research using qualitative methods, are need-
ed to explore the barriers to conducting RCTs which compare web-based employa-
bility interventions to regular trade union support. Consequently, a large RCT ap-
pears to be very expensive and infeasible.  
Implications for future research 
Before conducting a full-scale study, several key elements need to be improved. At 
this time, the web-based employability intervention was not associated with an 
economically relevant impact over regular trade union support for a heterogeneous 
population with work- and disability related concerns. However, based on the 
knowledge gained from this pilot economic evaluation, the administration of data 
collection as well as deciding upon cost categories and outcome measures can be 
used to direct future research. An intervention should attempt to be easily accessi-
ble for interested people to ask questions about disability, health and work. The 
web-based tool might also benefit from better ‘targeting’ given the heterogeneous 
population and from revising and enlarging its intensity.  
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Technical Appendix 
Cost calculation  
Questionnaires measuring the use of resources with a three month recall period 
were provided to the respondents at baseline and three months after commence-
ment of the intervention to identify healthcare, patient-and family and productivity 
costs (indexed to the reference year 2013).  
 Health care costs comprised visits for primary, secondary, alternative care, 
hospitalization, and medication. The Dutch Manual for Costing was used to value 
health care utilization. For prescribed medication, prices were calculated by first 
determining the standard daily dose as reported in the Dutch Pharmacotherapeutic 
Compass and then multiplied the price per dose by the number of days. 
 Patient and family costs included out-of-pocket costs (i.e. travel- and parking 
costs and informal care costs). Travel- and parking costs incurred while making use 
of health services are valued by computing the costs per kilometer to a health ser-
vice, adding parking costs, for the health care resource used. The reference price for 
informal care was based on the hourly minimum wage of a housekeeper at 40 
hours per week from the age of 23 years.  
 Productivity costs (i.e. costs in other sectors) comprised losses in productivity 
from paid word (absenteeism) and costs due to reduced productivity while at work 
(presenteeism). Sick leave hours were derived from the total duration of sick leave 
days in the previous three months by converting them into work-hours equivalents 
based on the Dutch average of 1,540 work hours per year. The human capital theo-
ry was used to value productivity losses by multiplying the sick-leave hours by the 
gender and age-specific productivity levels per paid employee.   
 Costs of the web-based employability intervention were calculated by using a 
bottom-up costing approach and included those related to implementing and oper-
ating the employability intervention (Table 1). In depth cost calculation methods 
can be obtained by contacting the corresponding author.   
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Table 1. Costs (all in Euro) of the web-based employability intervention 
Intervention Component  Units Unit Prices Annual costs
(n=336) 
Participant 
costs  
(i) Operational costs website 'Wijzer met Welder' 
Maintenance ICT 52 45 2,340 6.96 
Actualisation content 52 65 3,380 10.06 
Content support 260 45 11,700 34.82 
Hosting, telephone, etc. ‡ NA 3,500 10.42 
Handling – administration 52 35 1,820 5.42 
Customer management 16 80 1,280 3.81 
Marge ‡ NA 1,500 4.46 
Total costs per participant per year 25,520 75.95 
Total costs per participant - 3month 
follow-up 
18.99 
(ii) Utilization costs WAI-test  
Price arrangement (invoice) - licence: 
WAI-test including questionnaires, 
updates and protocol   
NA NA 1,337 3.98 
Total costs per participant per year 3.98 
Total costs per participant - 3month 
follow-up 
1.00 
(iii) Feedback coach   
Facilitating  10 minutes 47.7 NA 7.95 
Preparation  10 minutes 47.7 NA 7.95 
Conversation  30 minutes 47.7 NA 23.85 
Registration  1 minute 47.7 NA 0.795 
Total costs per participant per 
uptake   
40.55 
(iv)Personal Advice   
Mailing or advisory telephone line  15 minutes 47.7 NA 11.925 
Registration  5 minutes 47.7 NA 3.975 
Total costs per participant per 
uptake  
15.9 
(v)Forum   
Moderator  5 hours per 
week 
95 24,700 73.51 
Total costs per participant per 
uptake  
73.51 
‡ average estimate
NA= not applicable     
Outcome measures 
Work ability was measured via “The Work Ability Index” (WAI), a questionnaire of 
7 items assessing the work ability of an individual employee by scoring from ‘2’ 
(very bad) to ‘10’ (very good). The WAI takes into consideration both the physical 
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and mental demands of the work. The index helps to identify those that need sup-
port. A point improvement on the WAI was denoted a substantial improvement and 
was used to demonstrate the effect for the cost effectiveness of the intervention.  
 Differences in Quality Adjusted Life Years (QALYs) gained during the three 
month follow-up were assessed in the cost utility analysis. A QALY combines sur-
vival and utilities into one single measure. Utilities refer to the preference for any 
particular set of health outcomes and are indicated with a number between ‘0’ 
(death) and ‘1’ (perfect health). Utilities were calculated using EuroQol-5D-5L by 
measuring health outcomes on five dimensions (mobility, self-care, daily activities, 
pain/discomfort and depression/anxiety). Each dimension can be rated on five 
levels ranging from none to major complaints. A crosswalk to the 3 level value sets 
was used to calculate the utility weights based on EuroQol scores using Dutch tariff. 
Utilities at baseline and after three months follow-up were used to compute QALYs 
by means of the area under the curve method.   
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Abstract 
Objective: To assess the cost effectiveness, -utility, and –benefit of a new organizational 
return-to-work (RTW) intervention to improve Cooperation between Sick-listed employees 
and their Supervisors (COSS).  
Methods: A field study with six months follow-up comparing COSS with common practice 
randomized participants aged 18-60, working at least 12 hours/week and absent for at least 
two weeks. Outcomes were initial RTW, quality adjusted life years (QALYs), and productivity 
gains.  
Results: After six months, COSS generated less costs when compared with common practice. 
Participants in the COSS group returned to work earlier, improvement in QALYs were uncer-
tain. Net benefits of COSS versus common practice yielded a productivity gain of €395.89.  
Conclusion: Implementing COSS for sick-listed employees has potentials to reduce costs and 
improve productivity, and potentially quality of life. Longitudinal research might detect 
whether COSS also has the potential reaching sustainable RTW.   
 
Key words: cost effectiveness analysis, cost utility analysis, cost benefit analysis, return-to-
work, initial return-to-work, productivity, QALY, intervention, collaboration, employer, 
worker. 
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Introduction  
Long-term sickness absence contributes largely to the total costs of work disability 
in Western countries. In the Netherlands, sickness absence among employees was 
up to 3.9 percent in 2013 [1]. Long term sickness absence adds to health- and eco-
nomic problems as it is associated with a reduced probability of eventual return-to-
work (RTW), followed by economic and social withdrawal. Reducing work disabil-
ity to decrease absence and enhance RTW is an international government’s top 
priority [2]. Cost effective RTW interventions are needed to achieve these aims. 
However, insight into the economic consequences of most existing RTW interven-
tions is lacking. Although several studies performed cost effectiveness evaluations, 
most were among patients with specific diagnoses (i.e. distress, back pain, etc.) and 
are usually accessible to employees via healthcare providers or insurers [3-7]. 
These interventions can be regarded as a continuation of medical/clinical treat-
ment (see, for example [8]).  
 The newly developed organizational intervention to enhance ‘COoperation 
regarding return-to-work between Sick-listed employees and their Supervisors’ 
(COSS) is innovative and generic as it is can be applied to all employees, regardless 
of their diagnoses or medical treatment. Supervisors will be interested in such in-
terventions as they are not always allowed to ask employees about their health 
complaints [9]. COSS aims to resolve bottlenecks at the organizational level that 
were described in earlier research such as a lack of trust and open communication 
between the sick-listed employee and the supervisor [10-13]. COSS is complemen-
tary to Dutch legislation, which in itself appears to be insufficient to realise an ade-
quate cooperation between sick-listed employees and their supervisors [13]. 
 The objective of this study is to conduct an economic evaluation of COSS by 
assessing the cost effectiveness, -utility, and -benefit of COSS compared with com-
mon practice.  
Methods  
Study design  
An economic evaluation was carried out alongside a field study comparing COSS 
with common practice with a six months follow-up. The field study was conducted 
in the Netherlands between 2012 and 2014 by researchers from Maastricht Univer-
sity. The field study whereof data was used for the economic evaluation was regis-
tered at the Dutch trial register (NTR3151). The Medical Ethics Committee (METC) 
of the Maastricht University was consulted and declared no ethical approval was 
necessary. The study protocol for conducting the economic evaluation and interpre-
tations of the data [14] as described in this manuscript was approved by the local 
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Ethics Committee of Psychology at Maastricht University, the Netherlands 
(ECP107).  
 Most data were self-reported, except for sick-leave data which were retrieved 
from the participating organization’s administration (a banking organization, which 
preferred to be anonymous). 
 An economic evaluation was conducted from both the societal and organiza-
tional perspective. Cost effectiveness- (CEA), cost utility- (CUA), and cost benefit 
(CBA) analyses were performed. The costs included were categorized into interven-
tion, healthcare, patient and family, and other sectors (i.e. productivity).  To avoid 
double counting in the CEA when productivity served the outcome of interest, sole-
ly intervention-, health care-, and patient and family costs were accounted for. More 
details on the cost categories can be seen in Table 2. (Supporting information 1 
presents an overview of the different perspectives and types of economic evalua-
tions conducted in this study). 
Study population  
Eligible participants were aged 18-60; sick listed for at least two weeks and per-
formed paid labor for at least 12 hours per week at the onset of absence. Partici-
pants were excluded when their actual sick leave at baseline overreached 10 weeks 
or were terminally ill.  
Interventions  
Common practice  
Dutch legislation requires supervisors to compensate their employees at sick-leave 
for at least 70% of their income during two years [9, 15, 16]. The Improved Gate-
keeper Act prescribes obligatory procedures for employees and supervisors during 
this period (e.g. compose an action plan for RTW, monitor its progress, etc.)[17]. 
According to the Act, occupational physicians should be contacted (and paid for) by 
supervisors to analyze the employees’ functional limitations and to advise regard-
ing RTW [9, 15, 16].  
 Additional to legislation, the banking organization has an own sick leave policy 
that prescribed weekly meetings between sick-listed employees and their supervi-
sors.  
COSS 
Additional to the legal requirements and the organizational policy, the cooperation 
between sick-listed employees and their supervisors was guided by the COSS inter-
vention. COSS consisted of: (i) a conversation roadmap (step-by-step cooperation 
plan); (ii) a regular monitoring of the cooperation by using questionnaires at prede-
termined time points; and (iii) extra occupational physician support. The research 
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team analyzed the questionnaire results (cut-off scores) and wrote an advice on the 
cooperation for the OP who provided extra support if needed. The intervention was 
provided continuously until full RTW.  
 More in depth details regarding COSS- and common practice can be found 
elsewhere [18].  
Main outcomes  
The main outcomes were initial return-to-work (iRTW) and quality-adjusted life 
years (QALYs). iRTW was measured as duration in calendar days from the moment 
of employee inclusion onwards until initial return-to-work (iRTW) until maximally 
six months after inclusion. iRTW is conceptualized as the first moment at which 
progress is made in hours worked, even if the employee works less hours than con-
tracted or if the employee is still (partly) sick listed [19]. Quality Adjusted Life 
Years (QALY) was assessed by using the self-administered EuroQol-5D-5L ques-
tionnaire. Health outcomes were measured on five dimensions: mobility, self-care, 
daily activities, pain and discomfort, and depression and anxiety [20]. Utilities were 
delineated by using the EQ-5D-5L crosswalk value set [21] to obtain Dutch tariffs 
and an overall utility score for population-based quality of life [22]. QALYs were 
calculated by multiplying the utility with the amount of time a patient spent in a 
particular health state. The maximum possible number of QALYs within the six 
months is 0.5 (half a year multiplied by 1, the optimal health state). 
Resource use and valuation 
Intervention costs 
Intervention costs were calculated based on a bottom-up micro-costing approach 
(Supplementary file 2) and consisted of expenditures related to both developing 
and offering the intervention. For the economic evaluation, the costs of offering 
COSS were relevant; i.e. monitoring cooperation based on the questionnaires and 
training and extra support by occupational physicians (Supplementary file 2, part 
B). The reach (of potential participants) is based on the average number of sick-
listed employees in the participating organization (N=2,266).  
Healthcare costs  
Self-reported questionnaires with a recall period of six months were posted to the 
participant at baseline and six months after randomization to collect resource use 
frequencies. Discounting of costs was not necessary because the follow-up was one 
year. At every assessment, information was collected about the volume of health 
care consumption using a modified version of the Trimbos/iMTA questionnaire for 
costs (Tic-P) [23]. The modified questionnaire comprised medical aids through 
consults and admissions to the general practitioner, occupational physician, move-
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ment therapist, medical specialist, mental healthcare worker, alternative treatment, 
professional home care, hospitalization, rehabilitation clinic, and psychiatric insti-
tution. The respective units of resource use were multiplied by standard Dutch unit 
prices according to the Dutch guideline for costing research [24]. Costs were in-
dexed to 2012 Euro (€) by means of the consumer price indexes of Statistics Neth-
erlands [25]. Tariffs or average prices were used when standard price weights were 
not available. The costs of prescription medicines were calculated by deriving the 
standard daily dosage as published by the Dutch Pharmacotherapeutic Compass 
[26] and multiplied by the price per dose [27] and the number of intake days. The 
pharmacist’s dispensing costs (€5.99) and the general practitioners’ prescription 
costs were added (€14) to the costs of prescription medicines [24]. Over the coun-
ter drugs (including 6% taxes) were based on their market prices. Aids such as 
home interior elements, orthotics, mobility aids, etc. were based on the total costs 
per user for the reference year 2012 within the aid category as provided by the 
Dutch care institute [28]. 
Patient and family costs 
Patient and family costs relate to informal care costs and parking and travel costs 
incurred while using health care resources. As the official unit price for informal 
care is not available, it was valued against the ‘shadow price’ of the wage rate per 
hour of a housekeeper [29]. Travelling and parking costs were calculated by multi-
plying average distance with the standard price weights according to the Dutch 
guideline for costing research  or on average distance as presented in Warmerdam 
et al. 2010 [30]. 
Costs in other sectors (productivity costs) 
The ‘friction costs approach’ (FCA) was used to value productivity costs. FCA states 
there is a short-run friction period during which the organization might incur loss-
es as an adjustment is made to an employees’ absence. However, in the long run, no 
(more) losses are held to occur because the employee either returned to work and 
the productivity returned, or the organization replaced the injured employee and 
productivity became comparable to what it was before [29, 31]. The friction cost 
approach thus assumes productivity losses only occur during the ‘friction period’; 
the time needed to replace and train new employees. The friction period for the 
Netherlands was estimated based on the availability of labor—that is, the level of 
unemployment [32]. The friction period for 2012 in the Netherlands contained 
13.24 weeks (92.68 days). Productivity cost estimates were based on self-reported 
average daily wage rates multiplied with the number of days until initial work re-
sumption (sick-leave data retrieved from the banking organization) and with 0.8 to 
adjust for the elasticity between working time and productivity, which represents 
reduced labor efficiency, as prescribed by the costing manual [24]. Productivity 
costs were only calculated when lost work was not compensated (i.e. through extra 
working hours, by colleagues or by temporary or permanent replacement) as it was 
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assumed that absenteeism compensated for did not result in lost productivity. De-
tailed information on the calculation used to estimate the friction period and the 
productivity costs can be derived via the first author.   
Data analyses  
Data were analyzed according to the intention-to-treat principle. All participants 
were analyzed in the condition to which they were randomized after inclusion 
based on their baseline questionnaire responses. Missing values at baseline were 
imputed via mean imputation techniques. Missing data at follow-up were imputed 
by using the last observation carried forward, assuming no changes in effect or cost 
over time. All analyses were conducted in IBM SPSS Statistics 21 and Microsoft 
Excel. 
Economic Evaluation  
For the cost effectiveness analyses (CEA), incremental cost effectiveness ratios 
(ICERs) were determined to indicate the additional investments needed for COSS to 
gain one extra unit of effect compared with common practice. The following calcu-
lation was used; (C1-C0)/(E1-E0), where C is the average cost and E is the proportion 
of respondents achieving initial RTW. The total costs were calculated by the sum of 
the intervention-, healthcare-, and patient and family costs. In order to calculate the 
incremental cost utility ratio (ICUR) the incremental costs (intervention-, 
healthcare-, patient and family-, and productivity costs) are divided by the differ-
ence in QALYs. The cost benefit analysis (CBA) calculated the net monetary benefit 
(NB) and the benefit-cost ratio (BCR) from the organizational perspective. The NB 
was derived by subtracting the mean difference in intervention costs between both 
groups from the difference in productivity costs. The BCR was calculated by divid-
ing the benefits of the investment by the costs of the investment in order to calcu-
late the amount of money returned per Euro invested. Financial returns were posi-
tive if NB > 0 and BCR > 1.  
 Non-parametric bootstrap re-sampling techniques were used to capture the 
uncertainty surrounding the incremental costs. Using the original data, 5,000 repli-
cations of the cost-effect pairs were generated and plotted on one of the four quad-
rants of the cost effectiveness plane to display differences in costs on the vertical 
axis and differences in effects on the horizontal axis. In the North-east quadrant the 
intervention produces superior effects at additional costs relative to common prac-
tice. In the North-west quadrant less effect is produced for additional costs meaning 
the intervention is “dominated” by the common practice condition. In the South-
west quadrant less effect is produced, but there are some cost-savings. And finally, 
in the South-east quadrant the intervention generates superior effects for less 
costs; the intervention “dominates” common practice.  
 The bootstrapped ratios were furthermore used to construct an acceptability 
curve which indicates the probability of the intervention being cost effective at a 
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predetermined ceiling ratio (€); which is society’s willingness to pay (WTP) to gain 
one extra unit of effect (e.g. one QALY). The WTP depends on the type of disease 
and its severity; which is higher for very severe conditions (i.e. a tentative maxi-
mum of €80,000) than for mild conditions in the Netherlands [33]. For the COSS 
intervention it was difficult to choose one threshold based on the severity of condi-
tions, as participants in the field study have a variety of diseases. The acceptability 
curve however demonstrates the probability of COSS being cost effective at a ceiling 
ratio of €18,000, indicating that COSS has the likelihood of being cost effective for 
the whole spectrum of diseases from non-severe till severe conditions (see Figure 
2, part B).  
 To ascertain the robustness of the findings, different sensitivity analyses were 
carried out. As elder employees might stay on longer sick leave or use the claim of 
work disability absenteeism as an alternative to retirement, especially among those 
over 55 years of age was used [34], the first sensitivity analysis therefore tested 
whether faster work resumption due to COSS can be achieved among employees 
between 40 and 60 years of age when compared to common practice. Secondly, 
because COSS is developed to be broadly implementable because of its non-disease 
specific focus, a subgroup analysis controlling for chronic disability is conducted. 
Thirdly, a cost utility analysis was calculated by using similar costs as the cost effec-
tiveness analysis. Finally, a cost benefit sensitivity analysis was performed in which 
the intervention costs were higher as they were based on the actual uptakes 
(n=39).  
Results 
Participants 
90 participants from six departments at the banking organization were randomized 
to the COSS– and common practice group and filled in the baseline questionnaire. 
Complying with the inclusion criteria, the data of 39 participants in the COSS group 
and 25 in the common practice group were analyzed at baseline and after six 
months follow-up. Figure 1 provides more details on the participants’ flow 
throughout the study.  
 Fig
ur
e 
1.
 Pa
rti
cip
an
t’s
 flo
w 
ch
art
  
 
193 
C H A P T E R  8  
 194
Table 1 lists the baseline characteristics of both groups. Significant differences 
across both groups were found for age, gender and the average number of working 
hours. None of the cost categories were significantly different when comparing 
both groups, though on average, costs were higher in the common practice group.  
 
Table 1. Baseline characteristics (n=64) 
 Intervention Group (n=39) 
Control Group 
(n=25) 
p-value  
Age, mean (sd) 45.31 (9.2)  50.6 (7.4) 0.019 (a) * 
Female, N (%) 25 (64) 7 (28) 0.005 (b) ** 
Education, N (%)†    
Low 7 (18) 6 (24) 
0.06 (b) Intermediate 19 (49) 4 (16) High 12 (31) 14 (56) 
Other 1 (2) 1 (4) 
Working hours, mean (sd) 31.72 (6.8)  35.50 (4.6) 0.028 (a) * 
Marital Status, N (%)    
Married 24 (62) 21 (84) 
0.15 (b) Living together with a partner 9 (23) 3 (12) Divorced  5 (13) 0 
Single 1 (2) 1 (4) 
Children under 12 years, N (%) 18 (46) 6 (24) 0.07 (b) 
Permanent employment, N (%) 39 (100) 24 (96) 0.21 (b) 
Managerial position, N (%) 3 (8) 4 (16) 0.3 (b) 
Shift work, N (%) 2 (5) 1 (4) 0.84 (b) 
General Health, N (%)    
Excellent 1 (3) 1 (4) 
0.97 (b) Very Good 10 (26) 7 (28) Good 22 (56) 14 (56) 
Moderate 6 (15) 3 (12) 
Long term disability, N (%)    
None 30 (77) 16 (64) 0.26 (b) One or more  9 (23) 9 (36) 
EQ-5D-5L Utilities, mean (sd)₸ 0.64 (0.16)  0.63 (0.24) 0.8 (a) 
Costs, mean in € (sd)   
Healthcare costs 1,348.56 (1,609.7)  1,813.64 (2,099.89) 0.72 (c) 
Medication & aids 110.1 (206.17)  125.6 (184.48) 0.24 (c) 
Health care service use 1,238.46 (1,454.03)  1,688.04 (2,017.45) 0.7 (c) 
Patient and family costs  208.03 (376.06)  254 (462.18) 0.91 (c) 
Informal care costs  137.12 (364.54)  190.03 (457.03) 0.85 (c) 
Travel and parking costs  70.9 (60.48)  63.77 (40.32) 0.92 (c) 
†Low=preschool or primary school; intermediate=lower and upper secondary; high=tertiary school, universi-
ty, or postgraduate | ₸High scores indicate better perceived health outcomes | (a) Anova (b) Pearson Chi-
squared test (c) Non-parametric Kruskal Wallis test  | * Significant at the 5% level ** Significant at the 1% level 
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Costs 
After six months follow-up, no significant cost differences were found (Table 2). 
Despite for intervention costs, the average costs per category were highest in the 
common practice group. Occupational physician-, mental healthcare worker-, alter-
native treatment-, hospitalization-, and prescribed medication costs were higher in 
the COSS group. Incremental costs based on the bootstrapped subtotals indicated 
costs were lower in the COSS group when compared to the common practice group.   
 
Table 2. Total costs per cost item and subtotal bootstrapped costs after six months follow-up 
Cost category  Intervention 
group, costs € 
(n=39) 
Common practice 
group, costs € 
(n=25) 
Incremental costs, €  
(2,5-97,5 percentile) 
Intervention costs 2.19 0 n.a. 
Healthcare costs        
General practitioner 90.71 98.7  
Occupational physician 140.9 112.88  
Movement therapist  236.35 367.39  
Medical specialist 100.35 187.32  
      Mental healthcare worker 243.05 58.9  
Alternative treatment 45.89 13.42  
Professional home care  8.85 8.28  
Rehabilitation clinic  0 0  
Psychiatric institution  0 0  
Hospitalization (day parts) 314.38 191.91  
Hospitalization(admissions) 783.76 1308.47  
Prescription medication  77.21 50.6   
Over-the-counter medica-
tion 
4.79 10.64  
Aids  3.22 40.88  
Subtotal  2049.47 2449.39  
Bootstrapped subtotal,  
mean (sd)  
1105.57  
(140.76) 
1710.51  
(330.81) 
-605  
(-1343 to 38) 
Patient and family costs        
Informal care  106.5 114.12  
Parking and travel costs  94.34 110.75  
Subtotal  200.84 224.88  
Bootstrapped subtotal,  
mean (sd)  
201.49  
(50) 
226.34  
(59.24) 
-25  
(-175 to 129) 
Costs in other sectors       
Productivity costs  1004.64 1918.89  
Bootstrapped subtotal, 
mean (sd)  
1078.03  
(288.77) 
1944.80  
(497.05) 
-867  
(-1991 to 187) 
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Cost effectiveness analyses 
The CEA (see Table 3) showed an ICER of 26.78 (∆C=-421.77 / ∆E=15.75) meaning 
COSS was less costly and more effective (i.e. almost 16 reduced calendar days of 
absenteeism) compared to common practice and €26.78 is saved per day of work 
resumption. See also Figure 2 (part A) where 68% of the bootstrapped ICERs are 
located in the south east quadrant (indicating more effect and less costs). The cost 
effectiveness acceptability curve (CEAC) indicates that at a willingness to pay of 
€100 for one day earlier work resumption, the probability of COSS being cost effec-
tive is 87%.  
 
Figure 2. Cost effectiveness plane and cost effectiveness acceptability curve for differences in (A) initial 
RTW, (B) QALYs  
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Cost utility analysis 
The bootstrapped results in Figure 2 (part B) show that 44% and 47% of the cost 
effectiveness pairs are located in respectively the southwest and southeast quad-
rant where COSS is less costly but the difference in effect is uncertain (wide spread 
of the point estimates, Table 3).  Based on the acceptability curve, COSS has a prob-
ability of approximately 88% of being cost effective at the considered ceiling ratio 
of €18,000 for this study. The acceptability curve descends, meaning that the prob-
ability of COSS being cost effective decreases when the value society attaches to a 
QALY increases.  
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Cost benefit analysis 
The costs of the intervention were €2.19 higher than in common practice. Produc-
tivity costs according to the friction cost method were €867 lower in the COSS 
group compared to the common practice group (Table 2). The net benefit for the 
supervisor is €864.81 and the BCR is €395.89; indicating a productivity gain for the 
supervisor of almost €396 per invested Euro.  
Sensitivity analysis 
With respect to the first sensitivity analysis, results were robust when using the 
data of employees aged between 40 and 60 years. Almost €41 was saved per work 
resumption day. Results of the main analysis were also similar to the sensitivity 
analysis whereby only employees without a chronic disability were included in the 
analysis. One day earlier work resumption among employees without a chronic 
disability resulted in a cost saving of almost €50. The subgroup of employees with a 
chronic disability yielded faster return to work, however, contrasting the main 
analysis; an additional investment of almost €18 was needed. A summary of the 
findings is shown in Table 3. With respect to costs per QALY, the results of the 
fourth sensitivity analysis were robust when omitting productivity costs. The ac-
ceptability curve descended from 74% (best case with 3,000 Euro willingness to 
pay to gain one QALY) to 65% (worst case).  Assessing the robustness of the find-
ings from the organizational perspective by accounting the costs of the intervention 
depending on the actual uptake rates (N=39) were comparable to the results of the 
main analysis. The intervention costs increased from 2.19 Euro to 127.35 Euro. The 
net benefit for the supervisor is €739.65 and the BCR productivity was €6.89 per 
invested Euro, indicating that COSS still produced a positive financial return.  
Conclusions 
A new organizational RTW intervention for Cooperation between Sick-listed em-
ployees and their Supervisors (COSS) appeared to have substantial economic bene-
fits over common practice. The cost effectiveness acceptability curve indicated that 
the probability of COSS being cost effective compared with common practice was 
87% for ceiling ratios larger than €100 to gain one day of earlier initial return to 
work. For QALYs gained, the cost effectiveness acceptability curve indicated that 
COSS had a cost effectiveness probability of almost 88% at a ceiling ratio of 
€18,000.  
 This study combined different types of economic evaluations (i.e. cost effec-
tiveness, -utility, and -benefit) from diverse perspectives to compare the organiza-
tional intervention, regardless of the employees’ diagnoses, with common practice. 
Lower costs and higher effects of COSS when compared to common practice result-
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ed in an ICER of almost €27 per initial return-to-work calendar day. Exploring the 
robustness of the results in several sensitivity analyses resulted in comparable 
findings. COSS remained cost effective, even among the group of older employees 
(age range between 40 and 60 years) that generally have longer sickness absence 
spells [34]. Employees either with or without a chronic illness receiving COSS re-
turned to work faster when compared to common practice. Results in terms of 
QALYs were uncertain because the majority of the incremental cost utility ratios 
were located in the quadrant of ‘fewer costs, more effects’ and ‘fewer costs, less 
effects’.  Exploring the incremental cost utility omitting productivity costs resulted 
in comparable findings. From an organizational perspective, COSS can be regarded 
as cost saving to the employer, even when upgrading the intervention costs. A re-
cent review yielded similar overall positive results on the financial return of 
worksite health promotion programs [35].  
Strengths and limitations  
The main strengths of this study were its pragmatic (‘real life setting’) design, the 
different perspectives (i.e. societal, organizational, healthcare) used to assess dif-
ferent types of economic evaluations (CEA, CUA, and CBA), the use of objective sick-
leave data, and the transparent registration of the intervention costs, limiting the 
risk of over- or underestimation actual costs. Another strength is the inclusion of 
productivity loss caused by reduced labor efficiency by accounting for elasticity 
when using the net cumulative days of sick leave as the proxy for productivity loss. 
Accounting for presenteeism reduced the risk of over- or underestimating actual 
productivity costs in both groups alike. The effectiveness study confirmed the find-
ings of this study when investigating the time to first RTW (i.e. a tendency towards 
effectiveness in the COSS group). Also, when addressing full- and sustainable RTW 
in calendar days, positive effects were found in favor of the COSS group [36]. Fur-
ther research is needed to detect whether COSS has the potential of reaching sus-
tainable RTW at lower costs when compared to common practice. To economically 
evaluate the potential positive effects of COSS on full- and sustainable RTW over an 
adequate follow-up period and a longer time span more research is needed as it 
took more time than anticipated to recruit individual employees and supervisors. 
Furthermore, the generalizability of the study results is not boundless. The Nether-
lands holds a unique position regarding RTW policy [16], and COSS was specifically 
tailored to and implemented in the Dutch context. Taking into consideration that 
the common practice is already more intensive due to legal requirements for coop-
eration [16] when compared to other countries (e.g.  Belgium, Canada or the US), 
the effects of the intervention might be higher in countries where no legal require-
ments for cooperation and collaboration are set.  
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Concluding remarks 
In the Netherlands, there is a strong need for research regarding cost effectiveness 
studies of interventions on working conditions, social work environment and 
health [37]. This study demonstrated the cost effectiveness of COSS. For the cost 
utility, the high utility scores at baseline might explain the uncertainty regarding 
the effectiveness for both COSS and common practice, making it difficult to detect 
an increase over time. COSS yielded a cost saving and from an organizational per-
spective even a positive financial return regarding first RTW.  
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Supporting information 1.  Main analyses for economic evaluation 
Method Costs (€) Outcome
Cost Effectiveness  - healthcare costs
- patient and family costs 
- intervention costs 
Initial RTW
Cost Utility - healthcare costs
- patient and family costs 
- intervention costs  
- costs in other sectors (produc-
tivity) 
Quality Adjusted Life Years  
Cost Benefit  - intervention costs 
 
Monetary benefits 
(productivity gain) 
 
Supporting information 2. Total per participant intervention costs 
Type of costs Calculation Outcome (€) 
Part A: Development costs 
Development of the conversation 
roadmap  
Average wage rates per contributor multiplied 
with average number of hours worked on the 
developments  
2,112.54  
 
Development of questionnaires 
and online versions. Development 
of cut-off scores.  
Average wage rates per contributor multiplied 
with average number of hours worked on the 
developments 
2,447.64  
 
Sending out questionnaires and 
reminders, reminder phone calls 
and questionnaire analyses for 
occupational physicians and 
coaches 
Average wage rates per contributor multiplied 
with average number of hours worked  
5,932.50  
Improving COSS based on feed-
back 
Average wage rates per contributor multiplied 
with average number of hours worked 
158.20  
Total costs: 5,311.88 
Part B: Costs of offering the intervention
Printing costs of the conversation 
roadmap  
Number of prints multiplied with the amount per 
print  
561.60  
Use of roadmap by supervisors Hours required for reading and using the complete 
roadmap multiplied with average sick leave dura-
tion in months multiplied with average wage p. 
hour supervisor  
252.11 
Monitoring cooperation: Filling 
out questionnaires by supervisors 
Average time per questionnaire multiplied with 
average wage supervisor  
814.96 
Preparing and providing an 
accredited training session to 
occupational physicians/coach  
Average wage rates per contributor multiplied 
with average number of hours worked 
1,603.90  
 
Occupational physicians and 
coaches providing extra support 
to employees and/or supervisors 
Average wage rates per contributor multiplied 
with average number of hours worked 
1,734.42 
Total costs: 4,966.99 
Costs per participant* 2.19 
* 2,266 participants: representation of employees in the banking organization, accounting for the percen-
tage of absence during the reference year 2012 
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Abstract  
Objective To evaluate the cost effectiveness and cost utility of an integrated care- and partic-
ipatory workplace intervention provided to workers with rheumatoid arthritis (RA) to im-
prove their work productivity. 
Methods An economic evaluation was conducted alongside a randomized controlled trial 
with a six months follow-up in specialized rheumatology treatment centres in or near Am-
sterdam, the Netherlands. Adults aged 18-64 years, diagnosed with RA, working in a paid job 
for at least 8 hours per week and experiencing at least minor difficulties in functioning at 
work were randomized to the intervention (n=75) or the control group (n=75). Effect out-
comes were at-work productivity loss (measured in presenteeism hours) and quality adjust-
ed life years (QALYs). Health care costs, patient and family costs, costs in other sectors, and 
intervention costs were calculated from a societal perspective. Cost effectiveness- and cost 
utility analyses were conducted to indicate the incremental costs and benefits per additional 
unit of effect. A subgroup analysis and several sensitivity analyses to evaluate the impact of 
different methodological considerations on the results were conducted to attest the robust-
ness of the findings.  
Results At-work productivity loss was about 4.5 hours in the intervention group and 4 hours 
in the usual care group per two weeks (non-significant difference for both group, p-
value=0.103). The mean QALY was on average 0.39 for the control group and 0.38 for the 
intervention group, which was not significantly different comparing both groups (p-
value=0.09). In total, average costs after six months follow-up were highest in the interven-
tion group (€1,969.48) compared to the control group (€1,456.13). The main cost effective-
ness and cost utility analyses show that the intervention was more expensive and less effec-
tive than the control condition. Sensitivity analyses supported these findings.  
Conclusions Based on the six months data no evidence is forehanded to support the imple-
mentation of the intervention on cost-related grounds.  
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Introduction 
Rheumatoid arthritis (RA) patients experience more restrictions in participation in 
employment, have higher risk of becoming work disabled, and become more work 
disabled over time [1-3]. RA is a prevalent condition (between 0.5% and 1% of the 
population in the developed world) associated with severe impairments [4]. Fur-
thermore, RA disability related productivity losses due to time lost from work or 
during work (respectively absenteeism and presenteeism) have a substantial socio-
economic impact [5-7]. Previously conducted research on work disability in RA 
showed  that over a period of almost 13 years, almost 9% of RA patients gave up 
their paid work and 4% stopped and never resumed paid work [8]. According to 
Boonen & Severens (2011), sickness absence among patients with early RA ranges 
between 53-82% per year, resulting in substantial mean annual cost per patient for 
paid productivity loss (up to about €8,000) [4]. Absenteeism from paid work repre-
sents a major source of productivity costs; the weighted mean annual sick leave 
costs were as high as €2,770 per patient [4]. Presenteeism, which refers to at-work 
productivity loss, is an important cost contributor as well. Furthermore, presentee-
ism can occur without absenteeism, it can precede absenteeism, and it can follow 
absenteeism [4, 9]. Particularly in situations where the employee is not absent from 
paid work but struggling with work- and health related disability complaints, as is 
often the case with RA patients, costs related to presenteeism are at least as im-
portant as absenteeism costs. 
 In an attempt to reduce the burden for patients with RA regarding their work 
abilities, and to reduce high costs to society, a need emerged to develop (cost) effec-
tive worksite interventions to support work participation of workers with RA. Pre-
viously conducted studies have shown that suboptimal care by lack of communica-
tion may lead to long-term absenteeism from work and permanent work disability, 
and thereby high costs [10]. Integrated care programs on work participation in 
chronically ill patients were therefore developed, inducing that integrated care 
might increase work participation [11, 12]. Because of the need for recommenda-
tions for work activities in chronic diseases and the fact that involving the worksite 
might make a difference, an intervention program consisting out of both integrated 
care and a participatory workplace intervention was provided to workers with RA. 
Integrated care was already effective in increasing work participation among 
chronically ill patients [11, 12]. An integrated care program for patients sick listed 
because of chronic low back pain also had substantial economic benefits over usual 
care [11]. A participatory return-to-work intervention for sick-listed workers due 
to musculoskeletal disorders enhanced work resumption and generated a net soci-
oeconomic benefit [13].   
 Before implementing this intervention on a large scale, a broader picture of the 
total cost and effects of the intervention needs to be evaluated. As (occupational) 
healthcare budgets are limited, economic evaluations become more important. Cost 
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effectiveness analyses are conducted to estimate the incremental monetary costs 
and benefits of an intervention per unit of effect gained. Although intervention re-
lated costs to evaluate the cost effectiveness of a worksite intervention are im-
portant to account for, worksite interventions are also associated with healthcare 
and productivity-related costs. There is still an ongoing debate on how to identify, 
measure, and value productivity costs in economic evaluations [9, 14].  
 Economic evaluations are recommended to be conducted from the perspective 
related to the costs being evaluated [15]. According to the guidelines for economic 
evaluations, full economic evaluations are preferred to be conducted from the soci-
etal perspective, considering all costs and benefits of interventions no matter on 
whom they fall [16]. Adhering to the guidelines, this study includes all relevant 
costs from the societal perspective (healthcare-, patient and family-, and costs in 
other sectors). Defining costs in other sectors, this study focused on costs related to 
productivity. The main productivity cost terms and the different conceptions on 
how to value productivity costs as presented throughout this study are listed in 
textbox 1 (adapted from Krol, et al.  2013) [14].  
 
Textbox 1. Main productivity cost terms
Absenteeism Not attending work 
Presenteeism  Attending work with diminished functioning (reduced work 
quantity and quality) 
Compensation  Methods in which lost productivity is compensated for (e.g. extra 
hours, co-workers took over, etc.)  
Human Capital  
approach 
All potential lost productivity not performed by a person due to 
work disability 
Friction Cost approach  Lost productivity is limited until the time needed to replace a 
work disabled worker and train his/her substitute  
 
The aim of this present study was to conduct an economic evaluation, including 
cost effectiveness- and cost utility analyses, in which the intervention (i.e. an inter-
vention program consisting out of both integrated care and a participatory work-
place intervention) was compared to usual care of workers with RA. The research 
questions were: 
(i) “Is the joint distribution of costs and at-work productivity loss preferable in the 
intervention group when compared to usual care?” 
(ii) “Is the joint distribution of costs and RA patients’ quality of life preferable in the 
intervention group when compared to usual care?” 
(iii) “How do different methodological considerations under a given set of assump-
tions impact the results? (risk-case analysis and sensitivity analyses)” 
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Methods 
The economic evaluation was conducted alongside a randomized controlled trial 
comparing a workplace intervention, which is consisting out of both integrated care 
and a participatory workplace intervention, with care as usual among workers with 
rheumatoid arthritis (RA). The study was conducted in the Netherlands between 
2011 and 2013 and the follow-up period was six months. The trial was registered in 
the Dutch Trial Register (NTR2886). The Medical Ethics Committee of the Sloter-
vaart Hospital and Reade, and the VU University Medical Center, Amsterdam, the 
Netherlands approved the study design, protocols, procedures, and informed con-
sent. Participation was voluntary and all participants signed informed consent. 
Study population 
RA patients who have visited a rheumatologist of one of the participating hospitals 
during the last year were approached. Eligible patients were adults aged 18-64 who 
were diagnosed with RA, had a paid job (paid-employment or self-employed) for at 
least 8 hours per week and experienced at least minor difficulties in functioning at 
work. Patients were excluded in case of (i) severe comorbidity as it would hamper 
compliance to the protocol; (ii) being unable to read or understand Dutch language, 
and (iii) taking more than three months sick leave at time of inclusion. Eligible pa-
tients received an information letter about the project from their own rheumatolo-
gist. Details of the study design are described elsewhere [17].   
Sample size  
At-work productivity loss, expressed as hours lost from work due to presenteeism, 
measured with the Work Limitation Questionnaire (WLQ) [18], was used to calcu-
late the sample size. A two hour per two weeks was considered a relevant differ-
ence, which implies a moderate standardized effect of 0.5. Assuming a dropout rate 
of 15%, power analysis revealed a sample size of 142 patients to be included in 
total (80% and an alpha of 0.05) [17]. 
Randomization 
Randomization to either the intervention group or control group was performed on 
patient level. To prevent unequal randomization, patients were pre-stratified by 
three prognostic factors: sex, number of working hours per week, and whether the 
patient performed light or heavy physically/ mentally demanding work [19]. A 
software program (Minim) based on the minimisation method was used for treat-
ment allocation [20]. Minimization allows pre-stratification by several prognostic 
factors, even in small samples [21, 22]. Due to the character of the intervention, 
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patients, therapists and researchers could not be blinded for the allocated treat-
ment after randomization.  
Intervention  
The participants in the intervention group were able to take part in the interven-
tion program consisting out of two components which complement each other: (i) 
integrated care, and (ii) participatory workplace intervention. Integrated care was 
provided based on a case management protocol whereby a trained clinical occupa-
tional physician (COP) acted as care manager. The care manager had an intermedi-
ate role between clinical and occupational care. During the first consultation the 
COP was responsible for history taking and physical examination, the planning and 
coordination of care, and for communication between all care providers. The pa-
tient visited the care manager within one week after randomization and, if needed, 
again after six and 12 weeks to evaluate and if necessary adjust the treatment plan. 
The participatory workplace intervention concerned workplace adaptations based 
on active participation and strong commitment of both the patient and, if relevant, 
the supervisor. The workplace intervention was coordinated by the occupational 
therapist that mainly concerned feasible solutions for the obstacles for functioning 
at work. Within the context of this study, two occupational therapists were trained 
by an expert to coordinate the workplace intervention. More details on the exact 
content of the intervention can be found elsewhere [17]. All participants received 
usual rheumatologist-led care as provided in the Netherlands. 
Main outcome measures 
At-work productivity loss 
The primary outcome measure for the cost effectiveness analysis was at-work 
productivity loss, examined as hours lost from work due to presenteeism per two 
weeks, measured with the Work Limitations Questionnaire (WLQ) [18]. Presentee-
ism refers to being present on the job, but being limited in meeting work demands. 
The WLQ consists of four subscales (time management demands, physical demands, 
mental-interpersonal demands, and output demands) which are calculated into 
scores ranging from 0 (no limitations) to 100 (highest limitations). All four sub-
scales have high internal reliability and internal consistency and the WLQ concern-
ing RA shows good validity and reliability [23-25]. The score on all 25 items (which 
presents the percentage of productivity loss) are multiplied by the number of work 
hours, resulting in an estimation of presenteeism hours per two weeks.   
 
Quality of Life  
The outcome measure for the cost utility analysis was quality adjusted life years 
(QALY) calculated using EuroQol-5D-5L [26]. The EQ-5D-5L measures health out-
comes on five dimensions (mobility, self-care, daily activities, pain/discomfort and 
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depression/anxiety) ranging from none to major complaints. The Dutch crosswalk 
value set was used to estimate the utility of health states as described by the re-
spondent [27]. Utilities at baseline and after six months follow-up were used to 
compute QALYs by means of the area under the curve method [28]. 
Cost measures and valuation  
In health economics, different cost categories can be used. The three categories of 
costs adhered to in this study were the healthcare costs, the patient- and family 
costs and the costs in other sectors. Intervention costs were aggregated to estimate 
the mean total societal costs [29]. Questionnaires with a six month recall period 
were posted to the respondents at baseline and six months after randomization 
included health care costs (i.e. health service uptake and medication usage), patient 
and family costs (e.g. out-of-pocket costs for travel and parking incurred while 
making use of health services and informal care costs), and costs in other sectors 
stemming from productivity changes (presenteeism and absenteeism). Costs were 
indexed to the reference year 2012 (the year in which most inclusions of partici-
pants took place). Discounting of costs was not needed because the follow-up peri-
od did not exceed one year. 
 
Healthcare costs  
Standard Dutch unit prices or average tariffs (when standard prices were not avail-
able) according to the Dutch Manual for Costing were used to quantify patient re-
ported healthcare resource utilization into a monetary value [30]. For prescribed 
medication, prices per dosage were multiplied by their average intakes. Prescrip-
tion charges were added. The Daily Defined Dosages (DDD) were derived from the 
Dutch Pharmacotherapeutic Compass [31], the price per dosage was based on drug 
costs in the Netherlands[32]. Non-prescription drugs were based on their average 
market prices, including a 6% tax. Medical, personal and professional aids were 
based on the aid categories as registered by the Dutch care institute [33] or based 
on their market prices.  
 
Patient and family costs  
Patient and family costs comprised informal care costs and travel and parking 
costs. Informal care costs were calculated by multiplying the hours of informal care 
with the wages that were valued against the shadow price of the wage rate per hour 
of a housekeeper [30]. Travel and parking costs were valued by multiplying the 
distance to the utilized health care service with the average costs per kilometer as 
presented in the Dutch guideline for costing research [30] and the frequency of 
used health care services. If applicable, parking costs were added.  
 
 
 
C H A P T E R  9  
 212
Costs in other sectors 
Costs in other sectors relate to costs through absenteeism (absent because of sick 
leave days) and presenteeism (present, but being limited in meeting work de-
mands). The friction costs method was used to calculate absenteeism costs by mul-
tiplying the days of production loss till replacement by the average day wage, based 
on the age- and gender specific productivity levels per paid employee. The time 
needed to replace and train new employees (i.e. the friction period) contained 
92.68 days in the Netherlands in 2012 [34-36]. Presenteeism costs were calculated 
by correcting for the degree of inefficiency. The inefficiency score for work quantity 
and –quality, derived from the Productivity and Disease Questionnaire [37], was 
multiplied with the number of presenteeism days in the previous six months, and 
multiplied with the wage-specific productivity levels [30].  
 
Intervention costs  
Intervention costs were calculated by using a bottom-up approach by multiplying 
the average time spent on each part with the average wage of the intervention pro-
vider. Table 2 presents the intervention costs for the main components. 
Data analysis  
The analyses were performed according to the intention-to-treat principle. Missing 
data were replaced by mean imputation using the mean of the outcome per group 
to replace the missing values per respondent. Parametric analyses (i.e. ANOVA) 
were conducted to compare the baseline characteristics between both groups. Non-
parametric analyses of Kruskal Wallis for continuous variables and Pearson Ӽ2 tests 
for categorical variables were used. The 95% confidence intervals around the mean 
cost differences were attained by non-parametric bootstrap techniques.  
 For the economic evaluation, an incremental approach was used by calculating 
the differences between the intervention- and usual care group. The incremental 
cost effectiveness ratio (ICER) was calculated by dividing the difference in costs 
(healthcare costs, patient and family costs and intervention costs) by the difference 
in at-work productivity loss (i.e. hours lost from work due to presenteeism), meas-
ured with the WLQ. The incremental cost utility ratio was calculated by dividing the 
difference in costs (healthcare costs, patient and family costs, costs in other sectors, 
and intervention costs) by the difference in QALYs. In the cost effectiveness analy-
sis, the costs in other sectors are not included to avoid double counting, because 
presenteeism serves as the outcome measure (i.e. at-work productivity loss). When 
conducting the cost utility analysis, the costs in other sectors are included as there 
is no risk for double counting. A full societal perspective is thereby not applied in 
the cost effectiveness analysis due to methodological concerns (i.e. double count-
ing) 
 Both the bootstrapped ICER and ICUR pairs were graphically plotted on a cost 
effectiveness plane (probabilities in bootstrap on the random sampling with re-
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placement based on individual data of the participants). Cost effectiveness accepta-
bility curves were generated if the ICER or ICUR was located in the north-east 
quadrant (i.e. the intervention produces superior effects at additional costs relative 
to control) or the south-east quadrant (i.e. the intervention generates superior 
effects against lower costs).  
Risk case- and sensitivity analyses 
First, a risk-case analysis, followed by three sensitivity analyses were conducted, 
aimed to detect whether potential different methodological considerations might 
impact the results as found in the main analyses.  
 The risk-case analysis comprised, on an explorative basis, the CEA and CUA for 
the subsample in which participants at risk were left out. Due to a systematic error 
in the minimisation procedure, a subgroup of 37 participants was considered at 
risk to be mistakenly allocated to the control or intervention group. To determine 
the potential influence of the allocation error on the study results a sensitivity anal-
ysis on a subsample in which the 37 participants at risk were left out was per-
formed.  
 For the sensitivity analyses, first, the human capital theory was used to value 
absenteeism costs. The human capital approach incorporates the relevant value of 
the complete lost production time. Although this might produce relatively large 
estimates of productivity costs, it might be relevant in this chronic ill population, as 
one could state that lost production time might be longer due to the chronic condi-
tion, and thereby not as easy to restore. The total number of sick leave days in the 
previous six months were multiplied by the gender and age-specific productivity 
levels per paid employee [30] without accounting for the friction period needed to 
restore productivity.  
 Secondly, compensation for lost work was accounted for when calculating ab-
senteeism costs. Absenteeism costs were only calculated when the work was taken 
over in extra hours or when new personnel were hired to compensate for the pro-
duction loss. Compensation during normal working hours was assumed not to re-
sult in productivity costs.  
 Finally, costs in other sectors (as recommended when conducting a full eco-
nomic evaluation from the societal perspective) were accounted for, omitting the 
risk of double counting for presenteeism costs and effects by only including the 
costs related to absenteeism.  
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Results 
Participants and baseline characteristics  
At baseline, 150 participants were included: 75 were randomized into the interven-
tion group and 75 into the control group. A more detailed description of the patient 
flow throughout the study is presented in Figure 1.  
 
Figure 1. Flow-chart of patient inclusion 
 
 
Table 1 presents the baseline demographic characteristics and mean costs for both 
groups. A significant difference in quality of work and in presenteeism hours (based 
on the WLQ) was found between both groups. Informal care costs were also signifi-
cantly different between the intervention- and control group. Managerial positions 
were more often present in the intervention group (nearly significant) and on aver-
age, medical aids were more often used by the control group (near to significance).  
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Table 1. Baseline characteristics (N=150) 
  Intervention Group (n=75) Control Group (n=75) p-value  
Age, mean (sd) 49.75 (8.6) 49.6 (8.7) 0.93 (a)  
Female, N (%) 63 (84) 63 (84) 0.604 (b)  
Education, N (%) † 
Low 16 (21) 16 (21) 
0.755 (b) Intermediate 22 (30) 26 (35) 
High 37 (49) 33 (44) 
Working hours, mean (sd) 29.22 (10.18) 28.21 (9.9) 0.54 (a)  
Managerial position, N (%) 25 (33) 16 (21) 0.064 (c)* 
Shift work, N (%) 13 (17) 15 (20) 0.83 (c) 
Absenteeism days, mean (sd) 6.14 (15.69) 3.79 (8.91) 0.261 (a) 
General Health, mean (sd)# 70.28 (13.8) 73.32 (15.7) 0.236 (a) 
Co-morbidity, N (%) 46 (61) 51 (68) 0.125 (c) 
Quantity of work, mean (sd) £ 8.29 (1.7) 8.74 (1.6) 0.096 (a) 
Quality of work, mean (sd) £ 8.56 (1.7) 9.17 (1.3) 0.014 (a)** 
WLQ based presenteeism hours, 
mean (sd)  4.55 (2.5) 3.41  (2.79) 0.012 (a)** 
Utilities, mean (sd) ₸ 0.75 (0,14)  0.78 (0,13) 0.112 
Costs, mean in € (sd) 
Prescription medication  493.9 (1003.86) 338.75 (506.93) 0.925 (d) 
Over-the-counter medicines  40.05 (86.58) 25.58 (58.36) 0.147 (d) 
Medical aids  76.61 (209.56) 134.25 (394.48) 0.084 (d)* 
Health care service utilization  499.25 (551.77) 585.2 (724.95) 0.901 (d) 
Total healthcare costs  1,109.81 (1353.83) 1,083.76 (1088.82) 0.739 (d) 
Informal care costs  43.76 (88.95) 23.42 (65.05) 0.048 (d)** 
Travel and parking costs  34.66 (35.06) 39.84 (46.42) 0.91(d) 
Total patient and family costs  78.42 (100.84) 63.26 (86.17) 0.331 (d) 
Absenteeism costs  1,642.39 (4,401.59) 988.56 (2,493.78) 0.74 (d) 
Presenteeism costs  1,198.61 (3,028.9) 1,132.31 (4,460.36) 0.4 (d) 
Total costs in other sectors  2,841 (5,390.34) 2,120.86 (6,689.75) 0.404 (d)  
†Low=preschool, primary school; intermediate= lower and upper secondary; high=tertiary school, university, 
or postgraduate.  
# Rated on a visual analogue scale from 0 (bad) to 100 (excellent) 
£ Rated on a visual analogue scale from 0 (very bad/low quality or quantity) to 10 (very good/high quality or 
quantity)  | High scores indicate better perceived quality of life outcomes, rated on a scale from (0) bad to 1 
(good) 
(a) Anova (b) Pearson Chi-squared test (c) Fisher's Exact test (d) Non-parametric Kruskal Wallis test   
* Nearly significant| ** Significant at the 5% level 
 
Outcomes 
After the intervention, the mean duration of hours lost from work due to presentee-
ism (i.e. at-work productivity loss) were 4.49 (SD 2.94) in the intervention group 
and 3.78 (SD 2.39) in the usual care group. The difference in hours lost from work 
due to presenteeism (i.e. at-work productivity loss) at six months follow-up was not 
significantly different for both groups (p-value=0.103).   
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In both groups, the mean utilities after six months follow-up were not significant 
for both groups ((control group -0.002 (95% CI -0.031 to 0.027) and intervention 
group -0.011 (95% CI -0.04 to 0.18)). The mean QALY, based on the utility scores at 
baseline and after six months follow-up, were on average 0.39 (sd 0.054) for the 
control group and 0.38 (sd 0.053) for the intervention groups, which was not signif-
icantly different comparing both groups (p-value=0.09).  
Costs 
The intervention costs are based on: (i) the integrated care provided by a clinical 
occupational physician, including three consults, and (ii) the workplace visit and 
advisory reports done by the occupational therapist. Details on the components and 
costs can be found in Table 2. Although the intervention costs depend on the uptake 
of the different intervention components and the type of employment (employee or 
self-employed) per patient, the overall costs were estimated at €91.84 per partici-
pant in the study (Table 3). 
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Table 2. Intervention costs calculation  
 
The mean healthcare-, patient and family-, intervention-, and productivity costs are 
presented in Table 3. Regarding healthcare costs, the main cost drivers are medica-
tion costs and costs related to hospital care. Significantly higher hospital care costs 
related to day treatment are found for the control group. Patients in the interven-
tion group used more healthcare provided by the medical specialist since the mean 
cost difference was significantly higher (Table 3). The mean costs associated with 
occupational health care (occupational physician and occupational therapist) were 
highest among the patients in the control group. Absenteeism and presenteeism 
accounted for the highest costs categories in both groups. 
 
 
 
Intervention components Average time 
spent (hours) 
Average 
wage (€) 
Outcome 
(time*wage) 
(€)  
Care manager – Integrated  care by clinical occupational physician (COP) 
First consultation  (including:  (i) development of 
treatment plan, (ii) Contact with rheumatologist and 
patient’s OP concerning treatment plan; (iii) Sending 
communication form to rheumatologist, OT, and pa-
tient’s OP; and (iv) Facilitate e-mail contact with OT, 
rheumatologist, and patient's OP) 
1.50 29.06 43.59 
Second consultation (6 weeks):  evaluation with patient 0.33 29.06 9.69 
Third consultation (12 weeks):  evaluation with patient 0.33 29.06 9.69 
Occupational Therapist (OT) – Workplace visit  
Employment contract  
Including: (i) Organizational preparation of the proto-
col, (ii) Workplace observation , (iii) Inventory ‘prob-
lems’ worker, (iv) Inventory ‘problems’ supervisor , (v) 
Conversations on solutions, (vi) Developing advisory 
reports, (vii) Meeting and contacts with ‘COP’  
4.33 15.84 68.52 
Self-employed 
Including: (i) Organizational preparation of the proto-
col, (ii) Workplace observation , (iii) Inventory ‘prob-
lems’ worker, (iv) Conversations on solutions, (v) Devel-
oping advisory reports, (vi) Meeting and contacts with 
‘COP’  
3.95 15.84 62.57 
Occupational Therapist (OT) – Advisory reports   
Instructing solutions, Control / evaluation, Adjusting 
and continuing   
0.74 15.84 11.72 
Wage scale Care Manager / Clinical Occupational Physician based on functional description(38): 11 to 14. 
Chosen median scale 12 (.8)= €5,033 Hourly wage = Wage per month/hours per week/4.33 = 
5,033/40/4.33 
Wage scale occupational therapist based on functional description(38): 6 to 10. Chosen median scale 7 (.9)= 
€2,743  Hourly wage = Wage per month/hours per week/4.33 = 2,743/40/4.33 
C H A P T E R  9  
 218
Economic Evaluation  
The main cost effectiveness and cost utility analyses show ICERs in similar direc-
tions: more expensive and less effective (respectively 49.03 and -37,073.45) (Table 
4). Note that the ICER for at-work productivity loss was positive because higher 
scores indicate more presenteeism hours, and thus worse outcomes when com-
pared with control. In both cost effectiveness planes, the majority of the boot-
strapped cost-effect pairs (ICER 54%; ICUR 80%) are located in the northwest 
 
Table 3. Mean component costs 
 Mean costs (sd)
 Intervention group 
(I) 
Control group (C) Mean cost difference 
(I-C) (95% CI)¶ 
Healthcare costs  
General practitioner 46.27 (50.36) 56.07 (55.21) -10 (-26 to 6) 
Medications¥ 407 (804.72) 319.50 (539.46) 87 (-120 to 316) 
Medical specialist 99.48 (83.06) 78.92 (49.78) 21 (0 to 43) 
Occupational physician 3.47 (19.47) 13.34 (41.57) -10 (-20 to -1) 
Occupational therapist  49.16 (232.24) 131.09 (244.83) -83 (-157 to -2) 
Alternative treatment 23.54 (80.17) 39.62 (172.63) -16 (-62 to 20) 
Professional home care 11.46 (48.97) 9.95 (62.01) 1 (-19 to 17) 
Psychologist 42.47 (169.29) 69.24 (249.76) -24 (-94 to 36) 
Hospital care  
Day treatment 36.75 (182.49) 144.57 (538.61) -106 (-254 to -1) 
Admission 145.84 (523.540 67.19 (393.78) 81 (-57 to 232) 
Total health care costs 864.95 (1,099.38) 929.5 (1,181.8) -75 (-433 to 279) 
Occupational health care  
 
Intervention care manager 39.46 (19.98) n.a. n.a.
Intervention occupational 
therapist 
52.38 (35.43)
 
n.a. n.a.
Total intervention costs 91.84 n.a. n.a.
Patient and Family costs  
Informal care 30.39 (68.11) 19.24 (50.28) 11 (-7 to 30) 
Parking and travel time 39.65 (42.02) 42.75 (47.34) -3 (-17 to 10) 
Total patient and family 
costs 
70.04 61.99 9 (-17 to 35) 
Costs in other sectors  
Absenteeism 893.21 (2,120.21) 838.82 (1,959.70) 68 (-589 to 722) 
Presenteeism 1,076.28 (2,681.33) 617.31 (1,384.46) 464 (-154 to 1,156) 
Total costs in other sectors 1,969.48 (3,915.11) 1,456.13 (2,440.13) 518 (-494 to 1,632) 
¶Mean cost differences and 95% confidence intervals around the mean cost differences were attained by 
non-parametric bootstrap techniques| ¥Including both prescription and over-the-counter medications| 
n.a.=not applicable 
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quadrant (Figure 2), also indicating that the intervention was more expensive than 
the control in obtaining an additional effect. 
 
Figure 2. Costs effectiveness planes for the incremental cost effectiveness ratio (A) and the incremental 
cost utility ratio (B) 
 
Risk- case and sensitivity analyses  
The results of the sensitivity analyses can be found in the lower part of Table 4. The 
overall conclusions did not change when solely analysing the subgroup of partici-
pants not at risk of being mistakenly randomized to one of the groups (n=37).  The 
results of the sensitivity analyses testing the robustness of the cost utility analysis 
results (using the results from the human capital theory used to value absenteeism 
costs, and compensation for lost work when calculating absenteeism costs) did not 
differ from the main analysis. Results of the sensitivity analysis in which the costs of 
absenteeism were included and the effect in productivity (number of hours lost 
from work due to presenteeism) were estimated did neither change the overall 
conclusions. In all sensitivity analyses the majority of the incremental cost-effect 
pairs remained located in the North West quadrant, indicating that the intervention 
was less effective and more costly when compared with control.  
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Discussion 
This study presents the cost effectiveness and cost utility analysis of an integrated 
care program for workers with rheumatoid arthritis to improve their work produc-
tivity. The intervention cannot be regarded cost effective. Although not significant, 
both costs and effects were more favourable in the control group than in the inter-
vention group over the measurement period of six months follow-up.  
 A previously conducted study evaluating the effectiveness of an integrated care 
program for patients with chronic low back pain found that integrated care was 
effective on return to work (HR 1.9), and sustainable return to work (P=0.003) 
after a measurement period of 12 months [39]. The same integrated care program 
was even found cost effective when compared with usual care for return to work 
and QALYs gained with 12 months’ follow-up [11]. The probability that the inter-
vention as described in this study might become cost effective on a longer time 
span might be possible. However, a study evaluating the cost effectiveness of inte-
grated, multidisciplinary care as compared with usual care for patients with mod-
erate to severe chronic hand dermatitis was neither cost effective nor effective after 
12 months follow-up, in contrast to the findings after six months follow-up [40].  
 Before outweighing the costs and benefits of the integrated care- and participa-
tory workplace intervention under study, a few remarks of the study should be 
noted. Firstly, the study was performed alongside a randomized controlled trial. 
Although a subgroup of the participants risked being mistakenly allocated to one of 
the groups, the results were reasonably robust. This RCT design allowed for the 
economic evaluation to be conducted in a real life setting collecting relevant cost 
and effect data. However, due to the character of the intervention, patients, thera-
pists and researchers could not be blinded for the allocated treatment after ran-
domization which might increase the risk of bias. Furthermore, the generalizability 
of the results to other work-disabled populations is unknown as the intervention 
program was tailored to workers with rheumatoid arthritis.  
 Secondly, this study reflected the societal perspective by including all costs 
regardless of who uses the resources or who benefits from them. A key note here 
might be the fact that the chosen perspective might influence the results. However, 
when not accounting for the societal perspective, the costs are merely shifted, not 
really saved. One might argue in the context of this study the insurer’s or healthcare 
perspective might have been interesting to incorporate in the analyses. An insurer 
might be looking to reduce its expenditure for medical costs. However, in the pro-
cess the insurer simply shifts the costs from itself to someone else. For example, 
outpatient care may reduce the medical expenses for a procedure of in-hospital 
care. However, the costs of the patients did not disappear; they shifted from the 
insurer to the patient (e.g. when informal care has to be provided and the informal 
caregiver needs to take time off from work). The same would hold for the produc-
tivity losses, shifting the costs of lost productivity from the insurer to the company. 
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Although the societal perspective is the recommended option, and therefore ap-
plied in this study, it might also be helpful to describe the costs from other perspec-
tives, for example by describing in detail what the intervention costs were (compa-
rable to the information provided in Table 2) and to demonstrate the return on 
investment or the value of providing the intervention for companies and employ-
ers. Other perspectives can therefore also be useful to demonstrate the value in 
supporting the intervention’s aims.  
 Thirdly, this study presents the collection of occupational health care costs (i.e. 
intervention costs) in a detailed manner. By transparently monetizing the interven-
tion, decision-makers and stakeholders with different perspectives are provided 
with comprehensive intervention costs to include in future (economic) evaluations. 
A significant difference in occupational health care costs was found, which is prob-
ably attributable to the fact that the intervention group receives this care in the 
intervention. In the control group, occupational health care was contracted via the 
regular path and not by the uptake of the intervention components. Therefore, 
costs related to contacts with the care manager, occupational physician, workplace 
visits and advisory reports were not applicable since these interventions were not 
offered to this group, explaining the significant differences. 
 Fourthly, the lack of effectiveness might be explained by the baseline values 
being already good, leaving less room for improvement (especially for quality of 
life), or the measurement instrument might not have been sensitive enough to de-
tect a difference (especially for quality of life) for this disease-specific population. 
Furthermore, the nature of the intervention is promoting (work productivity) and 
preventing (work disability) whereby the effects are potentially long-term, requir-
ing follow-ups exceeding six months. The time for follow-up in this study might 
therefore have been too short to detect effectiveness as long-term follow-up is es-
sential to evaluate the effects of a new innovative intervention critically. Another 
potential explanation for the lack of effectiveness, especially regarding presentee-
ism hours (i.e. at-work productivity loss), can be found in the so-called phenomena 
‘response-shift’. Hereby, it is hypothesized that patients who are confronted with 
health-related work disability, by for example actively paying attention to presen-
teeism as this is being ‘intervened’, are faced with the necessity to change their 
internal standards, values and conceptualization. This might result in more presen-
teeism hours, because of the attention that is being paid to it. Although response 
shift is routed in health-related quality of life research, it refers to a change in the 
meaning of one’s self-evaluation and can therefore occur in any field where self-
reports are required [41].  
 Finally, the cost data are highly skewed and common standards regarding the 
inclusion, identification, measurement and valuation of productivity costs, especial-
ly absenteeism- and presenteeism costs, are lacking [14, 42, 43]. However, despite 
of the different methods used in the sensitivity analyses to provide crude estimates 
of absenteeism- and presenteeism costs associated with the intervention, no differ-
ences in cost-effect ratios were detected. Furthermore, this study is about the joint 
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distribution of differences in costs and effects, whereby neither cost nor effect dif-
ferences should be individually significant to show clear cost effectiveness [44].   
Conclusion  
Although cautiously, it can be concluded that the intervention was not cost effective 
after six months follow-up. At the moment, no evidence to support its implementa-
tion on cost-related grounds is provided.  
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Abstract  
Objectives: Although diverse initiatives have been taken to increase awareness on work-
related health issues, general practitioner’s (GP) guidelines (at least in the Netherlands) do 
not yet include advice on timely addressing work-related problems. Therefore, a tailored 
educational training program for GPs was developed to increase GP awareness to work-
related health problems aiming for better treatment strategies to benefit both individual 
patients and society as a whole. The aim of the study was to determine whether GP educa-
tional training was preferable to usual GP care in terms of work-related self-efficacy for 
employees and in terms of employees’ quality of life.  
Methods: An economic evaluation from a societal perspective was conducted alongside a 
cluster randomized controlled trial. Patients between 18-63 years of age in paid work for at 
least twelve hours per week were eligible. The primary outcomes were work-related self-
efficacy, measured by the return-to-work self-efficacy (RTW-SE) scale and quality adjusted 
life years (QALYs) based on the euroqol-5D-5L. Cost data were collected via questionnaires 
directly after the consult and six months later. Data were analyzed according to the inten-
tion-to-treat principle. Missing data were imputed using mean imputation techniques. Boot-
strapped cost effect pairs were plotted on the cost effectiveness planes.  
Results: The difference in RTW-SE was minimal between the intervention- and control 
group. A negative incremental cost effectiveness ratio (ICER) (-€ 1,858.98) was found, mean-
ing that the intervention yielded less effects albeit higher costs. The cost utility analysis re-
sulted in similar findings: the intervention was less effective and more costly than the control 
condition. The gender sensitivity analyses all confirmed these findings. Based on the sensitiv-
ity analyses of the subgroup employees with a permanent employment contract and the one 
accounting for baseline differences at the start of the study, the intervention resulted in less 
effects albeit fewer costs when compared to the control condition.  
Conclusion: The training program to increase GPs’ awareness to work-related problems was 
not cost effective from the societal perspective regarding both RTW-SE and QALY outcomes. 
Based on cost-related grounds the intervention could therefore not be recommended for 
implementation.  
 
I N C R E A S I N G  G P  A W A R E N E S S  T O  W O R K - R E L A T E D  P R O B L E M S  
 229 
Objective  
Although most health professionals will acknowledge the importance of the pa-
tient’s work and workability, this is often not reflected in the attention they pay to 
these issues when treating patients. Even general practitioners (GPs), who are 
trained to take the background and context of their patients into consideration, do 
not always pay attention to work-related health issues [1, 2]. An important reason 
for the lack of attention for work-related health issues among Dutch GPs may be the 
fact that they, unlike their colleagues in most other countries, do not have a formal 
role in sickness certification or in the rehabilitation to work of disabled workers [3, 
4]. Furthermore, most GPs appear not to consider sickness certification to be 
amongst their most meaningful activities [5, 6]. Nonetheless, a more active role of 
primary care providers with respect to their patients’ working context is expected 
to be beneficial because of the (two way) relation that exists between health and 
work. Previous studies have demonstrated the relevance of work-related factors in 
both care- and cure settings [7] and recent Dutch research on GPs and work has 
demonstrated the importance of collaboration between  general and occupational 
practice [8]. However, collaboration remains poor, despite several measures being 
taken to improve this interaction [8]. In 2005 the Health Council of the Netherlands 
published a set of guidelines about the management of diseases that frequently lead 
to long term or permanent absenteeism to improve work awareness in curative 
care professionals [9]. More recently, the Dutch College of General Practitioners 
published its ‘core values’. In this publication, the importance of work as one of the 
contextual factors which GPs should structurally and proactively be paying atten-
tion to, is specifically emphasized [10]. Although a number of multidisciplinary- and 
GP guidelines have been developed and revised to include recommendations on 
occupational health, most GP guidelines do not yet include advice on timely ad-
dressing work-related problems.   
 Because male and female doctors act differently and discuss different subjects 
during consultations when confronted with similar problems and because male and 
female patients differ in consultation behavior, this study also addresses gender 
aspects in relation to work- and health related problems. Previous research found 
that gender influences doctor-patient communication and that sick-listing was 
shown to be influenced by gender [11-14]. To increase GP awareness on work-
related health problems and to improve treatment strategies, taking into account 
gender aspects related to work and health, a tailored educational GP training pro-
gram was developed with the expectation that this intervention would benefit both 
individual patients and society as a whole by decreasing healthcare costs.  
 This study assessed the cost effectiveness and cost utility of the GP educational 
training program. The aims of the study were (i) to determine whether the GP edu-
cational training program was cost effective when compared to usual GP care for 
employees regarding return to work self-efficacy (RTW-SE); and (ii) to detect 
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whether the GP educational training program was preferable in terms of employ-
ees’ quality of life when compared to usual GP care.  
Methods 
The economic evaluation was conducted alongside a cluster randomized controlled 
trial. Extensive information regarding the methodological details of this trial has 
been previously published [15]. Randomization was performed at practice level in 
order to prevent contamination. A block randomization scheme using a block size 
of two was generated to assign GPs to either the educational training program or 
the control group (1:1 allocation ratio). Patients who visited GPs who completed 
the GP educational training were compared with patients visiting their GP in the 
usual care setting. Patients were approached by the receptionist while in the wait-
ing room with a short questionnaire to establish eligibility to participate and, if so, 
obtain their consent. If patients consented, the first questionnaire was handed to 
them directly after the consultation, followed by a second after six months. The GP’s 
role in data collection was kept as limited as possible to minimize contamination of 
the care provision in the GP control group. 
Study Population  
Patients were included if they: (i) were 18-63 years of age, (ii) had paid work for at 
least twelve hours per week, (iii) sufficiently understood the Dutch language to fill 
in a questionnaire. The upper age limit of 63 was chosen to lower the chance that 
patients would drop out of the questionnaire study during follow-up due to retire-
ment.  
Educational training intervention 
GPs in the intervention group received an accredited five hour training intervention 
based on the findings of previously conducted focus groups [16]. During the train-
ing, lectures and interactive workshops were brought whereby the following seven 
items were covered: (i) the societal relevance of the connection between work and 
health and the potential role for primary healthcare; (ii) reflection by the partici-
pants’ on their own ‘usual care’ for work-related problems, including awareness of 
gender differences among patients and care providers in communication styles; 
(iii) the legislation regarding work and absenteeism, the role of the occupational 
physicians (OPs) and how to achieve an effective collaboration between GPs and 
OPs; (iv) knowledge exchange on gender aspects influencing occupation and work-
related problems; (v) methods to assess patients and instructions on how to em-
power them to solve their work-related problems (vi) advice regarding the struc-
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tural registration of work-related data (including occupation, number of hours 
working per week, possible occupational relation of the presented health problem, 
and adequate coding of work-related problems); and (vii) instructions on the study 
logistics and data collection. Two months after the initial training a three hour 
booster training event took place [15]. 
Care as usual  
The control group received care as usual. Receptionists, who were instructed and 
supported by a research assistant when possible, were responsible for the data 
collection in order to reduce the possibility that this process influenced the provi-
sion of usual care. After the data collection was completed, the GP control group 
was offered the same training as the intervention group as an incentive for adher-
ence to the study protocol [15].  
Outcome measures  
The primary outcome for the cost effectiveness analysis was work-related self-
efficacy, measured by the eleven item Return-to-Work Self-Efficacy scale (RTW-SE). 
The RTW-SE scale measures the extent to which people feel able to handle the de-
mands of their job which can be rated from ‘1’ (completely disagree) to ‘6’ (com-
pletely agree)[17]. A mean score of the eleven items at follow-up was used to com-
pute changes in the RTW-scale score and differences between both groups. The 
internal consistency (Cronbach’s alpha) of the scale is excellent (>.8) [17].  
 The main outcome for the cost utility analysis was quality adjusted life years 
(QALY), measured by using the EuroQoL five dimensions, five levels (EQ-5D-5L). 
These five dimensions are: mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. To estimate the utility of health states described by the pa-
tients the EQ-5D-5L crosswalk value set with the Dutch tariff was used [18]. Then, 
based on the utilities, QALYs were calculated using the ‘area under the curve’ meth-
od [19]. Higher QALYs indicate more improvement in quality of life.  
Resource use measurement and valuation 
Cost data were collected from a societal perspective via questionnaires directly 
after the consultation and six months later. All costs were adjusted to the index year 
2012 using consumer price indices [20]. Discounting of costs was not necessary 
because the cost measures did not exceed one year. Four main cost categories were 
used (intervention-, healthcare-, patient- and family-, and productivity costs). The 
intervention costs were calculated using a bottom-up approach (see Appendix 1).  
 Health care costs, covering care provider resource utilization (i.e. visits for 
primary and secondary care), home care, alternative care and medication, were 
calculated according to the guidelines for health care in the Netherlands by using 
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the Dutch manual for costing [21]. Tariffs or an average price from providers were 
used when standard cost prices were not available. The costs of prescription medi-
cines were calculated based on the price per dosage for medication costs in the 
Netherlands [22, 23]. Over the counter medication prices were based on market 
prices (including 6% VAT) and medical and personal aids (e.g. orthotics, mobility 
aids, etc.) were based on costs per user within the aid category provided by the 
Dutch care institute [24].  
 Patient and family costs were incorporated by assessing informal care costs 
and travel and parking costs incurred while utilizing health care. Informal care was 
valued against the ‘shadow price’ (i.e. the price used when an official price is not 
available) of the wage rate per hour of a housekeeper. Travel costs were calculated 
by multiplying average distance with the standard price weights as derived from 
the Dutch guideline for costing research [21].  
 Patient’s productivity was measured using the productivity and disease ques-
tionnaire (PRODISQ) [25]. The PRODISQ measures productivity loss from paid 
work (i.e. both absenteeism and presenteeism) in terms of total sick leave. Absen-
teeism refers to the total number of days lost from work and presenteeism refers to 
reduced work quantity and quality while at work [25]. Both absenteeism days and 
the inefficiency score were multiplied by the mean age- and gender wage rates of 
the Dutch population [21]. Productivity cost calculations were based on the friction 
cost approach which states that sick employees are replaced after a certain period 
of time called the friction period. After this friction period, no more lost productivi-
ty costs are assumed [26]. The friction period of 92.68 days for the Netherlands was 
estimated based on the level of unemployment in 2012 [27].  
Analysis 
Data were analyzed according to the intention-to-treat principle. Missing data were 
handled using SPSS missing value analysis on item level (mean imputation). Base-
line characteristics were compared for both groups by using analysis of variances 
(Anova), non-parametric Kruskal-Wallis analysis for continuous variables or Pear-
son Ӽ2 test for categorical comparisons of proportions. 
 Because of the highly skewed cost distribution, bootstrapping with 1000 repli-
cations was used to estimate bootstrap confidence intervals around the cost differ-
ences. The incremental cost effectiveness ratio (ICER) was calculated by dividing 
the incremental costs by the incremental effects. By dividing the incremental costs 
by the differences in QALYs, the incremental cost utility ratio was calculated. Non-
parametric bootstrapping was also used to estimate the uncertainty surrounding 
the incremental cost effectiveness ratio and the incremental cost utility ratio (5,000 
replications). Bootstrapped cost effect pairs were plotted on the cost effectiveness 
planes. Cost effectiveness acceptability curves demonstrate the probability of the 
intervention being cost effective at a certain threshold, i.e. the amount of money 
society is willing to pay to gain one unit of effect (e.g. €18,000 per QALY). The will-
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ingness-to-pay (WTP) in the field of occupational health care is an unknown quanti-
ty. We therefore used a series of WTP thresholds and calculated the probability that 
the intervention is more acceptable than usual care from a cost effectiveness point 
of view for each of the WTP thresholds (unless >70% of the bootstrapped ICERs are 
located in the North-west quadrant of the plane, indicating higher costs and fewer 
effects and the intervention is obviously dominated by the control condition).   
Sensitivity analyses  
Six sensitivity analyses were conducted to assess the robustness of the findings. 
First, four subgroup analyses were conducted to test for participant heterogeneity 
by assessing gender differences among patients and GPs. Then, because a signifi-
cant (Pearson Chi-square test significant at the 5% level) difference in job contract 
was found between the intervention and control group, the economic evaluation 
was redone including only the subgroup employees with a permanent employment 
contract. Because of overall lower self-rated health and more absenteeism days in 
the intervention group at the start of the study, the final sensitivity analysis was 
performed by accounting for the individual differences between patient baseline 
and the subsequent measurements (also called delta-adjustment) [28]. 
Results  
Sample 
An overview of the inclusion procedure is presented in Figure 1. Between February 
2012 and January 2013 the GP’s receptionists approached patients in the waiting 
room with a short questionnaire to deploy the selection criteria. When meeting the 
selection criteria patients could be included; they signed informed consent and 
then received the first questionnaire. A second questionnaire followed after six 
months, with a maximum completion time of twelve months. In the end 241 pa-
tients were included in the study; 113 in the intervention group and 128 in the 
control group. As can be seen in Figure 1 many patients were marked ‘untraceable’ 
at the start of the study and after completing the first questionnaire because no 
personal details were available at the GP practice or patients did not provide their 
contact details to the research team and could therefore not be directly approached.  
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Figure 1. Inclusion procedure 
 
 
The population characteristics are presented in Table 1. A small statistically signifi-
cant difference (p-value 0.045 Pearson Chi-square) was found for job contracts. 
Most employees were in permanent employment in both groups. The average 
health care utilization costs were highest in the control group. All other cost catego-
ries were highest for the intervention group. At baseline, absenteeism costs ac-
counted for the largest part of the costs in both groups (see Table 1).  
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Table 1. Baseline characteristics (N=241)
 Intervention 
(n=113) 
Control (n=128) p-value 
Age, mean (sd) 45.55 (9.8)  47.23 (10.2)  0.19 (a) 
Gender, N (%)  
Female 70 (62) 72 (56) 0.37 (b) Male 43 (38) 56 (44) 
Education, N (%)†  
Low 4 (4) 2 (2) 
0.61 (b) Intermediate 73 (65) 83 (65) 
High 36 (31) 43 (33) 
Working hours, mean (sd) 29.74 (10.7)  30.94 (11.3)  0.40 (a) 
Job contract, N (%)  
Entrepreneur 3 (3) 13 (10) 
 0.045*(b) 
Employee (permanent employment) 91 (81) 102 (80) 
Employee (temporary employment 
towards permanent employment) 6 (5) 5 (4) 
Employee  
(temporary employment/fixed term) 9 (7) 7 (5) 
Interim / temporary worker 0 1 (1) 
Social Employment Law worker  4 (4) 0 
Supervisor, N (%)  
One 103 (91) 109 (85) 0.15 (b) More than one 10 (9) 19 (15) 
Managerial position, N (%) 35 (31) 41 (32) 0.86 (b) 
Shift work, N (%) 20 (18) 25 (20) 0.51 (b) 
Job sector, N (%)   
Craft and industry  12 (11) 17 (13) 
0.64 (b)  
Transport 3 (3) 5 (4) 
Administration 16 (14) 12 (9) 
Commercial 10 (9) 13 (10) 
Services  5 (4) 10 (8) 
Heath and care 22 (19) 29 (23) 
Teaching 12 (11) 8 (7) 
Specialist (discipline, expertise) 3 (3) 7 (5) 
Agriculture  2 (2) 3 (2) 
Other  28 (24) 24 (19) 
Self-rated general health¥, mean (sd) 73.3 (22) 75.7 (21.3) 0.41 (a) 
Long term disability, N (%)  
No 67 (60) 78 (61) 0.9 (b) Yes 45 (40) 50 (39) 
Days absent from work past 6 months, 
mean (sd) 
9.32 (23) 6.49 (21) 0.37 (a) 
EQ-5D-5L Utilities, mean (sd)₸ 0.84 (0.1) 0.84 (0.1)  0.97 (a) 
RTW-Self efficacy, mean (sd) 4.71 (1.3) 4.83 (1.1)  0.43 (a) 
Costs, mean in € (sd)  
Health care utilization  438.41 (580)  530.08 (207)  0.12 (c) 
Medication and aids  139.37 (317)  106.27 (216)  0.48 (c) 
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Patient and family  52.57 (104.5)  36.07 (70.2)  0.13 (c) 
Informal care  12.78 (74.7)  3.52 (14.6)  0.24 (c) 
Travel and parking  39.79 (46.51)  32.55 (61.4)  0.17 (c) 
Productivity  2,332.89 (4,937) 1,569.94 (4,322.1)  0.32 (c)  
Absenteeism 2,282.67(4,906.4) 1,523.53 (4,290.7)  0.41 (c) 
Presenteeism 50.22 (64.24) 46.41 (66.7) 0.33 (c) 
†Low=pre- or primary school; intermediate=lower- or upper secondary; high=tertiary school, universi-
ty, or postgraduate  
¥ On a rating scale from 0 (worse health) to 100 (perfect health)  
₸High scores indicate better perceived health outcomes  
(a)Anova (b)Pearson Chi-squared (c)Non-parametric Kruskal Wallis  
* Significant at the 5% level  
Main outcomes 
The mean utilities (0.84) at baseline were similar and did not differ significantly (p 
> 0.05) between the intervention and the control group. The mean utilities im-
proved slightly after six-month follow-up (control group 0.86 and intervention 
group 0.85). The mean QALYs in the intervention group (0.42; SD 0.06) and the 
control group (0.42; SD 0.07) were comparable. The mean RTW-SE score at six 
months follow-up improved in the control group (5.03 (SD 0.96)) and remained 
stable (4.8 (SD 1.2)) in the intervention group. The incremental difference in effects 
for QALYs and RTW-SE are presented in Table 3.  
Cost analysis  
The intervention costs were almost negligible (€0.48) (see Table 2). Furthermore, 
Table 2 shows the healthcare costs at six month follow-up, which were higher in the 
intervention group (€516) than in the control group (€426). The mean cost differ-
ence (almost €90) was in favor of the control group. The average healthcare utiliza-
tion costs are higher in the intervention group, whilst at the start of the study 
healthcare utilization was highest in the control group. Medication and aids costs 
remained relatively stable over time. Incremental family and patient costs (€7) 
were in favor of the intervention group. The patient and family costs in the control 
group remained stable over time; a decrease within these costs occurred in the 
intervention group six months after inclusion. The productivity costs (mean 
€2,211.79 and €2,660.92 respectively in control and intervention group) continued 
to account for the largest part of the mean total costs. Productivity costs increased 
in both groups after six months follow-up and the incremental difference (€449) 
was in favor of the control group.  
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Table 2. Total costs per cost category and subtotal bootstrapped costs after 6 months follow-up 
Cost category  Intervention 
group, costs €  
Control group, 
costs €  
Incremental 
costs, € 
2.5-97.5 per-
centile 
Intervention  0.48 0   
Health care utilization  405.84 318.58  
Medication and aids 113.36 104.92  
Bootstrapped subtotal, 
 mean  
516.13 425.92 90 -195;475 
Patient and family     
Informal care 9.76 20.23  
Parking and travel  20.5 16.8  
Bootstrapped subtotal,  
mean  
30.03 36.63 -7 -28;12 
Other sectors  
(productivity) 
   
Absenteeism 2,577.43 2,176.82  
Presenteeism 57.36 38.68  
Bootstrapped subtotal,  
mean  
2,660.92 2,211.79 449 -943;1,894 
Bootstrapped total, 
 mean  3,176.92 2,670.51 506 -1,076;2,063 
Cost effectiveness 
Table 3 shows that the differences in RTW-SE were minimal between the interven-
tion and control group. A negative ICER of – 1,858.98 Euro was found, which means 
that the intervention yielded less effect though higher costs. The control condition 
dominates the intervention as 71% of the bootstrapped cost effectiveness pairs are 
located in the North West (fewer effects, higher costs) quadrant of the CEA plane 
(see Figure 2).  
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Cost utility 
The cost effectiveness plane from the CUA with a maximum WTP-level of €18,000 
is shown in Figure 3. The probability of the intervention being cost effective was 
only 28% for a WTP threshold of €18,000. Overall, as figure shows, the intervention 
was less effective and more costly than the control condition (mean ICUR: - 
€354,726.08; see Table 3). 
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Sensitivity analyses  
Results of the sensitivity analyses are shown in Table 3 (bottom part). The cost 
effectiveness planes (CE-plane) representing the uncertainty around the mean in-
cremental costs and effects for the four gender subgroups are shown in Figure 4. 
The first CE-plane showed that the intervention was not considered cost effective 
when studying RTW-SE among female patients and patients at consultation with 
female GPs. Regarding female GPs, an ICER of -3,715.3 Euro was found and most 
(77%) ICERs were located at the inferior quadrant. When only female patients are 
taken into consideration, differences in RTW-SE were small and the total costs were 
higher in the intervention group, indicating an ICER of -412.25 Euro. Most (about 
90%) of the bootstrapped ICERs are also located at the inferior quadrant, indicating 
fewer effects. Gender subgroup analyses among male patients and male GPs sup-
ports the findings of the main analysis. Male GPs showed slightly more than half the 
cost effect pairs (54%) located in the inferior quadrant, indicating less effects (-
0.25) for higher costs (€169.94) when comparing the intervention with the control 
condition. For male GPs, the majority of the ICERs (78%) are located in the North 
West (inferior) quadrant (large negative ICER).  
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The cost effectiveness analysis for the subgroup ‘employees with permanent em-
ployment’ deviated from the main- and other subgroup analyses. For the subgroup 
‘employees with permanent employment contracts’ (significant baseline differ-
ence), the intervention group yielded fewer effects (-0.19) on RTW-SE, albeit fewer 
costs (-€507.86) compared with the control condition, resulting in a positive in-
cremental cost effectiveness ratio of almost €2,612. Sacrificing one point on the 
RTW-SE scale resulted in a cost saving of almost €508. Additionally, the CE-plane 
(Figure 5a) showed that 65% of the bootstrap cost effect pairs were located in the 
south-west quadrant, which indicates the intervention is less effective and less 
costly than the control condition. The cost effectiveness acceptability curve (Figure 
5a) showed a 0.71 probability of the intervention being cost effective compared to 
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the control condition if one is willing to pay €250 for a one point increase on the 
RTW-SE scale. However, when increasing the WTP ceiling ratio, the probability of 
being cost effective decreases.  
 In the final sensitivity analysis, calculating the individual differences between 
the measurements, fewer effects (-0.15) on RTW-SE and lower costs (-€212.23) 
were found. As can be seen in Figure 5b, almost 50% of the ICERs were located in 
the south west quadrant (less effect, fewer costs). Figure 5b shows a slightly de-
creasing cost effectiveness acceptability curve and about 60% probability of the 
intervention being cost effective at a ceiling ratio of about €100.  
 
 
Discussion 
Main findings 
The results of this study show that the training program aimed at increasing GP 
awareness to work-related problems, did not lead to improved RTW self-efficacy 
among patients in the intervention group when compared to the control condition. 
Furthermore, the cost difference was in favor of the control condition. In the incre-
mental cost effectiveness plane, the majority of the ICERs fell in the quadrant of 
‘higher costs and less effects’. The gender-specific sensitivity analyses all confirmed 
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these findings. Based on the sensitivity analyses of the subgroup ‘employees with a 
permanent employment contract’ and the one accounting for baseline differences at 
the start of the study, the intervention resulted in less effects though fewer costs 
when compared to the control condition. In these analyses, the cost effectiveness 
plane the majority of the ICERs were located in the southwest quadrant (fewer 
costs, but less effective). Exploring the incremental cost utility resulted in findings 
comparable to the main cost effectiveness analysis (higher costs and fewer effects). 
Quality of life improved in both groups, though the difference between QALYs in 
both groups at six months follow-up was negligible (0.3). Overall, the lack of effec-
tiveness might be due to the baseline values already being at a certain ceiling 
(RTW-SE scores around 5 and utilities around 0.8), making it difficult to improve. 
Strengths and limitations  
One of the strengths of this study is its generalizability as the study was conducted 
in routine daily clinical practice. Thereby, a broad generic population could be re-
cruited which adequately represents patients visiting GP practices in the Nether-
lands and perhaps other countries with similar primary care systems. Furthermore, 
based on the characteristics of the intervention – and control groups, a successful 
randomization was achieved. Except for job contracts no significant differences 
between these groups were detected. Another strength of the study is the inclusion 
of costs related to both absenteeism and presenteeism in measuring productivity 
costs. Recent studies suggest that both measures are crucial since presenteeism 
attributes largely to the total productivity costs [29, 30]. Furthermore, the econom-
ic evaluation was carried out form a societal perspective. This enhances the possi-
bility of using the results to allocate resources at a Dutch societal level and poten-
tially to disaggregate data for future analyses from different perspectives (e.g. 
healthcare, employer, etc.). Furthermore, as previous research demonstrated the 
impact of gender on communication skills [11, 13, 14], this study provides in-depth 
insight into the cost effect pairs of the intervention group and the control group by 
including sub analyses regarding gender differences among both patients and GPs.  
 A number of limitations need to be considered as well. Firstly, it is possible that 
relatively motivated GPs were attracted by the training invitation. The fact that GPs 
were not blinded for the intervention (it was obvious whether they did or did not 
received the training) might have influenced their treatment approach underesti-
mating the effect. Secondly, the cost and effect data were obtained via patient self-
reported retrospective questionnaires which might have caused recall bias (the 
relevant period being six months). Recall bias could over- or underestimate true 
healthcare utilization and as such healthcare costs. However, as no ‘gold standard’ 
for measuring healthcare utilization is available, the method used in this study pro-
vides at least crude estimates of actual usage [31]. Due to practical and logistical 
reasons, the time span between both measurement points occasionally reached 
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over six months. However, the impact of potential recall bias was assumed to be 
equal for both groups due to the decent randomization procedure.  
Concluding remarks 
The intervention training program to increase GP awareness to work-related prob-
lems was not cost effective from a societal perspective with respect to both RTW-SE 
and QALYs outcomes. Based on these results the intervention could therefore not 
be recommended for implementation on cost-related grounds.  
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Discussion 
Information on the cost effectiveness of employability interventions for employees 
with health problems guides towards priority-setting in the field of occupational 
health. Methodologically sound economic evaluations play an important role in 
decisions about the development and implementation of these employability inter-
ventions. The starting point for this thesis was that further development and re-
finement of both employability interventions and the methodologies for economic 
evaluation in the field were needed. The objective of this PhD-thesis was to provide 
insight into both methodological and empirical (experimental) analyses of inter-
ventions aimed at achieving sustainable employability for employees with health 
problems. The thesis therefore provides insight into (i) the methodological chal-
lenges, and (ii) the application of this methodological knowledge to different em-
ployability interventions to generate economic evaluation results. 
 In Section I of the thesis, measurements for health-related productivity and 
resource use were critically assessed to improve the methodologies for economic 
evaluation. Furthermore, transparent information on potential methods to conduct 
economic evaluations in the field of occupational health was provided (Chapter 2-
4). In the Section II and Section III, this methodological knowledge has been applied 
to several existing (Chapters 5-7) and innovative (Chapters 8-10) interventions 
aimed at achieving sustainable employability for employees with health problems. 
The methodological knowledge has been applied to generate new evidence on their 
cost effectiveness.  
 This final chapter presents and discusses the main findings of the studies. Fur-
thermore, it reflects on practical and methodological considerations, and provides 
implications for future research and practice based on the experiences and conclu-
sions.  
Main findings 
(I) The methodological challenges when measuring health-related productivity and 
resource use  
A useful starting point to examine the state of affairs within a research field is to 
conduct a systematic review. A systematic review is a literature review focusing on 
a research question aimed at identifying, appraising, selecting, and synthesizing the 
research evidence relevant to the research question [1]. For this PhD-thesis, two 
systematic reviews have been conducted. 
 In the first systematic literature review (Chapter 2), the measurement proper-
ties in generic self-reported instruments measuring health-related productivity 
changes were critically appraised and compared [2]. Twenty-five articles were 
included, reporting on the reliability, validity, and responsiveness of 15 different 
instruments. The methodological quality appraisal was assessed using the COSMIN-
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checklist [3, 4]. The analyses showed that information on cross-cultural validity and 
information on measurement error was often lacking. Aside from evidence on the 
psychometric properties of the Work Limitation Questionnaire (which was the 
most frequently assessed instrument), the Stanford Presenteeism Scale, and the 
Productivity and Disease Questionnaire, the overall evidence of the other 12 in-
struments was limited and of fair to poor quality. The review concluded that high-
quality studies providing details on the measurement properties of instruments 
measuring health-related productivity were lacking. In addition, transparent infor-
mation to aid deciding on the appropriateness of the instrument was frequently not 
reported (e.g. information on the population of interest, the content of the instru-
ment, the purpose of its use, and the target country).  
 In the second systematic literature review (Chapter 3) the validity of self-
reported and administrative healthcare utilization tools for cost estimation in eco-
nomic evaluations was assessed. A quality appraisal tool, derived from existing 
guidelines, was used to evaluate the methodological reporting quality of studies 
comparing the validation evidence of healthcare resource use measurement tools. 
Out of the 16 included studies, only six studies scored ‘adequate’ on the minimal 
criteria for reporting, and could be considered trustworthy. However, no evidence 
was established that one measurement tool (measuring self-reported versus ad-
ministrative healthcare utilization) is better than the other. Next to both random 
and systematic errors, varying levels of agreement among the different data 
sources were found in the included studies. The validation evidence of the small 
number of studies with adequate methodological reporting quality cautiously sup-
ported the exchangeability of both the self-reported and administrative resource 
use measurement methods. 
 The study protocol (Chapter 4) provided information on possible methods 
used to conduct an economic evaluation (i.e. cost effectiveness, cost benefit, and 
cost utility) of employability interventions aimed at achieving sustainable employ-
ability for employees with health problems [5]. The comparisons between the em-
ployability interventions and the usual care- or control conditions were pragmatic 
in nature; replicating the actual ((occupational) health care) setting in which the 
studies occur. The design is compliant for different settings, for example when dif-
ferent unit prices for resource utilization, or divergent outcome measures, are pre-
ferred. 
 Given the results of the studies included in Part I of this PhD-thesis, the eco-
nomic evaluation of existing- and new employability interventions are based on 
solid methodologies, accounting for stakeholder interests, and proper methodologi-
cal reporting quality to ensure transparency. The economic evaluation results are 
summarized in the paragraphs below.  
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(II) The economic evaluation results of existing interventions aimed at achieving sus-
tainable employability for employees with health problems 
In the second part of this PhD-thesis, the economic evaluation results of two differ-
ent employability interventions are presented.  
 In Chapter 5, an economic evaluation alongside a pragmatic cluster random-
ised controlled trial was conducted to evaluate the comparative cost effectiveness 
of two strategies to promote work functioning among nurses by reducing symp-
toms of mental health complaints [6]. Three conditions were compared in two sub-
economic evaluations. After six-months follow-up, the comparison of the occupa-
tional physician condition group (existing of screening, feedback and referral to the 
occupational physician for screen-positive nurses) with the control condition group 
(consisting of online screening for mental health problems without feedback) re-
sulted in a dominant incremental cost effectiveness ratio. The comparison yielded a 
cost saving of €5,049 per treatment responder and could therefore be recommend-
ed for use in practice. Treatment response was defined as an improvement of at 
least 40% on nurses’ work functioning between baseline and after six-months. The 
second comparison was made between the control condition group (screening 
without feedback), and the e-mental health condition group (whereby screen-
positive nurses were provided with feedback regarding their screening results and 
referred to an e-mental health intervention). This resulted in less treatment re-
sponse and added costs per treatment responder (about €4,000) for the e-mental 
health condition. Because the e-mental health condition was associated with a 
higher probability of fewer benefits at higher costs, compared to the control condi-
tion, this employability intervention was recommended to not be put in practice.  
 A more in-depth analysis was conducted for nurses at elevated risk of mental 
health complaints and lost productivity (Chapter 6). To evaluate the balance be-
tween the costs of a preventive intervention and the cost offsets stemming from 
improved productivity from a business perspective, a cost benefit analysis was 
studied. Within six months, the intervention costs of personalized feedback and 
occupational physician utilization were more than recouped, representing a fa-
vourable business case from the employer’s perspective. A return-on-investment of 
up to €11 per invested Euro per nurse was found.  
 A pilot cost effectiveness study evaluated how economic evaluation results 
contributed to the development and implementation of a web-based employability 
intervention (Chapter 7). The pilot cost effectiveness study assessed a web-based 
employability intervention aimed at increasing self-perceived work ability among 
employees who experienced problems in relation to their employability. This pilot 
economic evaluation demonstrated the value of cost effectiveness analyses preced-
ing a full-scale study. Both the content and the study-design of the web-based em-
ployability intervention were critically considered. Content related improvements 
were required. Firstly, low uptake and compliance rates, particularly for the online 
intervention element (3%), were found for the web-based employability interven-
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tion. Secondly, additional analyses concluded that the intervention appeared too 
general for specific situations, such as prolonged health problems requiring specific 
questions on work and health. Thirdly, the originated tendency that females and 
participants aged 50 or older are more sensitive for an intervention effect support-
ed the need for better targeting of the web-based intervention. In general, the web-
based employability intervention was not associated with an economically relevant 
impact over regular trade union support for a heterogeneous population with 
work- and disability related concerns. Based on the results of the pilot economic 
evaluation of the web-based employability intervention, also the study design re-
quired adaptations. The mean incremental differences on work ability and quality 
adjusted life years were unable to demonstrate an effect of the web-based interven-
tion (respectively -0.51 and -0.01 point improvement). It is therefore disputed 
whether the most appropriate outcome was selected to assess the true effect of the 
intervention, or whether the effect of the intervention was influenced by other fac-
tors (for instance derived information other than via the web-based employability 
intervention). Well-thought outcome measures are needed in future studies for this 
context. In addition, based on the relative contribution of diverse cost categories 
with respect to the total overall costs, cost category measurements require revision 
as well. Based on the negligible relative contribution of patient- and family out-of-
pocket costs to the total overall costs, data gathering for these cost categories could 
be omitted to minimize the burden for the employees and their environment.  
 
(III) The economic evaluation results of innovative interventions aimed at achieving 
sustainable employability for employees with health problems 
In the third part of the thesis, the economic evaluation results of three newly devel-
oped employability interventions are presented.  
 The cost effectiveness, cost utility and cost benefit of a new organizational re-
turn-to-work intervention to improve Cooperation between Sick-listed employees 
and their Supervisors (COSS) was carried out alongside a field study with a six-
month follow-up (Chapter 8). The main outcomes were the number of days until 
return to work, quality adjusted life years, and productivity gains. The number of 
days until return to work was conceptualized as the first moment at which progress 
is made in hours worked, even if the employee works less hours than contracted or 
if the employee is still (partly) sick listed. When compared to common practice, 
employees in the COSS-group reduced almost 16 calendar days of absenteeism and 
saved approximately €27 per day of work resumption. The cost utility analysis also 
exhibited reduced costs, however the gain in quality adjusted life years was uncer-
tain. From an organizational perspective, the net benefit of COSS compared to 
common practice yielded a productivity gain of almost €396 per invested Euro. 
Implementing COSS for sick-listed employees has a large potential to reduce socie-
tal and organizational costs and to improve productivity among sick-listed employ-
ees.  
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A short-term economic evaluation was conducted to provide first insights into the 
cost effectiveness of an intervention program aimed at improving work productivi-
ty for workers with rheumatoid arthritis (Chapter 9). The intervention coordinat-
ed clinical- and occupational care at the worksite to support work participation for 
workers with rheumatoid arthritis. Although not significant, at-work productivity 
loss was about 0.5 hours higher in the intervention group, and the mean QALY was 
on average 0.01 point lower when compared to the control group. Neither one was 
preferable in terms of costs. After six-months follow-up the costs in the interven-
tion group were approximately €500 higher compared to the control group. Based 
on the six-month economic evaluation results, no evidence was found to support 
the implementation of the intervention.  
 A final economic evaluation was conducted for a tailored educational training 
program for general practitioners with the aim of increasing their awareness of 
work-related health problems (Chapter 10). This training program aimed to im-
prove treatment strategies in the primary care setting by increasing work-related 
self-efficacy (measured with the return-to-work self-efficacy scale) and quality of 
life for employees. Differences in the main outcome measures between the inter-
vention group and the usual GP-care group were minimal. A negative incremental 
cost effectiveness ratio revealed fewer effects at higher costs for both the cost effec-
tiveness and –utility analyses. Based on the six-month economic evaluation results, 
no evidence was found to support the implementation of the intervention. 
Main considerations  
Practical considerations  
At the start of the study several practical difficulties occurred when recruiting prac-
tices to participate. Although nine practices initially showed interest in participat-
ing in the study, few of them were either unable to provide the minimum required 
number of participants; did not want to have their intervention assessed in a com-
parative design; or were unable to provide a comparable control group. At the start 
of the PhD-study, five employability interventions were planned to be assessed (see 
Figure 1, Chapter 4)[5].  Throughout the trajectory, several practical difficulties 
recurred, slowing recruitment of eligible participants, and consequently the data 
collection. The initial selected existing practices involved in the PhD-study were 
unable to recruit the required number of participants. Therefore, a number of other 
initiatives had to be instigated. Figure 1 describes the included employability inter-
ventions and the corresponding chapters wherein the economic evaluation results 
are presented in this PhD-thesis.  
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Figure 1. Employability interventions whereof the economic evaluation results are included in this PhD-
thesis 
 
Another practical consideration when conducting the economic evaluation of em-
ployability interventions was the follow-up period. Ideally, the follow-up time was 
18 months because after this point in time the results are expected to extend into 
the subsequent years [5]. However, because of the recruitment difficulties during 
the study period, an 18-month follow-up period was not achieved. The economic 
evaluation results presented in this PhD-thesis therefore compare the employabil-
ity interventions (in terms of costs, effects, and utilities) to usual care over a time-
span of six months. The ‘Mental Vitality @ Work’ (Chapters 5 and 6) and the ‘COSS’ 
(Chapter 8) studies are completed and the economic evaluation results are pub-
lished or submitted for publication. When preparing and discussing possibilities to 
conduct the economic evaluation of the web-based employability intervention 
(Chapter 7), the minimum required number of participants could not be reached. 
Because both the researchers and the practices wanted to learn from the research, 
a different research approach was followed - a pilot economic evaluation. For the 
remaining two interventions (‘Work in General Practice’ and ‘Care for Work’), the 
data collection is still ongoing, and consequently, the economic evaluation results 
included in this dissertation thesis are interim-analyses (Chapters 9 and 10). The 
possible directions for decision-making will be explored below, even though a short 
follow-up time had been used for the analyses.  
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Methodological considerations  
According to the health economic guidelines it is recommended to explicitly state 
the chosen perspective in each study as it influences the costs and effects to be 
measured [7, 8]. Furthermore, economic evaluations are strongly recommended to 
focus on the society as a whole, which is translated in terms of ‘the societal perspec-
tive’. By presenting all socially relevant costs and effects in a disaggregated form, 
the findings can be generalized to other settings [7, 8]. Subsequently, the analyses 
can be narrowed by solely focusing on those costs and effects that affect the inter-
ested stakeholders, thus, conducting the analysis from another perspective. For 
example, when conducting the economic evaluation of a health care intervention, 
healthcare providers are the interested stakeholders. From their perspective and 
only those costs related to healthcare utilization would seem relevant. It is clear 
that when conducting the economic evaluation of a healthcare intervention from 
the provider’s perspective, by solely measuring and valuing healthcare utilization 
costs, the broader societal perspective cannot be applied afterwards. The societal 
perspective in fact also assumes the incorporation of productivity costs, patient 
out-of-pocket costs, and those costs that would be difficult to incorporate at the end 
of the study. Throughout this PhD-study resource use is self-reported by partici-
pants and collected separately from the unit costs or prices of those resources. Col-
lecting resource utilization separately provides opportunities to apply health care- 
and intervention- provider specific prices to the units of resource use. 
 In the field of occupational health, the perspective of economic evaluative stud-
ies is just as essential as in general health technology assessments. However, in 
order to be as complete as possible, this field requires a more narrow view than the 
societal perspective, and a broader one than the focus of the organization or em-
ployer. Different perspectives take different costs and consequences into account, 
depending on the stakeholder’s interest. Therefore, explicitly reasoning and flexibil-
ity in the choice of study perspective is warranted. To illustrate this, investing in 
employability interventions whereby the benefits (for example quality of life) are 
entirely for the employees, without impacting productivity, can be justified from a 
healthcare perspective. Investing in this ‘QALY increase’ can also be justified in 
social terms, but might not seem that relevant from the employer’s perspective who 
is mainly interested in productivity changes. Although there is a strong case for 
focusing on a wide range of health-related outcomes (such as QALYs), financial 
outcomes are also important. Whether human or financial outcomes are more im-
portant is another discussion, and not addressed in this PhD-thesis. The issue here 
is that the perspective of the study should be determined in collaboration with the 
relevant stakeholders, and if needed, be supplemented with analyses incorporating 
additional or divergent effects and/or costs (such as a return-on-investment analy-
sis from the organizational perspective).  
 Elaborating on the study perspective also stresses the inclusion of relevant cost 
categories in this field of study. The answer to the question which costs to include 
always depend on the chosen study perspective [9]. Including all costs despite of 
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who bears or benefits them, runs the risk of double counting. The consequences of 
employability interventions are often expressed in terms of changes in health-
related productivity [10, 11]. Including all costs also implies the inclusion of chang-
es of health-related productivity into a financial metric [12]. It is clear that when 
health-related productivity has to be included as a cost parameter in order to com-
ply with the guidelines [7, 8], they cannot serve as the outcome measure. Adjusting 
the preferred societal perspective (according to the health economics) as presented 
in the guidelines [7, 8], is an important methodological consideration that should be 
taken into account [12]. Where possible throughout the studies included in this 
PhD-thesis, double counting was avoided in the cost effectiveness analyses by cal-
culating and summing intervention-, health care-, and patient- and family- costs in 
the cost effectiveness analysis. When productivity served as the outcome of interest 
(i.e. at-work productivity loss), the costs of changed productivity were omitted. 
Hence, a full societal perspective could not be applied. 
 When assessing interventions aimed at achieving sustainable employability 
among employees with health problems, the quality of the measurement method 
and the valuation method to quantify costs influence the usefulness of the economic 
evaluation results [2, 13]. The debate continues on what is the most reliable and 
best method for collecting costs in economic evaluations [14, 15]. Because there is 
no consensus, data collection is generally guided by pragmatic concerns, such as the 
resources available or the characteristics of the populations under research. None-
theless, more attention needs to be paid to both measuring and valuing costs. The 
measurement tools used for cost-data collection (health-related productivity and 
healthcare resource use) would benefit from high-quality methodological reporting 
in order to trust the validation evidence forehanded. Practical and applicable 
knowledge is best to be considered with insight into the reliability, validity and 
responsiveness of instruments used to evaluate cost-data [2, 3]. This PhD-thesis 
found that the methods used to measure resource utilization costs resulted in in-
conclusive results. The validation evidence of a (small) number of studies with 
adequate methodological reporting quality only cautiously support the exchangea-
bility of both self-reported and administrative resource use measurements. The 
reason for this is essentially the paucity of coherent methodological quality ham-
pering the interpretation of estimates and collected validation evidence. Because 
the provision of healthcare services has become more integrated, economic evalua-
tions need to include information from many different healthcare providers. How-
ever, healthcare utilization is not always registered in social security systems (e.g. 
alternative care), hampering the calculation of economic costs. Therefore, a robust, 
uniform and transparent method is required. 
 This thesis also found that there is a need for adequate measurement and valu-
ation of productivity costs. Currently, sick leave days are most commonly used [16]. 
However, no certainty can be provided to whether this proxy accurately reflects the 
true cost related to lost production (as not all sick leave days result in lost produc-
tivity). In all economic evaluations included in this PhD-thesis, costs stemming from 
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changed productivity incorporated both the number of days absent from work (ab-
senteeism) and the number of workdays lost due to decreased work performance 
(presenteeism). To value productivity losses, three principals could be used. One is 
based on the human capital approach. To value the costs, the complete lost produc-
tion time is incorporated [17]. The second is based on the friction cost approach, 
which states that productivity loss only occurs until the tasks of the absent employ-
ee are compensated for. After a fixed friction period, it is assumed productivity has 
restored to its maximum and no more costs are attributed to the absent worker 
[17]. The third method assumes that productivity costs only arise when lost work is 
not compensated for, for example by colleagues or through extra hours [18]. The 
three methods risk the production of widely different results. The human capital 
approach assumes continuous productivity costs. The friction cost approach applies 
only during a fixed period until the production is restored. The third approach as-
sumes that changed productivity compensated for does not result in any lost 
productivity costs. The latter approach is hard to put in practice in the Netherlands. 
Even compensated productivity losses are not costless since every employer in the 
Netherlands has the obligation to continue paying salary for two years when em-
ployees are absent from work due to health problems [19]. This law was introduced 
to stimulate the employers’ responsibilities for reintegration of sick employees 
(Gatekeeper Act). Dutch employers must continue to pay at least 70% of the salary 
of sick employees for the first two years4. Within this period, productivity might be 
restored in terms of output, when, for example, the sick employee was replaced by 
an outplacement worker. The costs for the employer increase then because an ‘ex-
tra worker’ has to be hired to restore productivity, on top of the wage payment 
obligation the employer has towards his absent employee for the upcoming two 
years [19]. This insight is important since the perspective of the employer has be-
come more prominent as a result of a number of legislative developments. The 
generalizability of the findings in The Netherlands towards other countries howev-
er might therefore be limited by legislative differences.    
 Applying the friction cost method to calculate productivity costs due to health 
constraints among employees in countries other than the Netherlands require ad-
justments for country-specific social security arrangements. As illustrated above, 
disability pensions are only rewarded after two years of sick-leave and sufficient 
reintegration efforts. In the Netherlands, the friction period was estimated to be 
about 13 weeks5. Generalizing this approach to another country, with a different 
                                                                  
4 Most employers top up the wage payment from 70% (legally required) to 100% on the basis of collec-
tive agreements; so a supplement of 30% is customary in the first 52 weeks. In the second year, this 
supplement is no longer customary.  
5 The following formula was used to calculate the friction period in weeks:  ܨܲ = ቀ୭୴ୡ୴ ∗ 12ቁ ∗ 4.35 + 4  In the equation, ov represents the average number of open vacancies in one year and cv represents the 
average number of completed vacancies in one year. The average vacancy duration in months is converted 
to weeks with the 4.35 conversion factor. The added 4 weeks estimate the period which supervisors are 
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social security system where disability pensions are paid sooner and the duration 
of the friction periods vary, will most likely result in divergent outcomes. 
 Additionally, increased attention for the relative contribution of different cost 
categories with respect to the overall costs is preferred. This would ultimately pro-
vide insight into the relevance of measuring the costs from a societal perspective as 
recommended by the guidelines [7, 20]. Furthermore, there are other methodologi-
cal considerations with respect to the outcome measures selected. As previously 
mentioned, the choice of outcome (for instance days of productivity versus QALYs) 
in this field of study is often influenced by the type of economic evaluation and the 
risk of double counting. Properly addressing a priori usage and identification of 
items for effect estimations is essential. Productivity consequences of health im-
provements can be measured as an effect of the intervention. However, it is im-
portant to also look at a broader range of effects available to employees and society 
as a whole. To identify the full extent of consequences, QALYs can be used. Includ-
ing QALYs improves the generalizability of employability interventions by enabling 
potential comparison of economic evaluation results of various general health in-
terventions [21]. When conducting a cost utility analysis whereby QALY serves as 
the outcome of interest, the costs in other sectors (productivity costs) can be in-
cluded without risking double counting. Although several studies in this PhD-thesis 
used utility measures of health changes associated with employability interven-
tions, the QALY was not always sensitive enough to detect an intervention effect. A 
QALY combines health gains from reduced morbidity and mortality into a single 
measure based on the ‘desirability’ of the different outcomes [21]. When using 
QALYs as a means to gather economic evaluation results for employability interven-
tions among employees with health problems, a QALY must satisfy a constant pro-
portional trade-off between quality and quantity of life, and must be independent of 
disease incidence and impact [21]. It can be argued that this is discriminating 
against work-disabled people or employees with health problems impeding their 
labor participation. Therefore, after considering this ‘equity distribution’, a sensible 
use of the technique and adequate interpretation of findings is needed. Even more 
so, the studies in this PhD-thesis which used QALYs as an outcome measure, 
showed high baseline utilities, inducing ceiling effects which makes it difficult to 
detect substantial improvements [22]. Nonetheless, insight into changes in the 
quality of life due to the employability intervention produces useful information to 
aid decision-making in the field. Additionally, it is recommended to include the 
effect of work disability on productivity in a quality of life instrument [23]. Re-
spondents do not include the effect of health constraints on productivity if the 
measurement instrument used does not explicitly ask about this effect [23]. Poten-
tial reasons for the discrepancy between work disability and QALY scores should be 
                                                                                                                                                                  
supposed to use before deciding on temporary or permanent replacement of the absent worker. Based on 
the formula, the friction period for 2012 in the Netherlands contained 13.24 weeks (92.68 days).  
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further assessed. This will attribute to gain insight into the psychometric properties 
of quality of life instruments (e.g. EQ-5D-5L) among employees with health prob-
lems, especially in a disease-specific population (such as for example patients with 
rheumatoid arthritis).  
Considerations regarding the interventions  
Several employability interventions in this PhD-thesis were unable to detect a sub-
stantial improvement in their main outcome measures. This however does not im-
ply the employability interventions are not meaningful in general. Considerations 
regarding the interventions have to be taken into account though.  
 A first consideration might postulate that usual work resumption in the Nether-
lands is already of high quality; that is, the control condition was already likely 
effective, which limits the visibility of the improvements in outcome due to the 
intervention. Another consideration could be the poor implementation of the em-
ployability interventions (or components of the employability intervention).  
 In addition, some effect measurements do not represent what is truly relevant 
to expect of an employability intervention for employees with health problems. For 
example, generic QALYs are not  sensitive enough to assess the effect of an employ-
ability intervention for employees with a diverse range of health problems that 
impede their labor participation [22]. Nonetheless, the added value of each em-
ployability intervention should be assessed properly, clearly stated and communi-
cated to all stakeholders involved. Economic evaluation results are extremely valu-
able for informing judgements on the ‘worthiness’ of investing in employability 
interventions.  
 Although all interventions in this thesis were developed to improve employabil-
ity amongst employees with health problems, the included studies induced that the 
field of occupational health is not that easily affected, even when the economic 
evaluation results of the employability interventions are relatively positive. Ade-
quate implementation of the employability intervention in practice requires meet-
ing the needs of all stakeholders. Stakeholders affected by the intervention have 
concerns about the distribution of costs and consequences, and have divergent 
priorities and incentives. To illustrate this, a broad range of costs and consequences 
across the different parties involved has to be considered to express the distribu-
tional implications of the alternatives. At first sight, the investment costs of an em-
ployability intervention are primarily allocated with the employer and the benefits 
of, for example health and quality of life do not appear relevant. However, the eco-
nomic evaluation results might show contrasting and interesting benefits for the 
employees, at minor investment costs, making it worth to invest in the employabil-
ity intervention. Hence, decision making requires the acknowledgement of context-
specific characteristics, which make the employability intervention more or less 
relevant to particular stakeholders. 
 Aside from full economic evaluations, pilot economic evaluations are useful to 
investigate the reach, compliance and perceived cost effectiveness of an employa-
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bility intervention before implementation occurs. Pilot economic evaluations re-
sults attribute to the intervention development. Valuable resources can be saved 
when adjustments in content and design can be made before large-scale studies are 
set up [24-26], and this PhD-thesis shows that this also applies to economic evalua-
tion studies. Insight into how and where to target the intervention, given its popula-
tion of interest, would be very valuable.  
Implications for practice and future research 
The findings described throughout this PhD-thesis have implications for practice 
and future research as they contribute to the methodological and practical debate 
concerning the need for sustainable employability among employees with health 
problems. 
 When poor methodological reporting quality is at stake, there is a risk that the 
economic evaluation results are biased, which lead to inappropriate decision-
making. To illustrate this, there is no common reference standard for measuring 
resource use. Furthermore, based on the findings of systematic review (Chapter 3), 
only six studies were found to support the exchangeability of self-reported and 
administrative healthcare resource use measurements. This could result in the risk 
of misleading conclusions. Furthermore, the methods for measuring and valuing 
health-related productivity costs induce the risk that results could be biased, de-
spite a large number of measurement tools that have been developed over recent 
years to measure changes in work productivity due to health-related absenteeism 
and presenteeism [2, 10, 11, 27]. Both systematic reviews included in this PhD-
thesis established that there was a lack of details on the measurement properties 
resulting in low methodological reporting quality. This impedes the decision mak-
ing for choosing an appropriate instrument.  
 Although economic evaluations require assumptions to be made, more focus on 
testing these uncertainties in sensitivity analyses would help to present the robust-
ness of the results under alternative scenarios. Conducting an economic evaluation 
of employability interventions in future research can justify the choice of candidate 
variables for the sensitivity analysis. Preferably those variables with an impact on 
the economic evaluation results and inconclusive measurement properties (such as 
changes in health-related productivity and resource utilization costs) should be 
included. In future research more attention could also be paid to subgroup analyses 
to account for participant heterogeneity, which provides valuable information on 
how to target the interventions aimed at achieving sustainable employability for 
employees with health problems.  
 In addition more focus on characterizing the uncertainty around the joint cost-
effect estimates (CEA-plane) is preferred. At the moment the precision of the cost-
effect estimates is quantified and non-parametric bootstrapping techniques deal 
with the highly skewed nature of cost data [28]. However, no visual methods (such 
as the cost effectiveness acceptability curve), have yet been developed to help oc-
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cupational health decision makers interpret the results based on a uniform willing-
ness-to-pay or willingness-to-accept for increased health-related productivity.  
 Furthermore, more insight into the relationship between health consequences 
and productivity consequences, that is, health-related productivity, is warranted. 
For example, health utility measures do not yet explicitly consider productivity in 
the elicitation questions asked when assessing QALYs in occupational health re-
search [23]. Assigned utility weights on quality of life are debatable for different 
health conditions, and can thereby impact on productivity. Additionally, this also 
relates to the issue of double-counting, as it remains unclear whether productivity 
changes are to be addressed; as a cost- or outcome parameter, and how to avoid 
double counting. Since incremental cost effectiveness ratios are sensitive to what is 
placed in the numerator and denominator [29], a clear description of the content of 
both the numerator and denominator is needed to meaningfully compare the re-
sults of different studies.  
 Awareness into compensation mechanisms is also required. Changes in produc-
tivity due to health problems are compensated because colleagues take over the 
work, or workers themselves make up for the lost work after their return. Despite 
uncertainty regarding the valuation methods to be used, more research on factors 
influencing changed productivity and the measurement of productivity costs would 
be helpful to interpret the results. For example, the type of job is important, as the 
production process nowadays is more individually oriented. Future research could 
evaluate productivity changes across a variety of jobs and workplaces, requiring 
adequate methodological reporting quality with respect to the psychometric prop-
erties of the measurement tools used.  
 Next to that, clear insight into the intervention costs aids insights in the content 
of the intervention. Distinctions between human and material resources help to 
unravel the precise content of the intervention. Understanding the mechanisms of 
the intervention is helpful to better appreciate why parts of an intervention are 
poorly implemented or not adequately tailored to the target participants. To illus-
trate this for purpose of cost calculations, material resources are reported in capital 
items with a time span longer than one year (e.g. equipment needed to build the 
interventions), and recurrent or revenue items consumed in less than one year (e.g. 
maintenance costs). This information can positively affect content related im-
provements regarding the intervention. When minimal maintenance costs through-
out the year are detected, this could induce a minimal of ‘updates’ regarding the 
intervention in order to keep it tailored. As an example, e-health requires renewals 
to correspond with continuous software updates. If maintenance costs are minimal, 
it can be assumed that no updates occurred over the last year, hampering adequate 
implementation of components of the interventions, and thereby impeding ade-
quate targeting.  
 Additionally it is often assumed cost effectiveness analyses are only useful after 
complete intervention development, and not in the exploratory phase of interven-
tion development. However, because economic evaluations add new perspectives, 
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cost effectiveness analyses are also very useful to contribute to the development of 
the intervention, and – as in the scientific literature regarding pilot studies is em-
phasized – the study design [24-26]. In all, information from economic evaluations 
can help inform decision-making. However, the economic evaluation results of the 
different existing and innovative interventions aimed at achieving sustainable em-
ployability for employees with health problems indicated difficulty adhering to all 
stakeholders’ interests. The trade-off that matters most to the stakeholders affected 
by the intervention, determined the type of economic evaluation chosen. Through-
out this PhD-thesis, mainly cost-benefit, cost-utility, and cost-effectiveness analyses 
were conducted. Cost benefit analyses were more relevant from the employers’ 
perspective as it provided a direct assessment of the impact of the investment in 
employability on productivity changes for the organization. Cost utility-, and cost 
effectiveness analyses were more relevant to represent the interest of workers and 
healthcare providers or other stakeholders (e.g. health insurers) because of the 
related health outcomes. Nonetheless, the costs and consequences of employability 
interventions are distributed across multiple involved stakeholders, future insight 
therefore should include the reporting of both monetary- (productivity changes) 
and non-monetary (health, work-ability, QALY, etc.) outcomes for public and organ-
izational consequences. Future research should allocate the reporting of conse-
quences in multiple ways and separately. Additionally, an aggregate summary 
measure should be included, in order to highlight the intervention’s impact on both 
types of consequences.  
 An innovative method to do so is by conducting a so-called ‘social cost- benefit 
analysis’ (MKBA in Dutch) [30]. The ‘MKBA’ is an information tool that systematical-
ly portrays and values the advantages and disadvantages of an intervention from 
the perspective of society as a whole and supports the policy choices regarding the 
implementation of an intervention, wherever possible, on objective grounds. The 
MKBA is applicable to all types of interventions in all policy areas and provides an 
overview of the effects, the risks and the uncertainties attributable to the interven-
tions. By quantifying the extent of possible advantages and disadvantages and to 
value them (expressed in Euros), the MKBA provides insight into the impact of the 
intervention on social welfare [30]. In other words: the balance of benefits meas-
ured in Euros minus costs. This balance also includes the costs and consequences of 
the intervention on components of the social wealth for which no market prices 
exist (e.g., security, culture and social cohesion) [31]. By monetizing the impact of 
the interventions they become comparable. Furthermore, answers can be provided 
to the question of whether the social costs of a measure outweigh the social bene-
fits. Of course it is also possible that knowledge regarding the consequences is too 
uncertain to quantify in monetary terms. Nevertheless, MKBAs can be useful to 
display, in an orderly way, what is known about the intervention, and what is not. 
The decision-making can then be structured and become pragmatic in its approach. 
In summary, an MKBA can be used to steer future practice by providing insight into 
the potential changed overall social welfare and the distribution of costs and bene-
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fits of the diverse range of employability interventions for employees with health 
problems.  
 To further aid decision-making in practice, insight into expected long-term 
costs and consequences should be valued too. As mentioned earlier, an 18-month 
follow-up period would be preferred to assess the full impact of an intervention. 
However, because of several practical limitations none of the studies were able to 
achieve this. The six-month follow-up period used throughout this PhD-study can 
therefore be insufficient to capture the true consequences of the analyzed interven-
tions. Although the data collection methods chosen were suitable and as complete 
as possible for conducting economic evaluations, the measurement is limited to the 
length of the trial to which the economic evaluation is attached. In future research, 
it would be innovative and interesting to account for the costs and consequences 
after this period. Economic evaluation using decision analytical modeling can 
bridge the gap between trial-based observations and the expected long-term costs 
and consequences. By using decision analytical modeling, the expected costs and 
consequences of decision options regarding the implementation of employability 
interventions could be compared by synthesizing information from multiple 
sources and applying mathematical techniques [32]. The aim would be to provide 
decision makers and relevant stakeholders with the best available long-term evi-
dence to reach a decision by comparing alternative options. 
 Lastly, it is hypothesized that employees are not used to the ‘treating’ role of 
occupational physicians such as offered in several employability interventions. 
Within the Dutch legislation, treatment and sickness certification are separate 
tasks, performed by different professionals without exchange of medical infor-
mation unless the patient/employee gives consent [33]. In the studies included in 
this thesis, employees could have felt uncomfortable meeting with employers, 
healthcare providers and occupational physicians all at once, or within a very short 
time span. In an attempt to integrate occupational health more in the ‘treating’ 
healthcare system, collaboration between the different stakeholders (e.g. the occu-
pational physician, the employee, the employer, etc.) needs to be improved. Alt-
hough it is an assumption that employees feel uncomfortable with the ‘treating role’ 
of the occupational physician, the hypothesis is interesting to study, for example 
with qualitative research methods. Additionally, awareness of worker preferences 
should be assessed in order for employability interventions to embrace a more 
individualized approach, which meets the preferences of workers. Discrete-choice 
experiments are commonly known preference-based measures in economic evalua-
tion [34], which can be used to comprehend employee’s preferences regarding 
employability interventions.  
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Concluding remarks 
Occupational health is a complex field of study and practice because of its transdis-
ciplinary nature with multiple stakeholders involved. Many employability interven-
tions exist that aim for sustainable employability among employees with health 
constraints. Nonetheless, appropriate decision making for implementation might be 
hampered for many reasons (such as methodological reasons). Economic evalua-
tion results can aid to inform these decisions. The findings of this PhD-thesis could 
be used to guide decision making by outlining solutions to various methodological 
challenges, and by deducing the generated economic evaluations results of employ-
ability interventions assessed in practice. The information as presented throughout 
this PhD-thesis can support and guide diverse stakeholders such as researchers, 
occupational health practitioners, employees, employers, and decision makers, in 
selecting the employability intervention to be assessed through research or to be 
implemented in practice. The findings from this PhD-study help to substantiate 
these decisions. The included studies showed that the field of occupational health is 
not that easily affected, despite of the relative positive economic evaluation results 
of the employability interventions. A clear interface between what stakeholders 
find relevant, insight in context-specific characteristics of an intervention, and ade-
quate measurement and valuation tools for both costs and outcomes is warranted.  
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Work is central in people’s lives. Work influences well-being and impacts the physi-
cal, mental, financial, and social health of individuals. The health and growth of our 
communities is thereby directly influenced by our ability to maintain a healthy 
workforce. Hence, it is important that those employees who get influenced in their 
work-ability because of health complaints can maintain their place in the work-
force. This valorization chapter addresses the main findings of this PhD-research 
relevant to the most prominent stakeholders present in the workforce, and thereby 
in occupational health. The sections below describe the target groups and elaborate 
on various points of interest which have the potential to be valorized and appear 
relevant for each stakeholder group.  
Employees with health complaints 
The employee is seen as the individual who is absent from the workplace due to 
health complaints or who is experiencing substantial burden of the heath com-
plaints while at work, hampering his or her employability.  
Message from the thesis 
Changed productivity is an important asset of employability interventions and 
should therefore be taken into account when assessing the cost effectiveness of 
employability interventions. For employees, however, increased productivity might 
not always be the primary aim, and thus not the main outcome of interest in the 
analyses. Individual employees are often more interested in other benefits associ-
ated with sustainable employability such as quality of life, work ability, self-efficacy, 
and so on.  
Points of interest  
Before selecting or implementing an employability intervention, it is important to 
ensure that the outcomes are also important from an employee perspective. Meas-
uring a broader range of outcomes within the analysis of employability interven-
tions will provide outcome evidence to select the most adequate employability 
interventions. Employees with health complaints need to be aware of their current 
and future (financial) position, as well as their current and future health state. Both 
employees’ needs and preferences require visibility. Any assistance from profes-
sionals, researchers, or experts needs to be put in practice.  
Efforts made to disseminate this knowledge  
The following efforts are made to disseminate the knowledge: publication of study 
results of diverse employability interventions in scientific journals; publication of 
diverse methodological investigations in scientific journals; and several press re-
leases and other publication types (such as reports). 
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Additional actions to be taken  
Although the importance of outcome measures such as quality of life, productivity, 
and work ability are unquestionably relevant, more insight in what is relevant and 
important for the employee is needed. Identifying a broader range of employee-
centred outcomes, as well as employee preferences, might indicate more properly 
whether the employee’s goals fit the aims of the other stakeholders. Gaining these 
insights might indicate why certain employability interventions are more, or less, 
cost effective when compared to common practice.  
Co-Workers  
This interest group relates to those individuals directly affected by the work ability 
of the individual employee with health complaints.  
Message from the thesis 
Measuring the consequences of an employee’s work-related health problems for 
the co-workers can be incorporated in measuring the so-called ‘compensation 
mechanisms’. Compensating for the lost productivity will influence the related 
costs. Co-workers can take over (and thus compensate for) the lost work of the 
employee with work-related health complaints. The impact thereof is illustrated in 
the changed productivity costs, assuming less productivity costs if the work is com-
pensated for by co-workers.  
Points of interest 
When measuring changed productivity due to work-related health complaints, it is 
recommended to also include the measurement of compensation mechanisms (e.g. 
co-worker compensation). Co-worker’s efforts need to be recognized.  
Efforts made to disseminate this knowledge 
The following efforts are made to disseminate the knowledge: publication of study 
results of diverse employability interventions in scientific journals; publication of 
diverse methodological investigations in scientific journals; presentations and 
workshops at (inter)national conferences; and several other publication types 
(such as reports). 
Additional actions to be taken 
The consequences for co-workers need to be taken into account to accommodate 
sustainable employability for employees with work-related health complaints, and 
to prevent the co-workers from developing work-related health complaints them-
selves. Insight is required in both the burden of extra work experienced by the co-
worker when compensating for the employee with work-related health complaints, 
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and the co-worker’s expectancies towards the returning worker. Researchers have 
a large role in gaining and disseminating these insights.  
Employers  
The group of employers addressed are those organisations which employ workers 
or those individuals that relate to the employee via the workplace. One can think of 
company owners, supervisors, human resource managers, and so on.  
Message from the thesis 
The employability interventions assessed from an employer’s perspective have 
demonstrated that it is recommended to invest in employability because productiv-
ity increased in a cost-beneficial way. For employees in the Netherlands these anal-
yses are especially relevant since they are obliged under the Dutch law to guarantee 
at least 70% of the salary of their absent employees with health complaints. If em-
ployers are about to invest in employability interventions, it is essential to provide 
them with this information so they can make evidence-informed decisions. 
Points of interest  
Aside from increasing productivity, employers are essential actors to also decrease 
the burden of work-related health complaints. A distinction is preferably to be 
made between those stakeholders which have to oversee the broader vision of the 
company - and thus primarily aim for increased productivity- and those in direct 
contact with the employees,  who aim for reduced burden of work-related health 
complaints.  
Efforts made to disseminate this knowledge 
The following efforts are made to disseminate the knowledge: contacts with (a 
group of) employers to discuss the needs and to disseminate the newly gained 
knowledge; publication of study results of diverse employability interventions in 
scientific journals; publication of diverse methodological investigations in scientific 
journals; presentations and workshops at (inter)national conferences; and several 
press releases and other types of publications (such as reports) 
Additional actions to be taken 
For company owners and human resource managers it is necessary to gain insight 
into the impact of the work-related health complaints on the functioning of their 
organisation. Assessing the cost effectiveness of employability interventions pro-
vides an excellent method to gain more insight in impending efforts to control the 
costs of changed productivity. Direct supervisors play a key-role in sensing what 
happens at the workplace. Identifying a broader range of employee-centred out-
comes, as well as employee preferences, might indicate more properly whether the 
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employee’s goals fit the aims of the direct supervisors. Gaining these insights might 
indicate why certain employability interventions are more, or less, cost effective 
when compared to common practice.  
Insurance companies 
Depending on the country’s social welfare system, insurance companies become the 
ones paying for activities designed to help employees recover from their health 
complaints and assist them towards employability, or to compensate for their work 
disability. Based on the Dutch social welfare system, insurance companies can be 
involved as income insurer for companies (to insure the extended wage-payments 
in case of sickness absence), or as collective health insurer.  
Message from the thesis 
In the Netherlands, insurers for companies benefit from sustainable employability 
through lower or no ‘benefits’ or ‘compensation payments’ for lost productivity and 
the reduced extended wage-payments. Health care insurers also benefit from in-
vesting in employability interventions when less healthcare is utilized. In all, invest-
ing in cost effective employability interventions helps employees to maintain ‘fi-
nancially healthy’. Sustainability is an important aspect as it demonstrates success-
ful employability and reduces the negative impact, and lowers the likelihood, of 
recurrent absenteeism and presenteeism.  
Points of interest 
Insurers can have varying interest as they might concentrate on healthcare costs 
associated with work-related health complaints, lost productivity costs due to ab-
senteeism and presenteeism or the funding of  (a potential range of) employability 
interventions. Despite of these varying rationales, and perhaps divergent motives 
for payments, it is the insurer’s interest to invest, or at least facilitate, sustainable 
employability. 
Efforts made to disseminate this knowledge 
The following efforts are made to disseminate the knowledge: publication of study 
results of diverse employability interventions in scientific journals; publication of 
diverse methodological investigations in scientific journals; presentations and 
workshops at (inter)national conferences; provided input for symposia and confer-
ences addressing insurance-related issues; and input for press releases and reports 
to provide guidance for insurance-related issues 
Additional actions to be taken 
Different motives for payments from insurers are best to be supported by clear, 
concise and transparent research evidence in order for insurance companies to 
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make evidence-informed decisions to invest in employability interventions. The 
subjective weights attached to insurer’s motives are best prevented by systemati-
cally providing evidence on the effects, both in terms of economic motives (e.g. 
productivity costs, healthcare utilization costs), and in terms of more ‘humanitari-
an’ motives such as quality of life, preferences, work ability, and so on.  These in-
sights might also more properly indicate why certain employability interventions 
are more, or less, cost effective when compared to common practice.  
Healthcare providers 
This group of stakeholders includes all those that provide assistance in helping the 
employee with health complaints to recover and sustainably (return to) work.  
Although the main objective of healthcare providers is focused on optimising 
‘health’, healthcare providers become increasingly involved in occupational 
healthcare as well.  
Message from the thesis 
Healthcare providers play an important role in preparing an employee with work-
related health complaints to return to work. Furthermore, they play an essential 
role in work-disability prevention. Healthy and sustainable employability can be 
seen as a function of (medical) treatments whereby patients return to active partic-
ipation.  
Points of interest 
As healthcare providers consist out of a very heterogeneous group (such as general 
practitioners, specialists, and so on) and employees with work-related health com-
plaints can consult a diverse range of healthcare providers, a clear role description 
for each healthcare provider is preferred. Sickness severity and duration, as well as 
the context of both the condition and labour participation need to be acknowledged 
by the different healthcare providers. In order to reduce a potential negative impact 
of the variation of what is priority is based on a clear description of the healthcare 
provider’s role and tasks, and on cooperation and communication between these 
stakeholders. 
Efforts made to disseminate this knowledge 
The following efforts are made to disseminate the knowledge: contacts with 
(groups of) healthcare providers to discuss the needs and to disseminate the newly 
gained knowledge; publication of study results of diverse employability interven-
tions in scientific journals; publication of diverse methodological investigations in 
scientific journals; presentations and workshops at (inter)national conferences; 
and several press releases and other publication types (such as reports).  
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Additional actions to be taken 
More guidance and insight might help those healthcare providers that experience 
difficulties in accurately reflecting on an individual’s work disability status. Open 
communication between the healthcare providers and patients with paid work 
regarding the patient’s work, work-ability and preferences should be a standard 
point of interest.  
Reintegration professionals & agencies 
This group of stakeholders includes those that work in the reintegration field. In the 
Netherlands, this field has evolved into a mix of public and private organizations, 
with a wide range of reintegration professionals. For employees, the reintegration 
professionals most commonly known are ‘occupational physicians’. In the Nether-
lands, the employers hire occupational physicians. They deliver a private service, 
but work under public legislation. According to the Dutch law, occupational physi-
cians have a legal obligation to offer guidance to employees with health complaints 
in the first two years of sickness absence. Additionally, employers can also contract 
a private reintegration agency to offer for example more extensive training and 
counseling.  
Message from the thesis 
Just as wide and diverse as the involvement of diverse reintegration professionals 
or agencies can be, as broad are their approaches. Insight in the cost effectiveness 
of employability interventions provided by reintegration professionals and reinte-
gration agencies is needed to winnow the wheat from the chaff.  
Points of interest  
In practice, not all reintegration agencies operate in a systematic manner. Evidence-
based employability interventions are seldom put in practice; it is often more a 
matter of availability. Systematic intervention-mapping is rarely done.  Lacking 
insights in the cost effectiveness of employability interventions hamper their con-
tinuation and optimization.  
Efforts made to disseminate this knowledge 
The following efforts are made to disseminate the knowledge: publication of study 
results of diverse employability interventions in scientific journals; publication of 
diverse methodological investigations in scientific journals; presentations and 
workshops at (inter)national conferences; and several press releases and other 
publication types (such as reports)  
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Additional actions to be taken 
More research is needed on whether and why reintegration interventions are suc-
cessful or not. More evidence-based employability interventions are needed. By 
conducting economic evaluations, not only insight in the worthiness of investing in 
employability interventions, but  also insight in the feasibility of these interventions 
is gained. Only by more systematic assessments, employability interventions can be 
compared, adjusted and potentially put in practice. Researchers and reintegration 
professionals-, and agencies should work more closely together.  
Policy makers 
This interest group is located at the local and/or national governmental level, at-
tempting to optimise occupational health and to reduce social welfare costs. Policy 
makers are defined in terms of their role in maintaining and regulating society.  
Message from the thesis 
As policy makers are (legally) responsible to enhance labour participation, and to 
reduce work-related health problems, economic evaluation results from the socie-
tal perspective are preferably to be used to aid evidence-informed policy making.   
Points of interest 
It could be argued that the view of policy makers is embodied in societal legisla-
tions, approaches to social security, and healthcare service provisions. Despite of 
the relatively positive economic evaluation results of the employability interven-
tions assessed in this thesis, the field of occupational health requires more evidence 
to inform policy-making. Policy makers need to shape both the macro level of em-
ployability (e.g. institutions), as well as the context wherein work-related health 
problems occur (micro level). The motivation to strive for sustainable employabil-
ity might rest on different foundations (e.g. more seen as a social, or more as an 
individual responsibility).  
Efforts made to disseminate this knowledge 
The following efforts are made to disseminate the knowledge: publication of study 
results of diverse employability interventions in scientific journals; publication of 
diverse methodological investigations in scientific journals; presentations and 
workshops at (inter)national conferences; and several press releases. 
Additional actions to be taken 
Policy-makers would benefit from acquiring the knowledge of key methodological 
principles underlying economic evaluations. Exchange and access of information 
from health technology assessment researchers or health economists for policy-
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makers would be helpful. At the moment the exchange of information, and thus 
information-based policy, is already commonly used within the field of high value 
cost conscience healthcare and within the assessment of medicines (e.g. structural 
guideline revisions). Within occupational health it is rather lacking. More insight in 
methodological and content-related indications, and more insight in economic 
evaluation results, could aid policy-makers to ensure that occupational health pro-
grams are providing mandated and high quality employability interventions, and 
thereby maintaining and regulating society.  
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Summary 
Health problems continue to limit labor participation, creating a growing need for 
sustainable employability. Structural methods are needed to develop appropriate 
responses when health problems impede employability and labor participation. 
This PhD-thesis addresses this by providing insight how the methodology underly-
ing economic evaluations within occupational health care can be improved. The 
first central aim throughout this PhD-study is therefore to generate knowledge and 
insight into the methodological challenges when conducting economic evaluations of 
employability interventions (Part I). Given the results, efforts to improve the current 
methodology are required. Throughout this PhD-study, the required efforts were 
applied to practice in order to conduct methodological high quality economic eval-
uations in employability interventions. To properly assess the added value of both 
existing-, and innovative employability interventions, this PhD-thesis furthermore 
describes the underlying health economic aspects, and the economic evaluation 
results of employability interventions aimed at achieving sustainable employability 
for employees with health problems. The second central objective of this PhD-
thesis is therefore the application of the generated methodological knowledge to 
different employability interventions, and the thereby generated economic evalua-
tion results of different existing and innovative interventions aimed at achieving sus-
tainable employability for employees with health problems (Part II and III).  
Part I: Methodological Challenges  
Chapter 2 presents a systematic review in which the measurement properties of 
generic self-reported instruments that measure health-related productivity chang-
es are critically appraised. 25 articles assessing the reliability, validity and respon-
siveness of 15 different generic self-reported instruments measuring health-related 
productivity changes were included. The Work Limitation Questionnaire (WLQ) 
was most frequently evaluated and yielded moderate to strong positive evidence 
for content and structural validity. The Stanford Presenteeism Scale (SPS) and the 
Productivity and Disease Questionnaire (PRODISQ) also yielded strong positive 
evidence for several measurement properties. The overall evidence on the psycho-
metric properties of the other 12 instruments was limited and of fair to poor quali-
ty. Based on these findings, the WLQ, SPS, and in a Dutch context, the PRODISQ are 
cautiously preferred until high-quality studies are in place to accurately assess the 
measurement properties of the currently available instruments. This study also 
warrants careful consideration of the content of the instrument, usage purpose, 
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target country and population of interest, and available evidence to guide decision 
making.  
 The results of another systematic review are presented in Chapter 3. The ex-
changeability of self-reported and administrative healthcare resource use meas-
urements for cost estimation was studied. The methodological reporting quality of 
studies comparing the validation evidence of healthcare resource use measurement 
tools was assessed with an appraisal tool. This tool was derived by combining as-
pects from the Guidelines for Reporting Reliability and Agreement Studies and The 
Standards for Reporting Diagnostic Accuracy. Out of the 16 included studies, seven 
scored ‘good’ on more than 75% of the reporting criteria. In the end, six studies 
scored ‘good’ on the minimal criteria for reporting. These criteria included: (i) a 
clear description of the measurement methods with a critical review of evidence 
relevant for the study, (ii) a rationale for the relationship between the self-report 
and the administrative data, (iii) the methods or measurement procedures for the 
self-report, and (iv) the methods and measurement procedures for the administra-
tive data. Despite varying levels of agreement among the different data sources, the 
validation evidence of the small number of studies with adequate methodological 
reporting quality cautiously supported the exchangeability of both the self-reported 
and administrative resource use measurement methods. 
 Chapter 4 describes how to preferably conduct economic evaluations of multi-
ple different employability interventions based on a similar methodological frame-
work. This framework enables the development of guidelines on how to conduct 
economic evaluation in this field and thereby contributes to the decision-making 
regarding treatment options in occupational health practice. The paper describes a 
consistent and transparent methodological design to analyze the cost effectiveness 
of five different employability interventions directed at work disabled employees 
with divergent health complaints. The comparisons between the employability 
interventions and usual care or the control conditions were pragmatic in nature 
replicating the actual ((occupational) health care) setting in which the studies oc-
cur. The design is compliant for different settings, for example when different unit 
prices for resource utilization, or divergent outcome measures, are preferred. Ac-
cording to sample-size calculations, each employability intervention needed a total 
of 142 participants to detect decreased sick leave duration. Eligible participants 
were employees aged 18 to 63, working at least 12 hours per week, and at risk of 
work disability, or already work-disabled due to medical restrictions. The economic 
evaluation results for each employability intervention are described elsewhere. 
This chapter discussed the methods, strengths and weaknesses of the study proto-
col. 
 Given the results of the studies included in Part I of this PhD-thesis, the eco-
nomic evaluation of existing- and new employability interventions are based on 
solid methodologies, accounting for stakeholder interests, and proper methodologi-
cal reporting quality to ensure transparency. The economic evaluation results are 
summarized in the paragraphs below. 
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Part II: Existing practices  
In Chapter 5, the results of a comparative cost effectiveness of two strategies to 
promote work functioning among nurses by reducing symptoms of mental health 
complaints are presented. In total, 617 nurses from one academic medical centre in 
the Netherlands were included and divided over either the control condition 
(online screening for mental health problems without feedback about the screening 
results), the occupational physician condition (screening, feedback and referral to 
the occupational physician for screen-positive nurses), or the e-mental health con-
dition (screening, feedback, and referral to e-mental health). After six months, sig-
nificant improvement in work functioning occurred in all three groups. The incre-
mental cost effectiveness ratio for the occupational physician condition versus the 
control condition was dominant, suggesting cost savings of €5,049 per treatment 
responder. The occupational physician condition resulted in greater treatment 
responses for less costs relative to the control condition and was therefore recom-
mended to be put in practice. The incremental cost effectiveness ratio for the e-
mental health condition versus the control condition was estimated at €4,054 
(added costs) per treatment responder, producing less treatment response than the 
control condition and therefore not recommended to be put in practice.  
 Chapter 6 addresses the question to whether a preventive intervention in the 
work setting is cost-saving from a business perspective. Alongside a cluster-
randomized trial in a Dutch academic hospital, the control condition (screening 
without feedback) was compared to the experimental condition (screening, per-
sonalized feedback and referral to the occupational physician for screen-positive 
nurses) to evaluate the balance between the invested intervention costs and the 
cost offsets stemming from improved productivity. Net-savings of €244 per nurse 
were observed when only absenteeism is regarded and €651 when presenteeism is 
also taken into account. Within half a year, the costs of offering the preventive in-
tervention were more than recouped. A return-on-investment ranging from €5 up 
to €11 per Euro invested was found. Offering the preventive intervention repre-
sents a favourable business case as seen from the employer’s perspective.  
 Chapter 7 focusses on the results of a pilot cost effectiveness study. This study 
aimed to detect how to improve a web-based employability intervention aimed at 
increasing self-perceived work ability among employees who experienced prob-
lems in relation to their employability. This study detected elements requiring im-
provements and thereby demonstrated the value of cost effectiveness analyses 
within a pilot study, preceding a full-scale study. First, content related improve-
ments were recommended based on the low uptake and compliance rates, particu-
larly for the online intervention element. Additional analyses concluded that the 
intervention appeared too general for specific situations, such as prolonged health 
problems requiring specific questions on work and health. Furthermore, the web-
based employability intervention was not associated with an economically relevant 
impact over regular trade union support for a heterogeneous population with 
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work- and disability related concerns. However, there was a tendency females and 
participants aged 50 or older might be more sensitive for an intervention effect. 
Ongoing tailoring and better targeting was therefore recommended. Secondly, im-
provements regarding the study design of the web-based employability interven-
tion were also recommended based on the results of the pilot economic evaluation. 
Negligible incremental differences on work ability and quality adjusted life years 
were unable to demonstrate an effect of the web-based intervention. Future studies 
should avoid discussion on whether the most appropriate outcome was selected to 
assess the true effect of the intervention, or whether the effect of the intervention 
was influenced by other factors (for instance derived information other than via the 
web-based employability intervention). In addition, the relative contribution of 
patient- and family out-of-pocket costs to the total overall costs was minimal. Data 
gathering for these cost categories could be omitted to minimize the burden for the 
employees and their environment. Based on the pilot economic evaluation results, 
the intervention content needs to be improved with respect to targeting and inten-
sity. Regarding the study design, reconsideration of the selected outcome measures 
and the collection of cost data is preferred.  
Part III: Innovative interventions  
In the third part, in Chapter 8 a field study is described that assessed the cost effec-
tiveness, -utility, and –benefit of a new organizational return-to-work (RTW) inter-
vention to improve Cooperation between Sick-listed employees and their Supervi-
sors (COSS). After six months follow-up, employees in the COSS-group reduced 
almost 16 calendar days of absenteeism and saved approximately €27 per day of 
work resumption. The cost utility analysis also exhibited reduced costs; however 
the gain in quality adjusted life years was uncertain. From an organizational per-
spective, the net benefits of COSS versus common practice yielded a productivity 
gain of almost €396. COSS has the potential to improve productivity at reduced 
societal and organizational costs when implemented among sick-listed employees. 
Long-term research needs to detect whether COSS also has the potential reaching 
sustainable RTW.   
 Chapter 9 provides the results of a short-term economic evaluation. First in-
sights into the cost effectiveness of an intervention coordinating clinical- and occu-
pational care at the worksite are provided. This intervention is aimed to support 
the work participation of workers with rheumatoid arthritis. After six months, both 
at-work productivity loss and QALY differences were in favor of the control group. 
Together with the higher costs of the intervention group compared to the control 
group, no evidence was found to support the implementation of the intervention. 
The main cost effectiveness and cost utility analyses show that the intervention was 
more expensive and less effective than the control condition. Sensitivity analyses 
supported these findings. 
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In Chapter 10, another economic evaluation was conducted. A tailored educational 
training program for general practitioners was provided to increase GPs’ aware-
ness of work-related health problems. This training program aimed to improve 
treatment strategies in the primary care setting. Awareness for work-related health 
problems in the GP practice is assumed to increase work-related self-efficacy and 
quality of life for patients in paid work. After six months follow-up, the differences 
in the main outcome measures between the intervention group and the usual GP 
care group were minimal. A negative incremental cost effectiveness ratio revealed 
fewer effects at higher costs for both the cost effectiveness and –utility analyses. 
Based on cost-related grounds the intervention could therefore not be recommend-
ed for implementation. 
Part IV: Discussion 
In Chapter 11 the main practical and methodological considerations and consider-
ations regarding the employability interventions that aim for sustainable employa-
bility among employees with health constraints are touched upon.  
 Practical considerations regard the recruitment of organizations and partici-
pants to take part in the research. To conduct an economic evaluation, at least a 
minimum required number of participants, a comparative design, and a comparable 
control group needs to be guaranteed. These practical considerations might slow 
down data collection as they require contacting other parties. Another practical 
consideration is the follow-up time, which is preferably stated before the study 
begins, but often not achieved due to practical issues.   
 Methodological considerations concentrate around the perspective of study. 
Within this field of study the perspective often has to deviate from the preferred 
societal perspective according to the health economic guidelines when accounting 
for specific stakeholder’s interest and when preventing the risk of double counting 
productivity changes. Further methodological considerations concern the methodo-
logical (reporting) quality of measurement tools, more specifically those that meas-
ure and value costs. Uniform and transparent methods are still lacking. Next, gener-
alizability issues might also be at stake when applying these findings to another 
country, and thus another social security system. A final methodological considera-
tion distresses the lack of insight into changes in the quality of life due to health 
problems impeding labor participation, and how employability interventions might 
improve the effect of productivity on health and quality of life.  
 Final considerations regard the intervention. The studied control groups were 
already likely effective, limiting the visibility of the effectiveness of different em-
ployability interventions. In addition, some effect measurements did not represent 
what is truly relevant to expect from an employability intervention for employees 
with health problems (e.g. generic QALYs). The results of the included studies 
demonstrated that the field of (Dutch) occupational health is not that easily affect-
ed, even when the economic evaluation results of the employability interventions 
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are relatively positive. Adequate implementation of the employability intervention 
in practice requires meeting the needs of all stakeholders. Hence, decision making 
also requires the acknowledgement of context-specific characteristics, which make 
the employability intervention more or less relevant to particular stakeholders. 
Pilot economic evaluations, conducted before large-scale studies, appeared to pro-
vide valuable insight into how and where to target the intervention, given its popu-
lation of interest.  
 In future research more attention could preferably be paid to subgroup anal-
yses to account for participant heterogeneity, which provides valuable information 
on how to target the interventions aimed at achieving sustainable employability for 
employees with health problems. In addition more focus on characterizing the un-
certainty around the joint cost-effect estimates (CEA-plane) is preferred. At the 
moment no visual methods, such as a uniform willingness-to-pay or willingness-to-
accept for increased health-related productivity, has yet been developed to help 
occupational health decision makers interpret the economic evaluation results. 
Also, more insight into health-related productivity and research on factors influenc-
ing changed productivity (e.g. compensation) and the measurement of productivity 
costs would be helpful to interpret the results. Portraying and valuing the ad-
vantages and disadvantages of an employability intervention (from the societal 
perspective) will support the policy choices regarding the implementation of such 
an intervention. The MKBA is suggested as an appropriate method since it is appli-
cable for all types of interventions in all policy areas and provides an overview of 
the effects, the risks and the uncertainties attributable to the interventions.  
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Samenvatting 
Recentelijk zijn diverse interventies ontwikkeld die streven naar duurzame inzet-
baarheid van werknemers met gezondheidsproblemen. Deze interventies worden 
‘inzetbaarheidsinterventies’ genoemd. Gezien de betrokkenheid van meerdere be-
langhebbenden is gezondheid op het werk een complex onderzoeksgebied. Hier-
door kunnen besluiten over het inzetten van de juiste inzetbaarheidsinterventies 
bemoeilijkt worden. Verschillende afwegingen moeten worden gemaakt. Onder-
zoek, en voornamelijk economisch evaluatieonderzoek, kan helpen om deze afwe-
gingen op een gegronde manier te maken. De resultaten ondersteunen besluitvor-
ming over het al dan niet implementeren van de specifieke inzetbaarheidsinterven-
tie en informeren onder welke voorwaarden dit gedaan moet worden om het be-
oogde effect te bereiken.  
 Deze dissertatie beoogt: (i) het genereren van kennis en inzicht in de methodo-
logie van economisch evaluatie onderzoek bij inzetbaarheidsinterventies (deel I), 
en, (ii) het interpreteren van de resultaten van economisch evaluatie onderzoek van 
zowel bestaande als innovatieve inzetbaarheidsinterventies gericht op het realiseren 
van duurzame inzetbaarheid van werkenden met gezondheidsproblemen (deel II & 
III).  
Deel I: Methodologische uitdagingen  
In hoofdstuk 2 werden generieke, zelf-gerapporteerde instrumenten die gezond-
heidsgerelateerde productiviteit meten kritisch beoordeeld in een systematische 
review. In totaal konden 15 verschillende instrumenten geïncludeerd en geëvalu-
eerd worden. De betrouwbaarheid, validiteit en responsiviteit van deze verschil-
lende instrumenten werd onderzocht. The Work Limitations Questionnaire (WLQ) 
was het meest frequent geëvalueerd en die studies leverden een matig tot sterk 
positief bewijs voor zowel inhoudelijke als structurele validiteit. Ook de Stanford 
Presenteeism Scale (SPS) en de PROductivity and DISease Questionnaire (PRO-
DISQ) leverden sterk positief bewijs voor meerdere psychometrische eigenschap-
pen. Op basis van deze bevindingen werden de WLQ, SPS, en (in een Nederlandse 
context) de PRODISQ voorzichtig aanbevolen. Om de besluitvorming te begeleiden 
werd tevens aanbevolen zorgvuldige afwegingen te maken ten aanzien van de in-
houd van het instrument, het streefdoel en de doelgroep. 
 In een tweede systematische review in hoofdstuk 3 werden meetmethoden 
bestudeerd om de kosten van gezondheidszorg te meten. De ‘uitwisselbaarheid’ van 
zelf-gerapporteerde en administratieve data ten aanzien van het zorggebruik werd 
onderzocht. Om hierover uitspraken te doen, werden gepubliceerde validatie-
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studies beoordeeld. Deze beoordeling richtte zich op de kwaliteit van de methodo-
logische verslaglegging aan de hand van een nieuwe ‘tool’. Deze tool werd samen-
gesteld door aspecten van verschillende richtlijnen te combineren (Guidelines for 
Reporting Reliability and Agreement Studies en The Standards for Reporting Diagnos-
tic Accuracy). Uit de resultaten bleek dat zelf-gerapporteerde als administratieve 
meetmethoden over het algemeen goed genoeg uitwisselbaar zijn. 
 Vervolgens werd in hoofdstuk 4 beschreven hoe een consistente en transpa-
rante methodologische onderzoeksopzet ontwikkeld werd. Deze onderzoeksopzet 
beschrijft hoe de economische evaluatie van verschillende interventies gericht op 
duurzame inzetbaarheid bij werkenden met uiteenlopende gezondheidsklachten 
uit te voeren. Door interventies in het veld van arbeid en gezondheidszorg systema-
tisch te onderzoeken wordt de vergelijking van deze behandelopties eenduidiger. 
De vergelijkingen tussen inzetbaarheidsinterventies en de controle condities (de 
gebruikelijke interventies) zijn bij voorkeur pragmatisch van aard om de werke-
lijkheid zo goed mogelijk te repliceren. De beschreven onderzoeksopzet kan breed 
ingezet worden en rekening houden met de vereisten van bijvoorbeeld diverse 
organisatie en aanbieders.  
Deel II: Bestaande inzetbaarheidsinterventies 
De eerste studie, beschreven in hoofdstuk 5, betrof een vergelijkende kosteneffec-
tiviteitsanalyse van twee strategieën om het functioneren van verpleegkundigen te 
bevorderen door psychische symptomen te verminderen. In totaal werden 617 
verpleegkundigen verdeeld over een controle conditie (online screening voor gees-
telijke gezondheidsproblemen zonder feedback over de resultaten van de scree-
ning), een ‘bedrijfsarts-interventiegroep’ (screening, feedback en doorverwijzing 
naar de bedrijfsarts voor screen-positieve verpleegkundigen), of een ‘e-mental 
health groep’ (screening, feedback, en verwijzing naar e-mental health). Gezien de 
dominante kostenbesparing van €5.049 ten opzichte van de controle conditie, werd 
implementatie aanbevolen voor de ‘bedrijfsarts-interventie’. De incrementele kos-
teneffectiviteit ratio voor de ‘e-mental health conditie’ versus de controle conditie 
bedroeg €4.054 extra kosten. Implementatie van de ‘e-mental health interventie’ in 
de praktijk werd op basis van de vergelijking met de controle conditie niet aanbe-
volen. 
 In hoofdstuk 6 werd vervolgens onderzocht of een preventieve interventie in 
dezelfde werksetting resulteerde in een positieve ‘business case’ vanuit het per-
spectief van de werkgever. De controle conditie (screening zonder feedback) werd 
vergeleken met de experimentele conditie (screening, persoonlijke feedback en 
doorverwijzing naar de bedrijfsarts voor screen-positieve verpleegkundigen). De 
interventie gerelateerde (investerings-)kosten werden afgezet tegen de kosten die 
voortvloeien uit veranderde productiviteit. Er werden netto besparingen variërend 
van €244 tot €650 per verpleegkundige waargenomen. Binnen een tijdsbestek van 
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een half jaar werd een positieve return-on-investment tussen €5 tot €11 per geïn-
vesteerde euro behaald.  
 Hoofdstuk 7 richtte zich op een pilot kosteneffectiviteit studie van een web-
based inzetbaarheidsinterventie gericht op het vergroten van werkvermogen onder 
werknemers met gezondheidsklachten. De pilot kosteneffectiviteit studie onder-
zocht of (a) inhoudelijke verbeteringen, en/of (b) verbeteringen ten aanzien van de 
studieopzet nodig waren.  Op basis van de lage respons en minimale gebruik van 
(onderdelen van) de interventie werden aanbevelingen gedaan om zowel de res-
pons als het gebruik te bevorderen. Inhoudelijke aanbevelingen ten aanzien van de 
interventie werden gebaseerd op het gebrek aan noemenswaardige effecten van de 
interventie. Hoewel de verbeteringen ten aanzien van werkvermogen minimaal 
waren, detecteerden subgroep analyses groepen gevoeliger voor een effect van de 
interventie. Doelgerichter inzetten van interventieonderdelen voor specifiek gevoe-
ligere groepen (‘targetten’) werd aanbevolen. Verbeteringen ten aanzien van de 
onderzoeksopzet werden ook aanbevolen op basis van de minimale effectiviteit van 
de interventie, vooral de marginale verschillen voor werkvermogen en de kwaliteit 
van leven. De relatieve bijdrage van kosten voor de patiënt en familie aan de totale 
kosten waren verwaarloosbaar, waardoor ook op basis van deze bevindingen aan-
bevelingen werden gedaan om verbeteringen door te voeren. Alvorens grootschalig 
onderzoek naar implementatie op te zetten, dragen pilot kosteneffectiviteit studies 
bij aan zowel inhoudelijke als methodologische inzichten om interventies in het 
veld van arbeid en gezondheidszorg te verbeteren.  
Deel III: Innovatieve inzetbaarheidsinterventies  
Hoofdstuk 8 beschreef de economische evaluatie van een innovatie gericht op de 
organisatorische aspecten die terugkeer naar arbeid beïnvloeden. De COSS-
interventie richtte zich op de verbeterde samenwerking tussen verzuimende werk-
nemers en hun werkgevers. Na zes maanden follow-up reduceerde verzuim (geme-
ten als initiële terugkeer naar werk) bij de werknemers in de interventiegroep met 
bijna 16 kalenderdagen en werd ongeveer €27 per dag bespaard door de werkher-
vatting. Vanuit organisatorisch oogpunt leverde de interventie (vergeleken met de 
controle conditie) netto- productiviteitswinst op van bijna €396 per werknemer.  
 Hoofdstuk 9 presenteerde korte-termijn resultaten van een inzetbaarheidsin-
terventie die klinische- en arbeidsgerelateerde zorg trachtte te optimaliseren. De 
interventie ondersteunde de arbeidsparticipatie van werknemers met reumatoïde 
artritis. Na zes maanden interim analyse bleek dat de interventie duurder en min-
der effectief (in termen van arbeidsproductiviteit en kwaliteit van leven) was dan 
de controle conditie. Momenteel worden nog data verzameld voor een langere ter-
mijn follow-up. 
 In hoofdstuk 10, werd een op maat gemaakt educatief trainingsprogramma 
voor huisartsen economisch geëvalueerd. Het doel van de interventie was het be-
wustzijn van huisartsen ten aanzien van werk gerelateerde gezondheidsproblemen 
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in de huisartsenpraktijk te verhogen en hiermee de werk gerelateerde ‘self-efficacy’ 
en de kwaliteit van leven voor patiënten in betaald werk te verhogen. Na een inte-
rim-analyse van zes maanden bleken de verschillen in effectiviteit tussen de inter-
ventiegroep en de gebruikelijke huisartsenzorg-groep minimaal te zijn. Momenteel 
worden nog data verzameld voor een langere termijn follow-up. 
Deel IV: Discussie 
De bevindingen van deze dissertatie boden oplossingsrichtingen voor diverse me-
thodologische uitdagingen binnen het complexe onderzoeksgebied van gezondheid 
op het werk. Daarnaast werden de resultaten van verschillende economische eva-
luaties bij inzetbaarheidsinterventie in de praktijk gepresenteerd en geïnterpre-
teerd. Hoewel de studies aantoonden dat de praktijk van arbeid en gezondheid zich 
niet zo gemakkelijk laat beïnvloeden, boden de (relatief positieve) economische 
evaluatie resultaten van de inzetbaarheidsinterventies toch diverse mogelijkheden 
voor de belanghebbenden. De resultaten van de studies beschreven in deze disser-
tatie kunnen onder andere onderzoekers, werknemers, werkgevers en beleidsma-
kers ondersteunen in het selecteren van inzetbaarheidsinterventies voor zowel 
verder onderzoek als implementatie in de praktijk. Een duidelijke uitwisseling tus-
sen wat belanghebbenden relevant vinden, inzicht in context-specifieke kenmerken 
van een interventie, en adequate meting en waardering voor zowel kosten als uit-
komsten, bleken essentieel. 
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Dankwoord 
De reis is ten einde. En wat een reis was me dat! Als gevolg ligt hier nu dit proef-
schrift én ontstond er een ‘nieuwe ik’. Ik heb enorm veel geleerd tijdens deze reis en 
besef maar al te goed dat ik deze eindbestemming nooit had kunnen bereiken zon-
der de hulp en steun van velen. Dit is de plek waarop ik jullie allen, mijn reisgezel-
len, uitgebreid wil bedanken.  
 
Allereerst en in het bijzonder, alle deelnemers aan het onderzoek. Zonder jullie 
input was dit nooit gelukt. Jullie bijdrage heeft niet alleen dit proefschrift tot stand 
gebracht, maar draagt er ook toe bij dat het werk werkbaar wordt voor vele andere 
werknemers met gezondheidsklachten. Ik ben er zeker van dat ik ook in hun naam 
mag spreken wanneer ik zeg: “bedankt!”  
 
Veel dank ook aan mijn promotor Prof. dr. Frans Nijhuis. Wat een enorm respect 
heb ik voor jouw optimistische kijk op de wereld. Daar kan ik nog veel van opste-
ken. Ook voor de manier waarop je met slechts een enkel woord tot anderen kan 
doordringen heb ik bewondering. Je bent gedurende dit traject een groot voorbeeld 
voor me geweest en kon heel goed aanvoelen wanneer ik ‘gesust’ moest worden. Ik 
ben je dan ook enorm dankbaar voor je vertrouwen in mij als onderzoeker. Ik zal 
altijd met veel waardering naar onze bijzondere samenwerking terugkijken.  
 
Ook mijn promotor Prof. dr. Silvia Evers wil ik bedanken voor onze samenwerking. 
Silvia, je liet me altijd vrij om mijn eigen weg te zoeken maar stuurde het schip ook 
weer bij wanneer ik de foute koers dreigde te gaan varen. Ik ben dankbaar dat ik 
samen met jou deze tocht mocht maken en kijk er naar uit om de komende jaren 
verder samen te werken. Naast onze ‘wetenschappelijke praatjes’ was er ook tijd 
voor gezelligheid. Die combinatie heb ik altijd erg prettig gevonden, net zoals onze 
samenwerking in zowel onderzoek als onderwijs. Bedankt ook voor je ‘open-
mindedheid’. Daarzonder had dat sollicitatie Skype-gesprek vanuit Colombia naar 
Nederland waarschijnlijk nooit plaatsgevonden. Dankjewel voor alle kansen die je 
me geeft en gegeven hebt! 
 
Dr. Angelique de Rijk, mijn copromotor. Ook jou wil ik van harte bedanken voor de 
samenwerking. Jouw kritische en analytische scherpte hebben mede mijn ‘nieuwe 
ik’ gevormd. Je hebt me geleerd altijd goed voor ogen te hebben waar ik heen wilde, 
welke input ik hiervoor nodig had en welke aanpak daar wellicht het best bij paste. 
Waar ik soms te zeer ging inzoomen op details zorgde jij er altijd voor dat ik nooit 
het grote geheel uit het oog verloor. Je hebt me altijd erg geholpen bij het structure-
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ren en onderbouwen van bevindingen. Ik wil je dan ook bedanken voor de moge-
lijkheden die je me gegeven hebt om mij breder te ontwikkelen, zeker ook op het 
gebied van onderwijs.  
Ik bedank ook graag de leden van de beoordelingscommissie voor het lezen en 
beoordelen van mijn thesis: Prof. dr. Andries de Grip, Prof. dr. IJmert Kant, Prof. dr. 
Werner Brouwer, Prof. dr. Carolyn Dewa, onder voorzitterschap van Prof. dr. Dirk 
Ruwaard.  
 
Hiernaast wil ik ook graag mijn dankbaarheid tonen aan het Stichting Instituut Gak 
voor het financieel mogelijk maken van dit onderzoek. In het bijzonder veel dank 
aan Dr. Boudien Krol en Prof. dr. Peter van Lieshout voor hun interesse en advies.  
 
Heel graag wil ik de collegae bedanken waarmee ik heb samengewerkt om de stu-
dies binnen dit onderzoekstraject tot een goed einde te brengen. Ik ben erg dank-
baar dat ik betrokken mocht zijn bij zoveel projecten en zoveel nieuwe mensen heb 
leren kennen. Jullie hebben mij allemaal binnen jullie eigen mogelijkheden gehol-
pen om dit resultaat te verwezenlijken. Ik hoop van harte dat we in latere stadia 
nog mogen samenwerken.  
 
De afdeling ‘Work and Social Psychology’ (Maastricht University): Dr. Gemma van 
Ruitenbeek en Prof. dr. Fred Zijlstra, bedankt voor het vertrouwen en de voortva-
rende samenwerking tijdens de economische evaluatie van jullie project. Jullie inzet 
voor wajongers is inspirerend. Ik wens jullie nog veel succes toe met deze en soort-
gelijke projecten. Mariëlla Muermans, dank voor de gezellige praatjes, maar ook 
voor alle hulp met sleutels, afspraken, en dergelijke.  
 
Prof. dr. Han Anema, dr. Cécile Boot en Myrthe van Vilsteren, jullie wil ik graag be-
danken voor de prettige samenwerking inzake het ‘Care for Work’-project waar we 
ook nog even mee doorgaan. Dank voor jullie vertrouwen in mij als onderzoeker en 
de snelle acties en reacties wanneer overleg nodig was.  
 
Het Trimbos Instituut. In het bijzonder wil ik Prof. dr. Filip Smit bedanken voor de 
begeleiding tijdens de analyses van het ‘Mental Vitality @ Work’-project. Je hebt me 
gedurende mijn Trimbos-tijd een enorm welkom gevoel gegeven. Je professionali-
teit en hartelijkheid zijn inspirerend. Ik waardeer enorm dat ik, ook nu nog, bij je 
kan aankloppen. Ik ben er zeker van dat je nog veel jonge onderzoekers zal inspire-
ren! Ook wil ik graag Odile, Joran, Eva, Linda, en alle andere ‘ Trimbossers’ bedan-
ken voor de bijzondere tijd die ik bij jullie heb doorgebracht. Ik heb enorm veel 
opgestoken tijdens mijn ‘verblijf’. Dank hiervoor!  
 
In het kader van het eerder genoemde ‘Mental Vitality @ Work’-project wil ik ook 
graag de dames uit het Coronel Insitituut voor Arbeid en Gezondheid bedanken. 
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dank ook voor de leuke gesprekken, over allerlei, ze werkten motiverend. Dr. Karen 
Nieuwenhuijsen en Prof. dr. Judith Sluiter, dankzij jullie oog voor detail verbeterden 
onze analyses en conceptartikelen.  
 
De Welder groep, en in het bijzonder Catrien, Bruno, Joost, Jenny en Kerst, bedankt 
voor de samenwerking. Ondanks de spreekwoordelijke beren op onze weg hebben 
we toch altijd het doorzettingsvermogen weten te behouden. Dankzij het transpa-
rante contact hebben we samen mooi wetenschappelijk onderzoek neergezet en 
een aantal mooie publicaties weten te schrijven.  
 
Kees de Kock, jou wil ik graag bedanken voor je inzet in zowel het ‘Huisartsen 
Werk’- project, de vele taxiritjes naar het station, maar ook voor je expertise en 
kennis. Jij hebt voorkomen dat ik eindeloos de werking van bepaalde medicijnen 
moest uitzoeken. Die telefonische afstemming was erg waardevol, en bovendien 
minder tijdrovend. Dank voor je hulp! Ook jou dr. Romy Steenbeek wil ik hier be-
danken voor de energie die je in het ‘Huisartsen Werk’-project hebt gestopt, voor de 
overleggen die je begeleidde en de leuke gesprekken (die dan bijna uitsluitend over 
paarden gingen). Prof. dr. Toine Lagro-Janssen en Prof. dr. André Knottnerus, harte-
lijk dank voor jullie input tijdens het schrijven van conceptartikelen en advies inza-
ke de analyses voor het ‘Huisartsen Werk’-project. Francine van den Driessen-
Mareeuw, mocht ik het in de mails nog niet genoeg benadrukt hebben: bedankt, en 
alvast bedankt, jouw hulp is onmisbaar.  
 
Voor het nog steeds lopende onderzoek inzake hartrevalidatie wil ik de partners 
vanuit het Maastricht UMC+ en Adelante Zorggroep bedanken voor hun medewer-
king aan het onderzoek. Vele handen hebben inderdaad lichter werk gemaakt. Bij-
zonder veel dank daarom aan Tjerkje, Bianca, Suzanne & Pia (MUMC+) en aan 
Yvonne, Kim & Jeroen (Adelante). Dr. Petra Kuijpers en Prof. dr. Rob Smeets dank 
voor jullie input tijdens het schrijven van de onderzoeksvoorstellen en de interesse 
tijdens het project. We gaan er wat moois van maken.  
 
Care for Companies: Roel Leeuwenburgh, dank voor het vertrouwen en de kansen 
die je me gegeven hebt. Helaas hebben we vaak nieuwe plannen moeten maken en 
is er vooralsnog niet meteen uitgerold wat we destijds voor ogen hadden. Toch 
hoop ik van harte dat we ergens weer een draadje kunnen oppikken en toch onze 
visies op papier krijgen. Joke, Linda, Sita, Edith, Erwin, Ton en Nienke: we hebben 
met mekaar erg gedreven geprobeerd het project van de grond te krijgen. Ik hoop 
dat we te zijner tijd opnieuw de draad kunnen oppakken en dat de meesten van 
jullie ook weer betrokken zullen zijn. Ik heb onze samenwerking altijd erg construc-
tief ervaren. Jullie maakten graag tijd voor me en ik heb me altijd erg welkom ge-
voeld in Zoetermeer, dank daarvoor!   
Fania en Sara: dank dat we allemaal analyses op jullie data mochten loslaten, en 
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De vakgroep Sociale Geneeskunde (Maastricht University). Voornamelijk voor de 
samenwerking met Dr. Inge Houkes en Dr. Nicole Hoefsmit ben ik erg dankbaar. 
Onze samenwerking reikt verder dan het ‘COSS’-project. Inge, bedankt dat je altijd 
interesse hebt getoond in mijn werk en dat we ook samen aan onderwijs bouwen. 
Je bent enorm benaderbaar en dat waardeer ik erg. Nicole, jij mag je sinds kort ook 
doctor noemen. Nogmaals gefeliciteerd! Ik vond het een grote eer je paranimf te 
zijn. Bedankt, voor je vertrouwen in mij als onderzoeker, als paranimf, als collega, 
als vriend. Verder wil ik iedereen binnen de vakgroep Sociale Geneeskunde bedan-
ken; bij jullie vakgroep voel ik me altijd welkom. Dank in het bijzonder aan Prof. dr. 
Hans Bosma en Prof. dr. Frans Feron voor jullie waardering van mijn inzet en het 
mede mogelijk maken van mijn postdoc. Jullie bijzondere kijk op het onderzoeksle-
ven, waarbij grapjes niet mogen ontbreken, werken erg motiverend. Ook Isel van 
Noppen wil ik graag bedanken. Lieve Isel, ik weet dat je alleen het dankwoord en de 
stellingen gaat lezen, dat heb je me al verklapt. Maar net zoals jij een ‘open boek’ 
bent is dit proefschrift het ook, lees gerust wat verder, het is best de moeite waard. 
Dank voor je hulp, het inplannen van afspraken, de vele telefoontjes, maar ook voor 
je persoonlijkheid. Wat ben jij een vrolijk mens! Houden zo, je weet me altijd op te 
beuren!  
 
Graag wil ik ook mijn collegae aan de vakgroep Health Services Research bedanken 
voor hun samenwerking en interesse in mijn onderzoek. Ik wil graag een bedankje 
richten aan iedereen, van junior tot senior. HSR lijkt wel een grote familie, met hier 
en daar een verre nicht of neef, maar altijd eentje waarop je kan rekenen.  
 
Een aantal HSR-collegae wil ik graag persoonlijk bedanken. Inge van der Putten, 
wat heb jij veel werk voor me uit handen weten nemen. Dank voor je inzet! Veel 
succes ook aan jou met de afronding van je promotietraject. Dr. Ghislaine van Ma-
strigt, dank voor de samenwerking op vele fronten, maar ook voor de momenten 
wanneer we niet over het werk praatten. Ik wens je veel succes met je projecten, en 
vergeet ook zeker niet te genieten van die mooie dochters van je! Dr. Mark Govers, 
dankzij jouw vertrouwen in mij ben ik een (Colombiaanse) ervaring rijker. Dat zal 
ik altijd blijven waarderen, net zoals ik de koffietjes altijd weet te waarderen (hoe-
wel we dan ook vaak stiekem wilden dat het koffieapparaat wijn tapte). Brigitte en 
Suus, merci! Jullie zijn al sinds BEOZ mijn toeverlaat als ik weer eens ergens tegen-
aan loop, of gewoon, even afleiding zoek. Jullie hebben een gouden hart! Ook Janet 
en Joanna, dank voor al jullie hulp, en alvast bedankt voor alle hulp die ik nog van 
jullie ga krijgen. Mitchel van Eeden, mijn BEOZ-kamergenootje. Dank voor zowel je 
luisterend oor als voor alle grappige momenten die we samen hebben doorge-
bracht. Ik wens je enorm veel succes met je nieuwe baan. Jij gaat dat ongelofelijk 
goed doen, ben ik zeker van! De meiden van kamer 0.044! Lieve dames, dank voor 
al jullie advies en vooral voor alle mooie momenten. Lieve Janneke, even was je 
toch ook een klein beetje Belg, net zoals ik een klein beetje Nederlander ben. Ik heb 
veel bewondering voor jouw doorzettingsvermogen en vastberadenheid, en voor 
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hoe je in het leven staat. Geniet van die twee prachtige kereltjes van je, en van de 
afronding van je promotietraject. Je gaat dat super doen. Lieve Arianne, bij jou voelt 
een mens zich toch gewoon goed. Ik heb enorm veel waardering voor jouw positie-
ve kijk op de wereld. Ik hou van die goedlachse wijze waarop jij door het leven gaat. 
Dat meisje van jullie treft het, jullie worden fantastische ouders! Lieve Reina, of 
lieve Dr. Reina ;-) Dank ook aan jou voor de leuke 0.044 momenten, en daarbuiten. 
Met jou in de buurt valt altijd wat te beleven. Ik heb veel bewondering voor de dui-
zendpoot die je bent. Ik heb me meteen ‘op mijn gemak’ gevoeld bij jou, ook wan-
neer de taalbarrière weer eens tot hilarische taferelen leidde. Kamer 0.044 dames, 
laten we ook na Maastricht contact houden! Lieve Joan, met jou klikte het onmid-
dellijk. Ik hou van die geen-blad-voor-de-mond attitude van jou, gewoon lekker zijn 
wie je bent. Ik bewonder je gedrevenheid. Jij kan bergen verzetten. Met jou aan mijn 
zijde komt het vast goed. Dankjewel dat je mijn paranimf wil zijn! 
 
De Academie Medische Vervolgopleidingen (Maastricht UMC+), wat een stel leuke 
collegae! Dr. Scheltus van Luijk, wij waren meteen een goed duo! Ik heb veel respect 
en bewondering voor jou, je werk en je kennis. Ik ben er zeker van dat jij me nog 
veel kan leren. Bedankt dat je me overal bij betrekt en dat je ervoor zorgt dat ik 
mezelf blijf uitdagen. Prof. dr. Laurents Stassen, ook aan jou woorden van dank. 
Dank voor je vertrouwen in mij. Ondanks je drukke agenda weet ik dat ik altijd bij 
je terecht kan. Ik waardeer je toegankelijkheid en heb veel bewondering voor hoe jij 
je taken combineert en mensen weet te inspireren. Ook de dames: Danny, Suzanne, 
Marie-José, Nicole, Anouk, Yvonne en Marleen, bedankt voor jullie interesse in mijn 
proefschrift, mijn werk en mijn leven. En bedankt vooral voor jullie bekwaamheid, 
hulp en adviezen. Ik voel me al helemaal op mijn plek in het ziekenhuis. Bedankt 
dat jullie me meteen zo een warm en vertrouwd gevoel hebben gegeven! Wat zijn 
jullie gezellig!  
 
Ook de collegae van KEMTA (Maastricht UMC+) die ik nu veel vaker zie nu we een 
gang en een koffiezetapparaat delen, bedankt voor jullie interesse in mijn werk. In 
het bijzonder Dr. Brigitte Essers, bij jou kan ik altijd aankloppen! Ik vind de ge-
sprekken met jou altijd erg inspirerend en motiverend. Prof. dr. Carmen Diriksen en 
Dr. Manuela Joore, bedankt om jullie expertise te delen en me in deze fase van mijn 
carrière ook bij te staan met waardevol advies. Ik kijk er alvast naar uit om met 
KEMTA samen te werken. Dr. Jill Bindels en Dr. Bram Ramaekers, ook jullie zie ik 
ondertussen weer wat vaker. Het is altijd erg gezellig wanneer we elkaar treffen. 
Bedankt voor de mooie verhalen die we met elkaar delen.  
 
The CIHR Strategic Training Program In Work Disability Prevention. A special 
thank you word to Prof. dr. Patrick Loisel who made it possible for me to be part of 
such an inspiring group of researchers. Dear Sandra Knol, thank you for everything 
you did to help me arrange my yearly visits to Canada. Your presence and assis-
tance was of tremendous value. I think I can speak on behalf of every WDPI-trainee 
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when I say: ‘you are a wonderful person!’ Many thanks also to Dr. William Shaw and 
Dr. Ellen McEachen for acting as my mentors during the optional courses. I learned 
a lot from working with both of you. Also a huge thank you to the whole group of 
inspiring trainers and trainees. I feel privileged to know and to have worked with 
you. A special thanks to Dr. Sheilah Hogg-Johnson, Prof. dr. Emile Tompa, Prof. dr. 
Carolyn Dewa, Prof. dr. Ute Bultman, Dr. Christian Stahl, Dr. Freek Lotters, Dr. Juli-
ette (Archie) Cooper, Prof. dr. Glenn Pransky, Dr. Katia Costa-Black, Dr. Philippe 
Mairiaux, you are truly an inspiration.  
 
My WDPI-cohort. What a wonderful, enriching experience that was! Three years in 
a row: Toronto, with the most amazing group of people I’ve ever worked with. One 
by one you guys have amazing personalities. I feel blessed to have met you all, and 
above all, to be able to call you all my friends! Asa, Emilie, Mette, Ulrik: my Scandi-
navian friends. Thank you guys so much, for all the wonderful moments we have 
spent. Genevieve and Susan, my wonderful Australian friends. A very special thank 
you is in place here, not only for the lovely moments we have spent, the funny 
things we have did, the great experiences we shared, but also for your help in writ-
ing this thesis. Thank you both so much for the English editing of parts of this the-
sis, your advices and your comments. I’m so looking forward to come and visit you 
both in Australia! I promise, one day I’ll be at your doorstep. Dear Daniella, the 
sweetest Brazilian girl I have ever met. You have such a warm personality. Do we 
share some great memories! I know for sure that whenever I want to ‘escape’ Eu-
rope, there will be a place for me to stay in Brazil. Thank you! Sweet ‘Dutchies’: 
Hardy en Martine. I feel so fortunate to have met you guys. From the first moment 
we met, we connected. We share the same interests and never run out of things to 
talk about. It feels like I know you for ages. Martine, never lose that beautiful spon-
taneity of yours.  
 
In het bijzonder wil ik ook graag An & Stefan bedanken. Ik weet dat ik altijd op jullie 
mag rekenen, bedankt voor jullie steun en vertrouwen. Verder ook veel dank aan de 
‘tuttenclub’: Loe & Mariette, Mariet, Ine & Harry, voor de heerlijke etentjes en de 
gezellige momenten. Merci voor jullie interesse in mijn werk. Ook Martin & Maria, 
Guido & Rochelio, veel dank!  
 
In dit dankwoord wil ik ook graag mijn vele vrienden bedanken die, soms intens en 
soms wat meer vanaf de zijlijn, met dit werk hebben meegeleefd. Zonder mijn 
vrienden zou ik nooit gestaan hebben waar ik nu sta en zou dit vooral een erg saaie 
reis geweest zijn. Ik wil iedereen daarom uit de grond van mijn hart bedanken voor 
de interesse maar vooral ook voor de afleiding. Het leven is heel erg de moeite 
waard met jullie erin! Een spreekwoord zegt: ‘Het leven is één groot feest, je moet 
alleen zelf de slingers ophangen.’ Wat kunnen wij goed slingers ophangen!  
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Lieve Waltwilder-vrienden: de meeste van jullie ken ik via de KLJ, een heerlijke tijd. 
Nooit zal ik onze hilarische momenten beleven. Ik kijk er enorm naar uit om samen 
nog meer geschiedenis te schrijven. In het bijzonder: Dennis, Ann, Giel & Elien, Da-
vid & Lien, Tom & Anneke, Els & Wannes, Elke & Jan, en natuurlijk alle andere 
KLJ’ers, MERCI!  
 
Lieve Eigenbilzen-vrienden: Chantal & Stefan, Daisy & Robby, Tonia & Matti, Viv’ke 
& Guido, Mario & Geert, Robert & Diane, Rudi & Alinda, Peter, Johnny & Lizzy, Chris-
tel & Frank ook aan jullie ‘ne dikke merci’. Bedankt voor alle mooie momenten sa-
men, we gaan er nog meer memorabele maken!  
 
Lieve stallèrkes: Kevin & Sylvia, Kenneth & Dorien, Lexie, Heleen & Kim, Joyce, Hen-
kie, Robrecht & Els, Stijn & Carolina, Yannick, wat zijn we een leuk clubke! Merci 
voor de fantastische momenten die we al hebben mogen delen, en merci ook voor 
jullie interesse in mijn werk. Hier is het dus, het is af   
 
Lieve vrienden, jullie zijn stuk voor stuk van onbeschrijfelijke waarde voor mij! 
Graag wil ik hier de gelegenheid nemen om een aantal van jullie in het bijzonder in 
het zonnetje te zetten.  
 
Els, wat een mooie cover is het geworden! Ik ben ‘super-content’, ge zijt een talent! 
Bedankt, echt!  
 
Anneke & Luc, Hanne & Kristof, wat zijn jullie schatten van vrienden. Met jullie heb 
ik altijd plezier. Ik zou me serieus geen raad weten moest onze vriendschap ophou-
den te bestaan. Wat hecht ik veel aan jullie. Jullie hebben het hart op de juiste 
plaats, en bovendien, dat hart van jullie kleurt ook nog eens goud! Merci lieverds!  
 
Veerle & Kevin, wat ben ik graag bij jullie. De positieve, goedlachse ‘vibe’ die jullie 
uitstralen werkt aanstekelijk. Merci voor alle interesse die jullie getoond hebben, de 
leuke gesprekken en leuke momenten die we delen, en natuurlijk ook voor het ‘me-
terschap’ van Coopertje   
 
Joyce en Roberto, een prachtig koppel. Met jullie is het fun verzekerd! Joske, verlies 
nooit die mooie, spontane, praatgrage persoonlijkheid van jou, ik waardeer ‘m 
enorm!  
 
Nick, mijn maatje! Ik heb veel bewondering voor hoe jij in het leven staat, voor alle 
stappen die je al hebt gezet en voor alle plannen die je maakt. Ondanks de afstand 
weet ik dat ik altijd op u kan rekenen, en weet dat dat wederzijds is. Ik wens u echt 
het allerbeste toe, een leven vol liefde en geluk. In Bilzen, Londen of Australië, you’ll 
always be my best friend!  
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Steven, wat gaan wij ver terug in de tijd. Een onvoorwaardelijke vriendschap, ook al 
zijn we ongeveer 200 km van mekaar verwijderd. Ik heb veel bewondering voor jou 
als werkpaard, liefdevolle partner voor Miriam en ongelofelijk tedere vader voor 
jullie liefste schat Sven. Het is hartverwarmend om te zien wat een warm en hecht 
gezin jullie zijn. Ik heb me dan ook altijd enorm thuis gevoeld bij jullie in Drieber-
gen. Bedankt ook Miriam dat je me zo nauw weet te betrekken bij de grote stappen 
die lief Svennetje al zet!  
 
Ellen & Herwig, ook voor onze vriendschap ben ik bijzonder dankbaar! De slingers 
blijven nog wel een tijdje hangen ;-) Liefste Ellen, ik kijk enorm uit naar jullie huwe-
lijk en voel me erg vereerd dat ik je getuige mag zijn. Bedankt voor alle mooie mo-
menten, en vooral ook voor de liefde en vriendschap die ik van je krijg!  
 
Sara & Kim, Harold & Paula, jullie maken dit mede mogelijk. Misschien zonder het 
goed en wel te beseffen, maar zonder jullie hulp zou ik never-te-nooit op mijn ge-
mak zijn wanneer ik ergens hoog in Nederland of ver overzee ben. Dank dat ik altijd 
op jullie mag vertrouwen en op jullie mag rekenen. Daarom, ook in naam van mijn 
allerliefste schat Astar: ‘ne welgemeende dikke merci!  
 
Lieve Carmen, lieve Katrien, lieve Chloé, mijn rotsen in de branding, my girls. Wat 
ben ik dankbaar voor jullie in mijn leven. Laten we voor altijd vriendinnen blijven!  
 
Lieve Carmen, onze humor reikt verder dan de meesten kunnen begrijpen. Je bent 
een heerlijke vriendin: goedlachs, met een luisterend oor en altijd in-for-a-party. De 
herinneringen die wij delen, de momenten die wij beleefd hebben, onze schaterbui-
en, onze fratsen, wat een heerlijk leven is het met jou erin! We spreken één ding af: 
laten we nooit volwassen worden!  
 
Lieve Katrien, we kennen elkaar al van toen we kleine pagadderkes waren, ganse 
dagen gespendeerd op de manege. Het verrijkt mijn leven te weten dat ik altijd, no-
matter-what, op jou kan rekenen. Ik heb enorm veel bewondering voor je wils-
kracht en de manier waarop je in het leven staat. Je weet wat je wil, en daar ga je 
voor. Kaatje, ik hecht immens veel waarde aan onze vriendschap, en onze eeuwige 
gesprekken over honden en paarden  wat delen wij bijzondere momenten samen. 
Stelling 10 is voor ons!  
 
Liefste Chloé, wat gaan ook wij ver terug in de tijd. En wat hebben wij al veel avon-
turen beleefd! Ook al laat je buitenkant dat niet altijd uitschijnen, je hebt echt een 
klein, gouden hartje. Je staat altijd voor me klaar en nooit is je wat te veel. Je bent 
mijn reddertje in nood, mijn afleiding, mijn rots! Het geeft me veel vertrouwen te 
weten dat je naast me staat tijdens mijn verdediging: bedankt dat je altijd in me 
bent blijven geloven! Gij en ik tegen de wereld!  
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Graag wil ik ook in dit dankwoord mijn schoonfamilie bedanken. Dankjewel tant 
Paulette, bompa, Elviera, Kirsten, en de liefste tweeling van de wereld: Ties & Stien, 
voor alle mooie momenten die we de afgelopen jaren al hebben beleefd. Vooral ook 
heel veel dank voor jullie interesse en medeleven in dit werk. Het is af  Lieve Ties 
& Stien, ik ben blij dat ik jullie “tante’ke” ben mogen worden. Ik geniet ervan jullie 
te zien opgroeien!  
 
Liefste schoonouders, Teejoo & Viviane: onbeschrijflijk veel dank voor alles wat 
jullie voor mij, voor ons, doen. Ik waardeer enorm dat jullie altijd voor ons klaar 
staan en dat jullie mij een tweede thuis hebben gegeven! Met jullie kan ik over alles 
praten en vooral ook heel veel plezier maken. Ik prijs me enorm gelukkig dat ik 
zulke lieve, joviale en sociale schoonouders heb mogen treffen. Ik hou van jullie!  
 
Lieve familie “papa’s kant”: tant Miet, nonk Gerard, Johnny, Vicky, Lucy & Amy, Jan, 
Stephanie, Kristel, Kenny, en lief vechtertje Lobke. Het geeft me veel vertrouwen te 
weten dat ik ook altijd op jullie mag rekenen. Bedankt voor jullie interesse in mijn 
werk en voor de fijne momenten die we delen. Lieve Kristel en Kenny, ik heb veel 
respect voor de manier waarop jullie zijn blijven doorzetten. Jullie zijn fantastische 
ouders, Lobke had niet beter kunnen treffen! Ik ben trots op jullie.  
 
Familie “mama’s kant”: Lieve nonk Eric, tant Monique en Bart, bij jullie voel ik me 
altijd welkom. Bedankt voor de hechte band die we hebben en de leuke tijden die 
we samen beleven. Lieve Ingrid, Fons, Steven & Yana en Koen, dank jullie wel voor 
alle grappige, leuke en bijzondere momenten die wij samen gespendeerd hebben. 
Lieve Steven en Koen, jullie zijn mijn favoriete neefjes, dat weten jullie toch hé (niet 
tegen Bart zeggen hoor ). Tata’ke, wat een bijzonder lieve tante jij bent. Jij staat 
altijd voor me klaar en ik weet dat je enorm trots op me bent. Dankjewel voor alle 
liefde die je me geeft! Bonke en Bonnemie, mijn grootouders. Kijk, dit is nu waar ik 
zo lang aan heb gewerkt. Ik weet dat jullie ook zonder dit boekje heel erg trots op 
me zijn en dat doet me goed! In het bijzonder wil ik bonnemie bedanken, mijn me-
ter. Ook uwe naam pronkt op dit boek! Ge zijt een sterke vrouw waaraan ik weet 
wat ik heb. Lieve bonnemie, ik hoop uit de grond van mijn hart dat ge nooit zult 
opgeven en dat ge altijd zult proberen aan mijn zijde te staan. Ik wil nog heel wat 
mijlpalen zetten en kan me niet voorstellen dat gij daar niet bij zou zijn. Met u in de 
buurt is het nooit saai, wat moet ik altijd lachen met uw ‘fratsen’. Lieve bonnemie, 
lieve familie, ik hou van jullie, onvoorwaardelijk veel!  
 
De volgende dankwoorden richt ik graag aan mijn ouders en broertje. Jullie zijn van 
onschatbare waarde voor mij. Jullie geven mijn leven kleur en betekenis, en ik kan 
me geen betere ouders voorstellen! Ik ben enorm dankbaar dat ondanks het feit dat 
jullie, mama en papa, niet meer bij mekaar zijn, wel altijd als één front achter me 
zijn blijven staan. Vele ouders zouden aan jullie een voorbeeld mogen nemen!  
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Lieve papa, jij bent de lijm die ons samenhoudt, onze steun en toeverlaat. Ik heb 
veel respect voor u papa. Voor de manier waarop je altijd positief probeert te blij-
ven, hoe hard het leven soms ook voor je is. Bedankt dat je altijd voor me klaar 
staat. Ik waardeer enorm dat je me altijd goede raad weet te geven en dat je altijd 
het beste met me voor hebt, ook al wil ik dat soms niet meteen inzien. Papa, ik hou 
van u! Lieve Brigitte, ook voor u alleen maar liefde. De band die wij hebben is erg 
bijzonder, en vooral onbreekbaar. Je bent een tweede mama voor me. Ik heb enorm 
veel respect voor uw doorzettingsvermogen en wilskracht. Je bent een sterke en 
dappere vrouw en ik kijk enorm naar je op. Het vult mijn hart te zien hoe goed je 
bent voor mij, voor papa en voor Niek. Dankjewel lieve Brigitte! Niek, lieve Niek, 
mijn kleine broertje. Wat gaat de tijd snel! 15 word je al bijna. Ik herinner me nog 
zo goed toen ik je voor de eerste keer in mijn armen hield. Ik ben een trotse zus en 
een trotse meter! Je bent een lieve kerel, met het hart op de juiste plaats! Ik hoop 
dat je weet dat ik altijd voor je klaar zal staan en dat je altijd bij me terecht kan. Je 
blijft toch mijn ‘kleine broertje’. Ik hou van je!  
 
Lieve mamie, mijn grote voorbeeld, mijn eeuwige steun en toeverlaat, dit boek 
draag ik op aan jou. Jij bent altijd in mij blijven geloven, ook wanneer ik dat zelf niet 
meer deed. Bedankt voor je onvoorwaardelijke liefde. Ik ben erg dankbaar dat je me 
vrij hebt gelaten om mijn eigen weg te zoeken, maar vooral ook dat je me altijd bent 
blijven steunen, zelfs wanneer ik de weg even kwijt was. Mamie, ik weet dat je het 
soms moeilijk had wanneer ik weer eens voor een tijdje naar het buitenland ging, 
maar kijk, het is helemaal goed gekomen. Veel dank dat je me alle kansen hebt laten 
grijpen, ook al moest je daar zelf soms wat voor laten. Mocht ik later nog maar half 
zo een goede mama worden dan jij bent, dan zal ik nog de beste zijn. Ik kan me echt 
geen betere mama voorstellen. Je bent onmisbaar in mijn leven! Wij blijven vriend-
jes, jij en ik, tot de laatste snik! Ik hou van u!  
 
Liefje, jou bewaarde ik tot de laatste. Ik zou inderdaad zo opnieuw 300 pagina’s 
kunnen vullen met hoeveel jij voor me betekent ;-) Ik bewonder je spontane ka-
rakter en vind het heerlijk hoe jij me laat lachen. Bedankt dat je me andere perspec-
tieven hebt leren waarderen en me soms uit mijn ‘comfort-zone’ haalt. Jij maakt van 
mij een beter mens. De kaft van dit boek, strak en in hoogglans wit, heb ik voor jou 
uitgekozen (misschien toch een goed idee voor onze keuken later). Het is bijzonder 
hoe wij mekaar aanvullen en het geeft me een heerlijk gevoel te weten dat je me 
graag ziet. Sinds jij in mijn leven bent is het compleet. Lieve Wim, onze reis is nog 
lang niet ten einde, je bent de man van mijn leven, ik wil voor altijd bij je blijven. Ik 
hou van je, tot aan de maan en terug!  
 
 
Bilzen, 8 mei 2015  
  
 301 
Curriculum Vitae 
 
Cindy Noben was born in Tongeren, Belgium, on June 1st, 1986. After completing 
her secondary education she studied General Health Sciences at Maastricht Univer-
sity for which she obtained her bachelor degree in 2009. During the bachelor 
(2008) she was enrolled in the Erasmus Exchange Program to participate in Ad-
vanced Courses for Research in Public Health at Mälardalen University, Västerås, 
Sweden.  
 In September 2009 Cindy enrolled in the master program Health Policy, Eco-
nomics and Management at Maastricht University. During the master she conduct-
ed field research at Hospital Universitario Mayor Méderi, Bogotá, Colombia and 
combined this work with finishing her master thesis at Universidad del Rosario, 
Bogotá, Colombia.  
 After obtaining her master’s degree in August 2010, she started working as a 
PhD candidate at the research school CAPHRI, department Health Services Re-
search of Maastricht University. Cindy enrolled in the large research project enti-
tled ‘Arbeid & Zorg’ funded by the Dutch Foundation Institute Gak. During her PhD 
trajectory she got involved in various research projects and working groups. From 
2012 to 2014, she got granted to enroll in the CIHR Strategic Training Program in 
Work Disability Prevention at the University of Toronto, Dalla Lana School of Public 
Health, Canada. Cindy was also appointed as an external researcher at the Nether-
lands Institute of Mental Health and Addiction (the Trimbos Institute) from Sep-
tember 2012 until May 2013. Aside from her research activities she performed 
various educational roles such as tutor, trainer and lecturer within the bachelor and 
master programs in Health Sciences offered at Maastricht’s Faculty of Health, Medi-
cine and Life Sciences. 
 Since October 2014, Cindy works in a post-doc function at CAPHRI within the 
research programs ‘Health Technology Assessment’ and ‘Social Participation and 
Health’ of Maastricht University. She is currently involved as a module planning 
group member of the course on Health Policy General Principles Applied to Local 
Settings offered within the bachelor program General Health Sciences, and as a 
planning group member of the Master program Work, Health and Career. Cindy 
currently also functions as region coordinator (South-East Netherlands) at the 
Maastricht School of Post Graduate Medical Education of the Maastricht University 
Medical Centre.  
  
  
 303 
Scientific 
contributions, 
grants & awards 
Scientific journal contributions 
Publications  
° Cindy Noben, Frans Nijhuis, Angelique de Rijk, Silvia Evers. Design of a trial-
based economic evaluation on the cost-effectiveness of employability interven-
tions among work disabled employees or employees at risk of work disability: The 
CASE-study. BMC Public Health. 2012; 12(1):43 
° Cindy Noben, Filip Smit, Karen Nieuwenhuijsen, Sarah Ketelaar, Fania Gärtner, 
Brigitte Boon, Judith Sluiter, Silvia Evers. Comparative cost-effectiveness of two 
interventions for improving work functioning among nurses: pragmatic cluster 
randomised trial. International Journal of Nursing Studies. 2014, 51:10. 
° Cindy Noben, Silvia Evers, Frans Nijhuis, Angelique de Rijk. Quality appraisal of 
generic self-reported instruments measuring health-related productivity changes: 
A systematic review. BMC Public Health. 2014, 14:115.  
° Ben Wijnen, Inge van der Putten, Siebren Groothuis, Reina de Kinderen, Cindy 
Noben, Aggie Paulus, Bram Ramaekers, Gaston Vogel, Michael Hiligsmann. Dis-
crete-Choice Experiment versus Rating Scale Exercise to Evaluate the Relative 
Importance of Attributes. Expert Review of Pharmacoeconomics & Outcomes 
Research. 2015;1-8. 
° Cindy Noben, Filip Smit, Karen Nieuwenhuijsen, Sarah Ketelaar, Fania Gärtner, 
Judith Sluiter, Silvia Evers. Protecting and promoting mental health of nurses in 
the hospital setting: Is it cost-effective from an employer's perspective? Accepted 
for publication by International Journal of Occupational Medicine and Envi-
ronmental Health 
Revised submissions 
° Cindy Noben, Angelique de Rijk, Frans Nijhuis, Jan Kottner, Silvia Evers. Patient 
self-reported and administrative data used for cost estimations of healthcare re-
source use: A systematic review of methodological quality and validation evi-
dence. Journal of Clinical Epidemiology (first revision) 
S C I E N T I F I C  C O N T R I B U T I O N S ,  G R A N T S  &  A W A R D S  
 304
° Cindy Noben, Silvia Evers, Frans Nijhuis, Joost van Genabeek, Angelique de 
Rijk. A pilot economic evaluation to improve a web-based employability interven-
tion for employees. Journal of Occupational Health (first revision) 
° Cindy Noben, Nicole Hoefsmit, Silvia Evers, Angelique de Rijk, Inge Houkes, 
Frans Nijhuis. Economic evaluation of a new organizational RTW intervention to 
improve Cooperation between Sick-listed employees and their Supervisors (COSS): 
A field study. Journal of Occupational and Environmental Medicine (first revi-
sion) 
Submissions 
° Nicole Hoefsmit, Inge Houkes, Nicolle Boumans, Cindy Noben, Bjorn Winkens, 
Frans Nijhuis. The effectiveness of an intervention to enhance cooperation be-
tween sick-listed employees and their supervisors (COSS). Journal of Occupational 
Rehabilitation.  
Other publications 
Reports 
° In Dutch: Eindrapportage Wajongproject “Een passende baan bij het Slotervaart-
ziekenhuis”. Maastricht University, 2014. Gemma van Ruitenbeek, Marike Mul-
der, Philippe Nelissen, Ghislaine van Mastrigt, Cindy Noben, Silvia Evers, Fred 
Zijlstra & Frans Nijhuis. 
° In Dutch: Biedt inzicht uitzicht? Verslag van een onderzoek naar het gebruik van 
de interventie ‘Wijzer met Welder’ door een groep leden van CNV Publieke Zaak. 
TNO Hoofddorp, 2014. Joost van Genabeek, Cindy Noben, Bram Rooijackers, 
Maartje Bakhuys Roozeboom, Jenny Huijs, Karen Oud Hengel, Anneke Huson, 
Agnes Meershoek & Angelique de Rijk.   
° In Dutch: Onderzoeksprogramma Arbeid & Gezondheidszorg: Inspiratie voor 
werkconferentie ‘geïntegreerde arbeidsgerelateerde zorg’. KPMG Plexus, 2015. 
David Ikkersheim, Frans Nijhuis, Romy Steenbeek, Femke van der Voort, Nicoe 
Hoefsmit, Cindy Noben, Kees de Kock & Myrthe van Vilsteren.  
Daily journal 
° In Dutch: ‘’Wajonger bespaart bedrijf geld’’. De Volkskrant, October 29th 2014. 
Based on report “Een passende baan bij het Slotervaartziekenhuis”. 
Newsletter webpage 
° In Dutch: “Aandacht voor psychische gezondheid werknemer loont”. Trimbos 
nieuws, May 2nd 2013. Based on “Comparative cost-effectiveness of two interven-
tions for improving work functioning among nurses: pragmatic cluster random-
ised trial”.  
 
S C I E N T I F I C  C O N T R I B U T I O N S ,  G R A N T S  &  A W A R D S  
 305 
Scientific conference contributions  
Organized sessions  
° Cindy Noben, Bram Ramaekers, Joanna Thorn, Silvia Evers, William Holling-
worth. Methodological Challenges in Healthcare Resource Use Measurement: 
Towards Developing Good Practice. Topical Seminar at the international Health 
Economics Association/European Conference of Health Economics, 10th World 
Congress. July 14 – 16, 2014, Dublin, Ireland.  
° Cindy Noben, Silvia Evers, Angelique de Rijk, Frans Nijhuis. Employees’ respon-
sibilities in work disability prevention – could they? (2014). Topical Seminar at 
the Third Scientific Conference on Work Disability Prevention and Integration. 
September 29 – October 1, 2014, Toronto, Canada. 
Presentations  
° Cindy Noben. Werkhervatting bij hartpatiënten. Invited speaker at ‘Continuous 
Nursing Education’ door de Nederlandse Vereniging voor Hart- en Vaat Ver-
pleegkundigen (NVHVV). 21 april 2015. Utrecht, Nederland. 
° Cindy Noben, Angelique de Rijk, Frans Nijhuis, Silvia Evers. Self-report methods 
to assess costs: how valid are they? (2012) Gaceta Sanitaria vol. 26 – Especial 
Congreso 2 – Junio 2012, Bilbao, Spain. 
° Cindy Noben, Silvia Evers, Angelique de Rijk, Frans Nijhuis. Systematic review 
of generic self-reported health-related workplace productivity loss instruments 
(2012) Gaceta Sanitaria vol. 26 – Especial Congreso 2 – Junio 2012, Bilbao, 
Spain. 
° Cindy Noben, Frans Nijhuis, Angelique de Rijk, Silvia Evers. Design of a trial-
based economic evaluation on the cost-effectiveness of employability interven-
tions among work disabled employees or employees at risk of work disability: The 
CASE-study (2012). Gaceta Sanitaria vol. 26 – Especial Congreso 2 – Junio 2012, 
Bilbao, Spain.  
° Cindy Noben, Silvia Evers, Frans Nijhuis, Angelique de Rijk. Quality appraisal of 
generic self-reported instruments measuring health-related productivity changes: 
A systematic review. Progress in health economics, 9th European conference on 
health economics (ECHE), July 2012, Zürich, Switzerland. 
 
Poster presentations 
° The CASE-study: cost effectiveness sustainable employability (Maastricht Uni-
versity, CAPHRI research meeting, the Netherlands. September 2011) 
° Cost effectiveness of return to work interventions (RTWi): A research protocol 
(Maastricht University, CAPHRI research meeting, the Netherlands. April 2012) 
 
 
S C I E N T I F I C  C O N T R I B U T I O N S ,  G R A N T S  &  A W A R D S  
 306
° Comparative cost effectiveness of two interventions for improving work func-
tioning among nurses: pragmatic cluster randomized trial (Xth ENMESH inter-
national conference mental health care in Europe, Verona, Italy. October 3-5, 
2013) 
Grant  
° Honored trainee at the “Work Disability Prevention CIHR Strategic Training 
Program”, University of Toronto, Dalla Lana School of Public Health, Canada 
Award 
° Award for Best Poster at the Xth ENMESH international conference mental 
health care in Europe, Verona, Italy. October 5th 2013. “Comparative cost-
effectiveness of two interventions for improving work functioning among nurses: 
pragmatic cluster randomised trial”  

